Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Linkesch Werner |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Lerch K, Leng C, Pinto A, Linkesch W, Sill H, Linden O, Viardot A, Keller U, Hess G, Lastoria S, Frigeri F, Neik N, Pott C, Scholz CW and Pezzutto A 90Yttrium-Ibritumomab Tiuxetan as First Line Treatment for Follicular Non-Hodgkin Lymphoma. 5 Year Results from an International Multicenter Phase II Clinical Trial
Blood. 2016; 128(22):-Annual Meeting of the American Society of Hematology; December 2016; San Diego, FL. [Poster]

 

Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
CL LYMPH MYELOM LEUK. 2015; 15: S183-S183. [Oral Communication]
Web of Science

 

Guilaksen, SE; Skavland, J; Warzocha, K; Gavasso, S; Tosevski, V; Thielen, N; Voglova, J; Ferrant, A; Linkesch, W; Thaler, J; Lang, A; Stentoft, J; Cedde-Dahl, T; Hjorth-Hansen, H; Majeed, W; Verhoef, G; Hellmann, A; Mihaylov, GG; Dumrese, C; Giles, F; Hochhaus, A; Sopper, S; Stenke, L; Labar, B; Janssen, J; Porkka, K; Ossenkoppele, GJ; Mustjoki, S; Wolf, D; Gjertsen, BT Single-Cell Immune Signatures in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Treated with Nilotinib: An ENEST1st Sub Study
BLOOD. 2015; 126(23):
Web of Science

 

Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic Stem Cell Transplantation in patients with acute myeloid leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
ONCOL RES TREAT. 2014; 37: 134-134. [Poster]
Web of Science

 

Giannotti,F; Ruggeri,A; Deconinck,E; Mohty,M; Michalet,M; Sanz,G; Chevalier,P; Gahri,JY; Legrand,F; Rovina,M; Passweg,J; Cornelissen,JSierra,JNguyen,S; Maillard,M; Yahoub-Agha,I; Linkesch,W; Connel,P; Marcatti,M; Bay,JO; Rocha,V; Kröger,N; Gluckman,E; Olavarria,E; Robin,M Unrelated Cord Blood Transplantation in Adults with Primary and secondary Myelofibrosis: A retrospective study on behalf of Eurocord and CMWP-EBMT
Bone Marrow Transplantation. 2014; 49(Suppl1):58-59.-40th Annual Meeting of the European Blood and Marrow Transplantation Group; March 28 to April 2, 2914; Milano, Italia. [Oral Communication]

 

Linkesch, W The role of autologous stemcell Transplantation in PCNSL
Current Concepts in Primary CNS Lymphoma; May 9, 2014; Wien, Austria. 2014. [Keynote lecture]

 

Linkesch, W Neuere Entwicklungen in der Behandlung von hämatologischen Neoplasien
Medizinisch-Wissenschaftliche Gesellschaft für Kärnten und Osttirol; JULI 3, 2014; Klagenfurt, AUSTRIA. 2014. [Keynote lecture]

 

Linkesch, W Allogene Stammzelltransplantationen aus Nabelschnurblut bei Erwachsenen
Symposium des Berufsverbandes Österreichischer Gynäkologen "Stammzellen aus Nabelschnurblut "; März 28, 2014; Graz, Austria. 2014. [Keynote lecture]

 

Noesslinger, T; Moestl, M; Tinchon, C; Koller, E; Linkesch, W; Keil, F Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin's Lymphoma
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.3982.3982
Web of Science FullText FullText_MUG

 

Nösslinger,T; Möstl,M; Koller,E; Tinchon,C; Mulabecirovic,A; Linkesch,W; Sallaberger,E; Hundsamer,A; Keil,F Autologous Stem Cell Transplantation with BeEAM in aggressive NHL and Hodgkin"sLymphoma
Bone Marrow Transplantation. 2014; 49(Suppl1):167-168.-40th Annual Meeting of the European Blood and Marrow Transplantation Group; March 28 to April 2, 2914; Milano, Italia. [Poster]

 

Pascal,L; Tucunduva,L; Ruggeri,A; Blaise,D; Mohty,M; Fegueux,N; Chevalier,P;Cornelissen,J; Maillard,N; Milpied,N; Petersen,E; Linkesch,W; Sengeloev,H; Kenzey,C; Gluckman, E; Rocha,V; Yakoub-Agha,J and EUROCORD and EBMT Impact of Rabbit Anti-Thymocyte Globulin-Containing Reduced Intensity Conditioning Regimens on Outcomes of Adults undergoing Unrelated Cord Blood Transplantation for Haematological Malignancies
Bone Marrow Transplantation. 2014; 49(Suppl1):78-79.-40th Annual Meeting of the European Blood and Marrow Transplantation Group; March 28 to April 2, 2914; Milano, Italia. [Oral Communication]

 

Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.2284.2284
Web of Science FullText FullText_MUG

 

Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
BLOOD. 2014; 124(21):
Web of Science

 

Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstoker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.3681.3681
Web of Science FullText FullText_MUG

 

Sezer,O; Beksac,M; Hajek,R; Sucak,G; Cacirgan,S; Linkesch,W; Akay, OM; Armbrecht,G; Plesner,T; Snowden,JA; Nahi,H; Gulbas,Z; Potamianou,A; Couturier,C; Olie,R; Feys,C; Allietta,N; Terpos,E Effects of single-Agent Bortezomib as posttransplant Consolidation on Multiple Myeloma-related Bone Didease; First Results from a Multicenter,randomized Phase 2 Study
Haematologica. 2014; 99(S1):362-362.-19th Congress of the European Hematology Association; June 12-15, 2014; Milan, ITALY. [Poster]
Web of Science

 

Abdyli, L; Van de Caerin, C; Huber-Krassnitzer, B; Troppan, K; Theiler, G; Linkesch, W; Multizentrische, einarmige Studie mit Pomalidomid in Kombination mit niedrig dosiertem Dexamethason bei Patienten mit refraktärem und/oder relapsiertem Multiplen Myelom.
Memo. 2013; 06(1/13):22-22.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B; Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S393-S393. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013) [Poster]
Web of Science

 

Cerny-Reiterer, S; Herndlhofer, S; Stefanzl, G; Blatt, K; Hoermann, G; Muellauer, L; Beham-Schmid, C; Baumgartner, S; Sperr, W; Mannhalter, C; Linkesch, W; Valent, P The BCR/ABL Tyrosine Kinase Inhibitor Imatinib produces profound mast cell deficiency in Chronic Myeloid Leukemia
Haematologica. 2013; 98(1):293-293.-18th Congress of the European Hematology Association; JUN 13-16, 2013; Stockholm, SWEDEN. [Poster]

 

Cerny-Reiterer, S; Herndlhofer, S; Stefanzl, G; Blatt, K; Hörmann, G; Müllauer, L; Beham-Schmid, C; Baumgartner, S; Sperr, WR; Mannhalter, C; Linkesch, W; Valent, P; The BCR/ABL tyrosine kinase inhibitor imatinib produces profound mast cell deficiency in chronic myeloid leukemia
Memo. 2013; 06(1/13):24-24.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Cerny-Reiterer, S; Herndlhofer, S; Stefanzl, G; Blatt, K; Hormann, G; Mullauer, L; Beham-Schmid, C; Baumgartner, S; Sperr, WSR; Mannhalter, C; Linkesch, W; Valent, P The tyrosine kinase inhibitor (TKI) imatinib produces mast cell deficiency in Ph plus chronic myeloid leukemia
ONKOLOGIE. 2013; 36: 63-63. [Oral Communication]
Web of Science

 

Cerny-Reiterer, S; Herndlhofer, S; Stefanzl, G; Blatt, K; Hörmann, G; Müllauer, L; Beham-Schmid, C; Baumgartner, S; Sperr, WSR; Mannhalter, C; Linkesch, W; Valent, P Imatinib induziert eine ausgeprägte Mastztell-Defizienz in Patienten mit Chronisch Myeloischer Leukämie / The tyrosine kinase inhibitor (TKI) imatinib produces mast cell deficiency in Ph+ chronic myeloid leukemia
Onkologie. 2013; P219--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 18-22, 2013; Vienna, AUSTRIA. [Poster]

 

Cerny-Reiterer,S;Rabenhorst,A;Stefanzl,G;Herndlhofer,S;Blatt,K;Hoermann,G;Müllauer,L;Baumgartner,S;Beham-Schmid,C;Sperr,W;Linkesch,W;Mannhalter,C;Arock,M;Hartmann,K;Valent,P Imatinib inhibits SCF induced Development of human Mast Cells in vitro and induces profound and selective Mast Cell Deficiency in Patients with Phpos. CML
BLOOD. 2013; 12(21):3988-3988.-55th Annual Meeting of the American Society of Hematology; Dez 7-10, 2013; New Orleans, USA. [Poster]

 

Hopfinger, G; Noesslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Greil, R Lenalidomid in combination with Vorinostat and Dexamethasone in relapsed/refractory peripheral T-cell Lymphoma (PTCL): Safety Analysis of the PTCL-1 Trial of the AGMT
Hematological ONCOLOGY. 2013; 31(1):242-243.-12th International Conference on Malignant Lymphoma; JUN 19-22, 2013; Lugano, SWITZERLAND. [Poster]

 

Huber-Krassnitzer, B; Troppan, K; Abdyli, L; Theiler, G; Van de Caerin, C; Linkesch, W; Randomisierte, doppelt-verblindete Parallelstudie zum Vergleich von Fidaxomicin mit Vancomycin bei Patienten mit Clostridium difficile Infektion unter immunsuppressiver Therapie.
Memo . 2013; 06(1/13):23-23.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Kqiku, X; Kovacs, G; Abdyli, L; Reitter, S; Linkesch, W; Olschewski, H Screening for early pulmonary vascular changes in patients with chronic myeloproliferative disorders
ONKOLOGIE. 2013; 36: 64-64. [Poster]
Web of Science

 

Kqiku, X; Kovacs, G; Abdyli, L; Reitter, S; Linkesch, W; Olschewski, H Suchtest auf frühe pulmonale vaskuläre Veränderungen bei Patienten mit chronischen myeloproliferativen Erkrankungen / Screening for early pulmonary vascular changes in patients with chronic myeloproliferative disorders
Onkologie. 2013; P224--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 18-22, 2013; Vienna, AUSTRIA. [Poster]

 

Lindner, B; Nachbaur, D; Linkesch, W; Krieger, O; Peters, C; Zojer, N; Russ, G; Koller, E; Urban, C; Isak, E; Buxhofer-Ausch, V; Greul, R; Greinix, H on behalf of the Austrian Stem Cell Transplantation Working Group A closer look at registry data: MED-A reporting in Austria in the years 2000 to 2011
Bone Marrow Transplantation. 2013; 48 (suppl 2): S 507-S 507.-39th Annual Meeting of the European Group for Blood and Marrow Transplantation; APR 7-10, 2013; London, UK. [Poster]

 

Linkesch, W CML - Heilung nach Absetzen der Therapie?
12. Onkologisch Wintergespräche; Jan 19, 2013; Wien, AUSTRIA. 2013. [Keynote lecture]

 

Linkesch, W Successful story of targeted treatment in CML
Romanian Society of Hematology; OCT, 9-11, 2013; Sanaia, ROMANIA. 2013. [Keynote lecture]

 

Linkesch, W Abstoßungsreaktion bei allogener Stammzelltransplantation / Graft versus Host Disease
Onkologie. 2013; V109--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 18-22, 2013; Vienna, AUSTRIA. [Oral Communication]

 

Linkesch, W Graft versus Host Disease
ONKOLOGIE. 2013; 36: 24-24. [Keynote lecture]
Web of Science

 

Linkesch, W CMK - Heilung nach Absetzen der Therapie?
12. Onkologisch Wintergespräche; Jan 19, 2013; Wien, AUSTRIA. 2013. [Keynote lecture]

 

Linkesch, W; Zinke-Cerwenka, W; Wölfler, A; Sill, H; Neumeister, P Allogene Nabelschnurtransplantation mit niedrig-dosiertem ATG bei Erwachsenen / UCBT with low-dose ATG in adult patients
Onkologie. 2013; P460--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 18-22, 2013; Vienna, AUSTRIA. [Oral Communication]

 

Linkesch, W; Zinke-Cerwenka, W; Wolfler, A; Still, H; Neumeister, P UCBT with low-dose ATG in adult patients
ONKOLOGIE. 2013; 36: 127-128. [Poster]
Web of Science

 

Linkesch,W Neue Immunsuppressiva zur GVHD Therapie
27th Meeting of Austrotransplant; OKT 23-25, 2013; Mayrhofen, AUSTRIA. 2013. [Keynote lecture]

 

Ludwig, H; Rauch, E; Zdenek, A; Kasparu, H; Greil, R; Leitgeb, C; Weißmann, A; Autzinger, E; Linkesch, W; Kuehr, T; Pour, L; Zojer, N Toxicity Profile during Treatment with Bendamustin-Bortezomib-Dexamethasone in Patients with relapsed/refractory Multiple Myeloma
Haematologica. 2013; 98(1):338-339.-18th Congress of the European Hematology Association; JUN 13-16, 2013; Stockholm, SWEDEN. [Poster]

 

Noesslinger, T; Keil, F; Moestl, M; Tinchon, C; Koller, E; Mulabecirovic, A; Unteregger, MJ; Hundsamer, A; Sallaberger, E; Linkesch, W Autologous Stem Cell Transplantation with BEAM (Bendamustin, Etoposide, Cytarabine, Melphalan) in aggressive NHL and Hodgkin Lymphoma
Hematological ONCOLOGY. 2013; 31(1):260-260.-12th International Conference on Malignant Lymphoma; JUN 19-22, 2013; Lugano, SWITZERLAND. [Poster]

 

Noesslinger, T; Keil, F; Mostl, M; Tinchon, C; Koller, E; Mulabecirovic, A; Unteregger, MJ; Hundsamer, A; Sallaberger, E; Linkesch, W Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma
ONKOLOGIE. 2013; 36: 7-7.-Jahrestagung der Österr. ,Deutschen und Schweizer Gesellschaften für Hämatologie und OnkologieOKT; OKT 15-16, 2013; Wien, Austria. [Poster]
Web of Science

 

Noesslinger, T; Keil, F; Möstl, M; Tinchon, C; Koller, E; Mulabecirovic, A; Unteregger, MJ; Hundsamer, A; Sallaberger, E; Linkesch, W Autologe Stammzelltransplantation mit BeEAM (Bendamustin, Etoposid, Cytarabin, Melphalan) bei aggressiven NHL und Hodgkin Lymphomen / Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma.
Onkologie. 2013; V36--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 18-22, 2013; Vienna, AUSTRIA. [Oral Communication]

 

Nösslinger,T;Möstl,M;Unteregger,M;Tinchon,Ch;Koller,E;Mulacebirovic,A;Hundsamer,A;Sallaberger,E;Linkesch,W;Keil,F Autologe Stammzelltransplantation mit BeEAM(Bendamustin, Etoposid,Cytarabin, Melphalan bei lymphatischen Systemerkrankungen
European Surgery. 2013; 45(Suppl3):17-17.-27th Meeting of Austrotransplant; OKT 23-25,2013; Mayrhofen, AUSTRIA. [Poster]

 

Pascal,LB;Tucunduva,L;Riggeri,A;Blaise,D;Mohty,M;Ceballos,P;Chevallier,P;Cornelissen,J;Maillard,N;Tabrizi,R;Petersen,EJ;Linkesch,W;Sengeolev,H;Kenzey,C;Gluckman,E;Rocha,V;Yakoub-Agha,I; Impact of Rabbit ATG-containing Reduced-Intensity-Conditioning Regimens on Outcomes of Adults undergoing Unrelated Cord Blood Transplantation for Haemarological Malignancies
Blood. 2013; 12(21):412-412.-55th Annual Meeting of the American Society of Hematology; Dez 7-10, 2013; New Orleans, USA. [Oral Communication]

 

Robin,M;Giannotti,F;Deconinck,E;Mohty,M;Michallet,M;Sanz,G;Chevallier,P;Cahn,YJ;Legrand,F;Rovira,M;Passweg,J;Cornelissen,J;Sierre,J;Nguyev,S;Maillard,N;Yakoub-Agha,I;Linkesch,W;Cannell,P;Marcatti,M;Bay,JO;Rocha,V;Kröger,N;Gluckman,E;Olavarria,E;Ruggeri,A Outcomes afterUnrelated Cord Blood Transplantation for Adults with Primary or secondary Myelofibrosis. A retrospective study on behalf of Eurocord and Chronic Malignancy Working Party-EBMT
Blood. 2013; 12(21):2156-2156.-55th Annual Meeting of rhe American Society of Hematokogy; Dez 7-10, 2013; New Orleans, USA. [Poster]

 

Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlogl, E; Fridrik, M; Krieger, O; Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Hausler, C; Woll, E; Oexle, H; Schnallinger, M; Pober, M; Rochau, U; Siebert, U; Thaler, J; Gastl, G Updated report of the Austrian CML registry
ONKOLOGIE. 2013; 36: 63-63.-Jahrestagung der Österr., Deutschen und Schweizer Gesellschaften für Hämatologie und Onkolofie; OKT 15-16, 2013; Wien, Austria. [Poster]
Web of Science

 

Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlögl, E; Fridrik, M; Krieger, O, Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Häusler, C; Wöll, E; Oexle, H, Schnallinger, M, Pober, M; Rochau, U; Siebert, U; Thaler, J; Gastl, G Jährlicher Report des österreichischen CML-Registers / Updated report of the Austrian CML registry
Onkologie. 2013; P220--Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 18-22, 2013; Vienna, AUSTRIA. [Poster]

 

Sopper, S; Mustjoki, S; Loskog, A; Gjertsen, B; Greil, R; Lang, A; Linkesch, W; Thaler, J; Gedde-Dahl, T; Hjort-Hansen, H; Majeed, M; Lotfi, K; Richter, J; Lehman, S; Stenke, L; Olsson-Strömberg, U; Stentoft, J; Schattenberg, A; Posthuma, E; Smit, W; Vellenga, E; Verhoef, G; Ferrant, A; van Droogenbroeck, J; Mark, U; Haenig, J; Jurjonas, Ni; Gastl, G; Giles, F; Hochhaus, A; Ossenkoppele, G; Porkka, K; Wolf, D Modulation of Leukocyte Population during First Line Treatment with Nilotinib in early Chronic Phase CML - First Results from the ENEST1st Sub-Study CAMN107EIC01
Haematologica. 2013; 98(1):301-301.-18th Congress of the European Hematology Association; JUN 13-16, 2013; Stockholm, SWEDEN. [Poster]

 

Sopper, S; Mustojki, S; Loskog, A; Gjertsen, BJ; Greil, R; Lang, A; Linkesch, W; Thaler, J; Gedde-Thal, T; Hjorth-Hansen, H; Majeed, W; Lofti, K; Richter, J; Lehman, S; Stenke, L; Olsson-Strömberg, U; Stentoft, J; Posthuma, W; Smit, W; Vellenga, E; Verhoef, G; Ferrant, A; Van Droogenbroeck, J; Mark, U; Haenig, J; Jurjonas, N; Gastl, G; Giles, F; Hochhaus, A; Ossenkoppele, GJ; Porkka, K; Wolf, D Immune Monitoring in Patients with early chronic Phase chronic Myelogenous Leukemia treated with frontline Nilotinib
BLOOD. 2013; 12(21):2731-2731.-55th Annual Meeting of the American Society of Hematology; Dez 7-10, 2013; New Orleans, USA. [Poster]

 

Theiler, G; Troppan, K; Abdyli, L; Huber-Krassnitzer, B; Van de Caerin, C; Linkesch, W; Ibrutinib versus Ofatumumab bei Patienten mit relapsierter oder refraktärer chronischer lymphatischer Leukämie/small lymphocytic lymphoma (Phase-III-Studie).
Memo. 2013; 06(1/13):22-22.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Troppan, K; Abdyli, L; Huber-Krassnitzer, B; Van de Caerin, C; Theiler, G; Linkesch, W; Randomisierte, doppelblinde Phase-III-Studie, die orales MLN9708 plus Lenalidomid/Dexamethason versus Placebo plus Lenalidomid/Dexamethason bei erwachsenen Patienten mit relapsiertem/refraktärem Multiplen Myelom vergleicht.
Memo. 2013; 06(1/13):21-21.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Troppan, K; Valentin, A; Linkesch, W 90-Yttrium-Ibritumomab-Tiuxetan as First-Line Therapy or as Consolidation Treatment in advanced stage Follicukar NHL: Longterm results after a median follow-up of 61 months
BLOOD. 2013; 122(21):5123--55th Annual Meeting of the American Society of Hematology; Dez 7-10, 2013; New Orleans, USA.

 

Troppan, K; Van de Caerin, C; Theiler, G; Abdyli, L; Huber-Krassnitzer, B; Linkesch, W; Eine randomisierte, zweiarmige Phase-III-Studie, die Alisertib versus Pralatrexat/Gemcitabine bei Patienten mit relapsierten oder refraktären peripheren T-Zell Lymphomen vergleicht.
Memo. 2013; 06(1/13):20-20.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Tucunduva, L; Ruggeri, A; Sanz, G; Furst, S; Cornelissen, J; Linkesch, W; Mannone, L; Ribera, JM; Montesinos, P; Gluckman, E; Mohty, M; Rocha, V; Risk factors and outcomes after umbilical cord blood transplant for adults with Philadelphia positive acute lymphoblastic leukaemia and impact of minimal residual disease before transplant.
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S42-S42. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013) [Oral Communication]
Web of Science

 

Van de Caerin, C; Huber-Krassnitzer, B; Theiler, G; Abdyli, L; Troppan, K; Linkesch, W; Randomisierte, doppelblinde, multizentrische Studie, die Densoumab versus Zoledronsäure (Zometa) bei Patienten mit neu diagnostiziertem Multiplem Myelom und Knochenbeteiligung vergleicht.
Memo. 2013; 06(1/13):21-21.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Van de Caerin, C; Theiler, G; Huber-Krassnitzer, B; Troppan, K; Abdyli, L; Linkesch, W; Phase-II-Studie, die den Effekt von Spiegelmer NOX-H94 auf chronische Anämie bei Patienten mit Multiplem Myelom oder Lymphom untersuchen soll.
Memo. 2013; 06(1/13):20-20.-Frühjahrstagung ÖGHO; Apr 18-20, 2013; Linz. [Poster]

 

Wenzl, K; Troppan, K; Deutsch, AJA, Linkesch, W; Neumeister, P, Beham-Schmid, C Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas
Proceedings of 55th ASH Annual Meeting. 2013; -55th ASH Annual Meeting; December 7-10, 2013 ; New Orleans.
FullText

 

Wenzl, K; Troppan, K; Deutsch, AJA; Linkesch, W; Neumeister, P; Beham-Schmid, C; Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas.
BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013) Doi: 10.1182/blood.V122.21.4852.4852
Web of Science FullText FullText_MUG

 

Wenzl,K;Troppan,K;Deutsch,A;Linkesch,W;Neumeister,P;Beham-schmid,Ch Distinct Chemokine Receptor Profile in Chronic Lymphocyte Leukemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared to Germinal Center B Cells and de novo Diffuse Large B Cell Lymphomas
BLOOD. 2013; 122(21):4852--55th Annual Meeting of the American Society of Hematology; Dez 7-10, 2013; New Orleans, USA.

 

Wolf, D; Skavland, J; Seger, C; Sopper, S; Jedrzejczak, W; Sertic, D; Voglova, J; Mustjoki, S; Stenke, L; Ferrant, A; Greil, R; Lang, A; Thaler, J; Linkesch, W; Duletic-Nacinovic, A; Hellmann, A; Mihaylov, G; Gedde-Dahl, T; Hjort-Hansen, H; Majeed, M; Stentoft, J; Verhoef, G; van Droogenbroeck, J; Mark, U; Haenig, J; Jurjonas, Ni; Lion, T; Gastl, G; Giles, F; Hochhaus, A; Porkka, K; Ossenkoppele, G; Gjertsen, B Pharmacokinetic and -dynamic Monitoring during first line treatment with Nilotinib in early chronic phase CML-First Results from the ENEST1st Sub Study CAMN107EIC01
Haematologica. 2013; 98(1):296-296.-18th Congress of the European Hematology Association; JUN 13-16, 2013; Stockholm, SWEDEN. [Poster]

 

Wolf,D;Skavland,J;Seger,C;Sopper,S;Jedrzejczak,WW;Sertic,D;Voglova,J;Mustojki,S;Stenke,L;Ferrant,A;Greil,R;Lang,A;Thaler,J;Linkesch,W;DuleticJurrjonas;,N;Giles,F;Hochhaus,A;Porkka,K;Ossenkoppele,HJ;Gjertsen,BT-Nacinivic,A;Hellmann,A;Mihaylov,G;Gedde-Dahl,I;Hjorth-Hansen,H;Majeed,W;Stentoft,J;Verhoef,G;Van Droegenbroeck,J;Mark,U;Haenig,J; Early PK Analysis predicts Molecular Response in Patients with early Chronic Phase Chronic Myelogenous Leukemia treated with frontline Nilotinib
Blood. 2013; 12(21):1485-1485.-55th Annual Meeting of rhe American Society of Hematology; Dez7-10, 2013; New Orleans, USA. [Poster]

 

Zinke-Cerwenka, W; Troppan, K; Beham-Schmid, C; Pucher, F; Linkesch, W; Neumeister, P Brentuximab Vedotin is an effective Treatment of Classical Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder
Haematologica. 2013; 98(1):572-572.-18th Congress of the European Hematology Association; JUN 13-16, 2013; Stockholm, SWEDEN. [Poster]

 

Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic stem cell transplantation in patients with acute myeloid leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
European Surgery. 2012; 44(246):16-16.-26. Tagung der Österreichischen Gesellschaft für Transplantation, Transfusion und Genetik; OCT 17-19, 2012; Rust. [Oral Communication]

 

Hofmann, N; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Frühwirth, M; Beham-Schmid, C; Linkesch, W; Andreeff, M; Strunk, D Neo-vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells.
Magazine of European medical oncology Suppl 01/12. 2012; 2-3.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2007; Graz, Austria. [Keynote lecture]

 

Hofmann, NA; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Fruewirth, M; Beham-Schmid, C; Linkesch, W; Andreef, M; Strunk, D Novel role of oxygen sensing mesenchymal stem/progenitor cells as initiators of neo-vasculogenesis in vivo.
Haematologica. 2012; 1 (2012)(97(s1)):481-482.-17th Congress of EHA; JUN 14-17, 2012; Amsterdam, NETHERLANDS. [Oral Communication]

 

Hofmann, NA; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Frühwirt, M; Liechtenstein, N; Beham-Schmid, C; Linkesch, W; Andreeff, M; Strunk, D A Novel Role for Mesenchymal Stem / Progenitor Cells As Hypoxia Sensors During Initiation of Neo-Vasculogenesis in Vivo.
Blood. 2012; 120(21):613-613.-54th ASH Annual Meeting and Exposition; DEC 8-11, 2012; San Diego, USA. [Keynote lecture]

 

Hofmann, NA; Ortner, A; Jacamo, R; Reinisch, A; Schallmoser, K; Rohban, R; Frühwirth, M; Beham-Schmid, C; Linkesch, W; Andreeff, M; Strunk, D Neo-Vasculogenesis in vivo is promoted by oxygen sensing mesenchymal stem and progenitor cells.
2012 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology.. 2012; 5(1):2-3.-ÖGHO; APR 12-14, 2012; Graz, AUSTRIA. [Oral Communication]

 

Keil, F; Nosslinger, T; Unteregger, MJ; Mostl, M; Tinchon, C; Koller, E; Mulabecirovic, A; Hundsamer, A; Linkesch, W; Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma.
ONKOLOGIE. 2012; 35: 42-42.-Gemeinsame Jahrestagung der Deutschen, Österr. Und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 19.23 ,2012; Stuttgart. [Poster]
Web of Science

 

Linkesch, W Mabthera- Update
Fortbildungssymposium LKH Fürstenfeld; MÄRZ 28, 2012; Fürstenfeld. 2012. [Keynote lecture]

 

Linkesch, W Stellenwert der allogenen Stammzelltransplantation
Symposium MDS - Neue Daten, Fakten, Standards; NOV 9- 10, 2012; Fuschlsee-Salzburg, AUSTRIA. 2012. [Keynote lecture]

 

Linkesch, W CML.Heilung ante portas
43.Jahrestagung der ÖGIM; SEP 22-29, 2012; Graz, AUSTRIA. 2012. [Keynote lecture]

 

Linkesch, W CML - Heilung ante portas?
43. Jahrestagung der Österr. Gesellschaft für Innere Medizin; SEP 20-22, 2012; Graz, Austria. 2012. [Keynote lecture]

 

Linkesch, W Chronische Myeloische Leukämie-Experimentelle Therapie und Zukunftskonzepte
Abstract Book. 2012; 21-21.-1. Zentral-Europäische Konferenz über Personalisierte Medizin; AUG 31-SEP 1, 2012; VIENNA, AUSTRIA. [Keynote lecture]

 

Linkesch, W Management der Nebenwirkungen der MM-Therapie
9.Symposium Multiples Myelom und Lymphome; Juni 23, 2012; Wien, AUSTRIA. 2012. [Keynote lecture]

 

Linkesch, W Follikuläres Lymphom
9.Symposium Multiples Myelom und Lymphome; Juni 23, 2012; Wien, AUSTRIA. 2012. [Keynote lecture]

 

Linkesch, W Problem Blutkrebs-Chronische Myeloische Leukämie Ursachen, Risikofaktoren und moderne Behandlungsformen
Mini Med Studium; MÄRZ, 15, 2012; Graz, Austria. 2012. [Keynote lecture]

 

Linkesch, W Stammzelltransplantation
Symposium; MÄRZ, 14, 2012; Technische Universität Graz. 2012. [Keynote lecture]

 

Linkesch, W Neues in der Hämatologie
Hämatologie- Onkologie Tage; NOV 2-3, 2012; Linz. 2012. [Keynote lecture]

 

Linkesch, W Konditionierungsdaten von Bendamustin bem Multiplen Myelom
Satelliten Symposium-Jahrestagung der Deutschen, Österr. und Schweizerischen Gesellschaften füt Hämatologie und Onkologie; OKT,19-23, 2012; Stuttgart. 2012. [Keynote lecture]

 

Linkesch, W Effekte auf die chronische GVHD bei verschiedenen Stammzelltransplantations.Arten
Symposium: Neue Perspektiven in der Stammzelltransplantation; OKT 11-12, 2012; Leutschach. 2012. [Keynote lecture]

 

Linkesch, W Fortschritte in der Therapie des Lymphoms und des MM
Symposium Serlbsthilfegruppe Lymphom und Myelom; FEB 7, 2010; Graz, AUSTRIA. 2012. [Keynote lecture]

 

Linkesch, W Bone Marrow Failure
Post- ASH Symposium; Jan 13, 2012; Salzburg, AUSTRIA. 2012. [Keynote lecture]

 

Linkesch, W Prophylaxis of febrile Neutropenia with G-CSF
Symposium Institute of Oncology; OCT 1, 2012; Ljubljana, SLOWENIA. 2012. [Keynote lecture]

 

Linkesch, W Chronische Myeloische Therapie-Etablierte personalisierte Therapie
Abstract Book. 2012; 20-20.-1. Zentral-Europäische Konferenz über Personalisierte Medizin; AUG 31-SEP 1, 2012; VIENNA, AUSTRIA. [Keynote lecture]

 

Linkesch, W Alternative Transplantationsstrategien; Cord blood, haploident oder beides?
Frühjahrstagung der ÖGHO; APR 12-14, 2012; Graz, Austria. 2012. [Keynote lecture]

 

Linkesch, W Therapie von Non-Hodgkin Lymphomen - Update
Frühjahrstagung der ÖGHO; APR 12-14, 2012; Graz, Austria. 2012. [Keynote lecture]

 

Linkesch, W Applikation von Wachstumsfaktoren-Update
Symposium Institut für Onkologie; APR 16, 2012; Ljubljana, SLOWENIA. 2012. [Keynote lecture]

 

Linkesch, W Role of ATG-Fresenius for GVHD prevention in different stem cell transplant settings
Future perspectives based on 30 years of experience; MAY 11-12, 2012; Warsaw, POLAND. 2012. [Keynote lecture]

 

Ludwig, H; Kasparu, H; Greil, R; Leitgeb, C; Muldur, E; Rauch, E; Zojer, N; Autzinger, EM; Linkesch, W; Kuhr, T; Pour, L; Adam, Z; Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012) Doi: 10.1182/blood.V120.21.943.943 [Keynote lecture]
Web of Science FullText FullText_MUG

 

Ludwig, H; Kasparu, H; Greil, R; Leitgeb, C; Muldur, E; Rauch, E; Zojer, N; Autzinger, EM; Linkesch, W; Kuhr, T; Pour, L; Adam, Z; Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA. [Poster]
Web of Science

 

Ludwig, H; Kasparu, H; Leitgeb, C; Greil, R; Rauch, E; Linkesch, W; Zojer, N; Pour, L; Fillitz, M; Adam, Z Impact of number of previous treatment lines and pre-treatment with Bortezomib or Lenalidomid on efficacy of Bortezomib-Bendamustin-Dexamethasone (BBD) in patients with relapsed/refractory Multiple Myeloma (MM).
Annals of Oncology. 2012; 23(9):348-349.-37th ESMO Congress; SEP 28-OCT 2, 2012; VIENNA, AUSTRIA. (ISBN: 1569-8041 ) [Oral Communication]
Web of Science

 

Ludwig, H; Pour, L; Kasparu, H; Greil, R; Linkesch, W; Thaler, J; Leitgeb, C; Rauch, E; Heintel, D; Zojer, N; Weissmann, A; Adam, Z Bortezomib-Bendamustine-Dexamethasone (BBD) in patients with relapsed/refractory myeloma and different risk profiles namely, cytogenetics, previous exposure to bortezomib or to lenalidomide.
Haematologica. 2012; 1 (2012)(97(s1)):347-347.-17th Congress of EHA; JUN 14-17, 2012; Amsterdam, NETHERLANDS. [Poster]

 

Nickelsen,M;Canals,C;Schmitz,N;Dreger,P;Kyriakou,C;Buzyn,A;Engelhardt,M;Relander,T;Linkesch,W;Koza,V;Meloni,G;Caballero,D;Lopez Giuillermo,A;Indrac,K;Wandt,H;Theorin,N;Glass,B;Wulf,G;Conde,E;Socie,G;Sureda,A EBMT Experience in T-cell Lymphoma
Proceedings of the 5th T-cell Forum 2012. 2012; 7-7.-T-Cell Lymphoma Forum; JAN 26- 28, 2012; San Francisco, USA. [Keynote lecture]

 

Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlogl, E; Fridrik, M; Krieger, O; Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Hausler, C; Woll, E; Oexle, H; Schnallinger, M; Andel, J; Geissler, D; Pober, M; Eisterer, W; Thaler, J; Gastl, G; Updated report of the Austrian CML registry.
ONKOLOGIE. 2012; 35: 50-50.-Jahrestagung de DÖGHO; OKT 19-23, 2012; Stuttgart. [Poster]
Web of Science

 

Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlögl, E; Fridrik, M; Krieger, O; Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Häusler, C; Wöll, E; Oexle, H; Schnallinger, M; Andel, J; Geissler, D; Pober, M; Eisterer, W; Thaler, J; Gastl, G; ASHO CML registry Register-report des österreichischen CML-Registers
Onkologie. 2012; 6/2012: 12-12.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart. [Poster]

 

Schmidt,St;Mader,S;Rochau,U;Burgstaller,S;Linkesch,W et all. Updated Report of the Austrian CMJ Registry
Proceedings of the EPIRARE. 2012; 12-12.-Internat. Workshop °Rare Diseases and Orphan Drug Registries"; OKT 5 2012; Milano, Italien. [Oral Communication]

 

Sormann, S; Bauer, F; Linkesch, W; Update from the myeloma registry of the University Hospital Graz - impact of new drugs on disease management in the transplant setting.
ONKOLOGIE. 2012; 35: 146-146.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart. [Poster]
Web of Science

 

Stojakovic, T; Zinke-Cerwenka, W; Unteregger, M; Truschnig-Wilders, M; Linkesch, W Comparison of two assays for serum free light chain kappa and lambda using polyclonal and monoclonal antibodies.
Clin Chem Lab Med. 2012; 50(9):A259-A259.-9th Annual Meeting of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL); SEP 26-29, 2012; Mannheim, GERMANY. [Poster]

 

Stojakovic, T; Zinke-Cerwenka, W; Unteregger, M; Truschnig-Wilders, M; Linkesch, W Vergleich zweier Methoden zur Bestimmung der freien Leichtketten Kappa und Lambda im Serum mit polyklonalen und monoklonalen Antikörpern.
Onkologie. 2012; 35(S6):142-142.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

Troch, M; Kiesewetter, B; Willenbacher, W; Willenbacher, E; Zebisch, A; Linkesch, W; Fridrik, MA; Müllauer, L; Greil, R; Raderer, M Rituximab plus subcutaneous Cladribine in patients with extranodal marginal zone B-cell Lymphoma of the Mucosa associated tissue (MALT-Lymphoma): A Phase II study by the AGMT
Annals of Oncology. 2012; 23(9):352-352.-37th ESMO Congress; SEP 28-OCT 2, 2012; VIENNA, AUSTRIA. (ISBN: 1569-8041 ) [Poster]
Web of Science

 

Troppan, K; Van de Caerin, C; Unteregger, M; Linkesch, W A randomized, controlled, double-blind phase III trial to compare the efficacy, safety and pharmacokinetics of GP2013 plus CVP vs. MabThera plus CVP, followed by GP2013 or MabThera maintenance therapy in patients with previously untreated, advanced stage follicular lympoma.
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Troppan, K; Van de Caerin, C; Unteregger, M; Linkesch, W A phase IIIb, single-arm study of Mabthera SC (subcutaneous rituximab) induction + maintenance therapy in patients with relapsed, indolent non-Hodgkin's lymphoma
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Unteregger, M; Troppan, K; Van der Caerin, C; Linkesch, W An open label, multicenter study investigating the saftety and efficacy of ofatumumab therapy versus physician`s choice in patients with bulky fludarabin refractory chronic lymphocytic leukemia (CLL).
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Unteregger, M; Troppan, K; Van der Caerin, C; Linkesch, W Ofatumumab versus rituximab salvage chemoimmunotherapy followed by ASCT in relapsed or refractory DLBCL
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Unteregger, M; Valentin, A; Linkesch, W; Sill, H; Wölfler, A Therapy-related myeloid neoplasms versus myeloid neoplasms following a primary malignancy treated with surgery alone.
Magazine of european medical oncology Suppl 01/12. 2012; 9-9.-Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2007; Graz, Austria. [Poster]

 

Valentin, A; Unteregger, M; Troppan, K; Zinke-Cerwenka, W; Cerroni, L; Linkesch, W; Neumeister, P; Unrelated stem cell transplantation induces long term disease control in patients with blastic plasmocytoid dendritic cell neoplasm.
ONKOLOGIE. 2012; 35: 212-213.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart. [Poster]
Web of Science

 

Valentin, A; Unteregger, MJ; Troppan, K; Zinke-Cerwenka, W; Cerroni, L; Linkesch, W; Neumeister, P Krankheitsfreies Langzeitüberleben durch allogene Fremdspenderstammzelltransplantation bei Patienten mit Blastisch Plasmozytoid Dendritischer Zellneoplasie
Onkologie. 2012; 6/2012: 11-11.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart. [Poster]

 

Van de Caerin, C; Unteregger, M; Troppan, K; Linkesch, W An open-label, multicenter, expanded access study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF).
Frühjahrstagung 2012 der Österreichischen Gesellschaft für Hämotologie & Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Zinke-Cerwenka, W; Valentin, A; Beham-Schmid, C; Eibl: Linkesch, W ; Neumeister, P Autologous Stem Cell Transplantation in T-Cell Non-Hodgkin´s Lymphoma- Long Term Follow-Up
Proceedings of COHEM. 2012; -2. World Congress in Controversies in Hematology; SEP 6-8,2912; Barcelona, SPAIN. [Poster]

 

Al-Ali, HK; le Coutre, P; Duyster, J; Linkesch, W; Wolf, D; Schanz, U; Baerlocher, GM; Wackwitz, B; Heim, D ENACT (Expanding Nilotinib Access in Clinical Trials) study in adult patients (pts) with Imatinib-resistant or -intolerant Chronic Myeloid Leukemia (CML): Subgroup analysis of Pts from Germany, Austria and Switzerland (DACH)
Onkologie. 2011; 34(6):267-267.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

Deutsch ,A; Steinbauer,E; Hofmann, N; Strunk, D; Linkesch, W;Beham-Schmid, C; Schaider, H:Neumeister, P Dregulation of multiple Chemokine Receptors during Gastric Malt Lymphomagenesis- Malignant Transformation is accompanied by loss of CXCR4-SDF-1 ?
Haematologica2011; 96 Suppl: 342-342.-16 th Congress of EHA; JUN 8-12, 2011; London. [Poster]

 

Deutsch, AJA; Rinner, B; Stradner, MH; Angerer, H; Linkesch, W; Beham-Schmid, C; Neumeister, P Cytosporone B induces NR4A1 meditated apoptosis in aggressive lymphoma cells
ONKOLOGIE. 2011; 34: 72-72. [Poster]
Web of Science

 

Haidmayer, C; Unteregger, M; Pichler, MM; Rohn, A; Linkesch, W A Phase IIIb, multicenter, open-label study of nilotinib in adult patients with newly diagnosed Philadelphia chromosome and/or BCR-ABL positive CML in chronic phase
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Haidmayer, C; Unteregger, M; Pichler, MM; Rohn, A; Linkesch, W A Phase-3, Multi-Center, randomized, doubleblind, placebo-controlled, parallel-group study to compare efficacy and safety of pomalidomide in subjects with myeloproliferative neoplasm - associated myelofibrosis and red blood cell-transfusiondependence
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Haidmayer, C; Unteregger, M; Pichler, MM; Rohn, A; Linkesch, W A Prospective, Phase IV, Open-Label, Multi-Center Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated with Immune (Idiopathic) Thrombocytopenia Purpura (ITP).
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Haidmayer, C; Unteregger, M; Pichler, MM; Rohn, A; Linkesch, W A Phase II, Single-Blind, Randomised, Placebo-Controlled Trial to study the Efficacy and Safety of Anti-von Willebrand Factor Nanobody administered as Adjunctive Treatment to Patients with Acquired Thrombotic Thrombocytopenic Purpura
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Rohn, A; Seeber, K; Strohmaier, A; Woelfler, A; Zollner-Schwetz, I; Linkesch, W; Krause, R. Posaconazole Serum Levels And Invasive Fungal Infections In Patients With Hematologic Malignancies
Mycoses. 2011; 54(sup2):180-180.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Poster]
Web of Science

 

Hoenigl, M; Salzer, HJ; Strohmaier, A; Valentin, T; Zollner-Schwetz, I; Rohn, A; Seeber, K; Grisold, AJ; Linkesch, W; Krause, R Risk Factors For Invasive Fungal Infection Among Patients With Hematologic Malignancies.
Mycoses. 2011; 54(sup2):51-51.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Oral Communication]
Web of Science

 

Hoenigl, M; Salzer, HJ; Valentin, T; Zollner-Schwetz, I; Rohn, A; Woelfler, A; Strohmaier, A; Seeber, K; Sill H; Linkesch, W; Grisold, AJ; Krause, R Impact of galactomannan testing on epidemiology of invasive fungal infection among patients with hematologic malignancies
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria. [Poster]

 

Hoenigl, M; Salzer, HJ; Valentin, T; Zollner-Schwetz, I; Strohmaier, A; Grisold, AJ; Rohn, A; Woelfler, A; Seeber, K; Linkesch, W; Krause, R Risk factors for invasive fungal infection among patients with hematologic malignancies.
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria. [Poster]

 

Linkesch, W Nabelschnur-Stammzelltransplantation bei akuten Leukämien
Frühjahrstagung der ÖGHO; MAI 5-7; Pörtschach. 2011. [Keynote lecture]

 

Linkesch, W Allogene Stammzelltransplantation mit Nabelschnurblut
Gesellschaft der Ärzte in Wien-Billrothhaus; NOV, 30; Wien, AUSTRIA. 2011. [Keynote lecture]

 

Linkesch, W Neue Therapieoptionen bei NHL und MM
Fortbildunsmeeting; OKT 12; Graz, AUSTRIA. 2011. [Keynote lecture]

 

Linkesch, W MM- Therapy 2011
Symposium Multiples Myelom; SEP 30, 2011; Timisoara, ROMANIA. 2011. [Keynote lecture]

 

Linkesch, W Mesenchymal Stem Cells and Endothelial Progenitor Cells
Proceedings of the 4th World Congress of RMS. 2011; 146-146.-4 th Annual World Congress of Regenerative Medicine& Stem Cell 2011; NOV 10 - 13, 2011; Beijing, CHINA. [Keynote lecture]

 

Linkesch, W Stammzelltransplantation bei MM- Update
Hämatologie- Update; SEP 16-17, 2011; Salzburg. 2011. [Keynote lecture]

 

Linkesch, W Stammzelltransplantation
Kiwanis; OKT 25, 2011; Graz. 2011. [Keynote lecture]

 

Linkesch, W ESA Therapie bei Myelodysplastischem Syndrom
Onkologisches Symposium- Spanische Hofreitschule; Dez 2, 2011; Wien, AUSTRIA. 2011. [Keynote lecture]

 

Linkesch, W MTX in der Hämatologie
Die gegenwärtige Position von MTX in der Medizin; APR 9; Wien, AUSTRIA. 2011. [Keynote lecture]

 

Linkesch, W Cord Blood Transplantation: Current Results and Single Centre Experience in Austria
Polish School of Hematology; MAR 25-26, 2011; Warschau. 2011. [Keynote lecture]

 

Linkesch, W Allogene Transplantation von Stammzellen aus der Nabelschnur - Gegenwart und Zukunft
Symposium - 1000. Stammtelltransplantation in Innsbruck; MAY, 27; Innsbruck. 2011. [Keynote lecture]

 

Linkesch, W Allogene Nabekschnurtransplantation
Stammzelltherapie - Science oder Fiction; MAY 26, 2011; Wien. 2011. [Keynote lecture]

 

Linkesch, W; Neumeister, P; Zinke-Cerwenka, W; Strunk, D; Sill, H UCBT with low-dose ATG in adults
BONE MARROW TRANSPLANT. 2011; 46: S128-S129. [Poster]
Web of Science

 

Linkesch, W; Sill, H; Zinke-Cerwenka, W; Neumeister, P; Strunk, D Results of UCBT with ATG in adults.
Onkologie. 2011; 34(6):271-271.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

Linkesch,W;Strunk , D:Zinke-Cerwenka, W:Sill, H:Neumeister, P UCBT with ATG in adult patients
J Clin Oncol2011; 29 Suppl: 6583-6583.-2011 Annual ASCO Meeting; JUN 2-7, 2011; Chicago, USA. [Poster]

 

Ludwig, H; Kasparu, H; Linkesch, W; Thaler, J; Greil, R; Leitgeb, C; Heintel, D; Rauch, E; Zojer, N; Pour, L; Seebacher, A; Adam, Z Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians
BLOOD. 2011; 118(21): 1262-1263. [Poster]
Web of Science

 

Pichler, M; Fried, I; Bodner, C; Hiden, K; Linkesch, W; Sill, H; Wölfler, A EZH2-und IDH1/2-Mutationen bei Patienten mit Therapie-assoziierter akuter myeloischer Leukämie (t-AML )
Magazine of European Medical Oncology. 2011; 4(Sup1):12-13. [Poster]

 

Pichler, MM; Rohn, A; Unteregger, M; Haidmayer, C; Linkesch, W A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabin Versus Placebo and Cytarabin in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (VALOR)
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Pichler, MM; Rohn, A; Unteregger, M; Haidmayer, C; Linkesch, W A Phase 3, Double-Blind, Multicenter, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome) for the Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukemia (ALL)
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Pichler, MM; Rohn, A; Unteregger, M; Haidmayer, C; Linkesch, W An open Phase I/IIa trial to investigate the maximum tolerated dose, safety, pharmacokinetics, and efficacy of intraveneous BI 6727 as monotherapy or in combination with subcutaneous cytarabine in patients with acute myeloid leukaemia
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Pichler, MM; Rohn, A; Unteregger, M; Haidmayer, C; Linkesch, W A confirmatory, multicenter, single-arm study to assess the efficacy, safety, and tolerability of the BiTE antibody blinatumomab in adult patients with minimal residual disease (MRD) of B-precursor acute lymphoblastic leukemia
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Egle, A; Sliwa, T; Linkesch, W; Fridrik, MA; Greil, R Activity of Azacitidine in 26 Unselected, Consecutive CMML Patients Included in the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group
BLOOD. 2011; 118(21): 747-747. [Poster]
Web of Science

 

Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Sliwa, T; Egle, A; Linkesch, W; Fridrik, MA; Greil, R Report on Response and Overall Survival of 128 Unselected, Consecutive AML Patients From the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group.
Blood. 2011; 118(21):4266--American Society of Hematology; DEC 10-13, 2011; San Diego, USA. [Poster]

 

Pleyer, L.; Stauder, R.; Thaler, J.; Ludwig, H.; Pfeilstoecker, M.; Steinkirchner, S.; Melchardt, T.; Weltermann, A.; Lang, A.; Linkesch, W.; Krippl, P.; Fridrick, M.; Egle, A.; Greil, R. Age- and comorbidity-specific evaluation of Azacitidine treatment, response and overall survival in 184 patients in the Austrian Azacitidine Registry
Leukemia Research2011; 35, Suppl 1: 457-457.-The 11th International Symposium on Myelodysplastics Syndroms; May 18-20, 2011; Edinburgh, GB. [Poster]

 

Pleyer, L.; Stauder, R.; Thaler, J.; Ludwig, H.; Pfeilstoecker, M.; Steinkirchner, S.; Melchardt, T.; Weltermann, A.; Lang, A.; Linkesch, W.; Krippl, P.; Fridrick, M.; Egle, A.; Greil, R. Overall survival data of patients with MDS, AML and CMML from the Austrian Azacitidine Registry of 184 consecutive patients
Leukemia Research2011; 35, Suppl 1: 450-450.-The 11th International Symposium on Myelodysplastics Syndroms; May 18-20, 2011; Edinburgh, GB. [Poster]

 

Rohn, A; Pichler, MM; Haidmayer, C; Unteregger, M; Linkesch, W A multicenter, randomized, double-blind, placebo controlled phase III study of panobinostat in combination with bortezomib and dexamethasone in patients with relapsed multiple myeloma
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Rohn, A; Pichler, MM; Haidmayer, C; Unteregger, M; Linkesch, W A Phase I/IIa, Open-Label, Multicenter, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of the Human Anti-CD38 Antibody MOR03087 as Monotherapy and in Combination with Standard Therapy in Subjects with Relapsed or Refractory Multiple Myeloma
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Rohn, A; Pichler, MM; Haidmayer, C; Unteregger, M; Linkesch, W A Phase 2, Multicenter, Randomised, Open-Label, Parallel Group Study to Evaluate the Effect of VELCADE on Myeloma related Bone Disease
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Rohn, A; Pichler, MM; Haidmayer, C; Unteregger, M; Linkesch, W A International, Multicenter, Randomized, Double-Blind Study of Vorinostat (MK-0683) or Placebo in Combination with Bortezomib in Patients with Multiple Myeloma (Phase III)
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Schlick, K; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W; Strunk, D; Aigelsreiter, A Histiocytis Sarcoma-Targeted Therapy: Novel Therapeutic Options? A Series of 4 Cases
Blood. 2011; 118(21):5005--American Society of Hematology; DEC 10-13, 2011; San Diego, USA. [Poster]

 

Scholz, C; Pinto, A; Linkesch, W; Linden, O; Viardto, A; Keller, U; Hess, G; Lerch, K; Frigeri, F; Frericks, B; Stroux, A; Pott, C; Pezzutto, A 90Yttrium Ibritumomab Tiuxetan as first line treatment for follicular lymphoma. 24 months follow up data from an international phase II clinical trial.
Onkologie. 2011; 34(6):270-270.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

Unteregger, M; Haidmayer, C; Rohn, A; Pichler, MM; Linkesch, W An open-label, multi-center, three arm randomized, phase III study to compare the efficacy and safety of GClb, RClb or Clb alone in previously untreated CLL patients with comorbidities
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Unteregger, M; Haidmayer, C; Rohn, A; Pichler, MM; Linkesch, W A Randomized, Open Label Study of Ofatumumab and Bendamustine Combination Therapy Compared with Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma Unresponsive to Rituximab-Containing Regimen During or Within Six Months of Treatment (OMB110918)
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Unteregger, M; Haidmayer, C; Rohn, A; Pichler, MM; Linkesch, W An open-label, multicenter, randomized, phase III study to investigate the efficacy and safety of bendamustine compared with bendamustine+RO5072759 (GA101) in patients with rituximab-refractory, indolent non-hodgkin's lymphoma
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Unteregger, M; Rohn, A; Haidmayer, C; Pichler, MM; Linkesch, W Randomized, Multicenter, Open-label, Phase III Study of Plitidepsin in Combination with Dexamethasone vs. Dexamethasone Alone in Patients with Relapsed/Refractory Multiple Myeloma
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie & Onkologie; MAY 5-7, 2011; Pörtschach. 2011. [Poster]

 

Zinke-Cerwenka, W; Rohn, A; Posch, U; Beham-Schmid, C; Linkesch, W; Wölfler, A; Sill, H Graft-versus-primary malignancy in patients with therapy-related myeloid neoplasms (t-MNs) undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT).
Onkologie. 2011; 34(6):274-274.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

Zinke-Cerwenka W, Rohn A, Posch U, Beham-Schmid C, Linkesch W, Wölfler A, Sill H. Allogeneic stem cell transplantation with reduced intensity conditioning in patients with therapy-related myeloid neoplasms
European Surgery. 2011; 43, Suppl. 242: 22--Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; Oktober 2011; Graz. [Oral Communication]

 

Aschauer, G; Greil, R; Linkesch, W; Pfeilstöcker, M; Stauder, R; Thaler, J; Fiegl, M; Fridrik, M; Girschikifsky, M; Keil, F; Petzer, AL First results from the Austrian project analyzing retrospectively „real-world“ treatments of patients with myelodysplastic syndromes (REALM)
memo2010; 3(1):9-9.-Frühjahrestagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz. [Poster]

 

Aschauer, G; Greil, R; Linkesch, W; Pfeilstocker, M; Stauder, R; Thaler, J; Fiegl, M; Fridrik, M; Girschikofsky, M; Keil, F; Petzer, AL Results from the Austrian Project analysing retrospectively the use of Lenalidomide in patients with myelodysplatic syndroms (REALM)
ONKOLOGIE. 2010; 33: 224-224. [Poster]
Web of Science

 

Aschauer, G; Greil, R; Linkesch, W; Pfeilstöcker, M; Stauder, R; Thaler, J; Fiegl, M; Fridrik, M; Girschikofsky, M; Keil, F; Petzer, AL Ergebnis der retrospektiven Analyse der Verwendung von Lenalidomid bei Patienten mit Myelodysplastischem Syndrom in Österreich (REALM).
Onkologie2010; 33(S6):125-125.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, Deutschland. [Oral Communication]

 

Bodner, C; Pichler, MM; Deutsch, AJ; Beham-Schmid, C; Linkesch, W; Sill, H; Wolfler, A IDH mutations in therapy-related and secondary AML evolving from myelodysplastic syndromes.
ONKOLOGIE. 2010; 33: 232-233.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. [Poster]
Web of Science

 

Deutsch, A; Rinner, B; Knausz, H; Linkesch, W; Beham-Schmid, C; Neumeister, P Ccytosporone-B Induces NR4A1 Meditated Apoptosis In Aggressive Lymphoma Cells
Proceedings of the 52nd Meeting of ASH2010; (467):-52nd Annual Meeting of American Society of Hematology; DEC 4-7, 2010; Orlando, FLORIDA. [Oral Communication]

 

Deutsch, AJA; Rinner, B; Knausz, H; Linkesch, W; Beham-Schmid, C; Neumeister, P Ccytosporone-B Induces NR4A1 Meditated Apoptosis In Aggressive Lymphoma Cells
BLOOD. 2010; 116(21): 208-209.
Web of Science

 

Garderet, L; Iacobelli, S; Moreau, P; Onida, F; Koenecke, C; Scheid, C; Doyen, C; Bouko, Y; Ketterer, N; Masszi, T; Crawley, C; Hajek, R; Linkesch, W; Ludwig, H; Harousseau, JL; Michallet, M; de Witte, T; Niederwieser, D; Gahrton, G Bortezomib (Velcade)-thalidomide-dexamethasone versus thalidomide-dexamethasone to treat multiple myeloma patients progression or relapsing after autologous transplantation: the MMVAR trial.
Bone Marrow Transplantation2010; 45(2):33-33.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation ; MAR 21-24, 2010; Vienna, AUSTRIA. (ISBN: 0268-3369 ) [Keynote lecture]

 

Jurczak, W; Giza, A; Skotnicki, AB; Deptala, A; Windemuth-Kiesselbach, C; Lorsbach, M; Suh, C; Zinzani, PL; Linkesch, WM; Trumper, LH Use of radioimmunitherapy for consolidation for chemosensitive mantle cell lymphoma (MCL): Summary of International Radioimmunotherapy Registry data.
Journal of Clinical Oncology2010; 28(15S):18519-18519.-46th Annual Meeting of ASCO; JUN 4-8, 2010; Chicago, USA. [Poster]

 

Krieger, O; Machhemdl-Spandl, S; Hauser, H; Binder, M; Greinix, H; Eder, S; Kahls, P; Rabitsch, W; Nachbaur, D; Ludwig, H; Linkesch, W; Jaeger, G; Sill, H; Lindner, B Stem cell transplantation for MDS patients 1987-2008: data from the Austrian transplant registry (ASCTR)
BONE MARROW TRANSPLANT. 2010; 45: S180-S181. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Langner, S; Staber, P; Linkesch, W; Strunk, D Long-term follow-up of minimal chronic graft-versus-host disease after reduced-intensity conditioning with pre-transplant low dose anti-thymocyte globulin in allogeneic stem cell transplantation
BONE MARROW TRANSPLANT. 2010; 45: S145-S145. - 36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Linkesch, W Optimizing Therapy in Multiple Myeloma- Update 2010
Int. Symposium on Multiple Myeloma; Sep. 11, 2010; Bukarest, ROMANIA. 2010. [Keynote lecture]

 

Linkesch, W Aktuelle Behandlungsmöglichkeiten des Lymphom-Rezidivs
8.Internationales Symposium MM.Lymphome.MDS; Okt 15-16, 2010; Wien, Austria. 2010. [Keynote lecture]

 

Linkesch, W Aktuelle Behandlungsmöglichkeiten des Rezidivs
Proceedings of the 8. International Symposium2010; 14-14.-8. Internationales Symposium; OCT 16, 2010; Wien, Austria. [Keynote lecture]

 

Linkesch, W Unrelated Cordblood Transplantation in Adults-A Single Centre Experience
Proceedings of the 2. Symposium on Stem cells2010; 14-14.-2.Symposium on Stem Cells:From Bench To Bedside; SEP 10-11, 2010; Gmunden, AUSTRIA. [Keynote lecture]

 

Linkesch, W Akute und chronische GvHD
Österreichische Gesellschaft für Radiologie; JUN 30, 2010; Graz, AUSTRIA. 2010. [Keynote lecture]

 

Linkesch, W Highlights of EBMT 2010-Cord Blood Transplantation
3.International Hematology Expert Meeting; APR 30-MAY 2; Dubrovnik, Kroatia. 2010. [Keynote lecture]

 

Linkesch, W Stellenwert der Transplantation beim MDS
Symposium" MDS - Herausforderungen im kliniischen Alltag; MAR 6, 2010; Hof bei Salzburg, Austria. 2010. [Keynote lecture]

 

Linkesch, W Nilotinib und andere TKI vor und nach Stammzell-Transplantation bei CML.
Symposium-Nilotinib in der CML- Therapie; AUG 27, 2010; Wien, AUSTRIA. 2010. [Keynote lecture]

 

Linkesch, W Stammzelltransplantation bei sekundärer AML
AML- Workshop 2010; JUL, 3, 2010; Wien, AUSTRIA. 2010. [Keynote lecture]

 

Linkesch, W Erstlinientherapie der CML
Update CML und PH-negative MPN; Mai 28, 2010; Linz. 2010. [Keynote lecture]

 

Linkesch, W Diagnose und Therapie der Eisenüberladung
Fortbildung-Kliniknachmittag der Univ. Klinik für Innere Medizin; May4, 2010; Graz, AUSTRIA. 2010. [Keynote lecture]

 

Linkesch, W Allogene Stammzelltransplantation bei AML
Tagung der ÖGHO; APRIL 8-10, 2010; Bregenz. 2010. [Keynote lecture]

 

Linkesch, W Therapy of NHL in multimorbid elderly patients
2. Convegno Internazionale Di Deriatria E Gerontologia; APR 28-MAI 1; Venezia, ITALIA. 2010. [Keynote lecture]

 

Linkesch, W Pathophysiologie, Diagnose und klinischer Verlauf der ITP
Jahrestagung der ÖGHO; APRIL 8-10, 2010; Bregenz. 2010. [Keynote lecture]

 

Linkesch, W Neues vom ASH bei MM und NHL
Myelom und Lymphom-Hilfe Österreich; FEB 4, 2010; Graz, Austria. 2010. [Keynote lecture]

 

Linkesch, W Behandlung von Komplikationen der Erkrankung und der Nebenwirkungen der Therapie
Ärzteseminar: Neue Entwicklungen beim Multiplen Myelom; OCT 15, 2010; Wien, AUSTRIA. 2010. [Keynote lecture]

 

Linkesch, W Chronische Myeloische Leukämie
Proceedings of The Wrap-Up ASH 2O1O Vienna2010; -Wrap-Up Hämatologie ASH 2010; DEC 17, 2010; Vienna, AUSTRIA. [Keynote lecture]

 

Neumeister, P; Schmidt, H; Linkesch, W; Pfeilstocker, M; Rohn, A SAFETY AND TOLERABILITY OF INTRATHECAL LIPOSOMAL CYTARABINE AS CNS PROPHYLAXIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
HAEMATOL-HEMATOL J. 2010; 95: 0621 -15th Congress of the European Hematology Association.; JUNE 10-13; Barcelona, SPAIN. [Poster]
Web of Science

 

Pichler, M; Beham-Schmid, C; Lackner, K; Linkesch, W; Fickert, P; Emberger, W; Schmidt, H Cholestatic hepatitis due to diffuse liver infiltration by Acute myelogenous leukemia with inv(16)(p13;q22): A case report and review of the literature
ONKOLOGIE. 2010; 33: 141-141.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Oct 1 -5, 2010; Berlin, Germany. [Poster]
Web of Science

 

Pichler, M; Bodner, C; Hiden, K; Linkesch, W; Sill, H; Wölfler, A IDH1 and IDH2 mutations in patients with therapy-related and secondary AML evolving from myelodysplasia.
Memo2010; 3 Suppl. 01/10: 13--Jahrestagung der Österr. Gesellschaft für Hämatologie und Onkologie; Apri 2010; Bregenz. [Poster]

 

Reinisch, A; Hofmann, N; Obenauf, A; Karl, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D STABLE VESSEL GENERATION TROUGH APPLICATION OF BLOOD-DERIVED ENDOTHELIAL COLONY FORMING PROGENITOR CELLS (ECFCS) AND MESENCHYMAL STROMAL/STEM CELLS (MSCS)
HAEMATOL-HEMATOL J. 15th Congress of the European Hematology Association. 2010; 95(s2):0509-220.-15th Congress of the European Hematology Association. ; JUN 10-13, 2010; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D Sustained vessel formation through co-transplantation of endothelial colony-forming progenitor cells with mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S52-S52. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Reitter, S; Bauer, F; Jager, G; Linkesch, W; Langner, S Targeted inhibition of angiogenesis suggests a promising therapeutic option in Histiocytic Sarcoma
ONKOLOGIE. 2010; 33: 178-179. [Poster]
Web of Science

 

Reitter, S; Bauer, F; Jäger, G; Linkesch, W; Langner, S Gezielte Hemmung der Angiogenese als mögliche therapeutische Option des Histiozytären Sarkoms.
Onkologie2010; 33(S6):104-104.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, Deutschland. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
BONE MARROW TRANSPLANT. 2010; 45: S283-S283. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, A; Reinisch, A; Horn, P; Ho, A; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL/STEM CELLS
HAEMATOL-HEMATOL J. 2010; 95(s2):0249-110.-15th Congress of the European Hematology Association. ; JUN 10-13, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Hom, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D Replicative senescence-associated gene expression changes in mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S281-S281. [Poster]
Web of Science

 

Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D Replicative senescence induces gene expression changes in human MSCs.
24th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2010; 42(237):7-8.-Austrotransplant; OCT 27-29, 2010; Villach, AUSTRIA. [Oral Communication]

 

Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D Replicative Senescence-Associated Gene Expression Changes In Human MSPCs Independent of Genomic Variations.
52nd annual meeting2010; 116(21):1839-1839.-American Society of Hematology; DEC 4-7, 2010; Orlando, USA.

 

Schallmoser K; Bartmann, C; Rohde E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D Similarity of Replicative Senescence-Associated Gene Expression Changes in Mesenchymal Stromal Cells under Various Culture Conditions.
XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI2010; 99(1):481-482.-XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI; JUN 26-JUL 2, 2010; Berlin, GERMANY. [Poster]
Web of Science

 

Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Genomic Stability of Mesenchymal Stromal/Stem Cells After Long-Term Culture
TRANSFUSION. 2010; 50: 24A-24A.-AABB; 08.-12.10.2010; Baltimore, MD, USA. [Oral Communication]
Web of Science

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D GENOMIC STABILITY IN LONG-TERM CULTURED MESENCHYMAL STROMAL/STEM CELLS
HAEMATOL-HEMATOL J. 2010; 95: 0247 [Poster]
Web of Science

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch W; Strunk, D Genomic Stability in Long-Term Cultured Mesenchymal Stromal/Stem Cells.
Genomic Stability in Long-Term Cultured Mesenchymal Stromal/Stem Cells. 2010; 2010(s2):109-109.-15th Congress of the European Hematology Association; JUN 10-13, 2010; Barcelona, SPAIN. [Poster]

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Alteration of genomic stability in long-term cultured mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S280-S280.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Schmidt, S; Wolf, D; Thaler, J; Burgstaller, S; Linkesch, W; Petzer, A; Fridrik, MA, Lang, A; Agis, H; Valent, P, Krieger, O; Walder, A; Korger, P; Schlögl, E First annual report of the Austrian CML registry
memo2010; 3(1):11-11.-Frühjahrestagung 2010 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 8-10, 2010; Bregenz. [Poster]

 

Scholz, CW; Pinto, A; Linkesch, W; Linden, O; Viardot, A; Keller, U; Hess, G; Lerch, K; Frigeri, F; Arcamone, M; Frericks, B; Pott, C; Pezzutto, A 90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma. First results from an International Phase II Clinical Trial.
Proceedings of the 52nd Meeting of ASH2010; (939):-52nd Annual Meeting of American Society of Hematology; DEC 4-7, 2010; Orlando, FLORIDA. [Keynote lecture]

 

Scholz, CW; Pinto, A; Linkesch, W; Linden, O; Viardot, A; Keller, U; Hess, G; Lerch, K; Frigeri, F; Arcamone, M; Frericks, B; Pott, C; Pezzutto, A 90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma, First Results from an International Phase II Clinical Trial
BLOOD. 2010; 116(21): 261-261. Doi: 10.1182/blood.V116.21.593.593
Web of Science FullText FullText_MUG

 

Sormann, S; Bauer, F; Reitter, S; Pichler, M; Stranzl, T; Dekic, D; Linkesch, W Results from the Myeloma Registry of the University Hospital Graz
ONKOLOGIE. 2010; 33: 249-250. [Poster]
Web of Science

 

Sormann, S; Bauer, F; Reitter, S; Pichler, M; Stranzl, T; Dekic, D; Linkesch, W Myelom-Register der Medizinischen Universität Graz: Auswertung 2008-2010.
Onkologie2010; 33(S6):133-133.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, Deutschland. [Poster]

 

Thaler, D; Fruthwirth, M; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Hartwig, U; Strunk, D Combined action of endothelial and mesenchymal niche cells to amplify haematopoietic progenitor expansion in a humanized system
BONE MARROW TRANSPLANT. 2010; 45: S53-S53. - 36th Annual Meeting of hte European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Worel, N; Rosskopf, K; Agis, H; Nachbaur, D; Kasparu, H; Russ, G; Keil, F; Linkesch, W; Greinix, H PLERIXAFOR PLUS G-CSF CAN SUCCESSFULLY MOBILIZE CD34+CELLS FROM PATIENTS WHO HAVE PREVIOUSLY FAILED CHEMOTHERAPY AND/OR CYTOKINE MOBILIZATION: THE COMPASSIONATE USE EXPERIENCE IN AUSTRIA
VOX SANG. 2010; 99: 9-10. [Poster]
Web of Science

 

Worel, N; Rosskopf, K; Nachbaur, D; Kasparu, H; Russ, G; Namberger, K; Leitner, G; Kalhs, P; Schogl, E; Witt, V; Greinix, H; Keil, F; Linkesch, W Plerixafor plus G-CSF can successfully mobilize CD34+cells from patients who have previously failed chemotherapy and/or cytokine mobilization: the compassionate use experience in Austria
BONE MARROW TRANSPLANT. 2010; 45: S318-S318. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Zinke-Cerwenka, W; Stojakovic, T; Rohn, A; Ziegler, I; Emberger, W; Sipurzynski, S; Linkesch, W; Neumeister, P First-line treatment with bortezomib, doxorubicine and dexamethasone followed by autologous peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma
BONE MARROW TRANSPLANT. 2010; 45(2):S149-S149.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Arbeiter, S; Wiesinger, K; Konrath, P; Thaler, J; Fridrik, M; Krieger, O; Linkesch, W; Lang, A; Greil, R; Geissler, D; Keil, F; Al-Sayegh, B; Wolf, D; Foditsch R; Pober, M; Thurmes, O; Punzengruber, R; Thamer, S; Petzer, A L Analysis of compliance by measurement of imatinib plasma levels and correlation of imatinib plasma through levels with cytogenetic and molecular remissions: A Project of the Austrian CML Platform
ONKOLOGIE2009; 32(4):173-173.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schwezerischen Gesellschaften für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg/Mannheim. (ISBN: 978-3-8055-9351-9 ) [Oral Communication]

 

Deutsch, AJA; Beham-Schmid, C; Linkesch, W; Neumeister, P The Nuclear Orphan Receptors NR4A1 and NR4A3 as Putative Tumour Suppressor Genes in Aggressive Non-Hodgkin's Lymphomas.
Blood2009; 114(22):1158-1158.-51st ASH Annual Meeting of the American Society of Hematology ; Dec 5-8, 2009; New Orleans, LA. [Poster]
Web of Science

 

Fruehwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D Contribution of endothelial and mesenchymal niche cells to haematopoietic progenitor expansion in a humanised system.
BONE MARROW TRANSPLANT. 2009; 43: S188-S189.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Poster]
Web of Science

 

Hoenigl, M; Zollner-Schwetz, I; Sill, H; Linkesch, W; Lass-Flörl, C; Krause, R; Outcome of invasive fungal infections in patients with hematologic malignancies.
Abstract Nr. 11; 3.Österreichischer Infektionskongress2009; -3.Österreichischer Infektiologiekongress der Österreichischen Gesellschaft für Infektionskrankheiten (OeGI); APR 22-25, 2009; Saalfelden, AUSTRIA. [Poster]

 

Jurczak, W; Skotnicki, AB; Deptala, A; Windemuth-Kieselbach, C; Lorsbach, M; Bischof Delaloye, A; Cheolwon, S; Zinzani, P; Cacchione, R; Linkesch, W; d'Amore, F; Truemper, LH Consolidation with Radioimmunotherapy May Prolong Survival in First Remission of Mantle Cell Lymphoma Patients Uneligible for Stem Cell Transplantation, An Analysis of the International RIT-Network.
BLOOD2009; 114(22):1442-1442.-Fifty-first annual meeting of American Society of Hematology; DEC 5-8, 2009; New Orleans, Louisiana. [Poster]
Web of Science

 

Linkesch, W Aktuelle Therapiekonzepte bei NHL und MM
Symposium Innovative Therapiestrategien im hämato-onkologischen Alltag; NOV 5; Graz, Austria. 2009. [Keynote lecture]

 

Linkesch, W Radioimmuntherapie bei NHL
NHL- Symposium; OKT 16, 2009; Klagenfurt, Austria. 2009. [Keynote lecture]

 

Linkesch, W Moderne Therapie der Niereninsuffizienz bei Multiplem Myelom
Symposium Nephrologie Graz; SEP 24, 2009; Graz. 2009. [Keynote lecture]

 

Linkesch, W Behandlungsoptionen für Ältere-von BSC zur nichtmyeloablativen Tx: Aggressive Behandlung
Frühjahrstagung der ÖGHO; APRIL16-18, 2009; Salzburg. 2009. [Keynote lecture]

 

Linkesch, W Meningiosis lymphomatosa
Fortbildung des Universitätsspitals Zürich; JUN, 16, 2009; ZÜRICH, SWITZERLAND. 2009. [Keynote lecture]

 

Linkesch, W Einführung in die CLL-Diagnosestandards, Prognosefaktoren, Behandlungs=indikationen
2009: Neue Standards in der Therapie der CLL; MAI 15-16; Graz, Austria. 2009. [Keynote lecture]

 

Linkesch, W Follikuläres und Diffus-großzelliges NHL
MM und Lymphom-Symposium; JUN 19-20, 2009; Wien, AUSTRIA. 2009. [Keynote lecture]

 

Linkesch, W EBMT-Highlights 2009
2. International Hematology Expert-Meeting; MAY 1-3; Nice, FRANCE. 2009. [Keynote lecture]

 

Linkesch, W Stammzelltransplantation bei AML
AML-Herbstworkshop 2009; NOV 7; Wien, AUSTRIA. 2009. [Keynote lecture]

 

Linkesch, W Depocyte in CNS Prophylaxis of hematological Malignancies
Meeting of the Romanian Society of Hematology; OCT 1-2, 2009; Sinai, ROMANIA. 2009. [Keynote lecture]

 

Linkesch, W Stellenwert der autologen Transplantation bei MM und NHL
Onkologie Herbstgespräche 2009 der ÖGHO; NOV 13-15, 2009; Mondsee. 2009. [Keynote lecture]

 

Linkesch,W RIT in stem cell transplantation and RIT network.
Frühlahrstagung der Österr. Gesellschaft für Hämatologie und Onkologie; APRIL16-18, 2009; Salzburg. 2009. [Keynote lecture]

 

Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D Vascular regeneration by adult blood-derived endothelial colony-forming cells expanded under animal serum-free conditions
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S19-S20.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Oral Communication]
Web of Science

 

Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D MESENCHYMAL STROMAL CELLS (MSC) SUPPORT VASCULAR REGENERATION BY ADULT BLOOD-DERIVED ENDOTHELIAL COLONY-FORMING CELLS (ECFC) EXPANDED UNDER ANIMAL SERUM-FREE CONDITIONS.
3rd International Workshop on Multipotent Stromal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009. [Poster]

 

Reinisch, A; Hofmann, N.A.; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher, M; Strunk, D Humanized Large-Scale Animal Serum-Free Expanded Blood-Derived Endothelial Colony-Forming Cells Function In Vitro and In Vivo.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009. [Poster]

 

Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Flicker, K; Linkesch, W; Speicher, M; Strunk, D Therapeutic Vasculogenesis in Vivo by Co-Transplantation f Endothelial and Mesenchymal Progenitor Cells.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):166-167.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 ) [Oral Communication]

 

Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D Stable vascular regeneration through co-application of adult blood-derived endothelial colony-forming cells (ECFCs) and mesenchymal stromal cells (MSCs).
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.2009; 41(231):23-23.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics.; OCT 21-23, 2009; Seefeld, AUSTRIA. [Oral Communication]

 

Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher; MR; Strunk, D Making functional Endothelial progenitors: animal serum-free humanized large-scale propagated adult blood-derived Endothelial colony-forming cells assemble stable perfused vessel in vivo.
2009 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology2009; 2(2):1-2.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 ) [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D CELLULAR THERAPEUTIC ANGIOGENESIS: IN VITRO FOAM CELL DEVELOPMENT OF MONOCYTES BUT NOT MESENCHYMAL STROMAL CELLS.
3rd International Workshop on Multipotent Stromal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D In vitro Foam Cell Development of Bone Marrow-Derived Cells: Implications for Therapeutic Angiogenesis?
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):215-216.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 ) [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Increased Foam Cell Potential of Human Blood and Marrow-Derived Cells after Pro-Angiogenic Induction as an Apparent Risk Factor of Therapeutic Angiogenesis.
42nd Annual Meeting of the German Society for Transfusion Medicine and Immunohematology2009; 26(S1):45-45.-German Society for Transfusion Medicine and Immunohematology (DGTI); SEP 15-18, 2009; Rostock, GERMANY. (ISBN: 978-3-8055-9325-0 ) [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D Foam Cell Development of human Blood and Marrow-Derived Cells as a Risk Factor of Therapeutic Angiogenesis?
ZMF-Doctoral Day; NOV 5-6, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Froehlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk D Safety of stem cell transplantation to treat cardiovascular diseases: foam cell formation of human blood and marrow-derived cells as a risk factor of therapeutic angiogenesis?
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2009; 41(231):10-11.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 21-23, 2009; Seefeld, AUSTRIA. [Oral Communication]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA.; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Elevated Foam Cell Formation After Pro-Angiogenic Inductions of Human Blood and Marrow-Derived Cells as an Apparent Risk Factor of Therapeutic Angiogenesis.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009. [Poster]

 

Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Fröhlich, E; Rechberger, G; Lanzer, G; Kratky, D; Linkesch, W; Strunk, D Atherogenesis as a risk factor accompanying cellular therapeutic angiogenisis?
2009 Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology2009; 2(2):19-20.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 ) [Poster]

 

Rohn, A; Sormann, S; Linkesch, W; Strunk, D Radioimmunotherapy as an Effective and Safe Therapeutic Option in Patients with Extensively Pretreaed Follicular Lymphoma.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):226-227.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 ) [Oral Communication]

 

Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer G; Linkesch, W; Strunk, D Variations in Genomic Stability Revealed by Long-Term Cultured Human MSCs.
ZMF-Doctoral Day; NOV 5-6, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Long-term cultured human MSCs reveal variations in genomic stability.
23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics2009; 41(231):9-10.-23rd Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 21-23, 2009; Seefeld, AUSTRIA. [Oral Communication]

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Evidence for genomic stability of bone marrow-derived MSCS after large-scale expansion in a humanised system.
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S187-S187.-35th Annual Meeting of the European Group for Blood and MarrowTransplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Poster]
Web of Science

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann C; Lanzer, G; Linkesch, W; Strunk, D Variations in Genomic Stability of Human Mesenchymal Stromal Cells Due to Long-Term Culture.
International Society for Stem Cell Research 7th Annual Meeting; JUL 8-11, 2009; Barcelona, SPAIN. 2009. [Poster]

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Human MSC Expansion in an Animal Serum-free System: A GMP-Compliant Protocol for Safe and Genomically Stable MSCs.
2009 Proceedings of the Austrian Society of Heamatology and Oncology2009; 2(2):18-18.-ÖGHO Frühjahrestagung; APR 16-18, 2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 ) [Poster]

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Genomic Variations in Human Mesenchymal Stromal Cells Induced by Long-Term Culture.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie.2009; 32(4):62-63.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 ) [Poster]

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Long-Term Culture of Human MSCs Induces Variations in Genomic Stability.
42nd Annual Meeting of the German Society for Transfusion MEdicine and Immunohematology2009; 36(S1):22-22.-42nd Annual Meeting of the German Society for Transfusion MEdicine and Immunohematology (DGTI); SEP 15-18, 2009; Rostock, GERMANY. (ISBN: 978-3-8055-9325-0 ) [Oral Communication]

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D ALTERED GENOMIC STABILITY DUE TO LONG-TERM CULTURE OF HUMAN MSCs.
3rd International Workshop on Multipotent Stomal Cells (MSCs) for Regenerative Medicine and Immune Regulation; JUN 12-13, 2009; Frankfurt am Main, GERMANY. 2009. [Poster]

 

Schmid, M; Ganser, A; Platzbecker, U; Beris, P; Linkesch, W; Habr, D; Domokos, G; Leismann, O; Gattermann, N Efficacy and Safety of Deferasirox (Exjade) during 1 Year of Treatment in Transfusion-Dependent Patients with Myelodysplastic Syndromes: Overall and Austrian/German/Swiss Results from EPIC Trial
ONKOLOGIE2009; 32(4):128-128.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schwezerischen Gesellschaften für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg/Mannheim. (ISBN: 978-3-8055-9351-9 ) [Poster]

 

Sormann, S; Bauer, F; Reitter, S; Pichler, M; Stranzl, M; Dekic, D; Linkesch, W Results from the Myeloma Registry of the University Hospital Graz
ONKOLOGIE2009; 32(4):206-206.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schwezerischen Gesellschaften für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg/Mannheim. (ISBN: 978-3-8055-9351-9 ) [Poster]

 

Sormann,S;Reitter,S;Pichler,M;Stranzl,T;Dekic,D;Linkesch,W; Tolerability of novel myeloma therapies in the clinical routine setting at University Hospital Graz.
Proceedings of the Annual meeting of the Austrian Society of Haematology and Oncology. 2009; 02: 12-13.-ÖGHO Frühjahrstagung; APR 16-18,2009; Salzburg, AUSTRIA. (ISBN: 1865-5041 ) [Poster]

 

Avivi, I; Canals, C; Niederwieser, D; Kanz, L; Finke, J; Greinix, H; Nagler, A; Vaernant, JP; Bregni, M; Haioun, C; Linkesch, W; Schwerdtfeger, R; Sureda, A Matched unrelated donor stem cell transplantation for patients with diffuse large cell B cell lymphoma: a retrospective analysis of 118 patients registered through the European Group for Blood and Marrow Transplantation (EBMT)
BONE MARROW TRANSPLANT. 2008; 41: S43-S43.-34 th Meeting of the EBMT; MARCH 30- APR 2, 2008; Florence, ITALY. [Keynote lecture]
Web of Science

 

Finke, J; Bethge, WA; Schmoor, C; Ottinger, H; Stelljes, M; Zander, A; Volin, L; Heim, D; Schwerdtfeger, R, Kolbe, K; Mayer, J; Maertens, J, Linkesch, W, Holler, E, Koza, V, Bornhaeuser, M, Einsele, H; Kolb, HJ, Bertz, H; Egger, M; Grichina, O; Socie, G A Randomized Prospecitve Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors
Blood. 2008; 112(11):28-29.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Oral Communication]
Web of Science

 

Frühwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D Combined Action of Endothelial and Mesenchymal Niche Cells to Amplify Hematopoietic Progenitor Expansion in a Humanized System.
Fiftieth annual meeting abstracts2008; 112(11):840-840.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA. [Oral Communication]
Web of Science

 

Hoenigl, M; Zollner-Schwetz, I; Sill, H; Linkesch, W; Lass-Flörl, C; Krause, R Epidemiology of invasive fungal infections and antifungal therapy in patients with hematologic malignancies
Abstractband20082008; -2. Österreichischer Infektionskongress; April 2-5, 2008; Saalfelden. [Poster]

 

Hohloch, K; Lorsbach, M; Codina, J.G; Linkesch, W; Chairman N; Zinzani, P.L; Trümper, L; The RIT Network provides real-life clinical data on radioimmunotherapy for lymphoma: An international registry for radioimmunotherapy-treated patients.
Annals of Oncology2008; 19(4):184-184.-10th International Conference on Malignant Lymphoma; JUN 4-7, 2008; Lugano, SWITZERLAND. [Poster]

 

Hohloch, K; Zinzani, PL; Linkesch,W; Deptala,A; Wojciech,J; Suh,C; Lorsbach, M; Windemuth-Kiesselbach, C; Trümper;LH Radioimmunotherapy is safe and effective in relapse after stem cell transplantation for B-cell Non Hodgkins Lymphoma, an analysis of the International RIT-Network
Blood. 2008; 112(11):1053-1053.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Poster]
Web of Science

 

Linkesch, W Diagnosis and Treatment of chronic GvHD.
Hematology Expert Meeting; MAY, 1-4, 2008; Nice, FRANCE. 2008. [Keynote lecture]

 

Linkesch, W Expertenkommentar zur Zytopenie
39. Tagung der ÖGIM; SEP 17- 20, 2008; Graz, Austria. 2008. [Keynote lecture]

 

Linkesch, W Zevalin-rezente Labelerweiterung & eigene Erfahrungsberichte betreeffend den Einsatz von Zevalin am Universitätsklinikum Graz
RIT-aktueller Stand und Zukunftsperspektiven; SEPT 12, 2008; Baden. 2008. [Keynote lecture]

 

Linkesch, W Therapiealgorithmus bei ITP
Gemeinsame Jahrestagung der DGHO,ÖGHO und SGH/SGO/ Advisory Board; OKT 10-14, 2008; Wien, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W Induktionstherapie bei Patienten mit Multiplem Myelom
4. Onkologie Herbstgespräche; NOV 8-9, 2008; Mondsee. 2008. [Keynote lecture]

 

Linkesch, W Problem Blutkrebs- Chronische Myeloische Leukämie
MINI-MED STUDIUM; NOV 27 , 2008; Graz. 2008. [Keynote lecture]

 

Linkesch, W Allogene Transplantation von Stammzellen aus dem Nabelschnurblut: Die neuen Entwicklungen
Seminar der Knochenmarkspenderzentrale; NOV 27 , 2008; Wien. 2008. [Keynote lecture]

 

Linkesch, W Therapie mit Antikörpern in der Hämatologie
19.Grazer Fortbildungstage der Ärztekammer Steiermark; OKT 6-11, 2008; Graz, Austria. 2008. [Keynote lecture]

 

Linkesch, W Roll der Transplantation nach Imatinib Versagen
CML / Ph+ ALL Forum Linz; NOV 15, 2008; Linz. 2008. [Keynote lecture]

 

Linkesch, W Potential von gewebsspezifischen Stammzellen in der Transplantation
23. Jahrestagung der Österr, Gesellschaft für Transplantation, Transfusion und Genetik ( AUSTROTRANSPLANT ); OKT 29-31, 2008; Zell am See. 2008. [Keynote lecture]

 

Linkesch, W RIT-Registry und eigene Zevalin-Daten
3.Tiroler Nuklearmed. Symposium; NOV 20-21, 2008; Innsbruck. 2008. [Keynote lecture]

 

Linkesch, W Therapie der CML in Zeiten der second line TKIs.
CML-Fortbildung; MAY 7, 2008; Graz, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W Fortschritte in der Therapie für Myelom- und andere Lymphompatienten - Neues vom ASH 2007.
MM-NHL Selbsthilfegruppe.; FEB 7, 2008; Graz, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W Radioimmuntherapie bei indolenten Lymphomen
Fortbildungsveranstaltung LKH Wr. Neustadt; 28.4.2008; Wr. Neustadt. 2008. [Keynote lecture]

 

Linkesch, W Bortezomib - Grazer Erfahrungen mit neuen Kombinationen beim jüngeren MM-Patienten.
Frühjahrestagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 10-12, 2008; Innsbruck, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W Clinical Practices in Liposomal Cytarabine.
34th Annual Meeting of the EBMT; MAR 30-APR 2, 2008; Florence, ITALY. 2008. [Keynote lecture]

 

Linkesch, W Einsatz von Zevalin.
European School of Oncology; FEB 23, 2008; St.Gallen, SWITZERLAND. 2008. [Keynote lecture]

 

Linkesch, W Targeting CD 20 als Quantensprung in der Lymphomtherapie
10 Jahre Mabthera; Sep 5, 2008; Alte Universität, Graz, Austria. 2008. [Keynote lecture]

 

Linkesch, W Myelom - Stellenwert der autologen/allogenen Transplantation.
Frühjahrestagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 10-12, 2008; Innsbruck, AUSTRIA . 2008. [Keynote lecture]

 

Linkesch, W Intrathekale Chemotherapie mit Depocyte® - Von der Behandlung zur Prophylaxe bei Hämatologischen Neoplasien.
Frühjahrestagung 2008 der Österreichischen Gesellschaft für Hämatologie und Onkologie und der Arbeitsgemeinschaft hämato-onkologischer Pflegepersonen in Österreich; APR 10-12, 2008; Innsbruck, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W ASH 2007-Update.
7. Onkologische Wintergespräche; JAN 19, 2008; Loipersdorf, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W Aggressive Non-Hodgkin Lymphome
4.Symposium der Selbsthilfegruppe MM und NHL; Sep 6, 2008; Kongresstentrum Leoben. 2008. [Keynote lecture]

 

Linkesch, W Bendamustine in the treatment of indolent lymphoma.
4th International CLL Workshop; MAY 17 2008; Hof bei Salzburg, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W Stammzelltransplantation in der Hämatologie.
Schladminger Gesundheitsgespräche; MAY 16-17 2008; Schladming, AUSTRIA. 2008. [Keynote lecture]

 

Linkesch, W; Strunk, D One Step to Therapeutic Mesenchymal Stem Cells
Proceedings of the EFBIC- Red Forum2008; 26-26.-EFBIC-RED Forum on Regenerative Medicine; SEP 25-26, 2008; Guangzhou, China. [Keynote lecture]

 

Linkesch,W Aktuelle Behandlungsmöglichkeiten des Lymphomrezidivs
8. Internat. Symposium MM/Lymphome/MDS; OKT 15-16, 2010; Wien, Austria. 2008. [Keynote lecture]

 

Ludwig, H; Spicka, I; Linkesch, W; Greil, R; Kasparu, H; Gunsilius, E; Thaler, J; Drach, J; Kuhn, I; WEißmann, A; Hinke, A Double transplantation with Melphalan (200 mg/m²) compared with triple transplantation with intermediate dose Melphalan (100 mg/m²) in patients with multiple myeloma
Blood. 2008; 112(11):1139-1139.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Poster]
Web of Science

 

Nickelsen, M; Canals, C; Schmitz, N; Kyriakou,C; Engelhardt,M, Relander,T; Linkesch,W;Koza V; Meloni,G; Lopez-Guillermo;L; Indrac,K; Caballero,D; Wandt, H; Theorin,N; Glass,B; Sureda, A Patients with Mature T-Cell Lymphoma show high relapse rates after high dose therapy and autologous stem cell transplantation
Blood. 2008; 112(11):287-287.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Oral Communication]
Web of Science

 

Nickelsen, M; Canals,C; Schmitz S; Glass, B; Leyvraz S; Engelhard M, Koza, V; Relander T; Holowiecki J; Linkesch, W; Losonczy H; Meloni G; Briones J; Sureda, A; Mature T-Cell Lymphoma Patients show high relapse rates after high dose therapy followed by Autologous Transplantation.
. 2008; 19(4): 113-114. [Poster]
Web of Science

 

Reinisch, A; Bartmann, C; Schallmoser, K; Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Human platelet-derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells.
. 2008; 41(1): S128-S128. [Poster]
Web of Science

 

Reinisch, A; Diwoky, C; Hofmann, N; Schallmoser, K; Linkesch, W; Stollberger, R; Strunk, D Molecular Imaging of Bone Marrow Stromal Cells Abstract only
Bone Marrow Transplantation2008; 41(1):S432-S432.-34th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT); MAR 30-APR 2, 2008; Florence, Italy. [Poster]
Web of Science

 

Reinisch, A; Diwoky, C; Hofmann, NA; Schallmoser, K; Rohde, E; Ingolic, E; Linkesch, W; Stollberger, R; Strunk, D Magnetic Resonance Imaging of Functional Human Endothelial Progenitor Cells.
2008 World Molecular Imaging Congress; SEP 10-13, 2008; Nice, FRANCE. 2008. [Poster]

 

Reinisch, A; Diwoky, C; Hofmann, NA; Schallmoser, K; Rohde, E; Ingolic, E; Linkesch, W; Stollberger, R; Strunk, D High Sensitivity and High Resolution Magnetic Resonance Imaging of Functional Endothelial Progenitor Cells.
ZMF Day; NOV 12, 2008; Graz, AUSTRIA. 2008. [Poster]

 

Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher, M; Strunk, D Making Functional Endothelial Progenitors: Humanized Large-scale Animal Serum-free Propagated Adult Blood-derived Endothelial Colony-forming Cells Assemble Stable Perfused Vessels In vivo.
Fiftieth Annual Meeting Abstracts2008; 112(11):659-659.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA. [Poster]
Web of Science

 

Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher, M; Strunk, D Humanized Large-Scale Propagation of Vessel-Forming Endothelial Progenitor Cells.
ZMF Day; NOV 12, 2008; Graz, AUSTRIA. 2008. [Poster]

 

Reinisch, A; Hofmann, NA; Rohde; E; Schallmoser, K; Kashofer, K; Thalder, D; Obenauf, A; Lanzer, G; Linkesch, W; Strunk, D Oligoclonal Large Scale Expansion of Functional Human Endothelial Progenitor Cells without Animal Serum
Onkologie2008; 31(S4):141-141.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Wien. (ISBN: 978-3-8055-9021-1 ) [Poster]

 

Reitter, S; Beham-Schmid, C; Höfler, G; Emberger, W; Linkesch, W; Brezinschek, R; Strunk, D; Neumeister, P; Schmidt, HH A Case of generalized Malt-Lymphoma with IGM paraproteinemia and peripheral blood involvement
Onkologie2008; 31(S4):153-153.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Wien. (ISBN: 978-3-8055-9021-1 ) [Poster]

 

Reitter, S; Posch, U, Eibl, M, Linkesch W, Zinke-Cerwenka W Richter Syndrom: A report of two cases with nonmyeloablative allogenic stem cell transplantation
Onkologie2008; 31(S4):43-43.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 10-14, 2008; Wien. (ISBN: 978-3-8055-9021-1 ) [Poster]

 

Reitter, S; Posch, U; Eibl, M; Sill, H; Linkesch, W Nonmyeloablative allogeneic Stem Cell Transplantation in patients with Richter Syndrome: A report of two Cases.
Haematologica2008; 93(1):537-537.-13th Congress of the European Hematology Association; JUN 12-15, 2008; Copenhagen, DENMARK. [Poster]

 

Reitter, S; Posch, U; Eibl, M; Sill, H; Linkesch, W; Zinke-Cerwenka, W NONMYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RICHTER SYNDROME: A REPORT OF TWO CASES
HAEMATOL-HEMATOL J. 2008; 93: 1410--13th Congress of the European-Hematology-Association; JUN 12-15, 2008; Copenhagen, DENMARK. [Poster]
Web of Science

 

Reitter, S; Zinke-Cerwenka, W; Zebisch, A; Sormann, S; Sill, H; Linkesch, W Haematopoetic stem cell transplantation in CLL: promising results using allogeneic reduced intensity conditioning compared with an autologous setting
BONE MARROW TRANSPLANT. 2008; 41: S309-S310.-34th Meeting oif the EBMT; MARCH 30- APR 2, 2008; Florence, ITALY. [Poster]
Web of Science

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Speicher, M; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Minimum requirements for fully humanised clinical scale propagation of multipotent mesenchymal stromal cells.
. 2008; 41(1): S314-S314. [Poster]
Web of Science

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk D Genomic stability of MSCs after short term clinical scale propagation in animal serum-free medium.
Onkologie2008; 31(S4):127-127.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Wien. (ISBN: 978-3-8055-9021-1 ) [Poster]

 

Schallmoser, K; Rohde E; Reinisch A; Obenauf AC; Bartmann C; Lanzer G; Linkesch W; Strunk D Short Term Clinical Scale MSC Propagation in Animal Serum-Free Medium: Minimum Requirements for Sufficient Transplants
Joint Annual Congress of the German Society for Transfusion Medicine and Immunohaematology (DGTI) and the Interdisciplinary European Society for Haemapheresis and Haeomotherapy (ESFH) in Cooperation with the Societe Francaise de Transfusion Sanguine (SFTS)2008; 35(1):87-87.-41st Congress of the German Society for Transfusion Medicine and Immunohematology; SEP 16-19, 2008; Düsseldorf, GERMANY. (ISBN: 978-3-8055-9013-6 ) [Poster]

 

Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Genomic stability and safety of MSCs after animal serum-free humanized clinical scale propagation.
Fiftieth annual meeting abstracts2008; 112(11):805-805.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA. [Poster]
Web of Science

 

Zinke-Cerwenka, W; Posch, U; Sill, H; Eibl, E; Linkesch, W FOLLOW-UP OF PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (PBSCT) FOLLOWED BY REDUCED-INTENSITY ALLOGENEIC PBSCT
HAEMATOL-HEMATOL J. 2008; 93: 1435 [Poster]
Web of Science

 

Zinke-Cerwenka, W; Posch, U; Zebisch, A; Linkesch, W; Sill, H Results of umbilical cord blood transplantations in adults with high-risk haematologic malignancies
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION.2008; 41: S158-S158.-34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group; MAR 30-APR 02, 2008; Florence, ITALY. [Poster]
Web of Science

 

Zinke-Cerwenka, W; Stojakovic, T; Eibl, M; Linkesch, W Newly diagnosed multiple myeloma patients treated with an induction chemotherapy consisting of Bortezomib, Doxorubicin and Dexamethasone followed by autologous stem cell transplantation
Onkologie2008; 31(S4):192-192.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 10-14, 2008; Wien. (ISBN: 978-3-8055-9021-1 ) [Poster]

 

Zinke-Cerwenka, W; Stojakovic, T; Sill, H; Eibl, E; Linkesch, W PROMISING THERAPY RESPONSE IN MULTIPLE MYELOMA PATIENTS TREATED WITH INDUCTION CHEMOTHERAPY CONSISTING OF BORTEZOMIB, DOXORUBICIN AND DEXAMETHASONE FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION
HAEMATOL-HEMATOL J. 2008; 93: 0222--13th Congress of the European-Hematology-Association; JUN 12-15, 2008; Copenhagen, DENMARK. [Poster]
Web of Science

 

Zinke-Cerwenka, W; Stojakovic, T; Sill, H; Eibl, M; Linkesch, W Promising therapy response in Multiple Myeloma patients treated with induction chemotherapy consisting of Bortezomib, Doxorubicin and Dexamethasone followed by autologous Stem Cell Transplantation.
Haematologica2008; 93(1):89-89.-13th Congress of the European Hematology Association ; JUN 12-15, 2008; Copenhagen, DENMARK. [Poster]

 

Zinke-Cerwenka, W; Stojakovic, T; Zebisch, A; Sill, H; Linkesch, W Promising results in multiple myeloma patients treated with induction chemotherapy consisting of bortezomib, doxorubicin and dexamethasone followed by autologous stem cell transplantation
BONE MARROW TRANSPLANT. 2008; 41: S185-S185.-34th Meeting of the EBMT; March 30- APR 2, 2008; [Poster]
Web of Science

 

Aigelsreiter, A; Deutsch, AJA; Stelzl, E; Beham-Schmid, C; Beham, A; Linkesch, W; Schaider, H; Kessler, HH; Neumeister, P Different chemokine receptor expression profile in extragastric and gastric MALT-lymphomas
LAB INVEST. 2007; 87: 232A-232A. [Poster]
Web of Science

 

Aigelsreiter, A; Deutsch, AJA; Stelzl, E; Beham-Schmid, C; Beham, A; Linkesch, W; Schaider, H; Kessler, HH; Neumeister, P Different chemokine receptor expression profile in extragastric and gastric MALT-lymphomas
MODERN PATHOL. 2007; 20: 232A-232A. [Poster]
Web of Science

 

Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression profiling of human MSC
Wiener Medizinische Wochenschrift2007; 157(121):11-11.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien. [Poster]

 

Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Human platelet-derived factors induce differential gene expression in bone marrow mesenchymal stem cells
HAEMATOL-HEMATOL J. 2007; 92: 318-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Human platelet-derived factors regulate gene expression of mesenchymal stem cells
Abstract Book2007; 117-117.-14th International Symposium on Recent Advances in Stem Cell Transplantation; April 26-28, 2007; Heidelberg, Germany. [Oral Communication]

 

Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression profiling of human multipotent mesenchymal stromal cells.
Abstract Book2007; 33-33.-2nd Symposium on Geneexpression & Microarray Technology; Oct 4-5 2007; ZMF, Graz, Austria. [Oral Communication]

 

Brezinschek, HP; Brezinschek, RI; Hermann, J; Brickmann, K; Lipp, R; Linkesch, W; Graninger, WB REMISSION OF RHEUMATOID ARTHRITIS AFTER TREATMENT WITH 90YTTRIUM IBRITUMOMAB TIUXETAN (ZEVALIN®)
Journal für Mineralstoffwechsel2007; 4: 16--Jahrestagung der Österreichischen Gesellschaft für Rheumatologie und Rehabilitation; NOV 23-24, 2007; Vienna, AUSTRIA. [Poster]

 

Deutsch, AJA; Aigelsreiter, A; Steinbauer, E; Linkesch, W; Beham-Schmid, C; Schaider, H; Neumeister, P Chemokine receptor expression profile in the model of parotid MALT lymphomagenesis: De novo expression of CXCR6.
BLOOD. 2007; 110(11):772A-772A.-49 th Annual Meeting of the American Society of Hematology; NOV 16, 2007; Atlanta, USA. [Poster]
Web of Science

 

Eibl, M; Schmidt, H; Zinke-Cerwenka, W; Linkesch, W; Imatinib and dexamethasone in an elderly patient with Ph+ ALL.
Onkologie, International Journal for Cancer Research and Treatment2007; -Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Okt 5-9, 2007; Basel, SCHWEIZ. [Poster]

 

Eibl, M; Zinke-Cerwenka, W; Schmidt, H; Linkesch, W Complete cytogenetic response of MDS 5q- after therapy with low-dose cytosinarabinoside and lenalidomide
Onkologie2007; 30(S3):221-222.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel. [Poster]

 

Fuchs, C; Vesely, P; Bambach, I; Schauer, S; Linkesch, W; Stemberg, DW; Hoefler, G; Staber, PB Identification of critical phosporylation sites within NPM-ALK that regulate JUNB mRNA translation
BLOOD. 2007; 110(11):1044A-1045A.-49 th Annual Meeting of the American Society of Hematology; NOV 8-11, 2007; Atlanta, Georgia, USA. [Poster]
Web of Science

 

Grossschmidt, P; Koller, E; Linkesch, W; Nachbaur, D; Kier, P; Geissler, D; Fischer, G; Geissler, K Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia - long term results of a randomized phase III study
Wiener Medizinische Wochenschrift; 157(121):15-15.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2007; Wien. [Oral Communication]

 

Langner, S; Staber, P; Schub, N; Gramatzki, M; Grothe, W; Behre, G; Rabitsch, W; Linkesch, W; Neumeister, P Palifermin in unrelated donor transplant recipients
HAEMATOL-HEMATOL J. 2007; 92: 172-173. [Poster]
Web of Science

 

Langner, S; Staber, P; Strunk, D; Linkesch, W Decreased chronic GVHD rate after reduced intensity conditioning with low dose ATG in allogeneic hematopoietic SCT
HAEMATOL-HEMATOL J. 2007; 92: 220-220.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Linkesch , W Diagnostik und Therapie des MDS
State of the Art in Hämatologie und Onkologie; 19.3.2007; Obergurgl. 2007. [Keynote lecture]

 

Linkesch , W Neueste Behandlungsmöglichkeiten beim Multiplen Myelom
Multiples Myelom -Selbsthilfe Österreich; 9.2.2007; Graz. 2007. [Keynote lecture]

 

Linkesch , W International Registry for Zevalin use in NHL
EANM Guidelines Conference of the National Institute of Cancer; 9.3.2007; Milano. 2007. [Keynote lecture]

 

Linkesch , W 5 Jahre Glivec- IRIS und die neuen CML Guidelines
6. Onkologische Wintergespräche; 20.1.2007; Loipersdorf. 2007. [Keynote lecture]

 

Linkesch , W Experiences with Zevalin from an European Register Program
Workshop " New Concepts for Therapy of CLL and NHL "; 31.3.2007; Hof bei Salzburg. 2007. [Keynote lecture]

 

Linkesch , W Zevalin in Clinical Practice
International Lymphoma Meeting; 7.3.2007; Ljubljana. 2007. [Keynote lecture]

 

Linkesch, W Eröffnungs-Festvortrag Haematology in the 21st Century
8 th Internat. Congress of Bone Marrow Biopsy Pathology; MAY 8 - 10, 2007; Graz, Austria. 2007. [Keynote lecture]

 

Linkesch, W Adaptive Immunotheraiy
19th Asia Pacific Cancer Conference; NOV 15- 17. 2007 ; Teheran, IRAN. 2007. [Keynote lecture]

 

Linkesch, W ZNS-Prophylaxe bei hämatologischen Neoplasien-wann ist sie indiziert?
Frühjahrstagung der ÖGHO; APR 12-14, 2007; Wien, Austria. 2007. [Keynote lecture]

 

Linkesch, W Optimizing treatment of CLL with Fludara and MabCampath
19th Asia Pacific Cancer Conference; NOV 15-17, 2007; Teheran. 2007. [Keynote lecture]

 

Linkesch, W Allogeneic Graft vs Malignancy Effect
Int. Symposium; JUL 6-7, 2007; Ljubljana, SLOWENIA. 2007. [Keynote lecture]

 

Linkesch, W Die Klinische Bedeutung der Radioimmuntherapie
Fortbildungstagung; SEP 6, 2007; LKH Fürstenfeld. 2007. [Keynote lecture]

 

Linkesch, W New trends in Therapy with ATG-Fresenius - allogeneic HSCT
19th Asia Pacific Cancer Conference; NOV 15-17, 2007; Teheran. 2007. [Keynote lecture]

 

Linkesch, W Lymphomatous Meningitis- from treatment to prophylaxis
Int. Conference on Haematology; SEP 27-28, 2007; Kosice, SLOVAKIA. 2007. [Keynote lecture]

 

Linkesch, W Cord blood transplantation - eine Alternative ?
Symposium Stammzelltransplantation; DEZ 5, 2007; Wien. 2007. [Keynote lecture]

 

Linkesch, W Lenalidomid in der klinischen Praxis
Frühjahrstagung der ÖGHO; 12.-14.4.2007; Wien. 2007. [Keynote lecture]

 

Linkesch, W Autologe HSZT und allogene HSZT mit Nabelschnurblut
Frühjahrstagung der ÖGHO- Arbeitsgruppe Transplantation; 12.-14.4.2007; Wien. 2007. [Keynote lecture]

 

Linkesch, W ITP - Einsatz von Antikörpertherapien
Frühjahrstagung der ÖGHO; 12.-14.4.2007; Wien. 2007. [Keynote lecture]

 

Linkesch, W Zielgerichtete Therapie in der Hämatologie- Aktuelles Spektrum
Österreichische Gesellschaft für Innere Medizin; SEP 27-28, 2007; Innsbruck. 2007. [Keynote lecture]

 

Linkesch, W Die Stammzelltransplantation beim Myelompatienten-quo vadis?
Onkologie Herbstgespräche 2007; OCT 19-21, 2007; Mondsee. 2007. [Keynote lecture]

 

Linkesch, W Konzepte, Daten und Perspektiven von Zevalin bei autologer SZT
Symposium; NOV 23-24, 2007; Krems. 2007. [Keynote lecture]

 

Linkesch, W Achieving research results with RIT-Network
Meeting of the Steering Committee of the RIT-Network; ASH, DEZ 8, 2007; Atlanta, USA. 2007. [Keynote lecture]

 

Linkesch, W Klinische Studien mit Zevalin- Internationales RIT Netzwerk
Frühjahrstagung der ÖGHO; 12.-14.4.2007; Wien. 2007. [Keynote lecture]

 

Linkesch, W Zevalin in follicular Lymphoma.
Internat. Symposium on RIT; MAY 23rd, 2007; Berlin, Germany. 2007. [Keynote lecture]

 

Linkesch, W Radioimmuntherapie-Gegenwart und Zukunft.
Fortbildung- Hanusch Krankenhaus; Mai 8, 2007; Wien. 2007. [Keynote lecture]

 

Linkesch, W Experiences of using Depocyte in prophylaxis and pretransplantation conditioning
EBMT; 27.3.2007; Lyon. 2007. [Keynote lecture]

 

Linkesch, W Radioimmunotherapy-Present Status and Future Directions
Universität Bern- Fortbildung; 4.1.2007; Bern. 2007. [Keynote lecture]

 

Linkesch, W Zevalin in Stem Cell Transplantation.
Experten-Meeting Zevalin, European Haematology Association; June 6, 2007; Vienna. 2007. [Keynote lecture]

 

Ludwig, H; Tothova, E; Hajek, R; Drach, J; Labar, B; Egyed, M; Spicka, I; Gisslinger, H; Greil, R; Fridrik, M; Zojer, N; Kuhn, I; Linkesch, W; Mistrik, M; Jaksic, B; Kusec, R; Hinke, A Thalidomide-dexamethasoneversus melphalan-prednisoloneas first line treatment in elderly patients with multiple myeloma: Second interim analysis
HAEMATOL-HEMATOL J. 2007; 92: 166-166. [Poster]
Web of Science

 

Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression profiling of human multipotent mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2007; 39: S51-S51. [Oral Communication]
Web of Science

 

Neumeister, PN; Pfeilstocker, M; Linkesch, W; Rohn, A Safety and tolerability of intrathecal liposomal cytarabine as cns prophylaxis in patients with acute lymphoblastic leukemia
HAEMATOL-HEMATOL J. 2007; 92: 8-9. [Poster]
Web of Science

 

Petrides, PE; Gisslinger, H; Steurer, M; Linkesch, H; Krumpl, G; Schuller, A; Widmann, R Differences in tolerability of two commercial anagrelide formulations may be caused by differences in bioavailability
HAEMATOL-HEMATOL J. 2007; 92: 244-244. [Poster]
Web of Science

 

Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bielic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Clinical scale propagation of functional cord blood stem cells in a humanized system
HAEMATOL-HEMATOL J. 2007; 92: 318-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic; Lanzer, G; Linkesch, W; Strunk, D Clinical scale propagation of functional cord blood MSC in a humanized system
Wiener Medizinische Wochenschrift2007; 157(121):26-26.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien. [Poster]

 

Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Human platelet lysate preserves in vitro potency of umbilical cord blood-derived MSC.
Onkologie2007; 30 (Suppl.3): 134-134.-Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO); OKT 5-9, 2007; Basel, Switzerland. [Poster]

 

Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Abstract Book2007; 37-37.-2nd Symposium on Geneexpression & Microarray Technology; Oct. 4th- 5th 2007; ZMF, Graz; Austria. [Oral Communication]

 

Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Human platelet lysate (HPL) preserves in vitro potency of umbilical cord blood-derived MSC.
European Surgery2007; 30 (Suppl. 218): 28[68]-28.-21st Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OKT 17-20, 2007; St Wolfgang, AUSTRIA. [Poster]

 

Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Human platelet lysate (HPL) – derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells.
Abstract Book2007; 711-711.-2nd Meeting of the Center for Medical Research ; Nov 21, 2007; ZMF, Graz, Austria. [Oral Communication]

 

Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Clinical scale expansion of human cord blood-derived multipotent stem cells in a new FBS-free system
BONE MARROW TRANSPLANT. 2007; 39: S132-S133. [Poster]
Web of Science

 

Reitter, S; Zinke-Cerwenka, W; Zebisch, A; Sill, H; Linkesch, W Haematopoietic stem cell transplantation in CLL
ACA Acta Chirurgica Austriaca - European Surgery2007; 39(218):29-29.-21st Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 17-20, 2007; St. Wolfgang. [Poster]

 

Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W, Guelly, C; Strunk, D Endotheliale Marker auf myeloischen Zellen: Molekulare Mimkry oder Transdifferenzierung?
Interdisziplinäre Gruppe für Labordiagnostik und Durchflusszytometrie, IGLD Symposium 2007; MAR 16-17, 2007; Günzburg, Deutschland. 2007. [Oral Communication]

 

Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic CFU-EC: unravelling the nature of endothelial progenitor cells
Wiener Medizinische Wochenschrift2007; 157(121):27-27.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien. [Poster]

 

Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic „CFU-EC“
Abstract Book2007; 109-109.-14th International Symposium on Recent Advances in Stem Cell Transplantation ; April 26-28, 2007; Heidelberg, Germany. [Oral Communication]

 

Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic the morphology of endothelial progenitor colonies in vitro
HAEMATOL-HEMATOL J. 2007; 92: 315-315.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D T cells and monocytes form CFU-hill in vitro
Onkologie2007; 30(S3):217-217.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 5-9, 2007; Basel, Switzerland. [Poster]

 

Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic endothelial progenitor colonies
TRANSFUSION. 2007; 47(3):69A-69A.-American Association of Blood Banks (AABB) 60th Annual Meeting; OKT 20-23, 2007; Anaheim, California, USA. [Poster]
Web of Science

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic endothelial progenitor colonies
BONE MARROW TRANSPLANT. 2007; 39: S123-S123. [Poster]
Web of Science

 

Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A; Lanzer, G; Linkesch, W; Strunk, D Multipotent mesenchymal stromal cells: minimum requirements for fully humanised clinical scale expansion
Onkologie [P531]2007; 30(S3):134-134.-Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO); OCT 5-9; 2007; Basel, SWITZERLAND. [Poster]

 

Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A; Lanzer, G; Linkesch, W; Strunk, D Minimum Requirements for fully humanized clinical scale MSC propagation.
Abstract Book2007; 711-711.-2nd Meeting of the Center for Medical Research; Nov 21, 2007; ZMF Graz, Austria. [Oral Communication]

 

Rohde, E; Schallmoser, K; Bartmann, C; Reinisch, A; Lanzer, G; Linkesch, W; Strunk, D Minimum requirements for fully humanized clinical scale MSC propagation.
European Surgery2007; 39 (Suppl. 218): 29--21st Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OKT 17-20, 2007; St Wolfgang, AUSTRIA. [Poster]

 

Rohn A; Brezinschek, R; Sormann, S; Strunk, D; Linkesch, W Radioimmunotherapy as a therapeutic option in patients with relapsed or refractory CD20+ non-Hodgkin Lymphoma
Onkologie2007; 30(S3):200-200.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel. [Poster]

 

Rohn, A; Leitner, C; Brezinschek, RI; Sormann, S; Linkesch, W; Strunk, D Radioimmunotherapy as a promising therapeutic option in patients with relapsed or refractory CD20(+) non-Hodgkins lymphoma
HAEMATOL-HEMATOL J. 2007; 92: 278-278.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Rohn, A; Leitner, C; Ulreich, R; Wassertheurer, S; Brezinschek, RI; Bauer, F; Lipp, RW; Strunk, D; Linkesch, W Yttrium-90 Ibritumomab as possible therapeutic strategy in elderly and extensively pretreated patients with CD20+ Non Hodgkin Lymphoma
Wiener Medizinische Wochenschrift; 157(121):27-28.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2007; Wien. [Poster]

 

Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Gülly, C; Lanzer, G; Linkesch, W; Strunk, D Clinical scale expansion of MSC with human platelet lysate
Wiener Medizinische Wochenschrift2007; 157(121):28-29.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 12-14, 2007; Wien. [Poster]

 

Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D A novel system for highly efficient clinical scale propagation of human mesenchymal stem cells with human platelet lysate
HAEMATOL-HEMATOL J. 2007; 92: 317-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D Two steps to clinical multipotent mesenchymal stromal cells with human platelet lysate
BONE MARROW TRANSPLANT. 2007; 39: S110-S110. [Poster]
Web of Science

 

Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D Clinical scale expansion of human MSC supported by human platelet lysate.
Abstract Book2007; 110-110.-14th International Symposium on Recent Advances in Stem Cell Transplantation; April 26-28, 2007; Heidelberg, Germany. [Oral Communication]

 

Schallmoser, K; Reinisch, A; Bartmann, C; Rohde, E; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D Animal serum-free clinical scale propagation of human MSC
TRANSFUSION. 2007; 47(3):28A-28A.-American Association of Blood Banks (AABB) 60th Annual Meeting; OKT 20-23, 2007; Anaheim, California, USA. [Oral Communication]
Web of Science

 

Staber PB; Vesely P; Sternberg W; Ott, RG; Kadin, ME; Linkesch, W; Schauer, S; Sexl, V; Kenner, L; Hoefler, G NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma promotes neoplasia by inducing JunB via ERK1/2 and mTOR signalling
Wiener Medizinische Wochenschrift2007; 157(121):5-5.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2007; Wien. [Oral Communication]

 

Zinke-Cerwenka, W; Posch, U; Zebisch, A; Strunk, D; Linkesch, W; Sill, H Outcome of umbilical cord blood transplanatations in adults with high-risk hematologic malignancies
ACA Acta Chirurgica Austriaca - European Surgery2007; 39(218):42-42.-21st Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 17-20, 2007; St. Wolfgang, Austria. [Poster]

 

Zinke-Cerwenka, W; Scheidl, S; Eibl, M; Posch, U; Linkesch, W Incidence of late-onset noninfectious pulmonary complications in allogeneic stem cell transplantation with non-myeloablative conditioning based on fludarabine/TBI or fludarabine/melphalan
BONE MARROW TRANSPLANT. 2007; 39: S295-S295. [Poster]
Web of Science

 

Zinke-Cerwenka, W; Stojakovic, T; Schamagl, H; Wassertheurer, S; Linkesch, W Therapy response by decrease of free light chain concentration in multiple myeloma patients treated with bortezomib/doxorubicin/dexamethasone as first-line therapy
BLOOD. 2007; 110(11):278B-278B.-49th Annual Meeting of the American Society of Hematology; DEC 8-11, 2007; Atlanta, USA . Doi: 10.1182/blood.V110.11.4818.4818 [Poster]
Web of Science FullText FullText_MUG

 

Zinke-Cerwenka, W; Stojakovic, T; Zebisch, A; Strunk, D; Sill, H; Linkesch, W First-line therapy in multiple myeloma patients with bortezomib, doxorubicin and dexamethasone followed by autologous stem cell
ACA Acta Chirurgica Austriaca - European Surgery2007; 39(218):42-42.-21st Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 17-20, 2007; St. Wolfgang, Austria. [Poster]

 

Aigelsreiter, A; Stelzl, E; Deutsch, A; Beham-Schmid, C; Beham, A; Lanzer, G; Linkesch, W; Kessler, H; Neumeister, P Association between Chlamydia psittaci infection and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT)-lymphomas.
J CLIN ONCOL. 2006; 24(18):438S-438S.-ASCO; 2.-6. Juni 2006; Altlanta, USA. [Poster]
Web of Science

 

Aigelsreiter, A; Stelzl, E; Leitner, E; Deutsch, A; Frühwirth, M; Beham-Schmid, C; Beham, A; Linkesch, W; Borel, N; Pospischil, A; Kessler, H; Neumeister, P Extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT)-lymphomas and Sjögren's syndrome are associated with Chlamydia psittaci infection
Onkologie . 2006; 29(S3)VIII+256(2006): -DGHO; NOV 4-8, 2006; Leipzig, GERMANY. [Poster]

 

Avivi, I; Canals, C; Taghipour, G; Niederwieser, D; Kanz, L; Ehninger, G; Finke, J; T.-Greinix, H; Nagler, A; Vernant, JP; Maury, S; Bregni, M; Linkesch, W; Schwerdtfeger, R; Sureda, A Matched Unrelated Donor Stem Cell Transplantation for Patients with Diffuse Large Cell B Cell Lymphoma: A Retrospective Analysis of 118 Patients Registered through the European Group for Blood and Marrow Transplantation (EBMT).
Blood. 108(11):182a-182a.-48 th Annual Meeting of the American Society of Hematology; 12, 2006; Orlando, USA. [Oral Communication]

 

Deutsch, A; Aigelreiter, A; Staber, P; Beham-Schmid, C; Beha, A; Frühwirth, M;Linkesch, W; Neumeister, P Extranodal marginal zone B-cell lymphoma of MALT type are targeted by aberrant somatic hypermutation.
Onkologie2006; 29(S3)VIII+256(2006): -DGHO ; NOV 4-8, 2006; Leipzig, Germany. [Oral Communication]

 

Fruehwirth, M; Deutsch, AJA; Staber, PB; Aigelsreiter, A; Linkesch, W; Beham-Schimid, C; Neumeister, P Aberrant somatic hypermutation of follicular lymphoma transformed to diffuse large B-cell lymphoma.
BLOOD. 2006; 108(11): 683A-683A. Doi: 10.1182/blood.V108.11.2413.2413 [Poster]
Web of Science FullText FullText_MUG

 

Langner, S; Staber, P; Radspieler, G; Triebl-Roth, K; Urban, C; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Neumeister, P Palifermin reduces oral mucositis and enhances the recovery of intestinal mucosa measured by citrulline serum levels in allogeneic and autologous stem cell transplant recipients
BONE MARROW TRANSPLANT. 37: S73-S74.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Poster]
Web of Science

 

Langner, S; Staber, PB; Strunk, D; Linkesch, W Pretransplant low dose anti-thymocyte globulin showed a decreased chronic graft versus host disease rate after reduced intensity conditioning in allogeneic stem cell transplantation
European Surgery. 38(S211):7-7.-Austrian Society of Transplantation, Transfusion and Genetics; OCT 18-21, 2006; Hof - Salzburg, AUSTRIA. [Oral Communication]

 

Langner, S; Staber, PB; Strunk, D; Linkesch, W Pre-transplant low dose anti-thymocyte glubulin showed a decreased cGvHD rate after reduced intensity conditioning in allogeneic stem cell tranplantation
Onkologie. 2006; 29(S3):119-119.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY. [Poster]

 

Langner, S; Staber, PB; Zebisch, A; Triebl-Roth, K; Urban, C; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Neumeister, P Reduced oral mucositis and enhanced intestinal mucosal recovery measured by citrulline serum levels in allogeneic and autologous stem cell transplant recipients treated with palifermin
Onkologie. 29(S3):125-126.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY. [Poster]

 

Langner, S; Staber, PB; Zebisch, A; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Greinix, H; Kalhs, P; Rabitsch, W; Neumeister, P Adding palifermin in allogeneic and autologous stem cell transplantation resulted in reduced oral mucositis and enhanced intestinal mucosal recovery measured by citrulline serum levels.
BLOOD. 2006; 108(11): 404B-404B. Doi: 10.1182/blood.V108.11.5251.5251 [Poster]
Web of Science FullText FullText_MUG

 

Leitner, C; Rohn, A; Brezinschek, RI; Strunk, D; Bauer, F; Ulreich, R; Wassertheurer, S; Lipp, RW; Dorda, A; Linkesch, W Yttrium-90 ibritumomab as a possible therapeutic strategy in elderly and extensively pretreated patients with CD20+ NHL
Onkologie. 29(S3):161-161.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY. [Poster]

 

Linkesch, W Salvage-Therapie post R-CHOP
4. Winterworkshop; 13.-14.1; Pichl. 2006. [Keynote lecture]

 

Linkesch, W Möglichkeiten des Behandlungszentrums Graz
Symposium der Myelomhilfe Österreichs; MAI, 5-6, 2006; Wien, AUSTRIA. 2006. [Keynote lecture]

 

Linkesch, W Therapiealgorithmus von Zevalin in der Therapie der follikulären Lymphome
Symposium der Universität Frankfurt; 20.9.2006; Frankfurt. 2006. [Keynote lecture]

 

Linkesch, W Liposomales Cytarabin bei hämatologischen Neoplasien- von der Behandlung zur Prophylaxe
Gemeinsame Jahrestagung der DGHO, ÖGHO und SGHO; 4.-9.11.2006; Leipzig. 2006. [Keynote lecture]

 

Linkesch, W Radioimmuntherapie bei follikulären Lymphomen
Workshop CLL und NHL; 18.-19.3.2006; Hof bei Salzburg. 2006. [Keynote lecture]

 

Linkesch, W Radioimmuntherapie mit Zevalin: State of the Art und neue Therapiestrategien
Frühjahrstagung der ÖGHO; 27.-29.4.2006; Wels. 2006. [Keynote lecture]

 

Linkesch, W Radio-Immuntherapie: Neue Perspektiven bei der Behandlung von NHL
Interdisziplinäre Lymphomkonferenz UniversitätsSpital Zürich; 16.11.2006; Zürich. 2006. [Keynote lecture]

 

Linkesch, W TBI- Kombinationstoxizität mit Chemotherapie
3. Radioonkologisches Seminar; 1.-2.9.2006; Großwalz. 2006. [Keynote lecture]

 

Linkesch, W Depocyte in der Klinischen Praxis und zukünftige Perspektiven in der NHL Prophylaxe
Frühjahrstagung der ÖGHO; 26,-29.9.2006; wels. 2006. [Keynote lecture]

 

Linkesch, W Maligne NHL: Neue Therapien und deren Auswirkungen auf Blutprodukte.
Frühjahrstagung der Österr, Ges. für Hämatologie und Onkologie; 26.-29.4.2006; Wels. 2006. [Keynote lecture]

 

Linkesch, W Neue therapeutische Perspektiven beim Multiplen Myelom.
Symposium der MM-Selbsthilfegruppe Österreichs; 24.4.2006; Graz. 2006. [Keynote lecture]

 

Linkesch, W Ist die Teilnahme an einer Klinischen Studie von Vorteil?
1. Europäisches Fortbildungsprogramm für Multiples Myelom; 24.-25.2.2006; Wien. 2006. [Keynote lecture]

 

Linkesch, W Erhaltungstherapie des Multiplen Myeloms
Symposium der Myelomhilfe Österreichs; 6.-7.5.2006; Wien. 2006. [Keynote lecture]

 

Linkesch, W Die allogene Stammzelltransplantation beim NHL
Onkologie- Herbstgespräche; 14.-15.10.2006; Mondsee. 2006. [Keynote lecture]

 

Linkesch, W Die wichtigsten Laborparameter und Untersuchungen beim Multiplen Myelom
Myelomhilfe Österreich; 26.9.2006; Graz. 2006. [Keynote lecture]

 

Linkesch, W 10 Jahre Stammzelltransplantationen an der Klinischen Abteilung für Hämatologie der Univ. Klimik für Innere Medizin.
10 Jahre Leukämiehilfe Steiermark; 23.9.2006; Rathaus Graz. 2006. [Keynote lecture]

 

Linkesch, W Thalidomide as salvage therapy in Multiple Myeloma
European Round Table ( Eurordis ); 21.6.2006; Brüssel. 2006. [Keynote lecture]

 

Ludwig, H; Linkesch, W; Kasparu, H; Krieger, O; Spicka, I; Gastl, G; Greil, R; Drach, J; Thaler, J; Kuhn, I; Zojer, N; Hinke, A Prospective, randomized comparison between double mransplantation (T) with melphalan (200 mg/m(2)) and triple T with intermediate dose melphalan (100 mg/m(2)) in patients with multiple myeloma (an interim analysis).
BLOOD. 2006; 108(11): 878A-879A. Doi: 10.1182/blood.V108.11.3083.3083 [Poster]
Web of Science FullText FullText_MUG

 

Malischnik, C; Rohde, E; Thaler, D; Linkesch, W; Lanzer, G; Strunk, D Preclinical protocol: two steps to propagate human MSC for therapeutic application
BONE MARROW TRANSPLANT. 2006; 37: S152-S152.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Malischnik, C; Schallmoser, K; Rohde, E; Linkesch, W; Lanzer, G; Strunk, D Two Steps to Clinical MSC Without Animal Serum.
Transfusion Medicine and Hemotherapy. 2006; (suppl 1) page 28[OS1.4] 2006; 33(1):2-2.-39th Annual Congress of the Society for Transfusion Medicine and Immunohematology ; September 19-22,2006; Frankfurt am Main, Germany. [Oral Communication]

 

Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression of human mesenchymal stem cells is regulated by human platelet-derived factors.
1st Meeting of the Center for Medical Research; OCT 24; Graz. 2006. [Oral Communication]

 

Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression of human mesenchymal stem cells is regulated by platelet-derived factors (poster & abstract)
EHA Scientific Workshop on Biology and Clinical Applications of Mesenchymal Stem Cells; OKT 6-8, 2006; Mandelieu, France. 2006. [Poster]

 

Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Human platelet-derived factors regulate mesenchymal stem cell gene expression.
BLOOD. 2006; 108(11): 142B-142B. [Poster]
Web of Science

 

Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression profiling of mesenchymal stem cells: human platelet-derived factors regulate multiple biological processes.
European Surgery 20062006; 38 (Suppl.211)(8):O18--20th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics 2006; OCT 18-21; Hof, Salzburg, Austria. [Poster]

 

Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression profiling of mesenchymal stem cells: human platelet-derived factors regulate multiple biological processes
Onkologie. 29(S3):232-232.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY. [Poster]

 

Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk D Impact of either human platelet lysate-versus fetal bovine serum-derived factors on mesenchymal stem cell gene expression Abstract book p46
Genomics for Health, Gen-Au Conference; OKT 15-18, 2006; Vienna, AUSTRIA. 2006. [Poster]

 

Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Strunk, D A humanized system to propagate cord blood derived mesenchymal stem cells for clinical application.
European Surgery. European Surgery2006; 38(S211):12-12.-Austrian Society of Transplantation, Transfusion and Genetics; OCT 18-21, 2006; Hof - Salzburg, AUSTRIA. [Oral Communication]

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic endothelial progenitor colonies.
BLOOD. 2006; 108(11): 513A-513A. Doi: 10.1182/blood.V108.11.1811.1811 [Poster]
Web of Science FullText FullText_MUG

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D EndoCult or T-Occult? Immune cell interactions control endothelial function
1st Minisymposium on Gene Expression and Microarray Technology; MAY 11, 2006; Graz, AUSTRIA. 2006. [Oral Communication]

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Towards the standardization of GMP-compliant generation of mesenchymal stem cells.
DGTI, Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie; Sept 19-22, 2006; Frankfurt, Germany. 2006. [Oral Communication]

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells support vascular regeneration: unraveling the nature of CFU-EC.
Onkologie. 29(3):28-28.-Deutsche Gesellschaft für Hämatologie und Onkologie, DGHO ; Nov 4-8, 2006; Leipzig, Germany. [Oral Communication]

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Vascular regeneration and immune cell support – unraveling the nature of CFU-EC.
1st Meeting of the Center for Medical Research ; OCT 24; Graz. 2006. [Oral Communication]

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk D Immune cells support vascular regeneration- unraveling the nature of CFU-EC.
European Surgery. European Surgery2006; 38(211):4-4.-20th Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; OCT 18-21, 2006; Salzburg, Austria. [Oral Communication]

 

Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk D Immune Cells and Vascular Regeneration - Unraveling the Nature of CFU-EC Abstract book p45
Genomics for Health, Gen-Au Conference; OKT 15-18, 2006; Vienna, AUSTRIA. 2006. [Poster]

 

Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D Molecular mimicry: monocytes display endothelial cell related marker molecules
BONE MARROW TRANSPLANT. 2006; 37: S24-S24.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nurses-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D Monocytes Mimic Endothelial Progenitor Cells
Transfus Med Hemother 20062006; 33(S1):26-26.-39th Annual Congress of the German Society for Transfusion Medicine and Immunohematology (DGTI); SEP 19-22, 2006; Frankfurt am Main, GERMANY. [Poster]

 

Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D Blood monocytes mimic endothelial progenitor cells
Work in Progress, Fortbildungsveranstaltung der Abteilung Transfusionsmedizin; JAN 25, 2006; Universität Ulm, GERMANY. 2006. [Oral Communication]

 

Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Preclinical expansion of mesenchymal stem cells is efficiently supported by human platelet lysate (poster & abstract)
EHA Scientific Workshop on Biology and Clinical Applications of Mesenchymal Stem Cells; OKT 6-8, 2006; Mandelieu, France. 2006. [Poster]

 

Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Preclinical expansion of mesenchymal stem cells is efficiently supported by human platelet lysate.
1st Meeting of the Center for Medical Research ; OCT 24; Graz. 2006. [Oral Communication]

 

Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Human mesenchymal stem cell therapy: Platelet lysate supports efficient preclinical expansion.
BLOOD. 2006; 108(11): 1042A-1042A. Doi: 10.1182/blood.V108.11.3649.3649 [Poster]
Web of Science FullText FullText_MUG

 

Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Mesenchymal stem cell therapy: human platelet lysate supports efficient preclinical expansion
Onkologie. Onkologie2006; 29(S3):232-232.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY. [Poster]

 

Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Mesenchymal stem cell therapy: human platelet lysates support efficient preclinical expansion
European Surgery. 38(S211):13-13.-Austrian Society of Transplantation, Transfusion and Genetics; OCT 18-21; Hof - Salzburg, AUSTRIA. [Oral Communication]

 

Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk D Human platelet lysates promote efficient preclinical expansion for human mesenchymal stem cell therapy Abstract Book p51
Genomics for Health, Gen-Au Conference; OKT 15-18, 2006; Vienna, AUSTRIA. 2006. [Poster]

 

Staber, PB; Vesely, P; Ott, R; Haq, N; Linkesch, W; Schauer, S; Hrzenjak, A; Kenner, L; Dirks, W; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma exerts its transforming potential by increasing translation of JUNB through mTOR and S6K1.
BLOOD. 2006; 108(11): 414A-415A. Doi: 10.1182/blood.V108.11.1428.1428 [Poster]
Web of Science FullText FullText_MUG

 

Vesely, P; Staber, PB; Ott, R; Pinent, M; Linkesch, W; Schauer, S; Hrzenjak, A; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK converts JUNB from a tumor suppressor to an oncogene.
BLOOD. 2006; 108(11): 419A-420A. Doi: 10.1182/blood.V108.11.1448.1448 [Poster]
Web of Science FullText FullText_MUG

 

Zinke-Cerwenka, W; Eibl, M; Neumeister, P; Sill, H; Linkesch, W Late effects after autologous peripheral blood stem cell transplantation followed by reduced-intensity allogeneic peripheral blood stem cell transplantation in patients with multiple myeloma
BONE MARROW TRANSPLANT. ; 37: S113-S113.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Poster]
Web of Science

 

Deutsch, A; Aigelsreiter, A; Barounig, A; Beham-Schmid, C; Beham, A; Linkesch, W; Schaider, H; Neumeister, P Analysis of 16 chemokine receptors in Sjögren’s Syndrome and nongastric mucosa-associated lympoid tissue (MALT)-type lymphomas of the parotid gland
Onkologie2005; 28(3):96-97.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie ; Okt 1-5, 2005; Hannover, Germany. (ISBN: 978-3-8055-8020-5 ) [Poster]

 

Deutsch, A; Aigelsreiter, A; Beham, A; Beham-Schmid, C; Schaider, H; Linkesch, W; Neumeister, P; Analysis of the 17 chemokine receptor expression profiles in nongastric mucosa-associated lymphoid tissue (MALT)-type lymphomas of the parotid gland.
Onkologie. 2005; 28: 96-96.- ; ; . [Poster]

 

Deutsch, A; Aigelsreiter, A; Beham-Schmid, C; Beham, A; Linkesch, W; Neumeister, P Aberrant somatic hypermutation in extranodal marginal zone B-cell lymphoma of MALT type.
BLOOD. 2005; 106: 125A-126A.-47th Annual Meeting of the American-Society-of-Hematology; DEC 10-13, 2005; Atlanta, GA.
Web of Science

 

Dorda, A; Piswanger-Sölkner, JC; Brezinsek, R; Linkesch, W; Lipp, RW; Bessere Therapieerfolge für Patienten mit Non-Hodgkin-Lymphom durch Radioimmuntherapie mit Y-90 Ibritumomab Tiuxetan möglich?
Nuklearmed. 2005; 44: 132-132.- ; ; . [Poster]

 

Holub, R; Staber, PB; Linkesch, W; Schmidt, H; Neumeister, P; Pegfilgrastim shows safety and efficacy similar to filgrastim in patients undergoing autologous stem cell transplantation for hematological malignancies.
Wien Med Wscr. 2005; 155(117):15-15. [Poster]

 

Langner, S; Sormann, S; Strunk, D; Linkesch, W; Decreased chronic graft versus host disease rate after reduced intensity conditioning with pretransplant low dose anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation.
Onkologie. 2005; 28: 67-67.- ; ; . [Poster]

 

Langner, SL; Strunk, D; Linkesch, W; A pilot study of reduced intensity conditioning (RIC) with low dose ATG in allogeneic hematopoietic stem cell transplantation (allo-SCT).
Haematologica. 2005; 90(2):471-471.- ; ; . [Poster]

 

Langner,S; Sormann, S, Strunk, D; Linkesch, W; Graft versus host disease after reduced intensity conditioning (RIC) with low dose ATG in allogeneic hematopoeietic stem cell transplantation Aallo-SCT).
Wien Med Wscr. 2005; 155(117):3-3. [Poster]

 

Leiner, C; Bauer, F; Lipp, R; Dorda, A; Linkesch, W; Brezinschek, RI; Yttrium-90 Ibritumomab Tiuxetan radioimmuntherapy: a safe and highly efficient therapy for patients with relapsed or refractory non-Hodgkin lymphoma.
Onkologie. 2005; 28: 236-236.- ; ; . [Poster]

 

Linkesch, W The Anahydret Study.
30. World Congress of ISH; SEP 28, 2005; Istanbul, Turkey. 2005. [Keynote lecture]

 

Linkesch, W Radioimmuntherapie in der Behandlung des NHL
Symposium der Med. Univ. Innsbruck; SEPT. 25, 2005; Innsbruck, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W Therapieerfahrungen mit Depocyte bei hämatologischen Neoplasien und zukünftige Perspektiven in der NHL- Prophylaxe
Symposium " Meet the Experts "; OKT 3, 2005; Hannover, DEUTSCHLAND. 2005. [Keynote lecture]

 

Linkesch, W Allogene Nabelschnur-Transplantation bei Erwachsenen
Frühjahrstagung der ÖGHO; APR 28- 30, 2005; Graz, Austria. 2005. [Keynote lecture]

 

Linkesch, W Safety aspects of Long term Treatment with Anagrelide
Opinion Leader Meeting; JUNE 24, 2005; Vienne, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W Neues aus der Hämato-Onkologie
Interdisziplinäres Roche- Wintersymposium; JÄN 6-11, 2005; Zürs, Austria. 2005. [Keynote lecture]

 

Linkesch, W Mucositisprävention, Erfahrungen mit Palifermin
Symposium der AG Stammzelltranspkantation; OKT 27, 2005; Wien, Austria. 2005. [Keynote lecture]

 

Linkesch, W DepoCyte in NHL: from the treatment to a prophylactic approach.
DGHO; OCT1-5, 2005 ; Hannover, GERMANY. 2005. [Keynote lecture]

 

Linkesch, W Role of polyclonal antibodies in MST.
21st meeting of the EBMT; MAR 20–23, 2005; Prague, Czech Republic. 2005. [Keynote lecture]

 

Linkesch, W Aktuelles aus der Stammzelltransplantation.
Leukämiehilfe Steiermark; MAR 10, 2005; Graz, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W; Intrathekale Prophxylaxe mit DepoCyte beim aggressiven Lymphom.
Österreichisches DepoCyte Advisory Board Meeting; Apr 30, 2005; Graz, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W; Erfahrungen im klinischen Einsatz der Radioimmuntherapie bei niedrig malignen Lymphomen.
Aktuelle Therapiekonzepte bei NHL und CLL.; Dec 2, 2005; Graz, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W; Safety aspects of long term treatment with Anagrelide.
ANAHYDRET STUDY (AOP 03007) Investigators/ Opinion Leaders Meeting; JUN 24, 2005; Vienna, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W; Schilddrüsenfunktionsstörungen bei Knochenmarktransplantationen.
Grazer Hormonsymposium VIII - Die Schilddrüse interdisziplinär im neuen Jahrtausend; SEP 16-17, 2005; Graz, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W; Aktuelle Therapiekonzepte bei NHL.
Aktuelle Therapiekonzepte bei NHL und CLL.; Dec 2, 2005; Graz, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W; Zevalin - the first RIT for follicular lymphoma.
18th Annual Congress of the European Association of Nuclear Medicine (EANM); OCT 17, 2005; Istanbul, Turkey. 2005. [Keynote lecture]

 

Linkesch, W; Therapieerfahrungen mit DepoCyte bei hämatologischen Neoplasien.
Österreichisches DepoCyte Advisory Board Meeting; Apr 30, 2005; Graz, AUSTRIA. 2005. [Keynote lecture]

 

Linkesch, W; Allogene Nabelschnurtransplantation bei Erwachsenen.
Symposium- Spende und Transplantation von Knochenmark und Blutstammzellen; SEP 22, 2005; Wien, AUSTRIA. 2005. [Keynote lecture]

 

Lipp.RW;PiswangerSoelkner,JC;Dorda.AF;Brezinschek,RI;Lackner.H; Linkesch,W Yttrium-90 (Ytracis) Labelled Ibritumomab Tiuxetan (Zevalin) in Patients with relapsed or refractory B-Cell Non Hodgkins Lymphoma
Eur J of Nuclear Medicine2005; 32(S1):93-93.-Annual Congress of the EANM; OCT 15-19, 2005; Istanbul. [Keynote lecture]

 

Ludwig, H; Drach, J; Tohova, E; Gisslinger, H; Jaksic, B; Linkesch, W; Hajek, R; Greil, R; Fridrik, M; Labar, B; Zojer, N Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma: An interim analysis.
J CLIN ONCOL 2005 23: 569S-569S.
Web of Science

 

Ludwig, H; Drach, J; Tothova, E; Gisslinger, H; Linkesch, W; Jaksic, B; Fridik, M; Thaler, J; Lang, A; Hajek, R; Zojer, N; Greil, R; Kuhn, I; Hinke, A; Labar, B Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma: An interim analysis.
BLOOD 2005 106: 231A-231A.
Web of Science

 

Ludwig, H; Drach, J; Tothova, E; Gisslinger, H; Linkesch, W; Jaksic, B; Fridrik, M, Thaler, J; Lang, A; Hajek, R; Zojer, N; Greil, R; Kuhn, I; Hinke, A; Labar, B; Thalidomide-Dexamethasone (TD) versus mephalan-prednisolone (MP) as a first line treatment in elderly patients with multiple myeloma (MM): an interim analysis.
Onkologie. 2005; 28: 14-14.- ; ; . [Poster]

 

Ludwig, HW; Drach, J; Tothova, E; Gisslinger, H; Linkesch, W; Jaksic, B; Fridrik, M; Thaler, j, Lang, A; Hajek, R; Zojer, N; Greil, R; Kuhn, I; Hinke, A; Labar, B; Thalidomide-Dexamethasone versus Melphalan-Prednisolone as first line treatment in elderly patients with multiple myeloma: an interim analysis.
Haematologica. 2005; 90(2):158-158.- ; ; . [Poster]

 

Malischnik, C; Rohde, E; Thaler, D; Linkesch, W; Lanzer, G; Strunk, D; Clonal density expanded mesenchymal stem cell retain immunoregulatory function.
Onkologie. 2005; 28: 25-25.- ; ; . [Poster]

 

Malischnik, C; Rohde, E; Thaler, D; linkesch, W; Lanzer, G; Strunk, D; A standard two-step procedure to expand mesenchymal stem cells for therapeutic application.
ÖGAI Abstract book2005; 98: 56-56.-Ann Meeting of the Austrian Society for Allergology and Immunology; DEC 1-3 2005; Graz,AUSTRIA. [Poster]

 

Malischnik, C; Rohde, E; Thaler, D; Vogel, B; Linkesch, W; Lanzer, G; Schaider, H; Strunk, D Low plating density boosts mesenchymal stem cell proliferation
BONE MARROW TRANSPLANT. 2005; 35: S139-S140.-31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

Piswagner-Sölkner, J; Dorda, A; Brezinschek, R; Lackner, H; Linkesch, W; Lipp, RW; Bessere Therapieerfolge durch die Kombination der konventionellen Chemotherapie bei Patienten mit Non-Hodgkin-Lymphomen.
Wien Med Wscr. 2005; 155(117):11-11. [Poster]

 

Rohde, E; Brulport, M; Malischnik, C; Lanzer, G; Linkesch, W; Hengstler, J; Strunk, D; Enrichment of human lineage-negative stem cells: a preclinical GMP study
Onkologie2005; 28: 15-15.-DGHO Wissenschaftliches Symposium des Arbeitskreises "Stammzellbiologie & Therapie"; OCT 1-5, 2005; Hannover, GERMANY. [Poster]

 

Rohde, E; Brulport, M; Malischnik, C; Thaler, D; Lanzer, G; Linkesch, W; Hengstler, J; Strunk, D Human lineage-negative cells for regenerative stem cell therapy
BONE MARROW TRANSPLANT. 2005; 35: S99-S100.-31st Annual Meeting of the European Group for Blood and Marrow Transplantation/21st Meeting of the EBMT Nurses Group/4th Meeting of the EBMT Data Management Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

Rohde, E; Brulport, M; Malischnik, C; Thaler, D; Lanzer, G; Linkesch, W; Hengstler, J; Strunk, D; Enrichment of human lineage-negative stem-cells: a preclinical study.
ÖGAI Abstract book2005; 98: 56-56.-Annual Meeting of the Austrian Society for Allergy and Immunology; DEC 1-3 2005; Graz,AUSTRIA. [Poster]

 

Rohde, E; Brulport, M, Malischnik, C; Thaler, D; Lanzer, G; Linkesch, W; Hengstler, W; Strunk, D; Human lineage-negative cells for regenerative stem cell therapy.
Keystone symposia abstract book2005; 100-100.-Keystone symposia ; FEB 10-15, 2005; Banff, Alberta. [Poster]

 

Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D How to define endothelial progenitor cells in human blood?
BONE MARROW TRANSPLANT. 2005; 35: S78-S78.-31st Annual Meeting of the European Group for Blood and Marrow Transplantation/21st Meeting of the EBMT Nurses Group/4th Meeting of the EBMT Data Management Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D Monocytes mimic Endothelial Progenitor Calls in Human Blood
Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO); OKT 1-5, 2005; Hannover, GERMANY. 2005. [Poster]

 

Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D How to define endothelial progenitor cells in human blood
Keystone Symposia Abstract book 20052005; P3013: 93--Keystone Symposia: Molecular Regulation of Stem Cells; FEB 10-15, 2005; Banff, Alberta, CANADA. [Poster]

 

Sipurzynski, S; Neumeister, G; Lanzer, G; Linkesch, W; Strunk D Modified Extracorporeal Photochemotherapy of Acute Graft-Versus-Host Disease of the Intestine - A case report
Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI); September 6-9, 2005; Erfurt, Germany. 2005. [Poster]

 

Sipurzynski, S; Neumeister, G; Lanzer, G; Linkesch, W; Strunk D Modified Extracorporeal Photochemotherapy of Acute Graft-Versus-Host Disease of the Intestine - A case report
Österreichische Gesellschaft für Hämatologie und Onkologie (ÖGHO); APR 28-29, 2005; Graz, AUSTRIA. 2005. [Poster]

 

Sipurzynski, S; Neumeister, P; Lanzer, G; Linkesch, W; Strunk, D Modified Extracorporeal Photochemotherpay of Acute Graft-Versus-Host Disease of the Intestine - A case report
Transfusion and Apheresis Science2005; 33(2):213-214.-15th Congress of the Interdisciplinary European Society for Hemapheresis and Hemotherapy; OCT 5-9; 2005; Antalya, Turkey. [Poster]

 

Sipurzynski, S; Neumeister, P; Lanzer, G; Linkesch, W; Strunk, D; Modified extracorporal photochemotherapy of acute graft-versus-host disease of the intestine - A case report.
Wien Med Wscr. 2005; 155(117):11-11. [Poster]

 

Sipurzynski, S; Neumeister, P; Lanzer, G; Linkesch, W; Strunk, D; Modified extracorporal photochemotherapy of acute graft-versus-host disease of the intestine - A case report.
Transfusion Medicine Hemotherapy. 2005; 32: 27-28.- ; ; . [Oral Communication]

 

Staber, PB; Vesely, P; Ott, R; Schauer, S; Linkesch, W; Kadin, ME; Dirks, W; Sternberg, DW; Höfler, G; NPM-ALK fusion kinase actiivates AP-1-DNA binding via junB.
Wien Med Wscr. 2005; 155(117):19-19. [Poster]

 

Strunk, D; Thaler, D; Rohde, E; Malischnik, C; Lanzer, G; Linkesch, W; Environmental conditioning of CFU-EC by primed blood monocytes.
Onkologie2005; 28: 181-181.-Deutsche Gesellschaft für Hämatologie und Onkologie (DGHO); OKT 1-5, 2005; Hannover, GERMANY. [Poster]

 

Thaler, D; Rohde, E; Malischnik, C; Lanzer, G; Linkesch, W; Strunk, D; Environmental conditioning of CFU-EC by blood monocytes.
ÖGAI Abstract book2005; 98: 55-55.-Ann Meeting of the Austrian Society for Allergy and Immunology; DEC 1-3 2005; Graz,AUSTRIA. [Poster]

 

Thaler, D; Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D Environmental conditioning of CFU-EC by primed blood monocytes
BONE MARROW TRANSPLANT. 2005; 35: S115-S115.-31st Annual Meeting of the European Group for Blood and Marrow Transplantation/21st Meeting of the EBMT Nurses Group/4th Meeting of the EBMT Data Management Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

Weingrill, E; Wölfler, A; Strunk, D; Emberger, W; Linkesch, W; Liebmann, PM; Roscovitine induces apoptosis and shows synergistic activity with alemtuzumab in isolated B-CLL cells.
Wien Med Wscr. 2005; 155(117):20-20. [Poster]

 

Zinke-Cerwenka, W; Neumeister, P; Eibl, M; Sill, H; Emberger, W; Wagner, T; Wolfler, A; Linkesch, W Planned sequential autologous/non-myeloablative allogeneic peripheral stem cell transplantation in patients with newly diagnosed high-risk multiple myeloma
BONE MARROW TRANSPLANT 2005 35: S387-S388.
Web of Science

 

Eibl, M; Auner, H; Zinke-Cerwenka, W; Sill, H; Linkesch, W Autologous stem cell transplantation with alemtuzumab as part of the conditioning for B-cell prolymphocytic leukaemia
BONE MARROW TRANSPLANT 2004 33: S290-S290.
Web of Science

 

Eibl, M; Zinke-Cerwenka, W; Neumeister, P; Wolfler, A; Sill, H; Linkesch, W Autologous stem cell transplantation for multiple myeloma in elderly patients
BONE MARROW TRANSPLANT 2004 33: S357-S357.
Web of Science

 

Holub, R; Staber, PB; Linkesch, W; Neumeister, P; Pegfilgastrim shows safety and efficacy in patients undergoing autologous hematopoeitic stem cell transplantation for hematological malignancies.
Acta Chir Aust. 2004; 36: 16-16.- ; ; . [Poster]

 

Langner, S; Schmidt, H; Linkesch, W; Emberger, W; A case of Philadelphia chromosome negative CML with a novel translocation t(7;17)(q22;q21).
Onkologie. 2004; 27: 168-168. [Poster]

 

Linkesch, W Zevalin - a new treatment modality in NHL.
Symposium der Ungarischen Gesellschaft für Hämatologie und Onkolgie; JUN 5, 2004; Budapest, HUNGARY. 2004. [Keynote lecture]

 

Linkesch, W Transplantation von hämatopoetischen Stammzellen aus der Nabelschnur
Symposium-15 Jahre Transplantation Hämatopoetischer Stammzellen von Nicht.verwandten Spendern in Österreich; Sept. 16. 2004; Wien, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W Mabthera in der Therapie der NHL.
; JUL 9, 2004; Villach, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W Zarnestra in der Behandlung des älteren Patienten mit AML.
Frühjahrestagung der ÖGHO; APR 16, 2004; Vienna, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W Glivec nach allogener Stammzelltransplantation.
Symposium; JAN 23 2004; Loipersdorf, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W Therapie mit Zarnestra in AML.
12th Annual Meeting of the Hellenic Society of Hematology and Oncology.; APR 22, 2004; Athens, GREECE. 2004. [Keynote lecture]

 

Linkesch, W Radioimmuntherapie mit Zevalin.
; JUL 9, 2004; Klagenfurt, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W, Cord Blood Transplantation.
9th Meeting of the Asian Pacific BMT-Society; Nov, 11, 2004; Teheran, IRAN. 2004. [Keynote lecture]

 

Linkesch, W, Conditioning therapy in multiple myeloma.
9th Meeting of the Asian Pacific BMT-Society; Nov, 11, 2004; Teheran, IRAN. 2004. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation
Symposium; SEP 5, 2004; Rust, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W; Innovative Therapie mit Erythropoietin.
Interdisziplinärer Winterworkshop; JAN 13 2004; Zürs, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W; Therapie der akuten Leukämie.
Symposium; JAN 16, 2004; Unterach, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W; Radioimmuntherapie bei NHL.
Symposium; SEP 29, 2004; Vienna, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W; Radioimmuntherapie.
Gemiensame Jahrestagung der Deutschen, Österreichischen und Schweizer Gesellschaft für Hämatologie und Onkologie; OCT 2, 2004; Innsbruck, AUSTRIA. 2004. [Keynote lecture]

 

Linkesch, W; ATG bei Stammzelltransplantation.
Symposium; OCT 9, 2004; Amman, JORDANIEN. 2004. [Keynote lecture]

 

Ludwig, H; Linkesch, W; Kahls, P; Zojer, N; Krieger, O; Greinix, H; Hinterberger, W; Pittermann, E; Bauer, F; Drach, J; Gisslinger, H; Greil, R; Gastl, G;; Results of autologous transplantation for multiple myeloma in Austia. An analysis based on data from the Austrian stem cell registry(ASCT).
The Haematol J. 2004; 5(2):126-126. [Poster]

 

Ludwig, H; Zojer, N; Linkesch, W; Kahls, P; Krieger, O; Greinix, HT; Hinterberger, W; Pittermann, E; Bauernhofer, T; Gastl, G Results of autologous transplantation for multiple myeloma (MM) in Austria. An analysis based on data from the Austrian Stem Cell Transplantation (ASCT) Registry
J CLIN ONCOL 2004 22: 596S-596S.
Web of Science

 

Neumeister, P; Holub, R; Staber, PB; Linkesch, W Pegfilgrastim shows safety and efficacy similar to filgrastim in patients undergoing autologous stem cell transplantation for hematological malignancies.
BLOOD 2004 104: 327A-327A. Doi: 10.1182/blood.V104.11.1156.1156
Web of Science FullText FullText_MUG

 

Neumeister,P; Strunk,D; Wölfler,A; Linkesch,W; Pegfilgastrim shows safety and efficacy in patients undergoing autologous hematopoietic stem cell transplantation for hematological malignancies.
Acta Med Aust. 2004; 31(5):19-19. [Poster]

 

Neumeister,P; Strunk,D; Wölfler,A; Linkesch,W; Pegfilgastrim shows safety and efficacy in patients undergoing autologous stem cell transplantation for hematological malignancies.
Onkologie. 2004; 27: 172-172. [Keynote lecture]

 

Rohde, E; Thaler, D; Lanzer, G; Linkesch, W; Strunk, D Human lineage-negative cells for regenerative stem cell therapy
BONE MARROW TRANSPLANT 2004 33: S171-S172.
Web of Science

 

Rohde, E; Volk, B; Malischnik, C; Lanzer, G; Linkesch, W; Schulz, MB; Strunk, D Human lineage-negative blood for regenerative stem cell therapy?
Deutsche Gesellschaft für Hämato-Onkologie (DGHO); OCT 3-6, 2004; Innsbruck, AUSTRIA. 2004. [Poster]

 

Rohde, E; Volk, B; Malischnik, C; Lanzer, G; Linkesch, W; Strunk, D Human lineage-negative blood for regenerative stem cell therapy?
Österreichische Gesellschaft für Hämato-Onkologie, ÖGHO; APR 15-17, 2004; Vienna, AUSTRIA. 2004. [Poster]

 

Schmidt, HH; Renner, H; Linkesch, W; Intrapleural instillation of Rituximab for the treatment of malignant pleural effusion in a patient with NHL.
Onkologie. 2004; 27: 191-191. [Poster]

 

Staber, PB; Brezinschek, R; Linkesch, W; Sill, H; Neumeister, P; Imantinib mesylate (STI571) induces cytogenetic and molecular remission in CML myeloid blast crisis after nonmyeloablative allogeneic stem-cell transplantation - a follow up report.
Acta Chir Aust. 2004; 36: 35-35. [Poster]

 

Staber, PB; Linkesch, W; Schauer, S; Moser, G; Kadin, ME; Dirks, W; Hoefler, G Genes regulated by NPM-ALK fusion kinase play a key role in the activation of AP-1 transcription factors.
BLOOD 2004 104: 74A-74A. Doi: 10.1182/blood.V104.11.245.245
Web of Science FullText FullText_MUG

 

Staber, PB; Linkesch, W; Schauer, S; moser, G; Kadin, ME; Dirks, W; Höfler, G; Expression profiling reveals NPM-ALK fusion kinase regulated genes and indicates a critical role for activation of AP-1-transcription factor.
Onkologie. 2004; 27: 130-130. [Poster]

 

Staber,PB; Linkesch,W; Schauer,S; Moser,G; Kardin,ME; Dirks,W; Hoefler,G; Functional targets of NPM-ALK fusion kinase expression revealed by combining cDNA subtraction and microarray analysis.
Acta Med Aust. 2004; 31: 4-4. [Keynote lecture]

 

Strunk, D; Rohde, E; Lanzer, G; Linkesch, W; Preclinical production of human lineage-negative cells from nonmobilized blood for regenerative stem cell therapy.
Onkologie. 2004; 27: 113-113. [Poster]

 

Strunk,D; Rohde,E; Lanzer,G; Linkesch,W; Phenotype and preclinical production of human lineage-negative cells for generative stem cell therapy.
Acta Med Aust2004; 31: 21-21.- ; ; . [Poster]

 

Wölfler,A; Erkeland,S; Leitner,C; Olipitz,W; Bodner,C; Renner,W; Pfeilstöcker,M; Tinchon,C; Linkesch,W; Touw,IP, Sill,M; Assoziation des funktionellen Glu785Lys Polymorphismus des G#CSF Rezeptors mit Hochrisiko-Myelodysplasie.
Acta Med Aust. 2004; 31: 8-8. [Keynote lecture]

 

Wölfler,A;Ekkeland,S;;Bodner,C;Vakhof,M;Renner,W;Leitner,C;Olipitz,W;Pfeilstöcker,M;Tinchon,Ch;Emberger,W;Linkesch,W;Touw IP;Sill,H A functional single nucleotide polymorphism of the GCSF receptor gene predisposes to high-risk myelodysplastic syndrome
99. Hämatologisch- Onkologischer Diskussionsabend; NOV 25 2004; Wien, Austria. 2004. [Keynote lecture]

 

Zebisch, A; Ofner, P; Sill, H; Linkesch, W; Krause, R; Auner, HW; Risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with hematopoietic malignancies.
Onkologie. 2004; 27: 8-8. [Poster]

 

Zebisch, A; Ofner, P; Sill, H; Linkesch, W; Krause, R; Auner, HW; Analysis of risk factors for early infectous complications after autologous peripheral blood stem cell transplantation in patients with hematopoietic malignancies.
Acta Chir Aust. 2004; 36: 17-17. [Poster]

 

Zebisch, A; Staber, PB; Fischereder, K; Bodner, C; Hiden, K; Linkesch, W; Auner, HW; Emberger, W; Sovinz, P; Schimek, MG; Höfler, G; Sill, H; Analysis of the proto-oncogenes A-, B- and C-RAF in acute myeloid leukemia.
The Hematol J. 2004; 5: 2-2. [Poster]

 

Zebisch, A; Staber, PB; Fischereder, K; Bodner, C; Hiden, K; Linkesch, W; Auner, HW; Emberger, W; Windpassinger, C; Schimek, MG; Hoefler, G; Troppmair, J; Sill, H Two novel activating germline mutations of the C-RAF proto-oncogene predisposing to solid tbmors and therapy-related acute myeloid leukemia.
BLOOD 2004 104: 920A-920A. Doi: 10.1182/blood.V104.11.3370.3370
Web of Science FullText FullText_MUG

 

Zebisch, A; Staber, PB; Fischereder, K; Bodner, C; Hiden, K; Linkesch, W; Auner, HW; Windpassinger, C; Höfler, G; Sill, H; C-RAF mutations in therapy-related acute myeloid leukemia.
Onkologie. 2004; 27: 118-118. [Poster]

 

Zebisch, A; Staber,P; Fischeneder,K; Bodner,C; Hiden,K; Linkesch,W; Auner,H; Emberger,W; Sovinz,P; Schirnek,M; Höfler, G; Sill,H. C-RAF Mutationen und B-RAF Gen Deletion bei therapieassoziierter akuter myeloischer Leukämie
98.Hämatologisch-Onkologischer Diskussionsabend der Österr. Gesellschaft für Hämatologie und Onkologie; JUNI. 17, 2004; Wien, AUSTRIA. 2004. [Keynote lecture]

 

Zebisch,a; Staber,PB; Fischereder,K; Bodner,C; Hiden,K; Linkesch,W; Auner,HW; Emberger,W; Sovinz,P; Schimek,MG; GHöfler,G; Sill,H; C-RAF missense mutations and B-RAF gene deletion in therapy related acute myeloid leukemia.
Acta Med Aust. 2004; 31: 9-9. [Keynote lecture]

 

Zinke-Cerwenka, W; Eibl, M; Sill, H; Höfler, G; Neumeister, P; Linkesch, W; Continuous molecular remission after discontamination of Imantinib mesylate following relapse after nonmyeloablative allogeneic stem cell transplantation for CML.
Acta Chir Aust. 2004; 36: 36-36. [Poster]

 

Zinke-Cerwenka, W; Eibl, M; Sill, H; Hofler, G; Staber, P; Linkesch, W Continuous molecular response after discontinuation of imatinib mesylate following relapse after non-myeloablative allogeneic stem cell transplantation for CML
BONE MARROW TRANSPLANT 2004 33: S348-S348.
Web of Science

 

Zinke-Cerwenka, W; Neumeister, P; Sill, H; Emberger, E; Wagner, T; Wölfler, A; Eibl, M; Staber, P; Linkesch, W Nonmyeloablative allogeneic peripheral stem cell transplantation following autograft for patients with newly diagnosed high-risk multiple myeloma
European Surgery 2004; 36(S200):25-25.- ; ; . [Poster]

 

Auner,HW; Zebisch,A; Schimek,G; Bodner,C; Hiden,kK, Linkesch,W; Haas,OA; Sill,H; Analysis of the sister-chromatid separation regulator and proto-oncogene hSecurin in myeloid leukemias.
Proceedings of the 17th meeting of the Int.Soc of Haematology2003; 22-22.-17th meeting of the Int.Soc of Haematology; SEP 7-10, 2003; Graz,AUSTRIA. [Poster]

 

Dornbusch, HJ; Benesch, M; Eibl, M; Lackner, H; Linkesch, W; Schwinger, W; Sovinz, P; Strenger, V; Urban, CE Successful management of invasive pulmonary aspergillosis (IPA) in two patients with high risk acute leukemia by combined antifungal treatment and reduced intensity conditioning (RIC) stem cell transplantation (SCT).
BLOOD 2003 102: 441B-441B.
Web of Science

 

Dornbusch,HJ; Eibl, M; Lackner,H; Linkesch,W; Schwinger, W; Sovinz,P; Strenger,V; Urban,C Successfull management of invasive pulmonary aspergillos by means of combination antifungal treatment in 2 patients with high risk acute leukemia and MUD-stem cell transplantation.
Eur Surg (suppl 194) 2003; 35: 13--17. Jahrestagung der österreichischen Gesellschaft für Transplantation, Transfusion & Genetik (Austrotransplant); OKT 17, 2003; Gosau. [Oral Communication]

 

Dornbusch,HJ; Eibl,M; Lackner,H; Linkesch,W; Schwinger,W; Sovinz,P; Strenger,V; Urban,C; Successful management of invasive pulmonary aspergilliosis by means of combination antifungal treatment in 2 patients with high risk acute leukemia and MUD-stem cell transplantation.
Acta Chir Aust. 2003; 35: 13-13.- ; ; . [Keynote lecture]

 

Eibl,M; Auner,HW; Linkesch,W; Treatment of B-Cell prolymphocytic leukemia with autografting, following conditioning which included Alemtuzumab.
The Hematol J. 2003; 4: 80-80.- ; ; . [Poster]

 

Eibl,M; Auner,HW; Sill,H; Linkesch,W; Autologous stem cell transplantation with Alemtuzumab as part of the conditioning for B-Cell prolymphocytic leukemia.
Acta Chir Aust. 2003; 35: 16-16.- ; ; . [Poster]

 

Eibl,M; Auner,HW; Zinke-Cerwenka,W; Sill,H; Dornbusch,HJ; Linkesch,W; High risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long term administration of Voriconazole.
Acta Chir Aust. 2003; 35: 14-14.- ; ; . [Poster]

 

Höfler, G; Staber, PB; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate and activation of the B-RAF/MEK/erk pathway at relapse of acute myeloid leukemia
LAB INVEST 2003 83: 235A-236A.
Web of Science

 

Höfler, G; Staber, PB; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate and activation of the B-RAF/MEK/Erk pathway at relapse of acute myeloid leukemia
MODERN PATHOL 2003 16: 235A-236A.
Web of Science

 

Kuhr, T; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Lutz, D; Vorlieek, J; Cernelc, P; Bernhart, M; Lin, W; Hausmaninger, H; Greil, R; Gastl, G; Michlmayr, G; Thaler, J Treatment of newly-diagnosed CML patients with interferon alpha and continuous versus intermittent cytarabin-ocfosfat (YNK01): A randomized Central European Leukemia Study.
BLOOD 2003 102: 311B-311B.
Web of Science

 

Kühr,T; Apfelbeck,U; Linkesch,W; Mistrik,M; Tothova,E; Koza,V; Lutz,D; Vorlieek,J; Cernelc,P; Bernhart,M; Lin,W; Hausmanninger,H; Greil,R; Gastl,G; Michlmayr,G; Thaler,J; Treatment of newly diagnosed CML patients with Interferon Alpha and continous versus intermittent Cytarabin-Ocfosfat (YNK01): a central European leukemia study.
Acta Med Aust. 2003; 30: 12-12.- ; ; . [Keynote lecture]

 

Linkesch, W; Stellenwert der neuen Antimykotica und Erfahrungen mit Voriconazol.
Symposium Mycologie; JAN 27, 2003; Innsbruck, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch, W; Glivec first line: Einsatz bei CML zum direkten Vergleichzu Interferon-Alpha/ARAC.
Frühjahrestagung der österreichischen Gesellschaft für Hämatologie ud Onkologie; MAR 25, 2003; Dornbirn, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch, W; Anitiemetische Therapie.
Winterworkshop; JAN 13 2003; Zürs, AUSTRIA. 2003. [Keynote lecture]

 

Linkesch, W; Klinische Erfahrungen mit Voriconazol.
Symposium, Antifungale Infektionen; JAN 16, 2003; Dornbirn, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch, W; Innovation in neutropenia management.
XIIth Meeting of the International Society of Haematology - European and African Division ; SEP 7-10, 2003; Graz, AUSTRIA. 2003. [Keynote lecture]

 

Linkesch, W; Fludarabine and radioimmunotherapy for the treatment of NHL.
XIIth Meeting of the International Society of Haematology - European and African Division ; SEP 7-10, 2003; Graz, AUSTRIA. 2003. [Keynote lecture]

 

Linkesch, W; Chronische myeloische Leukämie.
Fortbildung Ärztekammer für Steiermark; FEB 15, 2003; Knittelfeld, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch, W; Experience with Voriconazol in Hematology.
10th meeting European Society of Chemotherapy; JUL 1, 2003; Vienna, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation bei AML.
AML-Symposium; NOV 21, 2003; Vienna, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch, W; Verträglichkeitsprofil von Mitoxantron.
Symposium; NOV 7, 2003; Klagenfurt, AUSTRIA. 2003. [Keynote lecture]

 

Linkesch, W; CML: Besteht Hoffnung auf Heilung?.
Symposium; OCT 23, 2003; Klagenfurt, AUSTRIA. 2003. [Keynote lecture]

 

Linkesch, W; Glivec - the new gold-standard for newly diagnosed patients PH+CML.
XIIth Meeting of the International Society of Haematology - European and African Division ; SEP 7-10, 2003; Graz, AUSTRIA. 2003. [Keynote lecture]

 

Linkesch, W; Glivec - ein Durchbruch in der Therapie der CML.
Wissenschaftswoche ; SEP 24, 2003; Palma, SPAIN. 2003. [Keynote lecture]

 

Linkesch, W; Transplantation mit allogenen Stammzellen aus der Nabelschnur.
Österreichische Gesellschaft für Medizin ; SEP 19, 2003; Graz, AUSTRIA. 2003. [Keynote lecture]

 

Linkesch, W; Neuentwicklungen in der Erythropoietin-Therapie.
EPO-Symposium; JUN 6, 2003; Villach, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch, W; Cord blood transplantation.
Stammzellsymposium; MAR 4, 2003; Knittelfeld, AUSTRIA . 2003. [Keynote lecture]

 

Linkesch,W SZT bei Akuter Myeloischer Leukämie
Symposium Transplantation Hämatopoietischer Stammzellen; NOV 21, 2003; Wien, Austria. 2003. [Keynote lecture]

 

Ludwig,H; Klener,P; Spicka,I; Greil,R; Adam,Z; Gisslinger,H; Tarkovacs g; Linkesch,W; Morant,R; Drach,J; Randomized comparison between VMPC/IFN with continous prednisolone and convential VMPC/IFN as first-line chemotherapy in multiple myeloma.
J Clin Oncol2003; 22: 601-601.-Annual Meeting ASCO; MAY 31-JUNE 3, 2003; hicago, ILLINOIS. [Poster]

 

Neumeister,P; FionaPixley,J; Linkesch,W; Stanley,ER; Pestell,RG; Cyclin D1 (BCL-1) governs adhesion and motility of macrophages and may play a role in replicative senescence.
Proceedings of the 17th meeting of the Int.Soc of Haematology2003; 21-21.-17th meeting of the Int.Soc of Haematology; SEP 7-10, 2003; Graz,AUSTRIA. [Poster]

 

Olipitz,W; Auner,HW; Linkesch,W; Sill,H; Neutrophilic leukemoid reaction masking acute leukemia.
Acta Med Aust. 2003; 30: 5-5.- ; ; . [Keynote lecture]

 

Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Immunophenotypic analysis and preclinical GMP-grade production of human lineage-negative cells for regenerative stem cell therapy.
BLOOD 2003 102: 463A-463A.
Web of Science

 

Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Characterization of human lineage-negative cells for regenerative stem cell therapy
BONE MARROW TRANSPLANT. 2003; 31: S203-S203.
Web of Science

 

Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Prevalence of CD7(+) cells in CD34(-)/Lin(-) human hematopoietic stem cell fractions
TRANSFUSION 2003 43: 52A-53A.
Web of Science

 

Rohde,E; Lanzer,G; Linkesch,W; Strunk,D; Analysis of human Lin(-) cells for regenerative stem cell therapy.
European Surgery. 2003; 35 [V52](S194):18-18.- ; ; . [Poster]

 

Rohde,E; Lanzer,G; Linkesch,W; Strunk,D; Dominance of CD7+ cells in CD34/LIN stem cell fractions of human hematopoietic tissues.
Proceedings of the 17th meeting of the Int.Soc of Haematology2003; 12-12.-17th meeting of the Int.Soc of Haematology; SEP 7-10, 2003; Graz,AUSTRIA. [Poster]

 

Rohde,E; Lanzer,G; Linkesch,W; Strunk,D; Dominance of CD7+ cells in CD24-/LIN stem cell fractions of human hematopoietic tissues.
The Hematol J2003; 4: 137-137.-8th Congress of the European Hematology Association (EHA); JUN 12-15, 2003; Lyon, France. [Poster]

 

Rosskopf, k; Sipurzynski, S; Gilli, R; Posch, U; Olipitz, W; Linkesch, W; Gehrer, M; Wagner, T; Lanzer G Bacterial contamination rate in peripheral blood progenitor cell concentrates (PBPC) could be successfully reduced after installation of a laboratory according to GMP
Transfusion Medicine and Hemotherapy 2003; 30(S1):30-30.-DGTI ; ; . [Poster]

 

Rosskopf, K; Sipurzynski, S; Gilli, R; Posch, U; Olipitz, W; Linkesch, W; Gehrer, M; Wagner, T; Lanzer, G Marked reduction of bacterial contamination rate in peripheral blood progenitor cell concentrates after installation of a labaratory according to GMP
BONE MARROW TRANSPLANT. 2003; 31: S200-S200.
Web of Science

 

Rosskopf, K; Sipurzynski, S; Gilli, R; Posch, U; Olipitz, W; Linkesch, W; Gehrer, M; Wagner, T; Lanzer, G Bacterial contamination rate in peripheral blood progenitor cell concentrates (PBPC) could be successfully reduced after installation of a laboratory according to GMP
Vox Sanguinis. 2003; S200: -ISBT; ; Istanbul, Turkey. [Poster]

 

Schmidt, HH; Thaler, D; Linkesch, W; Emberger, W; Acute myeloid leukemia with t(8;16)(p11;p13): Monitoring minimal residual disease with RT-PCR.
Proceedings of the Annual Meeting of the British Society of Haematology. 2003; -Annual Meeting of the British Society of Haematology; APR, 7-9; Glasgow, SCOTLAND. [Oral Communication]

 

Schmidt,HH; Pirc-Danoewinata,H; Linkesch,W; Strunk,D; Wieser,R; Inv(3)(q21q26) in AML/MDS: Monitoring the malignant clone with interphase FISH.
Onkologie. 2003; 25(5):95-95.- ; ; . [Poster]

 

Schmidt,HH; Thaler,D; Linkesch,W; Emberger,W; Acute myeloid leukemia with t(8;16)(p11;p13): monitoring minimal residual disease with RT-PCR.
Brit J Haematol. 2003; 121: 10-10.- ; ; . [Poster]

 

Schmidt,HH; Thaler,D; Sill,H; Strunk,D; Linkesch,W; Jäger,U; Koenig,M; Strehl,S; Emberger,W; Haas,OA; AML with translocation t(8;16)(p11;p13): FISH and RT-PCR analysis of three cases.
Onkologie. 2003; 25(5):95-95.- ; ; . [Poster]

 

Sormann,S; Greinix,H; Loidolt,G; Niederwieser,D; Nachbaur,G; Fridrik,M; Krieger,O; Ludwig,H; Reisner,R; Linkesch,W; Autologous stem cell transplantation for acute myeloid leukaemia in first complete remission in Austria.
Proceedings of the 17th meeting of the Int.Soc of Haematology2003; 61-61.-17th meeting of the Int.Soc of Haematology; SEP 7-10, 2003; Graz,AUSTRIA. [Poster]

 

Staber, PB; Neumeister, P; Duerkop, H; Schauer, S; Linkesch, W; Hoefler, G CD30 induced cell death in anaplastic large cell lymphoma involves perforin/granzyme cell death pathway and the caspase dependent death receptors TNFR-1 and FAS/APO-1.
BLOOD 2003 102: 885A-885A.
Web of Science

 

Staber,P.B; Brezinschek,R; Linkesch,W; Sill,H; Neumeister,P; Augmentation of the graft versus leukemia effect by imantimib mesylate(ST1571) after nonmyeloablative allogeneic stem cell transplantation for myeloid blast crisis of chronic myeloid leukemia.
Acta Chir Aust. 2003; 35: 14-14.- ; ; . [Poster]

 

Staber,PB; Linkesch,W; Potential targets for antileukemic therapy uncovered by gene expression profiling.
Proceedings of the 17th meeting of the Int.Soc of Haematology2003; 21-21.-17th meeting of the Int.Soc of Haematology; SEP 7-10, 2003; Graz,AUSTRIA. [Poster]

 

Staber,PB; Linkesch,W; Beham-Schmid,C; Sill,H; Hoefler,G; Novel functional characteristics of AML blasts at relapse.
Acta Med Aust. 2003; 30: 6-6.- ; ; . [Keynote lecture]

 

Staber,PB; Linkesch,W; Schauer,S; Moser,G; Kardin,ME; Dirks,W; Hoefler,G; Functional targets of NPM-ALK fusion kinase expression revealed by combining cDNA subraction and microarray analysis.
Acta Med Aust. 2003; 31: 4-4.- ; ; . [Poster]

 

Strunk,D; Rohde,E; Lanzer,G; Linkesch,W; Preclinical study: GMP grade production of lineage (Lin)-negative cells for regenerative stem cell therapy.
European Surgery. 2003; 35[V53](S194):18-18.- ; ; . [Poster]

 

Wölfler, A; Erkeland, S; Leitner, C; Olipitz, W; Bodner, C; Renner, W; Pfeilstöcker, M; Tinchon, C; Linkesch, W; Touw, IP; Sill, H; Assoziation des funktionellen Glu785Lys Polymorphismus des G-CSF Rezeptors mit Hochrisiko-Myelodysplasie.
Acta Med Aust. 2003; 31(5):8-8.- ; ; . [Poster]

 

Wölfler, A; Erkeland, S; Leitner, C; Olipitz, W; Bodner, C; Wagner, T; Linkesch, W; Touw, IP; Sill, H A functional polymorphism of the granulocyte colony-stimulating factor receptor is associated with increased risk of myelodysplastic syndrome.
BLOOD 2003 102: 915A-916A.
Web of Science

 

Zebisch, A; Staber,PB; Fischereder,K; Bodner,C; Hiden,K; Linkesch,W; Auner,HW; Emberger,W; Sovinz,P; Schimek,MG; Höfler,G; Sill,H; C-RAF missense mutations and B-RAF gene deletion in therapy-related acute myeloid leukemia.
Acta Med Aust. 2003; 31(5):9-9.- ; ; . [Poster]

 

Apfelbeck, U; Eibl, M; Neumeister, P; Zinke-Cerwenka, W; Beham-Schmid, C; Höfler, G; Linkesch, W; Safety and Efficacy of high-dose therapy and stem cell transplantation in elderly patients with AML.
The Hematology Jv2002; 3: 369-369.- ; ; . [Poster]

 

Auner,H; Sill,H; Linkesch,W; Mulabecirovic,A; Krause,R; Infectous complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma and multiple myeloma.
The Hematology J. 2002; 3: 369-369.- ; ; . [Poster]

 

Auner,h, Sill,H; Mulabecirovic,A; Linkesch,W; Krause,R; Infectous complications after autologous hematopietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma and multiple myeloma.
Acta Med Aust. 2002; 29: 19-19.- ; ; . [Oral Communication]

 

Auner,H; Tinchon,W; Linkesch,W; Tiran,A; Quehenberger,F; Link,H; Sill,H; Prolonged monitoring of serum cardiac T as an early indicator of anthracycline cardiotoxicity.
Onkologie. 2002; 25: 129-129.- ; ; . [Oral Communication]

 

Auner,H.W; Tinchon,C; Sill,H; Wölfler,A; Sormann,S; Linkesch,W; Quehenberger,F; Halwachs-Baumann,G; Serum Troponin T as an indicator of anthracycline cardiotoxicity in adults.
J Clin Oncol. 2002; 20: 289-289.-Annual Meeting ASCO; MAY 18-21,2002; Orlando,FLORIDA. [Poster]

 

Baccarani, M; Durrant, S; Linkesch, W; Lechner, K; Cooper, M; Coutre, S; Leopold, L; White, B; Richie, M; Berger, M Preliminary report of a phase 2 study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine in patients with acute myeloid leukemia.
BLOOD 2002 100: 1322-1322.
Web of Science PubMed

 

Durrant,S; Schuster,M; Linkesch,W; Piccaluga,P; Jacky,E; Leopold,L; Munteanu,M; Eten,C; Berger,M; Preliminary report of the safety and efficacy of gemtuzumab ozogamicin(Mylotarg) given in combination with caytarabine in patients with acute myeloid leukemia(AML).
J Clin Oncol. 2002; 21: 271--Annual Meeting ASCO; MAY 18-21,2002; Orlando,FLORIDA. [Poster]

 

Eibl,M; Quehenberger,F; Zinke-Cerwenka,W; Sormann,S; Linkesch,W; Influence of the donor CMV serostatus on CMV infection in allogeneic stem cell transplant recipients.
Europ Surg. 2002; 34: 8-8.- ; ; . [Poster]

 

Eibl,M; Quehenberger,F; Zinke-Cerwenka,W; Sormann,S; Linkesch,W; Influence of the donor CMV serostatus on the incidence of CMV infection in allogeneic stem cell transplant recipients.
Onkologie. 2002; 25: 94-94.- ; ; . [Poster]

 

Eibl,M; Zinke-Cerwenka,W; Apfelbeck,U; Linkesch,W; Increased incidence of CMV infection in CMV seropositive stem cell transplant recepients with seronegative donors.
The Hematology J. 2002; 3: 32-32.- ; ; . [Poster]

 

Fridrik,M; Hausmanninger,h, Linkesch,W; Greil,R; Michlmayr,G; Krieger,O; Baldinger,C; Klocker,J; Pont,J; Radaszkiewicz,T; Long-term results with a dose dense therapy for aggressive Non-Hodgkin's Lymphoma. a study of the AGMT.
Acta Med Aust. 2002; 29: 11-11.- ; ; . [Oral Communication]

 

Krieger,O; Machherndl-Spandl,S; Greinix,H; Kahls,P; Mitterbauer,M; Rabitsch,W; Nachbaur,D; Niederwieser,D; Gadner,H; Karlhuber,S; Peters,C, Linkesch,W; Jäger,G; Schwinger,W; Pammer,G; Urban,C; Kasparu,H; Lutz,D; Gritsch,B; Stammzelltransplantationen in Österreich bei MDS-Patienten: Retrosp. Auswertung der ASCTR Daten.
Acta Med Aust. 2002; 29: 25-25.- ; ; . [Oral Communication]

 

Kuehr, T; Burgstaller, S; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Greil, R; Michlmayr, G; Lutz, W; Thaler, J Interferon alpha in combination with intermittent versus continuous YNK01 in patients with CML in early chronic phase: Preliminary results of a randomized phase III study.
BLOOD 2002 100: 328B-328B.
Web of Science

 

Kühr,T; Apfelbeck,U; Linkesch,W; Mistrik,M; Tothova,E; Koza,V; Krieger,O; Lutz,D; Vorlieek,J; Vernelc,P; Bernhart,M; Schlögl,E; Lin,w; Labar,B; Hausmanninger,H; Faber,E; Popescu,D; Greil,R; Geissler,D; Michlmayr,G; Ionita,H; Laszlo,E; Seewann,H; Udvari,M; Klamova,H; Egyed,M; Duba,C; Gastl,G; Thaler,J, Interferon alpha in combination with intermittent versus continous YNK01 in patients with CML in early chronic phase:preliminary results of a randomized phase III study.
Acta Med Aust. 2002; 29: 7-7.- ; ; . [Keynote lecture]

 

Linkesch, W Möglichkeiten und Granzen der Stammzellforschung und des Klonens.
Concentrum; MAY 15, 2002; Stadtschlaining, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Stellenwert von Myelotarg bei AML
Symposium Myelotarg; JUN 25, 2002; Wien, Austria. 2002. [Keynote lecture]

 

Linkesch, W Frühe ASCT bei peripheren T-Zell-Lymphomen
Frühjahrestagung d Österr Ges f Hämatologie und Onkologie; APR 25-27, 2002; Linz, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W New paradigm: Targeted drug therapy.
3rd CEOG; JUN 22, 2002; Opatija, CROATIA. 2002. [Keynote lecture]

 

Linkesch, W Hämatopoietische Stammzelltransplantation.
Symposium Österr. Ges. f. Rheumatologie; FEB 2, 2002; Vienna, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W IgM-enriched Immunglobulin for prevention of Infection in Stem cell Transplantation.
16th Meeting of the Internat. Society of Haematology - European and African Division; Jan 7 2002; Cairo, EGYPT. 2002. [Keynote lecture]

 

Linkesch, W Changes of paradigm in the treatment of chronic myelogenous Leukemia.
Int Symposium; FEB 1, 2002; Bukarest, ROMANIA. 2002. [Keynote lecture]

 

Linkesch, W Therapie der Leukämie.
Symposium Onkologie; OCT 5, 2002; Scheibbs, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Bisherige Erfahrungen mit Glivec.
Symposium ; JAN 26, 2002; Loipersdorf, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Therapie mit allogenem Nabelschnurblut.
Wissenschaftl Gesellschaft der Ärzte in der Steiermark und Steirische Akademie für Allgemeinmedizin; JUN 27, 2002; Graz, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Zur Evaluierung der Diagnose und Therapie von NOn-Hodgkin-Lymphomen.
Frühjahrstaung der ÖGHO; APR 25, 2002; Linz, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Therapie mit allogenem Nabelschnurblut.
31. steirische MTA-Tagung; OCT 4, 2002; Graz, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Stammzelltransplantation.
Lions Club; MAR 14, 2002; Leoben, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W STI-571- Targeted Therapy in CML.
Rumänische Hämatolog. Gesellschaft; OCT 12, 2002; Bukarest, ROMANIA. 2002. [Keynote lecture]

 

Linkesch, W Die hämatopoietische Stammzelltransplantation.
Jahrestagung ÖGG; MAY 31, 2002; Alpbach, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Hyper-CCVP bei aggresiven NHL.
NHL workshop; AUG 31, 2002; Dresden, GERMANY. 2002. [Keynote lecture]

 

Linkesch, W Stem Cell Transplantation.
2nd internat. Symposium on Cord Blood Sampling and Stem Cell Therapies; FEB 2, 2002; Vienna, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Workshop: Update Hämato-Onkologie.
Interdisziplinäres Symposium; Jan 14, 2002; Zürs, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W Primärplantationsdiagnostik aus der Sicht des Hämatoonkologen.
Österr Ges f Sterilität, Fertilität und Endokrinologie; JUN 18, 2002; Vienna, AUSTRIA. 2002. [Keynote lecture]

 

Linkesch, W; Hämatopoietische Stammzelltransplantation.
31.steirische MTA-Tagung Konferenzband2002; -31.steirische MTA-Tagung; OCT 3-4, 2002; Graz, AUSTRIA. [Keynote lecture]

 

Linkesch,W; Non-myeloablative stem cell transplantation in Morbus Hodgkin.
Proceedings of the 2nd Internat. Congress on Advances in Hematology2002; 186-186.-2nd Internat. Congress on Advances in Hematology; AUG 25-SEP 2 2002; Teheran, IRAN. [Poster]

 

Linkesch,W; Zinke-Cerwenka,W; Frühe ASCT bei peripheren T-Zell-Lymphomen.
Acta Med Aust. 2002; 29: 25-25.- ; ; . [Oral Communication]

 

Marcus, R; Linkesch, W; Solano, S; Alegre, A; Ljungman, P; Simonsson, B; Fischer, T; Soufi-Mahjoubi, R; Schmitz, N Effect of lenograstim on infections after high-dose chemotherapy and autologous peripheral stem cell transplantation
BONE MARROW TRANSPLANT. 2002; 29: S36-S36.
Web of Science

 

Olipitz,W; Hopfinger,G; Jäger,U; Gunsilius,E; Girschikofsky,M; Fonatsch,C; Buxhofer,V; Seewann,H; Hartnter,E; Linkesch,W; Sill,H; Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia.
Acta Med Aust. 2002; 29: 4-4.- ; ; . [Keynote lecture]

 

Rosskopf, K; Wagner, T; Schallmoser, K; Eibl, M; Brezinschek, R; Linkesch, W; Lanzer, G Clots In cryopreserved autologous peripheral blood stem cell concentrates (Pbsc) at the time of thawing - Possible causes and prophylactic strategies
BONE MARROW TRANSPLANT. 2002; 29: S203-S203.
Web of Science

 

Rosti,G; Pico,J.L; Wandt,H; Koza,V; Salvioni,R; Theodore,C; Lelli,G; Siegert,W; Horwich,A; Marangolo,M; Schmoll,H; Linkesch, W; Pizzocaro,G; Bouzy,J; Kramar,A; Droz,P; Biron,P; High-dose chemotherapiy(HDC) in the salvage treatment of patients falling first-line chemotherapy for advanced germ cell tumours (GCT); First results of a prospective randomised trial of the European Group for Blood and Marrow Transplantation(EBMT):IT-94-study.
J Clin Oncol. 2002; 21: 180-180.-Annual Meeting ASCO; MAY 17-19,1992; Orlando,FLORIDA. [Keynote lecture]

 

Rosti,G; Pico,JL; Wandt,H; Koza,V; Salvioni,R; Theodore,C; Lelli,G; Siegert,W; Horwich,A; Marangolo,M, Schmoll,H; Linkesch,W; Pizzocaro,G; Bouzy,J; Kramar,A; Droz,J; Biron,P; High-dose chemotherapy (HDC) in the salvage treatment of patients falling first-line chemotherapy for advanced germ cell tumors (GCT); First results of a prospective randomised trial of the European Group for Blood and Marrow Transplantation (EBMT); IT-94-study.
Ann of Oncology. 2002; 13(5):10-10.- ; ; . [Oral Communication]

 

Sormann,S; Linkesch,W; Greinix,H; Loidolt,G; Niederwieser,D; Nachbauer,G; Fridrik,M; Krieger,O; Ludwig,H; Reisner,R; Urban,C; Autologous stem cell transplantation for acute myeloid leucemia in complete remission in Austria.
Acta Med Aust. 2002; 29: 19-19.- ; ; . [Oral Communication]

 

Sormann,S;Linkesch,W; Greinix,H; Loidolt,G; Niederwieser,D; Nachbaur,G; Fridrik,M; Krieger,O; Ludwig,H; Reisner,R; Urban,C; (Austrian Group for Stem Cell Transplantation) Autologous stem cell transplantation for acute myeloid leucemia in complete remission in Austria
Acta Med Austriaca ( suppl 57 ) 2002; 19--Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie ; APR 27,2002; Linz. [Oral Communication]

 

Staber, P; Höfler, G; Schauer, S; Linkesch, W; Generation of an AML specific microarray.
Proceedings of the Array user meeting at DFKZ. 2002; -Array user meeting at DFKZ; ; Heidelberg,GERMANY. [Poster]

 

Staber, PB; Hoefler, G; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate in acute myeloid leukemia blasts at relapse due to activation of the B-Raf/MEK/Erk pathway.
BLOOD 2002 100: 330A-330A.
Web of Science

 

Staber,P; Hoefler,G; Schauer,S; Linkesch,W; Pathogenesis of refractory and relapsed acute myelogenous leukemia(AML) - generation of a specific microarray.
Acta Med Aust. 2002; 29: 25-25.- ; ; . [Oral Communication]

 

Staber,P; Hoefler,G; Schauer,S; Linkesch,W; Dramatic alterations in refractory and relapsed acute myeloid leukemia (AML) in comparison to AML prior to treatment detected by combining SSH and cDNA microarrays.
Onkologie. 2002; 25: 22-22.- ; ; . [Poster]

 

Strunk, D; Grube, R; Stadelmeyer, E; Chraust, S; Linkesch, W Early dendritic cell deficiency in CLL
2002; 205-209.-7th Annual Meeting of the European-Haematology-Association; JUN 06-09, 2002; FLORENCE, ITALY. (ISBN: 88-323-2606-X )

 

Strunk,D; Stadelmayer,E; Grube,R; Chraust,S; Linkesch,W; Impaired dendritic cell function in B-CLL.
The Hematology J. 2002; 3: 244-244.- ; ; . [Poster]

 

Thaler,J; Burgstaller,S; Kühr,T; Apfelbeck,U; Linkesch,W; Pontr,h; Sill,H; Seewann,H; Fridrik,M; Stiftner,E; Michlmayr,G, Krieger,O; Lutz,D; Lin,W; Kock,L; Abbrederis,K; Baldinger,C; Buder,R; Geissler,D; Hausmanninger,H; Lang,A; Zabernigg,A; Duba,C; Kühr,T; Hiolbe,W; Eisterer,W; Fiegl,M; Greil,R; Gastl,G; A randomised study comparing Interferon plus low dose Cytarabine and Interferon plus Hydroxyurea in early chronic phase chronic myeloid leukemia.
Acta Med Aust. 2002; 29: 5-5.- ; ; . [Keynote lecture]

 

Zinke-Cerwenka, W; Eibl, M; Beham-Schmid, C; Sormann, S; Neumeister, P; Linkesch, W Autologous stem cell transplantation in patients with peripheral T-cell lymphomas
BONE MARROW TRANSPLANT. 2002; 29: S88-S88.
Web of Science

 

Zinke-Cerwenka.W; Eibl,M; Beham-Schmid,C; Sormann,S; Neumeister,P; Linkesch,W; Early stem cell transplantation in patients with peripheral T-cell lymphoma.
The Hematology J. 2002; 3: 40-40.- ; ; . [Poster]

 

Zinke-Cerwenka,W;Eibl,M;Beham-Schmid,C;Sormann,S;Brezinschek,R;Neumeister,P;Linkesch,W Stem Cell Transplantation in Patients with Aggressive Non-Hodgkin's Lymphoma in 1.CR
ACTA MEDICA AUSTRIACA. 2002; 29(57):20-20.-Frühjahrstagung der ÖGHO; A 25-27, 2002PR; Linz, Ausiria. [Oral Communication]

 

Apfelbeck, U; Eibl, M; Brezinsek, R; Höfler, G; Linkesch, W; Richter's syndrome: complete molecular remission after autologous stem cell transplantation.
Onkologie. 2001; 24: 35-35.- ; ; . [Poster]

 

Apfelbeck, U; Eibl, M; Hoefler, G; Linkesch, W High-dose therapy and peripheral blood progenitor cell transplantation in elderly patients
BONE MARROW TRANSPLANT. 2001; 27: S315-S315.
Web of Science

 

Apfelbeck, U; Eibl, M; Hoefler, G; Linkesch, W; safety and efficacy of high-dose therapy and stem cell transplantation in elderly patients.
Leukemia Research. 2001; 25: 36-36.- ; ; . [Poster]

 

Apfelbeck, U; Eibl, M; Sormann, S; Hoefler, G; Zinke-Cerwenka, W; Linkesch, W; Early infections following stem cell transplantation results of blood culture monitoring.
The Hematol Journal. 2001; (1):224-224.- ; ; . [Poster]

 

Apfelbeck, U; Sormann, S; Brezinsek, R; Eibl, M; Zinke-Cerwenka, W; Hoefler, G; Linkesch, W; Peripheral autologous stem cell transplantation for acute myeloid leukemia in first remission.
The Hematol Journal. 2001; (1):220-220.- ; ; . [Poster]

 

Apfelbeck, U; Tinchon, C; Anderhuber, W; Aigner, R; Linkesch, W; Beham-Schmid, C; Positron emission tomography in follicular dendritic cell sarcoma.
Onkologie. 2001; 24: 202-202.- ; ; . [Poster]

 

Auner, HW; Tinchon, C; Brezinschek, RI; Eibl, M; Sormann, S; Maizen, C; Linkesch, W; Schmon-Kampel, R; Sill, H Serum cardiac troponin T (cTnT) levels, ventricular repolarization indices and echocardiographic parameters after fractionated total body irradiation and high-dose cyclophosphamide (fTBI/Cy).
BLOOD 2001 98: 5138-5138.
Web of Science

 

Auner,HW; Tinchon,C; Eibl,M; Brezincek,R; Soemann,S; Schmon-Kampel;R; Maizen,C; Halwachs-Baumann,G; Linkesch,W; Sill,H; Conditioning with fractionated total body irradiation and high-dose cyclophosphamide(fTBI/Cy) does not result in any cardiotoxicity as shown by serum cardiac troponin T (cTnT) levels, ventricular repolarisation indices ans echocardiography,.
Onkologie. 2001; 24: 120-120.- ; ; . [Poster]

 

Auner,HW; Tinchon,C; Sormann,S; Wölfler,A; Linkesch,W; Quehenberger,F; Halwachs-Baumann,G; Sill,H; Serum troponin T as an indicator of anthracycline cardiotoxicity in adults.
Acta Med Aust. 2001; 28: 10-10.- ; ; . [Keynote lecture]

 

Beham-Schmid,Ch; Apfelbeck,U; Hoefler,G; Tsybrovsky,O; Sill,H; Haas,O; Linkesch,W; STI571-therapy in patients with chronic myeloid leukemia causes regression of bone marrow fibrosis.
Onkologie. 2001; 24: 186-186.- ; ; . [Poster]

 

Eibl, M; Zinke-Cerwenka, W; Sormann, S; Apfelbeck, U; Linkesch, W Are CMV negative donors a special risk factor for CMV positive stem cell transplant recipients?
BONE MARROW TRANSPLANT. 2001; 27: S153-S153.
Web of Science

 

Eibl,ME; Zinke-Cerwenka,W; Neumeister,P; Apfelbeck,U; Rosskopf,K; Linkesch,W; Effective peripheral blood progenitor cell mobilisation in related donors by optimizing the G-CSF dosing schedule.
The Hematol Journal. 2001; (1):207-207.- ; ; . [Poster]

 

Eibl,MJ; Zinke-Cerwenka,W; Neumeister,P; Apfelbeck,U; Rosskopf,K; Linkesch,W; Peripheral blood progenitor cell mobilization in related donors: influence og the G-CSF dosing schedule.
Onkologie. 2001; 24: 45-- ; ; . [Poster]

 

Eibl,W; Zinke-Cerwenka,W; Neumeister,P; Apfelbeck,U; Linkesch,W; CBV as preperative regimen for ASCT in relapsed or refractory aggressive non-Hodgkin's lymphoma.
Onkologie. 2001; 24: 206-206.- ; ; . [Poster]

 

Fridrik, MA; Hausmaninger, H; Linkesch, W; Greil, R; Michlmayr, G; Krieger, O; Baldinger, C; Klocker, J; Pont, J; Radaszkiewicz, T Long term results with a dose density therapy for aggressive non-Hodgkin's lymphoma. A study of the ARGE medikamentoese tumortherapie.
BLOOD 2001 98: 135A-135A.
Web of Science

 

Greinix, HT; Nachbaur, D; Krieger, O; Eibl, M; Kalhs, P; Lutz, D; Linkesch, W; Niederwieser, D; Rosenmayr, A; Gritsch, B Factors impacting leukemia-free and overall survival of patients with acute myelogenous leukemia after allogeneic stem cell transplantation: report of the Austrian stem cell transplantation registry
BONE MARROW TRANSPLANT. 2001; 27: S81-S81.
Web of Science

 

Hilbe,W; Kühr,T; Apfelbeck,U; Fridrik,M; Seewann,H; Stöger,M; Linkesch,W; Pont,J; Baldinger,C; Hartner,E; Bernhart,M; Geissler,D; Krieger,O; Lang,A; Lin,W; Greil,R; Gastl,G; Thaler,J; Dose escalation of ARA-C improves response rates in a subgroup of CML patients with poor response rates un a subgroup of CML patients to IFN alfa and low dose ARA-C.
Acta Med Aust. 2001; 28: 49-49.- ; ; . [Keynote lecture]

 

Kreil,S; Lahaye,T; Müller,MC; Weißer,A; Schoch,C; Berger,u; Linkesch,W; LaRosée,P; Corbin,A; Druker,B; Cross,NCP; Schaidmeier,H; Hehlmann,R; Hochhaus,A; Molecular and chromosomal mechanism of resistance in CML patients after STI571 (Glivec) monotherapy.
Onkologie. 2001; 24: 186-186.- ; ; . [Poster]

 

Linkesch, W Therapie der CMV Infektion in der KMT
CMV - Symposium; May 31, 2001; Graz, Austria. 2001. [Keynote lecture]

 

Linkesch, W Erythropoietin in NHL
Masterclass "Erythropoietin bei lymphoproliferativen Erkrankungen "; APR 6-8, 2001; Salzburg, Austria. 2001. [Keynote lecture]

 

Linkesch, W; Molekulare Grundlagen des Einsatzes von Tyrosinkinasehemmern bei hämato-onkologischen Patienten.
Österr. Gesellschaft für Innere Medizin; OCT 5, 2001; Innsbruck, AUSTRIA . 2001. [Keynote lecture]

 

Linkesch, W; Anämie bei lymphoproliferativen Erkrankungen.
Int. Symposium ; APR 7, 2001; Salzburg, AUSTRIA. 2001. [Keynote lecture]

 

Linkesch, W; Hämatologische Erkrankungen im Alter.
Wissenschaftliche Gesellschaft der Ärzte; APR 21, 12001; Bad Aussee, AUSTRIA. 2001. [Keynote lecture]

 

Linkesch, W; Stem Cell Transplantation.
Symposium Haematology and Oncology Pharmacist Entering the new Millenium; JAN 25, 2001; Paris, FRANCE. 2001. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation.
Österr. Gesellschaft für Innere Medizin; OCT 5, 2001; Innsbruck, AUSTRIA . 2001. [Keynote lecture]

 

Linkesch, W; MacCampath, die zielgerechte Behandlung der CML.
Symposium; OCT 24, 2001; Graz, AUSTRIA. 2001. [Keynote lecture]

 

Linkesch, W; Glivec: clinical results in chronic and accelerated Phase CML.
Internationales Symposium; NOV 29, 2001; Innsbruck, AUSTRIA . 2001. [Keynote lecture]

 

Linkesch, W; Autologe Stammzelltransplantation bei AML.
Autotransplant; NOV 9, 2001; Going, AUSTRIA. 2001. [Keynote lecture]

 

Linkesch, W; Erythropoietin in der Hämato-Onkologie.
Interdisziplinäres Symposium; JAN 15, 2001; Zürs, AUSTRIA. 2001. [Keynote lecture]

 

Linkesch, W; Antikörpertherapie der AML
Symposium Hämatologie - State of the Art und neue Therapieperspektiven; JUN 30, 2001; Vienna, AUSTRIA . 2001. [Keynote lecture]

 

Linkesch, W; Bisherige Erfahrungen mit STI-571 (GLIVEC) in der akzelerierten Phase und dem Blasetenschub(P114+115) und in der chronischen Phase 2nd Linie(P113).
Frühjahrestagung der ÖGHo, Novartis Satelliten Symposium; MAY 3, 12001; Pörtschach, AUSTRIA. 2001. [Keynote lecture]

 

Linkesch, W; Grundlagen der Stammzelltransplantation.
Internationale Expertengespräche; DEC 1, 2001; Wien, AUSTRIA. 2001. [Keynote lecture]

 

Mulabecirovic,A; Auner,HW; Popper,h; Krause,R; Trinker,M; Linkesch,W; Sill,H; Fiberoptic bronchoscopy in immunocompromised hematological patients with pulmonary infiltrates.
Onkologie. 2001; 24: 213-213.- ; ; . [Poster]

 

Olipitz, W; Quehenberger, F; Hopfinger, G; Aguiar, RTC; Gunsilius, E; Girschikofsky, M; Bodner, C; Linkesch, W; Hoefler, G; Sill, H Defective DNA-mismatch repair: a potential mediatopr of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia.
Onkologie. 2001; 24: 88-88.- ; ; . [Poster]

 

Sormann,S; Linkesch,W; Greinix,H; Niederwieser,D; Autologous stem cell transplantation for acute myeloid leukemia in complete remission in Austria.
Onkologie. 2001; 24: 203-203.- ; ; . [Poster]

 

Stadelmeyer, E; Grube, R; Chraust, S; Linkesch, W; Strunk, D Alteration of dendritic cell function in B-CLL.
BLOOD 2001 98: 4891-4891.
Web of Science

 

Tinchon,C; linkesch,W; Strunk,D; Quantification of CD20-positive cells by FACS analysis in peripheral blood for prediction of side effects to treatment with rituximab.
Onkologie. 2001; 24: 128-128.- ; ; . [Poster]

 

Wölfler,A; Olipitz,W; Tinchon,C; Auner;H;Hoefler,G; Linkesch,W; Sill,H; Acute abdomen due to G-CSF treatment in a patient with myelodysplastic syndrome.
Onkologie. 2001; 24: 88-88.- ; ; . [Poster]

 

Zinke-Cerwenka, W; Eibl, M; Sormann, S; Neumeister, P; Linkesch, W Comparison of central venous catheters versus implantable intravenous devices in patients undergoing stem cell transplantation
BONE MARROW TRANSPLANT. 2001; 27: S311-S311.
Web of Science

 

Apfelbeck, U; Eibl, M; Brezinschek, R; Bauer, R; Hoefler, G; Linkesch, W; CD8 positive peripheral T-cell lymphoma in a patient with HIV infection.
Acta Med Aust. 2000; 27: 44-44.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Eibl, M; Hoefler, G, Linkesch, W; Fatal opportunistic infections in unrelated donor BMT receipients.
Clin Microbiology and Infection. 2000; 6: 241-241.- ; ; . [Poster]

 

Apfelbeck, U; Eibl, M; Höfler, G; Jäger, G; Linkesch, W; Treatment of patients with high-grade or intermediate-grade non Hodgkin lymphoma with Rituximab.
Int. Journ of Hematol. 2000; 72: 97-97.- ; ; . [Poster]

 

Apfelbeck, U; Eibl, M; Jäger, G; Höfler, G; Schmid-Beham, C; Linkesch, W; Treatment of high or intermediate-grade lymphoma with Rituximab.
Onkologie. 2000; 23: 578-578.- ; ; . [Poster]

 

Apfelbeck, U; Eibl, M; Sill, H; Hoefler, G; Linkesch, W; Richter's syndrome initially presenting as large-cell lymphoma in undiagnosed CLL.
Acta Med Aust. 2000; 27: 32-32.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Neumeister, P; Eibl, M; Beham-Schmid, Ch; Hoefler, G; Linkesch, W; Diffus alveolar hemorrhage after BMT in a patient with cutis marmorata congenita.
Bone Marrow Transpl. 2000; 25: 184-184.- ; ; . [Poster]

 

Apfelbeck, U; Sill, H; Höfler, G; Schmid-Beham, C; Linkesch, W; Regression og high-grade B-cell gastric lymphoma without cytotoxic treatment.
Onkologie. 2000; 32: 170-170.- ; ; . [Poster]

 

Apfelbeck, U; Sormann, S; Eibl, M; Neumeister, P; Höfler, G; Linkesch, W; High effociancy and low toxicity of peripheral blood progenitor cell autologous transplantation for elderly pytients.
Onkologie. 2000; 23: 488-488.- ; ; . [Poster]

 

Auner,H; Krause,R; Mulabecirovic,A; Sill,H; Linkesch,W; Stenotrophomonas maltophilia bacteremia in patients with hematologic malignancies and bone marrow transplant recepients.
Onkologie. 2000; 32: 628-628.- ; ; . [Poster]

 

Auner,H; Weger,M; Czejka,M; Linkesch,W; Pharmakokinetic and phase I/II study of liposomal doxorubicin (Caelyx)in combination with cyclophosphamide, vinorelbine and rednisone(Hyper-CCVP) for poor-prognosis aggressive non#Hodgkin's lymphoma(NHL).
Onkologie. 2000; 32: 569-569.- ; ; . [Poster]

 

Auner,HW; Beham-Schmid,C; Lindner,G; Fickert,P; Linkesch,W; Sill,H; Successfull non-surgical treatment of primary mucosa associated lymphoid tissue(MALT) lymphoma of colon presenting with multiple polypoid lesions.
Acta Med Aust. 2000; 27: 18-18.- ; ; . [Keynote lecture]

 

Brezinschek,R; Brezinschek,HP; Eder,S; Jäger,G; Linkesch,W; Reanalysis of VDJ-arrangements obtained from individual B cells using the germline query.
Onkologie. 2000; 23: 599-599.- ; ; . [Poster]

 

Brezinschek,RI; Brezinschek,HP; Eder,S; Bauer,F; Linkesch,W; Similar molecular features of immunoglobulin heavy chain genes in normal and chronic lymphocytic leukemia B cells.
Onkologie. 2000; 23: 101-101.- ; ; . [Poster]

 

Eibl,M; Apfelbeck,U; sormann,S; Linkesch,W; Influence of autologous stem cell transplantation on chronic hepatitis B or C.
Clin Microbiology and Infection. 2000; 6: 241-241.- ; ; . [Poster]

 

Eibl,M; Neumeister,P; Sormann,S; Zinke-Cerwenka,W; Linkesch,W; Progressive multifocal leucoencephalopathy by papova virus infection after allogeneic stem cell transplantation.
Bone Marrow Transpl. 2000; 25: 206-206.- ; ; . [Poster]

 

Eibl,M, Neumeister,P; Strunk,D; Sill,H; Linkesch,W; Adoptive transfer of vitiligo between HLA-identical siblings by bone marrow transplantation for Non-Hodgkin's Lymphoma.
Bone Marrow Transpl. 2000; 25: 114-114.- ; ; . [Poster]

 

Eibl,M; Zinke-Cerwenka,W; Neumeister,P; Sormann,S; Linkesch,W; Effiziente Stammzellmobilisierung bei Geschwisterspendern.
Acta Med Aust. 2000; 27: 33-33.- ; ; . [Keynote lecture]

 

Eibl,M,; Zinke-Cerwenka,W; Neumeister,P; Sormann,S; Rosskopf,K; Lanzer,G; Linkesch,W; Stammzellmobilisierung bei verwandten Spendern.
Acta Chir Aust. 2000; 32: 39-39.- ; ; . [Keynote lecture]

 

Eibl,M; Zinke-Cerwenka,W; Neumeister,P; Sormann,S; Strunk,D; Apfelbeck,U; Linkesch,W; Successful peripheral blood progenitor cell mobilization in healthy related donors.
Int. Journ of Hematol. 2000; 72: 30-30.- ; ; . [Poster]

 

Eibl,M; Zinke-Cerwenka,W; Neumeister,P; Sormann,S; Zander,A; Linkesch,W; ATG-containing conditioning regimen for stem cell transplantation in patients with CML.
Onkologie. 2000; 23: 524-524.- ; ; . [Poster]

 

Eibl,W; Zinke-Cerwenka,W; Sormann,S; Strunk,D; Rosskopf,K; Lanzer,G; Linkesch,W; The role of purging in autologous stem cell transplantation for Non-Hodgkin's lymphoma.
Onkologie. 2000; 23: 480-480.- ; ; . [Poster]

 

Greinix,HT; Nachbaur,D; Krieger,O; Eibl,M; Kahls,P; Lutz,D; Linkesch,W; Loidolt,H; Niederwieser,D; Rosenmayr,A; Gritsch,B; Long-term leukemia free survival of patients with acute myelogeneous leukemia after allogeneic stem cell transplantation(SCT): report of the Austrian stem cell registry.
Onkologie. 2000; 32: 4-4.- ; ; . [Poster]

 

Grube,R; Chraust,S; Linkesch,W; Strunk,D; Peripheral blood dendritic cell deficiency in chronic lymphocytic leukemia(CLL) patients.
Onkologie. 2000; 23: 621-621.- ; ; . [Poster]

 

Jager, G; Brezinschek, R; Neumeister, P; Linkesch, W Consolidation with Rituximab(Mab-Thera (TM)) after CHOP-induction as first-line treatment of follicular lymphoma. A phase II study.
BLOOD 2000 96: 240B-240B.
Web of Science

 

Jäger,G; Brezinschek,R; Beham-Schmid,Ch; Linkesch,W; Simultaneous occurence of acute myeloid leukemia(FAB-M4) and WAldenström's disease treatment with monoclonal anti-CD33-calicheamicin conjugate (CMA 676) and anti-CD20 (Rituximab).
Onkologie. 2000; 23: 397-397.- ; ; . [Poster]

 

Jäger,G, Brezinschek,R; Neumeister,P; Linkesch,W; CHOP-induction and anti-CD-20-(MAB-THERA) consolidation as first-line treatment of follicular lymphoma. preliminary data of phase II study.
Onkologie. 2000; 23: 573-573.- ; ; . [Poster]

 

Jäger,G; Neumeister,P; Raderer,M; Brezinschek,R;M Hinterleitner,T; Höfler,G; Ilsinger,P; Milneritsch,B; DeSantis,M; Linkesch,W; Treatment of low grade MALT-lymphomas with 2-chloro-deoxyadenosine. An organ preserving therapeutic concept.
Onkologie. 2000; 23: 176-176.- ; ; . [Poster]

 

Kahls,P; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Eibl,B; Lechner,K; Rosenmayr,A; Fischer,G; Unrelated donor BMT in adult patients: experience in 112 patients.
Bone Marrow Transpl. 2000; 25: 89-89.- ; ; . [Keynote lecture]

 

Kahls,P; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Eibl,B; Lechner,K; Rosenmayr,A; Fischer,G; Unrelated donor BMT in adults in Austria: experience in 134 patients.
Acta Chir Aust2000; 32: 19-19.- ; ; . [Keynote lecture]

 

Kahls,P; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Eibl,M; Lechner,K; Rosenmayr,A; Fischer,G; Unrelated donor BMT in adults in Austria: experience in 134 patients.
Onkologie. 2000; 23: 289-289.- ; ; . [Poster]

 

Linkesch, W Stem Cell Transplantation: Present Status and Future Directions
XI.Austrian- Arabic Medical Congress; NOV 10-19, 2000; Bagdad, IRAK. 2000. [Keynote lecture]

 

Linkesch, W Therapy of Acute Myelogenous Leukemia- Recent Advances
XI.Austrian- Arabic Medical Congress; NOV 10-19, 2000; Bagdad, IRAK. 2000. [Keynote lecture]

 

Linkesch, W Therapie der Lymphome 2000
Interdisziplinäres Roche-Symposium; JAN 14-19, 2000; Zürs, Austria. 2000. [Keynote lecture]

 

Linkesch, W Zukünftige Entwicklungen
Non-Myeloablative Stammzelltransplantation; DEZ 18; Graz, Austria. 2000. [Keynote lecture]

 

Linkesch, W. PegLiposomales Doxorubicin in der Therapie des Non-Hodgkin,s Lymphom
Gemeinsame Jahrestagung der Deutschen und Österreichischen Gesellschaften für Hämatologie und Onkologie; OKT 21-24. 2000; Graz, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch, W. Neue Therapiemöglichkeiten bei schweren Gram-positiven Infektionen
Gemeinsame Jahrestagung der Deutschen und Österreichischen Gesellschaften für Hämatologie und Onkologie; OKT 21-24. 2000; Graz, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch, W; Rituximab bei Non-Hodgkin-Lymphomen.
Interdisziplinäres Symposium; JAN 17-18, 2000; Zürs, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch, W; Infektionen nach Stammzelltransplantation.
Workshop "Der immungeschwächte Patient"; JUN 17, 2000; Krumbach, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch, W; PET und malignes Lymphom.
Grazer PET Symposium; Nov 24, 2000; Graz, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation.
33. Wiss. Fortbildungswoche für Apotheker ; FEB 27- MAR 3, 2000; Saalfelden, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch, W; Autologe Stammzelltransplantation bei Keimzelltumoren.
Int Symposium; JAN 28, 2000; Vienna, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch, W; PegLiposomales Doxorubicin in der Therapie des non-Hodgkin-Lymphoms.
Prinzip der Pegylierung - Fortschritt und Therapieoptimierung, Abstracts2000; 12-13.-Prinzip der Pegylierung - Fortschritt und Therapieoptimierung, Symposium im Rahmen der gemiensamen Jahrestagung der DÖGHO; OKT 24, 2000; Graz,AUSTRIA. [Keynote lecture]

 

Linkesch, W; Zukunft der Hochdosistherapie bei soliden Tumoren.
Frühjahrestagung 2000; MAY 4-6, 2000; Wien, AUSTRIA. 2000. [Keynote lecture]

 

Linkesch,W; Sormann,S; Greinix,H; Loidolt,G; Niederwieser,D; Nachbaur,G; Friedrik,M; Krieger,O; Ludwig,H; Reisner,R;Urban,C Autologous bone marrow transplantation for acute myeloid leucemia in CR in Austria. A longterm follow up.
Bone marrow transpl 2000; 25 ( suppl 1): S 82--26th Annual Meeting European Group of Blood and Marrow Transplantation; MÄRZ 6 , 2000; Innsbruck. [Oral Communication]

 

Ludwig,H; Greinix,HT; Nachbaur,D; Niederwieser,D; Linkesch,W; Lutz,D; Hinterberger,W; Pittermann-Höcker,E; Fridrik,M; Gastl,AG; Schuster,J; High-dose chemotherapy and stem cell transplantation in multiple myeloma: an analysis of the data reported to the Austrian stem cell transplantation registry(ASCTR).
Bone Marrow Transpl. 2000; 25: 325-325.- ; ; . [Poster]

 

Mitterbauer,W; Brugger; Neumeister,P; Kajls,P; Rabitsch,W; Loidolt,H; Keil,F; Hinterberger,W; Linkesch,W; Mannhalter,C; Mitterbauer,G; Greinix,HT; Clinical and molecular disease eradication after allogeneic stem cell transplantation in patients with advanced non-Hodgkin's lymphoma.
Bone Marrow Transpl. 2000; 25: 42-42.- ; ; . [Poster]

 

Mulabecirovic,A; Trinker,M; Auner,HW; Krause,R; Popper,H; Linkesch,W; Sill,H; Evaluation of fibroptic bronchoskopy in hematological patients with pulmonary infiltrates.
Acta Med Aust. 2000; 27: 46-46.- ; ; . [Keynote lecture]

 

Olipitz, W; Hopfinger, G; Hoefler, G; Girschikofsky, M; Bodner, C; Hiden, K; Aguiar, R; Linkesch, W; Sill, H Microsatellite instability but lack of alternations of genes targeted by defective DNA-mismatch repair in therapy-related MDS and leukemia.
BLOOD 2000 96: 104A-104A.
Web of Science

 

Olipitz,W; Hopfinger,G; Hoefler,G; Bodner,C; Hiden,K; Aguia,R; Ploner,F; Geissler,K, Linkesch,W; Sill,H; Analysis of DNA-mismatch repair in therapy-related myelodysplastic syndrome and leukemia.
Acta Med Aust. 2000; 27: 40-40.- ; ; . [Keynote lecture]

 

Olipitz,W; Hopfinger,G; Höfler,G; Bodner,C; Hiden,K; Aguiar,R; Ploner,F; Geissler,K; Linkesch,W; Sill,H; Evaluation of defective DNA-mismatch repair in the pathogenesis of therapy-related myelodysplastic syndrome and leukemia.
The Hematol Journ. 2000; 1: 298-298.- ; ; . [Poster]

 

Olipitz,W; Tilz,GP; Beham-Schmid,C; Eibinger,C; Kerzina,P; Linkesch,W; Sill,H; Lack of microsatellite instability in secondary acute myeloid leukemias.
Acta Med Aust. 2000; 27: 40-40.- ; ; . [Keynote lecture]

 

Rosskopf, K; Wagner, T; Helmberg, W; Sipurzynski, S; Gilli, R; Eibl, M; Linkesch, W; Hoefler, G; Lanzer, G CD34 positiv-(+) und Ein-Schritt-positiv-negativ-Selektion (+/-) autologer peripherer Blutstammzellen (PBSC) mit Isolex 300i
Acta Chirurgica Austriaca 2000; 32(170):37-37.-Austrotransplant; ; . [Poster]

 

Rosskopf, K; Wagner, T; Helmberg, W; Sipurzynski, S; Gilli, R; Eibl, M; Linkesch, W; Höfler, G; Lanzer, G CD34 positive compared to one-step positive-negative selection of autologous peripheral blood stem cells (PBSC)
TRANSFUSION 2000 40: 110S-110S.
Web of Science

 

Rosskopf, K; Wagner, T; Helmberg, W; Sipurzynski, S; Gilli, R; Eibl, M; Linkesch, W; Höfler, G; Lanzer, G CD34 positiv-(+) und Ein-Schritt-Positiv-Negativ-Selektion (+/-) autologer peripherer Blutstammzellen (PBSC) mit Isolex 300i
Acta Medica Austriaca 2000; 27(S1):A14-A14.-ÖGHO; ; . [Poster]

 

Rosskopf, K; Wagner, T; Helmberg, W; Sipurzynski, S; Gilli, R; Eibl, M; Linkesch, W; Höfler, G; Lanzer, G CD34 positive- (+) compared to one-step positive-negative-(+/-) selection of autologous peripheral blood stem cells (PBSC)
Onkologie. 2000; 23(S7):132-132.- ; ; . [Poster]

 

Rosskopf,K; Helmberg,w; Sipurzynski,S; Gilli,R; Neumeister,P; Linkesch,W; Höfler,G; Lanzer,G; CD34(+) and(+/-) selection of autologous peripheral blood progenitor cells (PBPC): a new selection of autologous peripheral blood progenitor cells(PBPC): a new software version of an immnuomagnetic cell sorter.
Vox Sanguinis. 2000; 78(51):612-- ; ; . [Poster]

 

Samonigg,H; Ludwig,H; Hinterberger,W; Lutz,D; Greinix,HT; Nachbaur,D; Niederwieser,D; Gastl,G; Baumgartner,G; Hausmanninger,H; Linkesch,W; Pittermann-Höcker,E; Fridrik,M; Schuster,J; High-dose chemotherapy and stem cell transplantation in patients with breast cancer: an analysis of the data reported to the Austrian stem cell transplantation registry(ASCTR).
Bone Marrow Transpl. 2000; 25: 325-325.- ; ; . [Poster]

 

Schlögl,D; Chraust,S; Linkesch,W; Strunk,D; Peripheral blood monocytes do not differentiate into langerhans cells.
Onkologie. 2000; 23(7):620-620.- ; ; . [Poster]

 

Sormann,S; Eibl,M; Zinke-Cerwenka,W; Linkesch,W; Early peripheral autologous stem cell transplantation for acute leukemia in first complete remission.
Onkologie. 2000; 23: 300-300.- ; ; . [Poster]

 

Sormann,S; Neumeister,P; Zinke-Cerwenka,W; Linkesch,W; Frühe autologe Stammzelltransplantation bei akuter myeloischer Leukämie in erster Remissionn - ein Update.
Acta Chir Aust. 2000; 32: 30-30.- ; ; . [Keynote lecture]

 

Sormann,S; Neumeister,P; Zinke,W; Linkesch,W; Frühe autologe Stammzelltransplantation bei akuter myeloischer Leukämie in erster kompletter Remission.
Acta Med Aust. 2000; 27: 35-35.- ; ; . [Keynote lecture]

 

Thaler,J; Hilbe,W; Apfelbeck,U; Linkesch,W, Sill,H; Seewann,H; Fridrik,M; Stiftner,E; Michlmayr,G; Krieger,O; Lutz,D; Lin,W; Köck,L; Abbrederis,K; Baldinger,C; Buder,R; Geissler,D; Hausmanninger,H; Lang,A; Zabernigg,A; Duba,C; Kühr,T; Eisterer,W; Figl,M, Greil,R; Gastl,G; A randomised study comparing Interferon plus low dose cytarabine and Interferon plus Hydroxyurea in early chronic phase chronic myeloid leukemia.
Onkologie. 2000; 23: 500-500.- ; ; . [Poster]

 

Tinchon,C; Auner,H; Linkesch,W; EBV-associated lymphoproliferative disease after therapy with fludarabin in AML.
Onkologie. 2000; 32: 623-623.- ; ; . [Poster]

 

Worel,N; Ludwig,H; schuster,J; Fridrik,M; Gastl,G; Hinterberger,W; Höcker,P, Linkesch,W; Lutz,D; Pittermann-Höcker,E; Schönitzer,D; Greinix,HT; Autologous stem cell transplantation in multiple myeloma: analysis of reported to the Austrian stem cell transplantation registry(ASCTR).
Acta Chir Aust. 2000; 32: 28-28.- ; ; . [Keynote lecture]

 

Worel,N; Ludwig,H; Schuster,J; Fridrik,M; Gastl,G; Hinterberger,W; Höcker,P; Linkesch,W; Lutz,D; Pittermann-Höcker,E; Schönitzer,D; Greinix,HT; Autologous stem cell transplantaion in multiple myeloma: an analysis of data reported to the Austrian stem cell registry(ASCTR).
Onkologie. 2000; 23: 300-300.- ; ; . [Poster]

 

Zinke-Cerwenka, W; Eibl, M; Sormann, S; Neumeister, P; Wagner, T; Linkesch, W Autologe Transplantation mit CD34+ selektionierten Stammzellen bei Patienten mit Multiplem Myelom
Acta Chirurgica Austriaca 2000; 32(170):7-7.-Austrotransplant; ; . [Poster]

 

Zinke-Cerwenka, W; Eibl, M; Sormann, S; Wagner, T; Neumeister, P; Linkesch, W Engraftment and clinical outcome in patients with multipe myeloma after single or tandem stem cell transplantation with or without CD34+ selection
Onkologie 2000; 23(S7):126-126.- ; ; . [Poster]

 

Zinke-Cerwenka,W; Eibl,M; Lind,P; Mikosch,P; Beham-Schmid,C; Linkesch,W; Analyse von falsch positiven PET-Befunden.
Acta Med Aust. 2000; 27: 24-24.- ; ; . [Keynote lecture]

 

Zinke-Cerwenka,W; Eibl,M; Neumeister,P; Sormann,S; Linkesch,W; Central venous catheters versus implantable intravenous devices in patients undergoing stem cell transplantation.
Onkologie. 2000; 23: 654-654.- ; ; . [Poster]

 

Apfelbeck, U; Beham-Schmid, Ch; Jakse, R; Höfler, G; Linkesch, W; Complete remission after combination chemotherapy(CHOP) in a patient with follicular dendritic cell tumor.
Onkologie1999; 22: 170-170.- ; ; . [Poster]

 

Apfelbeck, U; Kleinert, W; Höfler, G; Zinke, W; Linkesch, W; Cocomitant CMV encephalitis and cerebral toxoplasmosis after allogeneic BMT.
Onkologie1999; 22: 213-213.- ; ; . [Poster]

 

Auner,H; Beham-Schmd,Ch; Lindner,G; Fickert,P; Linkesch,W; Sill,H; Successful non-surgical treatment of primary colorectal MALT-lymphomas. An organ-preserving therapeutic concept.
Onkologie1999; 22: 89-89.- ; ; . [Poster]

 

Auner,H; Klintschar,M; Crevenna,R; Beham-Schmid,C; Höfler,G; Linkesch,W; Sill,W; Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukemia.
Haematologica1999; 84: 241-241.-EHA-4; ; . [Keynote lecture]

 

Auner,H; Olipitz,W; Höfler,G; Bodner,C; Konrad,D, Crevenna,R; Linkesch,W; Sill,H; Mutational analysis of the DNA mismatch repair gene hMLH1 in myeloid leukemias.
Onkologie1999; 22: 52-52.- ; ; . [Poster]

 

Auner,HW, Preisegger,KH; Beham-Schmid,C; Fonatsch,C; STreubl,B; Linkesch,W; Sill,H; Splenic Relapse of Hairy Cell Leukemia with a der (15;17)(q10;q10) Involving the p53 Tumor Suppressor Gene.
Acta Med Aust1999; 26: 8-8.- ; ; . [Keynote lecture]

 

Cjeka, M; Schueller, J; Linkesch, W; Eder, I; Zeleny, U; Kraule, C; Pernegg, C; Serum and tissue concentrations of doxorubicin in patients receiving i.v. mono- and polychemotherapy of encapsulated doxorubicin (stealth liposomas, Caelyx)
Proceedings of the 28th Annual Symposium Europ Soc of Clin. Pharmacy1999; 60-60.-28th Annual Symposium Europ Soc of Clin. Pharmacy; ; Berlin, GERMANY. [Poster]

 

Eibl,M; Neumeister,P, Linkesch,W; Successful preemptive therapy of CMV-viremia after allogeneic stem cell transplantation with cidofovir.
Onkologie1999; 22: 206-206.- ; ; . [Poster]

 

Fridrik,MA; Greil,R; Jäger,G; Kienzer,H; Hausmaninger,H; EhrengruberA; Chott,A; Linkesch,W The influence of low dose Interleukin-2 (Il-2) on cladrribine (2-CDA) induced CD4- lymphopenia in patients with low grade Non-Hodgkin's Lymphoma(NHL).
Ann of Oncol1999; 10: 124-124.- ; ; . [Poster]

 

Gilli, R; Sipurzynski, S; Helmberg, W; Wagner, T; Schmidt, H; Neumeister, P; Linkesch, W; Lanzer, G Amount of CD34+ cells in the peripheral blood - a real prediction for the yield of the stem cell concentrate?
BONE MARROW TRANSPLANT 1999 23: S214-S214.
Web of Science

 

Grube, R; Chraust, S; Linkesch, W; Strunk, D Peripheral blood dendritic cell deficiency in chronic lymphocytic leukemia (CLL) patients.
BLOOD 1999 94: 121A-121A.
Web of Science

 

Hilbe,W; Apfelbeck,U; Fridrik,M; Seewann,H; Michlmayr,G; Linkesch,W; Pont,J; Baldinger,C; Hartner,E; Bernhart,M; Geissler,D; Krieger,O; Lang,A; Lin,W; Ludwig,H; Duba,C; Greil,R; Gastl,G; Thaler,J; Retrospective analysis of 119 patients with CML treated with IFN-alpha and LD-ARA-C: benefit of ARA-c escalation?.
Onkologie1999; 22: 49-49.- ; ; . [Poster]

 

Jäger,G; Neumeister,P; Raderer,F; Brezinschek,R; HInterleitner,T; Höfler,G; Ilsingeru,P; Linkesch,W; 2-CDA (Leustatin) in the treatment of primary colorectal MALT-lymphoma presenting with multiple polypoid lesions.
Onkologie1999; 22: 148-148.- ; ; . [Poster]

 

Krieger,O; Kasparu,H; Greinix,H; Kahls,P; Rabitsch,W; Linkesch,W; Jäger,G; Gadner,H; Peters,C; Schwinger,W; Urban,Ch; Nachbaur,D; Gritsch,B, Niederwieser,D; Lutz,D; Stemcelltransplantation for mDS-patients: Data from the Austrian TX-Registry(ASCTR)
Onkologie1999; 22: 22-22.- ; ; . [Poster]

 

Linkesch, W; Mabthera (Rituximab) in der behandlung des Non-Hodgkin-Lymphoms.
Wiss Symposium - Neue Konzepte in der Tumortherapie; NOV 19-21, 1999; Grado, ITALY. 1999. [Keynote lecture]

 

Linkesch, W; Die hämatopoietische Stammzelltransplantation - Update 1999.
1st International Symposium; JUN 19, 1999; Wien, AUSTRIA. 1999. [Keynote lecture]

 

Linkesch, W; Einsatz von Wachstumsfaktoren bei Infektionen des neutropenischen Patienten.
Symposium: Klinik des immungeschwächten Patienten in der Hämatologie - therapeutische Optionen.; OCT 27, 1999; Graz, AUSTRIA. 1999. [Keynote lecture]

 

Linkesch, W; Therapie mit Erythropoietin bei Tumoranämie.
Interdisziplinäres Symposium; JAN 18-20, 1999; Zürs, AUSTRIA. 1999. [Keynote lecture]

 

Linkesch, W; Ist die Hochdosistherapie beim Mammakarzinom noch indiziert?
13. Jahrestagung der Österreichischen Gesellschaft für Transplantation, Transfusion und Genetik.; OCT 20-22, 1999; St. Wolfgang, AUSTRIA. 1999. [Keynote lecture]

 

Linkesch, W; First-line Hochdosistherapie bei Non-Hodgkin-Lymphomen.
Frühjahrestagung der ÖGHO; APR 15-16, 1999; Innsbruck, AUSTRIA . 1999. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation bei niedrig malignen Non-Hodgkin-Lymphomen.
30. Jahrestagung der Österr. Gesellschaft für Innere Medizin; SEP 25, 1999; Graz, AUSTRIA. 1999. [Keynote lecture]

 

Mitterbauer, M; Brugger, S; Neumeister, P; Kalhs, P; Rabitsch, W; Loidolt, H; Keil, F; Hinterberger, W; Linkesch, W; Mannhalter, C; Mitterbauer, G; Greinix, H Clinical and molecular disease eradication after allogeneic stem cell transplantation in patients with advanced non-Hodgkin's lymphoma.
BLOOD 1999 94: 4949-4949.
Web of Science

 

MItterbauer,M; Kahls,P; Brugger,S; Rabitsch,W; Loidolt,H; Keil,F; Hinterberger,W; Neumeister,P; Linkesch,W; Greinix,HT; Allogeneic stem cell transplantation (SCT) in patients with advanced Non-Hodgkin's Lymphoma.
Acta Chir Austriaca1999; 31: 7-7.- ; ; . [Keynote lecture]

 

Neumeister, P; Eibl, M; Sormann, S; Zinke-Cerwenka, W; Linkesch, W. Treatment of severe hepatic veno-occlusive disease with defibrotide
Acta Chir. Austriaca. 1999; 31: 8-8.-Austrotransplant 1999; OKT, 20-22, 1999; St. Wolfgang, AUSTRIA. [Oral Communication]

 

Neumeister, P; Zinke, W; Schmidt, HH; Linkesch, W Antithymocyte globulin may reduce transplant related mortality and chronic GVHD in patients undergoing allogeneic stem cell transplantation.
BONE MARROW TRANSPLANT 1999 23: S95-S95.
Web of Science

 

Neumeister, P; Zinke, W; Schmidt, HH; Wagner, T; Linkesch, W Life threatening bradycardia after infusion of cryopreserved stem cells.
BONE MARROW TRANSPLANT 1999 23: S177-S177.
Web of Science

 

Neumeister,P; Zinke,W; Schmidt,HH; Linkesch,W; Conditioning Regimen with Antithymocyte Globulin Modifies Acute and CHronic GVHD in Patients undergoing allogeneic Stem Cell Transplantation.
Acta Med Aust1999; 26: 16-16.- ; ; . [Keynote lecture]

 

Olipitz,W; Aigner,R, Beham-Schmid,C; Linkesch,W; Sill,H; Acute Myelofibrosis: Focal Bone Marrow Involvement and Lack of Response to Interferon-Gamma.
Acta Med Aust1999; 26: 8-8.- ; ; . [Keynote lecture]

 

Schloegl, D; Chraust, S; Linkesch, W; Strunk, D Human monocytes do not differentiate into Langerhans cells.
BLOOD 1999 94: 267B-267B.
Web of Science

 

Schlögl,D; Grube,R; Linkesch,W; Strunk,D; Human Monocytes do not differentiate into Langerhans cells.
Acta Med Aust1999; 26: 23-23.- ; ; . [Keynote lecture]

 

Sormann,S; Neumeister,P; Zinke-Cerwenka,W; Linkesch,W; Frühe autologe Stammzelltransplantation bei akuter myeloischer Leukämie in erster kompletter Remission.
Acta Chir Austriaca1999; 31: 8-8.- ; ; . [Keynote lecture]

 

Weger,M; Czejka,M; Linkesch,W; A phase I pharmacokinetic study of DOxil liposomal Doxorubicin in combination with Vinorelbine, Cyclophosphamide and Prednisone in NHL patients.
J Clin Oncol1999; 18: 894-894.- ; ; . [Poster]

 

Zinke, W; Neumeister, P; Linkesch, W Defibrotide - An approach in the treatment of severe hepatic veno-occlusive disease?
BONE MARROW TRANSPLANT 1999 23: S225-S225.
Web of Science

 

Zinke-Cerwenka,W; Beham-Schmid,Ch; Jakse,r; Höfler,G; Linkesch,W; The clinical relevance of whole-body FDG-Positron Emission Tomography for staging in patients with lymphoma and Hodgkin's desease.
Onkologie1999; 22: 152-152.- ; ; . [Poster]

 

Zinke-Cerwenka,W; Neumeister,P; Eibl,M; Sormann,S; Linkesch,W; Antithymocyte globulin (ATG) as part of conditioning regimen may reduce chronic graft-versus-host-disease in patients undergoing unrelated peripheral stem cell transplantation.
Acta Chir Austriaca1999; 31: 10-10.- ; ; . [Keynote lecture]

 

Zinke-Cerwenka,W; Neumeister,P, Linkesch,W; A promising approach in the treatment of severe hepatic veno-occlusive disease with defibrotide.
Onkologie1999; 22: 202-202.- ; ; . [Poster]

 

Zinke,W; Neumeister,P; Linkesch,W; Defibrotide- an approach in the treatment of severe hepatic veno-occlusive disease?
Acta Med Aust1999; 26: 7-7.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Gilli, R; Sormann, S; Linkesch, W; C-HAM: An Efficient Regimen for Consolidation Therapy and mobilization of CD34+ PBSC in AML.
Acta Chir Austriaca1998; 30: 22-22.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Höfler, G; Fonatsch, C; Linkesch, W; Successful treatment of a patient with extramedullary T-cell blast crisis in chronic myeloid leukemia.
Acta Med Aust1998; 25: 28-28.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Höfler, G; Jäger, G; Zinke, W; Linkesch, W; Treatment of concomitant acute myeloid leukemia and chronic lymphocytic leukemia.
Acta Med Aust1998; 25: 26-26.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Höfler, G; Kleinert, W; Jäger, G; Zinke, W; Linkesch, W; Concomitant CMV Enzephalitis and Cerebral Toxoplasmosis 10 Months after Allogeneic BMT.
Acta Chir Austriaca1998; 30: 21-21.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Höfler, G; Neumeister, P; Fonatsch, C; Linkesch, W; Allogeneic BMT from an unrelated donor in patients with extramedullary T-cell blast crisis in chronic myeloid leukemia.
Ann Hematol1998; 77: 217-217.- ; ; . [Poster]

 

Auner, H; Klintschar, M; Beham-Schmid, C; Höfler, G; Crevenna, R; Linkesch, W; Sill, H; Chronic idiopathic neutropenia - a preleukemic disorder.
Int Symposium-30 Jahre Leukämieforschung L.Boltzmann Institut Konferenzband1998; -Int Symposium-30 Jahre Leukämieforschung L.Boltzmann Institut; ; Wien, AUSTRIA. [Poster]

 

Auner, HW; Klintschar, M; Beham-Schmid, C; Hoefler, G; Crevenna, R; Linkesch, W Chronic idiopathic neutropenia - A preleukemic disorder?
BLOOD 1998 92: 208B-208B.
Web of Science

 

Auner,HW; Höfler,G; Beham-Schmid,C; Zinke,W; Linkesch,W, Sill,H; Chronic idiopathic neutropenia - a new preleukemic syndrome?
Acta Med Aust1998; 25: 26-26.- ; ; . [Keynote lecture]

 

Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
BONE MARROW TRANSPLANT. 1998; 22: S10-S10.
Web of Science

 

Dammacco,F; San Miguel, JF; Attal, M; Jost, L; Gimsing, P; Rossi, JF; Coiffier, B; Boccadero, M; Bladé, H; Gouveia, J; Linkesch, W; Bosly, A; Lederlin, P; Sebban, C; Danel, P; Dudziak, C; Moore, L Vinorelbine (VRL) plus high dose dexamethasone (DEX) for treatment of relapsing multiple myeloma(MM): a phase II study.
Blood1998; 92(10):319-319.-34th Annual Meeting; May 16-19, 1998; Los Angeles,CALIFORNIA. [Poster]

 

Fridrik, MA; Greil, R; Jager, G; Kienzer, HR; Hausmaninger, H; Ehrengruber, A; Chott, A; Linkesch, W The influence of low dose interleukin-2 (IL-2) on cladribine (2-CDA) induced CD4-lymphopenia in patients with low grade non-Hodgkin's lymphoma.
BLOOD. 1998; 92(10): 412A-412A.
Web of Science

 

Geissler, K; Koller, E; Hubmann, E; Niederwieser, D; Hinterberger, W; Geissler, D; Kyrle, P; Knobl, P; Pabinger, I; Thalhammer, R; Schwarzinger I; Mannhalter, C; Jäger, U; Heinz, R; Linkesch, W; Lechner, K; Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia - a randomized phase III study.
WiKliWo1998; -Gesellschaft der Ärzte in Wien-Wissenschaftliche Highlights; Apr 9, 1998; Wien, AUSTRIA. [Poster]

 

Gilli, R; Helmberg, W; Jager, G; Schmidt, H; Sipurzynski, S; Wagner, T; Linkesch, W; Lanzer, G Production of peripheral blood stem cell autografts for adults suffering from haematological disorders.
BONE MARROW TRANSPLANT 1998 21: S195-S195.
Web of Science

 

Gilli,R; Sipurzynski,S; Helmberg,W; Wagner,T; Schmidt,H; Neumeister,P; Linkesch,W; Lanzer,G; Amount of CD34+ cells in the peripheral blood - a real prediction for the yield of the stem cell concentrate.
Bol. Soc. Bras. Hematol1998; 189-189.- ; ; . [Poster]

 

Greinix, HT; Linkesch, W; Reiter, E; Keil, F; Seifert, M; Czerwenka, K; Elahi, F; Schulenburg, A; Hoecker, P; Kubista, E; Kalhs, P; High dose chemotherapy followed by reinfusion of immunomagnetic purged peripheral blood precursor cells in metastatic and high risk breast cancer patients.
Bone Marrow Transpl1998; 21: 61-61.- ; ; . [Poster]

 

Greinix, HT; Linkesch, W; Reiter, E; Keil, F; Seifert, M; Czerwenka, K; Elahi, F; Schulenburg, A; Hoecker, P; Kubista, E; Kalhs, P; Vienna, AKH A novel high-dose chemotherapy including paclitaxel with CD34-selected peripheral blood stem cell (PBSC) rescue in high-risk breast cancer patients.
BONE MARROW TRANSPLANT. 1998; 21: S61-S61.
Web of Science

 

Harousseau, JL; Dekker, A; Stamatoullas, A; Bassaris, H; Linkesch, W; Fassas, A; Fernandez, J; De Bock, B; Cobo, F; Vazquez, L; Seifert, W; De Beule, K Prophylaxis of fungal infections in hematological malignancies: A double blind trial comparing itraconazole oral solution to amphotericin B capsules.
BLOOD. 1998; 92(10): 53B-53B.
Web of Science

 

Jager, G; Neumeister, P; Hinterleitner, T; Hofler, G; Brezinschek, R; Linkesch, W Cladribine (2-CDA) as a therapy for low-grade MALT-lymphoma: An organ-preserving therapeutic concept.
BLOOD 1998 92: 236B-237B.
Web of Science

 

Linkesch, W Focus on Erythropoietin
Seminars in Omcology. 1998; 25(3):69-75.-Symposium Emeeging Therapies in OncologyCare; MAY 4-6, 1998; Nice, FRANKREICH. [Keynote lecture]

 

Linkesch, W; Stellenwert von Antithymozytenglobulin in der Prophylaxe der GvHD.
12.Jahrestagung der Österreichischen Gesellschaft für Transplantation, Transfusion und Genetik; OCT 21-23, 1998; Bad Tatzmannsdorf, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch, W; Knochenmarktransplantation (KMT) - verbesserte Chance in der Krebsbehandlung.
Leukämiehilfe Steiermark; MAR 3, 1998; Graz, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch, W; Indikationen für Hochdosischemotherapien und autologe Blutstammzelltransplantation
29. Jahrestagung der Österr Ges f Innere Medizin; SEP 24-26, 1998; Graz, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch, W; Neue Aspekte in der Therapie maligner Lymphome.
Klinik-Seminarabend; JAN 29, 1998; Graz, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch, W; Aspekte der Hochdosistherapie mit Stammzellsupport.
Österreichische Gesellschaft für Gastroenterologie und Hepatologie; Nov 27-28, 1998; St.Veit/Glan, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation bei niedrig-malignen NHL.
Frühjahrestagung d Österr Ges f Hämatologie u Onkologie; ; Baden bei Wien, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation bei Keimzelltumoren.
Frühjahrestagung der ÖGHO ; APR 23-25, 1998; Baden bei Wien, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch, W; CMV Update.
Chir Hörsaal; 1998; Graz, AUSTRIA. 1998. [Keynote lecture]

 

Linkesch,W; Stammzelltransplantation bei Keimzelltumoren.
Acta Med Aust1998; 25: 13-13.- ; ; . [Keynote lecture]

 

Neumeister,P; Apfelbeck,U; Zinke,W; Schmidt,HH; Aigner,R; Füger,G; Sill,H; Linkesch,W; Procalcitonin in Patients undergoing Hematopoietic Stem Cell Transplantation.
Acta Chir Austriaca1998; 30: 22-22.- ; ; . [Keynote lecture]

 

Neumeister,P; Apfelbeck,U; Zinke,W; Schmidt,HH; Aigner,R; Füger,G; Sill,H; Linkesch,W; Procalcitonin in patients undergoing hematopoietic stem cell transplantation.
Ann Hematol1998; 77: 205-205.- ; ; . [Poster]

 

Neumeister,P; Beham-Schmid,C; Höfler,G, Schmidt,HH; Sill,H; Linkesch,W; Seperate clones in concomitant multiple myeloma and chronic lyphocytic leukemia demonstrated by molecular analysis.
Acta Med Aust1998; 25: 36-36.- ; ; . [Keynote lecture]

 

Schlögl, D; Grube, R; Linkesch, W; Strunk, D; Human Monocytes Do Not Differentiate Into Langerhans Cells.
ÖGAI Konferenzband1998; -Jahrestagung der Österr Ges f Allergologie u Immunologie; OCT 15-17, 1998; . [Poster]

 

Schlögl, D; Hellweger, B; Linkesch, W; Strunk, D; Human Langerhans Cells Are Notderived from Monocytes .
ÖGAI Konferenzband1998; -Jahrestagung der Österr Ges f Allergologie u Immunologie; OCT 15-17, 1998; . [Poster]

 

Schmidt, HH; Sill, H; Jager, G; Neumeister, P; Strunk, D; Linkesch, W Capillary leak syndrome with late onset after autografting for multiple myeloma.
BONE MARROW TRANSPLANT 1998 21: S91-S91.
Web of Science

 

Sormann,S; Neumeister,P; Konrad,M; Linkesch,W; Continuous infusion of mitoxantrone combined with high dose cytarabine (c-HAM) in de novo AML.
Ann Hematol1998; 77: 205-205.- ; ; . [Poster]

 

Strunk,D; Hellweger,B; Kirsten,R; Linkesch,W; Acute myelogenous leukemia cells can be differentiated into dendritic cells in vitro.
Acta Med Aust1998; 25: 16-16.- ; ; . [Keynote lecture]

 

Thaler,J; Hilbe,W; Apfelbeck,U; Linkesch,W; Fridrik,M; Seewann,H; Stöger,M; Pont,J; Lin,W; Abbrederis,K; Baldinger,c; Bernhart,M; Geissler,D; Köck,L; Lang,A; Ludwig,H; Lutz,D; Niessner,H; Sill,H; Zabernigg,A; Duba,C; Eisterer,W; Greil;R; Niederwieser,D; Gastl,G; Aktuelle Ergebnisse der Österreichischen CML-Studiengruppe.
Acta Med Aust1998; 25: 17-17.- ; ; . [Keynote lecture]

 

Zinke, W; Wagner, T; Matzer, C; Schweiger, W; Lanzer, G; Linkesch, W G-CSF stimulated Granulocyte transfusion in life-threatening infection a case with sAML
Annals of Hematology 1998; 77(II):798-798.-GTH; Feb 25-28; Frankfurt, Germany. [Poster]

 

Zinke,W; Linkesch,W; Sill,H; Treatment of Acute Lymphoblastic Leukemia in a Jehovah's Witness.
Acta Med Aust1998; 25: 41-41.- ; ; . [Keynote lecture]

 

Apfelbeck, U; Höfler, G; Neumeister, P; Linkesch, W; Ott, A; Sill, H; Leukämisches Chemotherapie-resistentes angiotropisches Lymphom mit Veränderungen in mehreren Tumor Supressor Genen.
Onkologie1997; 20: 160-160.- ; ; . [Poster]

 

Beyer,J; Kramar,A; Mandanas,R; Linkesch,W; Greinix,a, Droz,JP, Pico,JL; Diehl,A; Bokemeyer,C; Schmoll,HJ, Nichols,CR; Einhorn,LH; Siegert,W; High-dose chemotherapy in germ cell tumors: indentification of progostic factors.
Bone Marrow Transpl1997; 19: 87-87.- ; ; . [Poster]

 

Fridrik,M.A; Jäger,G; Baldinger,Ch; Krieger,O; Chott,A; Bettelheim,P; Linkesch,W; First-line treatment of Waldenström's disease with cladribine(2-CdA).
J Clin Oncol1997; 17: 31-31.-3rd Annual Meeting ASCO; MAY 17-20, 1997; Denver,COLORADO. [Poster]

 

Fridrik,MA; Jäger,G; Kienzer,H; Hausmanninger,H; Oppitz,P; Krieger,O, Zabernigg,A; Lang,A; Neubauer,M; Weidinger,G; Schiller,L, Seewann,H; Chott,A; Linkesch,W; Arbeitsgemeinschaft Medikamentöse Tumortherapie Interleukin-2 abwechselnd mit Interferon nach Cladaribine Therapie von niedrig malignen Non Hodgkin Lymphomen.
Onkologie1997; 20: 160-160.- ; ; . [Poster]

 

Gilli, R; Helmberg, W; Jäger, G; Schmidt, H; Sipurzynski, S; Wagner, T; Linkesch, W; Lanzer, G First experiences in preparing autologous peripheral blood stem cells for adults suffering from haematological disorders.
European Society For Heamapheresis: Abstract Book1997; O-51: 140-140.-11th Congress of European Society For Heamapheresis; Sept 14-17; Dyon, France. [Poster]

 

Gilli,R; Helmberg,W; Jäger,G; Schmidt,H; Sipurzynski,S, Wagner,T; Linkesch,W; Lanzer,G; First experiences in Preparing Autologous Peripheral Blood Stem Cells for Adults Suffering from Haematological Disorders.
Acta Chir Austriaca1997; 17-17.- ; ; . [Keynote lecture]

 

Hilbe.W; Apfelbeck, U; Fridrik, M; Bernhart,M; Niessner, H; AbrederisK; Michlmayr,G; Pont,J; Linkesch, W; Hausmaninger, H; Arneitz, K; Baldinger,C; Fereberger,C; Duba,C; Greil,R; Konwalinka, G; Niederwieser,D; Gastl,G; Thaler, J Interferon-Alpha for the Treatment of elderly Patients with CML
Frühjahrstagung der ÖGHO; APR 18-19 , 1997; Salzburg. 1997. [Oral Communication]

 

Hilbe,W; Apfelbeck,U; Fridrik,M; Bernhart,M; Niessner,H; Abbrederis,k; Michlmayer,G; Pont,J; Linkesch,W; Hausmanninger,H; Arneitz,K; Baldinger,c; Duba,C; Eisterer,W; Greil,R; Konwalinka,G; Niederwieser,D; Gastl,G; Thaler,J; jür die Austrian CML Study Group Interferon Alpha in der Behandlung der chronischen myeloischen Leukämie bei älteren Patienten.
Onkologie1997; 20: 208-208.- ; ; . [Poster]

 

Hilbe,W; Apfelbeck,U; Fridrik,M; Bernhart,M; Niessner,H; Abbrederis,K; Michlmayr,G; Pont,J; Linkesch,W; Hausmanninger,h; Arneitz,K; Baldinger,C; Duba,C; Eisterer,W; Greil,R; Konwalinka,G; Niederwieser,D; Gastl,G; Thaler,J; for the Austrian CML study Group IFN-alpha for the Treatment of Elderly Patients with CML.
Acta Med Aust1997; 24: 29-29.- ; ; . [Keynote lecture]

 

Jäger,G; Auner,H; Sill,H; Linkesch,W; Erfahrungen mit hochdosiertem CHOP in der THerapie hochmaligner NHL mit hohem Risiko.
Frühjahrestagung der Österr Ges f Hämatologie und Onkologie1997; 35-35.- ; ; . [Keynote lecture]

 

Link, H; Wandt, H; SchonrockNabulsi, P; Ehninger, G; Franke, A; Gackle, R; Geer, T; Strobel, G; Linkesch, W; Krieger, O; Niederwieser, D; Nikiforakis, E; Ohl, S; Otremba, B; Pittermann, E; Schmidt, H; Tischler, J; Weiss, J; Wilhelm, M; Badri, N G-CSF (lenograstim) after chemotherapy for acute myeloid leukemia: A placebo controlled randomized trial.
EXP HEMATOL. 1997; 25(8): 35-35.
Web of Science

 

Linkesch, W Neuere Entwicklungen in der Stammzell/Knochenmarktransplantation.
Update in Innerer Medizin; JUN 16-20, 1997; Vienna, AUSTRIA. 1997. [Keynote lecture]

 

Linkesch, W Hochdosis - Chemotherapie bei metastasierten Malignomen.
Update in Onkologie; FEB 28-MAR 3, 1997; Vienna, AUSTRIA. 1997. [Keynote lecture]

 

Linkesch, W Die kurativen Chamcen bei akuter Leukämie.
51. Van Swieten Kongress; OCT 24, 1997; Vienna, AUSTRIA. 1997. [Keynote lecture]

 

Linkesch, W Predictors of response of epoetin alfa.
International Symposium on epoetin alfa; JUN 5-7, 1997; Nice, FRANCE. 1997. [Keynote lecture]

 

Linkesch, W Navelbine/Dexamethason als Zweittherapie beim multiplen Myelom.
ARGE Tumorttherapie; JAN 28, 1997; St. Gilgen, AUSTRIA. 1997. [Keynote lecture]

 

Linkesch, W; Neue Therapiestrategien bei malignen Lymphomen.
Fortbildungsreferat der Ärztekammer Steiermark; JUN 3 1997; 1997. [Keynote lecture]

 

Linkesch,W Hochdosis-Chemotherapie bei metastasierten Malignomen.
Update in Onkologie1997; 5: 8-9.- ; ; . [Keynote lecture]

 

Linkesch,W; Sormann,S; Neumeister,P; Konrad,M; A phase II trial of continuous mitoxantrone combined with high-dose cytarabine (c-HAM) in de novo adult acute myeloid leukemia.
J Clin Oncol1997; 17: 33-33.-3rd Annual Meeting ASCO; ; MAY 17-20, 1997; Denver, COLORADO. [Poster]

 

Neumeister,P; Höfler,G; Beham-Schmidt,C; Schmidt,H; Apfelbeck,U; Linkesch,W; Sill,H; Analyse des p16 Tumor Suppressor-Gens bei gastrintestinalen MALT-Lymphomen.
Frühjahrestagung der Österr Ges f Hämatologie und Onkologie1997; 67-67.- ; ; . [Keynote lecture]

 

Neumeister,P; Schmidt,H; Apfelbeck,U; Linkesch,W; Sill,H; Akute Flimmerarrythmie während einer niedrig dosierten Cyclophosphamid-Infusions bei einer NHL-Patientin mit KHK.
Onkologie1997; 20: 205-205.- ; ; . [Poster]

 

Schmidt,H; Jäger,G; Sill,H; Linkesch,W; Bone Marrow and Blood Stem Cell Transplantation - First Results of the division of Hematology, University Graz.
Acta Chir Austriaca1997; 17-17.- ; ; . [Keynote lecture]

 

Schmidt,H;Neumeister,P;Sill,H;Höfler,G;Kainer,M;Linkesch,W Interferontherapie der Essentiellen Thrombozythämie in der Schwangerschafr- Ein Fallbericht
ONKOLOGIE. 1997; (20):161-161.-Jahrestagung der ÖGHO; APR 18-19 ,1997; Salzburg, Austria. [Poster]

 

Sormann,S; Neumeister,P, Konrad,M; Linkesch,W; Continuous infusion of mitoxantrone combined with high dose cytarabine(c-HAM) in de novo AML.
Frühjahrestagung der Österr Ges f Hämatologie und Onkologie1997; 17-17.- ; ; . [Keynote lecture]

 

Sormann,S; Neumeister,P; Konrad,M; Linkesch,W;Linkesch,W; Continous infusion of mitoxantrone combined with high dose cytarabine (c-HAM) in de novo AML.
Onkologie1997; 20: 83-83.- ; ; . [Poster]

 

Sormann,S; Neumeister,P; Konrad,M; Linkesch,W;Linkesch,W; Continous infusion of mitoxantrone combined with high dose cytarabine (c-HAM) in de novo AML.
Ann Hematol1997; 74: A44-A44.- ; ; . [Poster]

 

Strunk, D; Kirsten, R; Hellweger, B; Linkesch, W; Induction of dendritic cell phenotype and function of acute myelogenous leukemia cells.
Konfernzband ÖGAI1997; -Jahrestagung der Österr Ges f Allergologie und Immunologie; 1997; Innsbruck, Austria. [Poster]

 

Strunk, D; Linkesch, W Acute myelogenous leukemia cells can be differentiated into dendritic cells in vitro.
BLOOD 1997 90: 829-829.
Web of Science

 

THaler,J; Hilbe,W; Apfelbeck,U; Linkesch,W; Sill,H; Fridrik,M; Seewann,H; Stöger,M; Pont,J; Lin,W; Abbrederis,K, Baldinger,C; Bernhardt,M; Geissler,D; Lang,A; Ludwig,H; Lutz,D; Niessner,H; Duba,C; Eisterer,W; Greil,R; Niederwieser,D; Gastl,G; für die öserr. CML-Studiengruppe Aktuelle Ergebnisse der Österreichischen CML-Studienergebnisse(CML5 und CML6)
Frühjahrestagung der Österr Ges f Hämatologie und Onkologie1997; 9-9.- ; ; . [Keynote lecture]

 

Thaler,J; Hilbe,W; Apfelbeck,U; Linkesch,W; Sill,H; Fridrik,M; Seewann,H; Stöger,M, Pont,J; Lin,W; Abbrederis,K; Baldinger,C; Bernhart,M; Geissler,D; Lang,A; Ludwig,H; Lutz,D; Niessner,H; Duba,C; Eisterer,W; Greil,R; Niederwieser,D; Gastl;G; Current results of the Austrian CML Study Group (CML5&CML6)
Onkologie1997; 20: 208-208.- ; ; . [Poster]

 

Zinke,W; Linkesch,W; Sill,H; Multiple Osteolysen bei nichttropischer Sprue - Kasuistik.
Acta Med Aust1997; 24: 42-42.- ; ; . [Keynote lecture]

 

Beyer,J; Kramar,A; Mandanas,R; Linkesch,W; Greinix,A; Droz,J,P; Pico,J,L; Diehl,A; Bokemeyer,C; Schmolle,H,J; NicholsC,R; Einhorn,L,H, Siegert,W; Optimizing high-dose chemotherapy in germ cell tumors: the application of prognostic factors.
Ann Hamatol1996; 73: A162-A162. [Poster]

 

Beyer,J; Kramar,A; Mandanas,R; Linkesch,W; Greinix,H.T; Droz,J.p; Pico,J.P; Diehl,A; Bokemeyer,C; Schmoll,C.J; Nichols,C.R; Einhorn,L.H; Siegert,W; High-dose chemotherapy (HDCT) as salvagetreatment in germ cell tumours(GCT): a multivariate analysis of prognostic variables.
J Clin Oncol1996; 15: 239-239.-38th Annual Meeting of ASH; DEC 7-8, 1996; Orlando,FLORIDA. [Keynote lecture]

 

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaszkiewicz,T; Hawlicuek;R; Seifert,M; Jäger,U; Höcker,P; Huber,H; Lechner,K; Greinix,H.T; Haematological and immunological reconstitution after high dose radio and/or chemotherapy with supportive infusion of unselected and CD34+ enriched Peripheral stem cells.
Bone Marrow Transpl1996; 17(1):134-134. [Poster]

 

Brugger,S.A; Kahls,P; Keil,F; reiter,e; Linkesch,W; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Jäger,U; Lechner,K; Greinix,H.T; Bone marrow and peripheral stem cell transplantation for Non-Hodgkin's Lymphoma - Results of the BMT-Centre Vienna.
Bone Marrow Transpl1996; 17: 26-26. [Poster]

 

Fridrik,M.A; Hausmaninger,H; Linkesch,W; Michlmayr,G; Silly,H; Seewann,H.D.; Klocker,J; Haidinger,R; Schiller,L; Pont,J; Lehnert,M; Radaszkiewicz; Raudaschl,G; Falck,M; A new hybrid regimen (CEOP-IMVP-DEXA) in the treatment of high-grade non-hodgking's lymphomas(NHL). An Austrian multicenter trial.
J Clin Oncol1996; 13: 1242-1242.-38th Meeting of ASA; DEC 7-8, 1996; Orlando,FLORIDA. [Poster]

 

Fridrik,MA; Jäger,G; Kienzer,HJ; Hausmanninger,H; Krieger,O; Neubauer,M, Gattringer,C; Oppitz,P; Schiller,L, Radaskiewicz,T, Linkesch,W; Interferon-alpha-2c(IF) maintenance after Cladaribine (2-CDA)Induction in low-grade Non-Hodgkin's Lymphoma(NHL). Preliminary Data of an Austrian Multicenter Trial.
Jahrestagung der Österr Ges f Hämatologie und Onkologie1996; 69-69.- ; ; . [Keynote lecture]

 

Fridrik,M;Jäger,G;Kienzer,Hausmanninger,H;Krieger,O;Neubauer,M;Gattringer,Oppitz,P;Schiller,L;Radaskiewicz,T;Linkesch,W Response and Toxicity of 2-CDA as first line therapy of low grade NHL. Preliminary data of an Austrian Multicenter Trial
Annals of Oncology. 1996; Vol 7(Supp 3):241-241.-6th International Congress on Malignant Lymphomas; June, 3-4 1996; Lugano, Switzerland. [Poster]

 

Geissler, K; Koller, E; Hubmann, E; Niederwieser, D; Hinterberger, W; Geissler, D; Kyrle, P; Knobl, P; Pabinger, I; Scherrer, R; Schwarzinger, I; Jaeger, U; Heinz, R; Linkesch, W; Lechner, K Concomitant administration of granulocyte colony-stimulating factor (G-CSF) and induction chemotherapy of adult acute lymphoblastic leukemia (ALL) - A multicenter openlabel, phase III study in randomized parallel groups
BRIT J HAEMATOL 1996 93: 221-221.
Web of Science

 

Geissler,K; Koller,E; Hubmann,E; Niederwieser,D; Hinterberger,W; Geissler,D; Kyrle,P; Knöbl,P; Pabinger,I; Scherrer,R; Schwarzinger,I; Jäger,U; Heinz,R; Linkesch,W; Lechner,K; Concomitant administration of granulocyte colonystimulating factor(G-CSF) and induction chemotherapy of adult acute lymphoblastic leukemia(ALL) - a multicenter openlabel, phase III study in randomized parallel groups.
Ann Hamatol1996; 73: A53-A53. [Poster]

 

Jäger,G; Auner,H; Sill,H; Linkesch,W; Remission rate and toxicity of intensified CHOP in the treatment of aggressive Non-Hodgkin-Lymphomas.
Ann Hamatol1996; 73: A137-A137. [Poster]

 

Jäger,G; Auner,H; Sill,H; Linkesch,W; Hoch dosiertes CHOP in der Therapie hochmaligner NHL.
Jahrestagung der Österr Ges f Hämatologie und Onkologie1996; 5: 5-5.- ; ; . [Keynote lecture]

 

Jäger,G; Fridrik,M.A.; Kienzer,H.J; Hausmanninger,H; Krieger,O; Neubauer,M; Gattringer,C; Oppitz,P; Schiller,L; Radaskiewicz,Th; Linkesch,W; Response and toxicity of cladribine(2-CDA) as first line treatment of low-grade Non Hodgkin's lymphomas(NHL). Preliminary Data of an Austrian Multicenter trial.
J Clin Oncol1996; 15: 410-410.-38th Annual Meeting of ASCO; DEC 7-8, 1996; Orlando,FLORIDA. [Poster]

 

Jäger,G;Fridrik,M;Kienzer,H;Hausmanninger,H;Krieger,O;Neubauer,M;Gattringer,C;Oppitz,P;Schiller,L;Radaskiewicz,T;Linkesch,W Response and Toxicity of Cladribine as first line Treatment of low grade Non -Hodgkin-Lymphomas. Preliminary Data of an Austrian Multicenter Trial
J Clin Oncology. 1996; 15: 253-253.-American Society of Clinical Oncology; DEZ 6-10, 1996; Orlando. USA. [Poster]

 

Keil,F; Kahls,P; Haas,O.A; Fritsch,G; Mitterbauer,G; Brugger,S; Lechner,K; Schwarzinger,I; Reiter,E; Mannhalter,C; Linkesch,W; Höcker,P; Greinix,H.T; Documentation of hematopoietic chimerism in relapse of BCR/ABL positive CML and all by cell sorting and fluorescent in situ hybridisation can predict aplasia after donor lymphocyte infusion.
Bone Marrow Transpl1996; 17: 85-85. [Poster]

 

Keil,F; Kahls,P; Haas,O.A; Fritsch,G; Mitterbauer,G; Brugger,S; Lechner,K; Schwarzinger,I; Reiter,E; Mannhalter,C; Linkesch,W; Höcker,P; Greinix,H.T; Graft failure after donor leukocyte infusion in relapsed chronic myeloid leukemia: Successful treatment with cyclophosphamid and antithymocyte globuline followed by peripheral blood stem cell infusion.
Bone Marrow Transpl1996; 17(1):90-90. [Poster]

 

Link, H; Wandt, H; SchonrockNabulsi, P; Ehninger, G; Franke, A; Gackle, R; Geer, T; Gramatzki, M; Linkesch, W; Lutz, D; Niederwieser, D; Nikiforakis, E; Ohl, S; Otremba, B; Pittermann, E; Schmidt, H; Tischler, J; Weiss, J; Wilhelm, M; Deutschmann, S G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial
BRIT J HAEMATOL. 1996; 93: 841-841.
Web of Science

 

Link, H; Wandt, H; SchonrockNabulsi, P; Ehninger, G; Franke, A; Gackle, R; Geer, T; Strobel, G; Linkesch, W; Krieger, O; Niederwieser, D; Nikiforakis, E; Ohl, S; Otremba, B; Pittermann, E; Schmidt, H; Tischler, J; Weiss, J; Wilhelm, M; Badri, N G-CSF (lenograstim) after chemotherapy for acute myeloid leukemia: A placebo controlled trial.
BLOOD. 1996; 88(10): 2654-2654.
Web of Science

 

Linkesch, W Knochenmarktransplantation - Indikation und Nachsorge.
Aktuelle Hämatologie, Barmherzige Brüder Graz-Eggenberg; MAR 16, 1996; Graz, AUSTRIA. 1996. [Keynote lecture]

 

Linkesch, W Knochenmarktransplantation, hämatopoietische Wachstumshormone, Monoclonals, drug targeting - Zukunft der Hämatologie.
IV. Medizinisches Forum Stolzalpe; JAN 12-13, 1996; Murau, AUSTRIA. 1996. [Keynote lecture]

 

Linkesch, W Neue Indikationen für autologe Stammzelltransplantation.
27. Jahrestagung der Österr Ges f Innere Medizin; SEP 26-28, 1996; Linz, AUSTRIA. 1996. [Keynote lecture]

 

Linkesch, W Knochenmarks-/Stammzelltransplantation: aktuelle Daten und Implikationen für die Zukunft.
Wissenschaftliche Ges d Ärzte in d Steiermark; APR 25, 1996; Graz, AUSTRIA. 1996. [Keynote lecture]

 

Linkesch, W Randomized trials of GM-CSF after ABMT.
22nd Annual Meeting of the European Group for blood and marrow transplantation.; MAR 3, 1996; Vienna, AUSTRIA. 1996. [Keynote lecture]

 

Linkesch, W Idarubicin bei de novo AML: Patienten über 60 Jahre.
Experten Meeting; JAN 1, 1996; Vienna, AUSTRIA. 1996. [Keynote lecture]

 

Link,H; Wandt,H; Schönrock-Nabulsi,P; Ehninger,G; Franke,A; Gäckle,R; Geer,T; Gramatzki,M; Linkesch,W; Lutz,D; NIederwieser,D; Nikiforakis,E; Öhl,S; Otremba,B; Pittermann,E; Schmidt,H; Tischler,J; Weiß,J, Wilhelm,M; Deutschmann,S; G-CSF after chemotherapy for acute myeloid leukemia first analysis of a placebo controlled trial.
Ann Hamatol1996; 73: A90-A90. [Poster]

 

Neumeister, P; Hofler, G; BehamSchmid, C; Schmidt, H; Apfelbeck, U; Linkesch, W; Sill, H Homozygous deletions of the p16 gene in high-grade gastric malt lymphomas.
BLOOD 1996 88: 3311-3311.
Web of Science

 

Neumeister,P; Höfler,G; Beham-Schmid,C; Schmidt,H; Apfelbeck,u, Strunk,D; Linkesch,W; Sill,H; Homozygous deletions of the cyclin dependent kinase inhibitor gene p16 may be involved in the transformation of gastric mnalt lymphomas.
Ann Hamatol1996; 73: A164-A164. [Poster]

 

Neumeister,P; Zinke,w; Apfelbeck,U; Schmidt,H; Sormann,S; Linkesch,W CLL und Myasthenia gravis.
Jahrestagung der Österr Ges f Hämatologie und Onkologie1996; 5: 6-6.- ; ; . [Keynote lecture]

 

Reiter,E; Greinix,H.T; Brugger,S; Keil,F; Hinterberger,W; Lechner,K; Linkesch,W; Höcker,P; Haas,O.A; Mannhalter,Ch; Kahls,P; Treatment of CML Relapse after Allogenic Bone Marrow Transplantation.
Bone Marrow Transpl1996; 17(1):90-90. [Poster]

 

Schmidt, HH; Haas, OA; Pire-Danoewinata, H; Sill, H; Schallhammer, L; Neumeister, P; Pickl, WF; Strunk, D; Linkesch, W A case of NK-cell leukemia with 13q14 abnormalities.
Ann Hamatol1996; 73: A126-A126. [Poster]

 

Schmidt,H; Sill,H; Apfelbeck,U; Sormann,S; Neumeister,P; Kurz,M; Höcker,P; Greinix,HT; Linkesch,W; Dexa-beam bei hoch-und niedrigmalignen Non-Hodgkin Lymphomen.
Jahrestagung der Österr Ges f Hämatologie und Onkologie1996; 5-5. [Keynote lecture]

 

Schmidt,HH; Haas,OA; Pirc-Danoewinata,H; Panzer-Grünmyer,E; Sill,H; Sedlmayr,P; Neumeister,P; Schmidt,HH; Haas,OA; Pirc-Danoewinata,H; Panzer-Grünmayer,E; Sill,H; Sedlmyr,P; Neumeister,P; Linkesch,W; Translocation t(3;5)(p26;q13) in a patient with chronic T-cell lymphoproliferative disorder.
Int J of Hemat1996; 64: 41-41. [Poster]

 

Sormann,S; Neumeister,P; Linkesch,W; C-HAM als Postremissionstherapie bei Patienten mit de novo AML.
Jahrestagung der Österr Ges f Hämatologie und Onkologie1996; 5: 7-7.- ; ; . [Keynote lecture]

 

Thaler,J; Hilbe,W; Apfelbeck,U; Linkesch,W; Sill,h; Seewann,H; Pont,J, Bernhardt M; Stöger,M; Niessner,H; Abbrederis,K; Geissler,D; Hausmanninger,H; Lin,W; Ludwig,H; Lang,A; Duba,C; Fluckinger,T; Greil,R; Grünewald,K; Kowalinka,A; Niederwieser,D; Fridrik,MA; Comperative Analysis of two consecutive phase II studies with IFN alfa + ARA-C in untreated chronic-phase CML patients.
Jahrestagung der Österr Ges f Hämatologie und Onkologie1996; 5: 8-8.- ; ; . [Keynote lecture]

 

Thaler,J; Hilbe,W; Fridrik,M,A; Apfelbeck,U; Linkesch,W; Sill,H; Seewann,H; Pont,J; Bernhart,M; Stöger,M; Niessner,H; Abbrederis,K; Geissler,D; Hausmanninger,H; Lin,W; Ludwig,H; Lang,H; Duba,C; Fluckinger,T; Greil,R; Grünewald,K; Konwalinka,G; Niederwieser,D; Gastl;g; Comparative analysis of two consecutive phase II studies with IFNalpha and ARA-C in untreated chronic-phase CML patients.
Ann Hamatol1996; 73: A116-A116. [Poster]

 

Virgolini,I; Kurturan,A; Leimer,M; Agis,H; Angelberger,P; Valent,P; Linkesch,W; Eichler,H; Inhalation receptor scintigraphy with 123 I-Interferon gamma-1b (INFg)
Europ J of Clin Investigation1996; 26: A57-A57.- ; ; . [Poster]

 

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaskiewicz,T; Hawliczek,R; Seifert,M; Jäger,U; Höcker,P; Huber,H; Lechner,K; Greinix,H.T; Hämatologische und immunologische Rekonstitution nach Hochdosis-Chemotherapie mit supportiver Infusion von nichtselektionierten und CD34+ angereicherten peripheren Blutstammzellen.
Acta Chir Austriaca1995; 27: 68-68. [Keynote lecture]

 

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Höcker,P; Jäger,U; Huber,H; Lechner,K; Greinix,H.T; Allogene und autologe Knochenmarkstransplantation als Therapie fortgeschrittener Non-Hodgkin-Lymphome: Ergebnisse der Universitätsklinik für Innere Medizin.
Acta Chir Austriaca1995; 27: 27-27. [Keynote lecture]

 

Brugger,S.A; Kahls,P; Keil,F; Reiter,E; Linkesch,W; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Jäger,U; Lechner,K; Greinix,H.T; Knochenmarktransplantation bei malignen Lymphomen - Ergebnisse der Universitätsklinik Wien.
Acta Med Aust1995; 22: 36-36.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 1995; Salzburg, AUSTRIA. [Keynote lecture]

 

Brugger,S.A; Kurz,M; Keil,F; Linkesch,W; Kahls,P; Höcker,P; Greinix,H.T; Peripheral-blood-progenitor-cell-rescue after high dose chemo/radiotherapy as treatment for malignancies.
Bone Marrow Transpl1995; 15: 97-97. [Poster]

 

Eibl,M; Schmidt,H; Sill,H; Beham-Schmid; Höfler,G; Linkesch,W; Plasmozellulärer Subtyp des Morbus Castleman in einem lokalisierten Stadium mit schweren systemischen Symptomen und vollständiger Rückbildung nach chirurgischer Tumorentfernung.
Frühjahrstagung, Österr Ges f Hämatologie u Onkologie1995; 6-6.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie ; 1995; Klagenfurt, AUSTRIA. [Keynote lecture]

 

Fridrik, MA; Linkesch, W; Jager, G; Kienzer, HJ; Hausmaninger, H; Krieger, O; Neubauer, M; Gattringer, C; Oppitz, P; Schiller, L Response and toxicity of cladribine (2-CdA) as first line treatment of low-grade non-Hodgkin's lymphomas (NHL). Preliminary data of an Austrian multicenter trial
BLOOD. 1995; 86(10): 210-210.
Web of Science

 

Greinix,H.T; Keil,F; Brugger,S; Höcker,P; Elahi,F; Kurz,M; Linkesch,W; Lechner,K; Kahls,P; Transplantation of autologous CD34-positive peripheral blood stem cells after high-dose chemo/radiotherapy for neoplastic disease.
Bone Marrow Transpl1995; 15: 40-40. [Poster]

 

Greinix,H.T; Linkesch,W; Seifert,M; Kubista,E; Czerwenka,K; Brugger,S.A; Höcker,P; Elahi,F; Keil,F; Sevelda,P; Reiter,E; Kurz,M; Kahls,P; Transfusion CD34 positiver Blutstammzellen nach hochdosierter Chemotherapie nach Taxol, Carboplatin und Cyclophosphamid bei Patientinnen mit Mammakarzinom und hohem Rezidivrisiko.
Acta Chir Austriaca1995; 27: 70-70. [Keynote lecture]

 

Hubmann,E; Neumeister,P; Sormann,S; Höfler,G; Linkesch,W; 2-CDA (Cladaribin) as first line treatment in BALT-lymphoma - a case report.
Onkologie1995; 18: 69-69. [Poster]

 

Hubmann,E; Wurzinger,G; Höfler,G; Linkesch,W; 2-CDA als Primärtherapie bei niedrig malignene NHL vom BALT Typ- Fallbericht.
Frühjahrstagung, Österr Ges f Hämatologie u Onkologie1995; 5-5.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie ; 1995; Klagenfurt, AUSTRIA. [Keynote lecture]

 

Kahls,P; Brugger,S; Keil,F; Höcker,P; Hawliczek,R; Hinterberger,W; Lechner,K; Linkesch,W; Greinix,H.T; Allogeneic BMT beyond the age of 40 years - experience in 42 patients with hematologic malignancy.
Bone Marrow Transpl1995; 15: 17-17. [Poster]

 

Kahls,P; Brugger,S.A; Keil,F; Reiter,E; Rosenmayr,A; Kurz,M; Lechner,K; Linkesch,W; Greinix,H.T; Knochenmarktransplantation mit Fremdspendern: Erfahrungen des KMT-Zentrums der Universität Wien.
Acta Chir Austriaca1995; 27: 26-26. [Keynote lecture]

 

Kahls,P; Keil,F; Brugger,S.A; Höcker,P; Hawliczek,R; Fischer,G; Hinterberger,W; Lechner,K; Linkesch,W; Greinix,H.T; Allogenic bone marrow transplantation for hematologic malignancy in patients aged 40 years and older.
Onkologie1995; 18: 16-16. [Poster]

 

Kalhs, P; Brugger, S; Keil, F; Hocker, P; Hawliczek, R; Hinterberger, W; Lechner, K; Linkesch, W; Greinix, HT Allogeneic marrow transplantation beyond the age of 40 years in patients with hematological malignancy.
BLOOD. 1995; 86(10): 3791-3791.
Web of Science

 

Keil, F; Kalhs, F; Haas, O; Fritsch, G; Brugger, S; Schwarzinger, ERI; Mannhalter, C; Linkesch, W; Hocker, P; Lechner, K; Greinix, HT Prolonged aplasia after donor leukocyte infusion in relapsed CML unresponsive to bone marrow infusion: Successful treatment with cyclophosphamide and antithymocyte globulin followed by PBSC.
BLOOD. 1995; 86(10): 3794-3794.
Web of Science

 

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Lechner,K; Mannhalter,C; Schwarzinger,I; Linkesch,W; Höcker,P; Greinix,H.T; Erfolgreiche Behandlung BCR/ABL positiver ALL und CML im Relaps nach allogener Knochenmarktransplantation durch Spenderleukozyten(DLI) - Nachweis von Chimärismus und molekularbiologischer Remission.
Acta Med Aust1995; 22: 35-35.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 1995; Salzburg, AUSTRIA. [Keynote lecture]

 

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Lechner,K; Mannthaler,Ch; Schwarzinger,L; Linkesch,W; Höcker,P; Greinix,H.&T; Monitoring of mixed chimerism and T Cell subsets after donor leukocyte infusions (DLI) for relapse of BCR/ABL positive leukemia.
Onkologie1995; 18: 157-157. [Poster]

 

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Lechner,K; Mannthaler,Ch; Schwarzinger,L; Linkesch,W; Höcker,P; Greinix,H.T; Successfull treatment of prolonged aplasia and graft failure after donor leukocyte infusion in Philadelphia chromosome positive chronic myeloid leukemia with cyclophpsphamide and antithymocyteglobuline followed by peripheral blood stem cell rescue.
Onkologie1995; 18: 157-157. [Poster]

 

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Schwarzinger,I; Lechner,K; Mannhalter,C; Linkesch,W; Höcker,P; Greinix,H.T; Donor lymphocyte induced aplasia for CML in relapse after sex-mismatch BMT: Recovery of minimal residual donor hematopoiesis in vivo and in long in vivo and in long term bone marrow culture(LTBMC).
Acta Chir Austriaca1995; 27: 38-38. [Keynote lecture]

 

Keil,F; Kahls,P; Haas,O; Fritsch,G; Brugger,S; Reiter,E; Schwarzinger,I; Lechner,K; Mannhalter,C; Linkesch,W; Höcker,P; Lechner,K; Greinix,H.T; Successful treatment of graft failure after donor leukocyte infusion-induced aplasiain Philadelphia chromosome positive chronic myeloid leukemia with cyclophosphamide and antithymocyteglobuline followed by peripheral allogeneic blood stem cell rescue.
Acta Chir Austriaca1995; 27: 37-37. [Keynote lecture]

 

Keil,F; Kahls,P; Haas,O; Fritsch,G; Mitterbauer,G; Brugger,S; Linkesch,W; Lechner,K; Mannhalter,C; Greinix,H.T; Stimulation of donor granulopoiesis with G-CSF in relapse of BCR-ABL-positive acute lymphoblastic leukemia (ALL) following allogeneic marrow transplantation.
Bone Marrow Transpl1995; 15: 68-68. [Poster]

 

Keil,F, Zsuh,H; Kahls,P; Brugger,S; Linkesch,W; Lechner,K; Greinix,H.T; Effect of IL3, SCF, GM-CSF and IL-1b on CFU-C proliferation, cytokine production and structure of the adherent layer in long term bone marrow culture(LTBMC).
Bone Marrow Transpl1995; 15: 39-39. [Poster]

 

Linkesch, W Hochdosis - Chemotherapie - aktuelle Daten und Implikationen für die Zukunft.
Update in Onkologie; NOV 11, 1995; Vienna, AUSTRIA. 1995. [Keynote lecture]

 

Linkesch, W Hodgkin Lymphom - Diagnostik und konservative Therapie.
Grazer Fortbildungstage der Ärztekammer f Steiermark; OCT 3, 1995; Graz, AUSTRIA. 1995. [Keynote lecture]

 

Linkesch, W Prognostic factors for treatment outcome after high dose chemotherapy in patients with germ cell tumors - a multivariate analysis.
Jahrestagung d Österr Ges f Transplantation, Transfusion und Genetik - Autotransplant; OCT 25-28, 1995; Meran, ITALY. 1995. [Keynote lecture]

 

Linkesch, W Hovchdosis-Chemotherapie bei soliden Tumoren - mit oder ohne Stammzellinfusion - Streitgespräch.
Gemeinsame Jahrestagung d Deutschen und d Österr Ges f Hämatologie und Onkologie; OCT 8-11, 1995; Hamburg, GERMANY. 1995. [Keynote lecture]

 

Linkesch, W Hochdosistherapie mit autologer Stammzellunterstützung bei soliden Tumoren.
Symposium "Modern Trends in der Onkologie"; NOV 8, 1995; Duisburg, GERMANY. 1995. [Keynote lecture]

 

Linkesch, W; Die klinische Bedeutung der Molekularbiologie in der Hämatologie.
Wissenschaftliche Ges d Ärzte in d Steiermark; MAI 5, 1995; Graz, AUSTRIA. 1995. [Keynote lecture]

 

Linkesch, W; Blutzelltransplantation beim Hodentumor.
BCT-Symposium; JUN 9, 1995; Vienna, AUSTRIA. 1995. [Keynote lecture]

 

Linkesch, W; Mikrozytäre Anämien.
26. Jahrestagung d Österr Ges f Innere Medizin; SEP 21, 1995; Graz, AUSTRIA. 1995. [Keynote lecture]

 

Linkesch, W; Was sich der niedergelassene Internist von einer Spezialabteilung erwartet - Hämatologie.
26. Jahrestagung d Österr Ges f Innere Medizin; SEP 21, 1995; Graz, AUSTRIA. 1995. [Keynote lecture]

 

Linkesch, W; Prognosefaktoren für das therapeutische Ansprechen nach Hochdosis-Chemotherapie und AKMT bei Keimzelltumoren - eine Multicenter Analyse.
Frühjahrstagung d Österr Ges f Hämatologie u Onkologie; MAR 17-18, 1995; Klagenfurt, AUSTRIA. 1995. [Keynote lecture]

 

Linkesch,W; Hochdosis-Chemotherapie: Aktuelle Daten und Implikationen für die Zukunft.
Update in Onkologie1995; 12: 29-29. [Poster]

 

Linkesch,W; GM-CSF in Transplantation.
Proceedings of the 22nd Annual Meeting of the European Group for Blood and Marrow Transplantation; Satellite Symposium1995; 22: 732-732.-22nd Annual Meeting of the European Group for Blood and Marrow Transplantation; Satellite Symposium; 1996; Vienna, Austria. [Poster]

 

Linkesch,W; Wertigkeit der peripheren Stammzellexpansion und Transplantation in der Therapie der Thrombopenie nach KMT.
Frühjahrstagung, Österr Ges f Hämatologie u Onkologie1995; 2-2.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie ; 1995; Klagenfurt, AUSTRIA. [Keynote lecture]

 

Linkesch,W; für die IGCCG,Graz Durchflusszytometrische Untersuchung zur Thrombozytenaktivierung bei knochenmarktransplantierten Patienten.
Frühjahrstagung, Österr Ges f Hämatologie u Onkologie1995; 4-4.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie ; 1995; Klagenfurt, AUSTRIA. [Keynote lecture]

 

Linkesch,W; on behalf of the IGCCCG Prognostic factors for treatment outcome after high dose chemotherapy in patients with germ cell tumors - a multivariate analysis.
Acta Chir Austriaca1995; 27: 69-69. [Keynote lecture]

 

Neumeister,P; Salat,C; Holler,E; Kolb,H.J; Hiller,E; Linkesch,W; Evaluation of platelet activation by flow cytometry in patients undergoing bone marrow transplantation.
Onkologie1995; 18: 162-162. [Poster]

 

Reiter,E; Keil,F; Brugger,s.A; Kahls,P; Hinterberger,W; Lechner,K; Linkesch,W; Höcker,P; Greinix,H.T; Allogene und syngene Knochenmarkstransplantation bei Patienten mit schwerer aplastischer Anämie - Langzeitergebnisse der Universitätsklinik Wien.
Acta Med Aust1995; 22: 34-34.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 1995; Salzburg, AUSTRIA. [Keynote lecture]

 

Reiter,E; Keil,F; Brugger,S.A; Kahls,P; Hinterberger,W; Lechner,K, Linkesch,W; Höcker,P, Greinix,H.T; Allogene und synogene Knochenmarkstransplantation bei Patienten mit schwerer aplastischer Anämie - Langzeitergebnisse der Universitätsklinik für Innere Medizin I,Wien.
Acta Chir Austriaca1995; 28: 26-26. [Keynote lecture]

 

Reiter,E, Keil,F; Brugger,S.A; Kahls,P; Hinterberger,W; Lechner,K; Linkesch,W; Höcker,P; Greinix,H.T; Allogenic and syngenic bone marrow transplantation in patients with severe aplastic anemia - long-term results of the University Hospital of Vienna.
Onkologie1995; 18: 38-38. [Poster]

 

Reiter,E; Keil,F; Brugger,S.A; Kahls,P; Hinterberger,W; Lechner,K, Linkesch,W; Höcker,P, Haas,O.A; Mannthaler,Ch; Greinix,H.T; Rezidivtherapie nach allogener Knochenmarktransplantation bei Patienten mit chronischer myeloischer Leukämie(CML).
Acta Chir Austriaca1995; 27: 36-36. [Keynote lecture]

 

Schmidt,H.H; Beham-Schmid,Ch; Höfler,G; Sill,H; Straz,I; Eibl,M; Linkesch,W; Coexistence of Castleman's and Hodgkin's disease.
Onkologie1995; 18: 78-78. [Poster]

 

Schmidt,H;Sill,H;Eibl,M;Beham-Schmid;Höfler,G;Haas,O;Linkesch,W;Krejs,GJ Mb Hodgkin als Sekundärneoplasie bei einem Fall von chronisch lymphatischer Leukämie mit Spontanremission
Konferenzband Frühjahrstagung der ÖGHO 1995. 1995; -Frühjahrstagung der Österr. Gesellschaft für Hämatologie und Onkologie; MÄRZ 27-28, 1995; Klagenfurt. [Oral Communication]

 

Sormann,S; Neumeister,P; Linkesch,W; Results of C-HAM as postremession chemotherapy in adults with de Novo AML.
Onkologie1995; 18: 136-136. [Poster]

 

Thaler,J; Hilbe,W; Fridrik,M; Linkesch,W; Apfelbeck,U; Sill,H; Seewann,H; Pont,J; Bernhard,M; Michlmayr,G; Niessner,H; Abbrederis,K; Geissler,D; Hausmaninger,H; Lin,W; Ludwig,H; Lang,A; Baldinger,C; Fereberger,W; Gadner,H; Duba,C; Fluckinger,T; Greil,R; Grünewald,K; Konwalinka,G; Niederwieser,D; Allogenic and syngenic bone marrow transplantation in patients with severe aplastic anemia - long-term results of the University Hospital of Vienna.
Onkologie1995; 18: 45-45. [Poster]

 

Virgolini,I; Kurtaran,A, Leimer,M; Angelberger,P; Kletter,K; Valent, P; Linkesch,W; Eichler,H; Inhalation scintigraphy in healthy volunteers.
Europ. J of Nuclear Medicine1995; 22: 732-732. [Poster]

 

Wurzinger,G, Hubmann,E; Popper,H; Linkesch,W; BALT-Lymphom - ein seltenes, niedrig malignes Lymphom des Bronchus assoziierten Lymphgewebes.
Jahrestagung der Österr Ges f Lungenerkrankungen und Tuberkulose1995; [Poster]

 

Zinke,W; Höfler,G; Linkesch,W; Fudarabine previously treated patients with chronic lymphocytic leukemia.
Onkologie1995; 18: 83-83. [Poster]

 

Zinke,W; Schmid,Ch; Höfler,G; Linkesch,W; Fludarabintherapie bei Patienten mit massiv vorbehandelter chronisch lymphatischer Leukämie.
Frühjahrstagung, Österr Ges f Hämatologie u Onkologie1995; 5-5.-Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie ; 1995; Klagenfurt, AUSTRIA. [Keynote lecture]

 

Brugger,S; Österreicher,C; Greinix,H; Kahls,P; Linkesch,W; Case report: fulminant candida sepsis with involvement of lung, skin, brain and spleen after allogeneic BMT in a patient with SAA.
Bone Marrow Transpl1994; 179-179.-20th Annual Meeting of EBMT; 1994; [Poster]

 

Brugger,S.A; Friedl,J; Keil,F; Österreicher,C; Kurz,M; Höcker,P; Linkesch,W; Kahls,P; Greinix,H.T; Erfolgreiche Behandlung der aregeneratorischen Anämie nach ABO-major-inkompatibler KMT durch Plasmaaustausch.
Acta Med Aust1994; 21(1):77-77.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Brugger,S.A; Kurz,M; Keil,F; Greinix,H; Kahls,P; Höcker,P; Linkesch,W; Transplantation mit peripheren Blut-Stammzellen mit oder ohne Knochenmark an der Universität Wien.
Frühjahrstagung, Österr Ges f Hämatologie u Onkologie1994; 8-8. [Keynote lecture]

 

Brugger,S.A; Kurz,M, Keil,F; Greinix;H.T; Kahls,P; Österreicher,C; Höcker,P; Linkesch,W; Transplantations with peripheral blood-stemcells with or without bone marrow at the UNiversity of Vienna.
Acta Med Aust1994; 21(1):301-301.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Brugger,S.A; Kurz,M; Keil,F; Greinix,H.T; Kahls,P; Österreicher,C; Höcker,P; Linkesch,W; Transplantationen mit peripheren Blutstammzellen mit oder ohne Knochenmark an der Universität Wien.
Acta Med Aust1994; 21(3):70-70.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Brugger,S.A; Kurz,M; Keil,F; Greinix,H.T; Kahls,P; Österreicher,C; Höcker,P; Linkesch,W; Transplantations with peripheral blood-stemcells with or without bone marrow at the University of Vienna.
Onkologie1994; 17(2):71-71. [Poster]

 

Eibl,M; Schmidt,H; Silly,H; Schmid,Ch; Höfler,G; Richtig,E; Linkesch,W; Krejs,G.J; Localized plasmacellular type castleman's disease with severe systemic symptoms disappearing after surgical resection.
Onkologie1994; 17(2):115-115. [Poster]

 

Fridrik,M.A; Hausmanninger,H; Linkesch,W; Michlmayr,G; Silly,H; Neubauer,M; Seewann,H.L; Klocker,J; Haidinger,R; Schiller,L; Pont,J; Radaszkiewicz,T; Raudaschl,G; Falk,M; Intensive therapy for elderly patients with high-grade non Hodgkin's lymphomas (NHL).
Onkologie1994; 17(2):146-146. [Poster]

 

Gaiger,A; Henn,T; Greinix,H; Kahls,P; Keil,F; Hört,E; Kyrle,P; Linkesch,W; Geissler,K; Lechner,K; Lion,T; Early detection of disease progression in CML patients using quantitative BCR-ABL PCR- a useful tool for defining the optimal time for BMT.
Bone Marrow Transpl1994; 148-148.-20th Annual Meeting of EBMT; 1994; [Poster]

 

GREINIX, HT; KEIL, F; KNAPP, S; BRUGGER, S; KALHS, P; LINKESCH, W; LECHNER, K; JAEGER, U ALLOGENEIC MARROW TRANSPLANTATION FOR ADVANCED-STAGE T(14-18) NON-HODGKINS-LYMPHOMA ELIMINATES PCR DETECTABLE CELLS FROM PERIPHERAL-BLOOD AND BONE-MARROW
BLOOD. 1994; 84(10): A214-A214.
Web of Science

 

Greinix,H; Kahls,P; Keil,F; Linkesch,W; Brugger,S; Österreicher,C; Knapp,S; jäger,U; Radaszkiewicz,T; Hawliczek,R; Hinterberger,W; Lechner,K; Knochenmarktransplantation bei malignen Lymphomen Ergebnisse der Universitätsklinik Wien.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 8-8.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

 

Greinix,H; Keil,F; Kahls,P; Linkesch,W; Brugger,S; Österreicher,C; Knapp,S; Kier,P; Hinterberger,W; Lechner,k; Jäger,U; Allogeneic bone marrow transplantation in Non-Hodgkin lymphomas with t(14;18) translocation
Bone Marrow Transpl1994; 154-154.-20th Annual Meeting of EBMT; 1994; [Poster]

 

Greinix,H; Zsuh,H; Keil,F; Kahls,P; Linkesch,W; Höcker,P; Kurz,M; Geissler,K; Lechner,K; Stem cell factor erhöht das Wacjstum hämatopoetischer Progenitorzellen nach ex-vivo Mafosfamid - Behandlung des Knochenmarks.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 3-3.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

 

Greinix,H.T; Keil,F; Brugger,S; Linkesch,W; Hinterberger,W; Lechner,K; Höcker,P; Hawliczek,R; Kahls,P; Allogene und autologe Knochnemarktransplantation (KMT) bei Patienten mit akuter myeloischer Leukämie(AML) Ergebnisse des KMT-Zentrums der Universitätsklinik Wien 1982-1994.
Acta Med Aust1994; 21(1):36-36.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Greinix,H.T; Keil,F; Höcker,P; Kurz,M, Elahi,F; Brugger,S; Linkesch,W; Knöbl,P; Lechner,K; Kahls,P; Autologe KMT mit Mafosfamid-gepurgtem Knochenmark als Konsolidierungstherapie akuter myeloischer Leukämie.
Acta Med Aust1994; 21(3):4-4.-Jahrestagung der Österreichischen Gesellschaft für Inere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Greinix,H.T; Keil,F; Linkesch,W; Kurz,M; Höcker,P; Brugger,S; Knöbl,P; Lechner,K; Kahls,P; Autologous marrow transplantation using purged marrow in acute myeloid leukemia in first and second remission.
Onkologie1994; 17(2):188-188. [Poster]

 

Greinix,H.T; Keil,F; Zhu,H; Elahi,F; Brugger,S; Höcker,P; Geissler,K; Linkesch,W; Lechner,K, Kahls,P; Transfusion von CD-34-angereicherten Blutstammzellen nach myeloablativen Chemo-/Radiotherapien.
Acta Med Aust1994; 21(3):68-68.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Kahls,P; Brugger,S; Keil,F; Höcker,P; Hawliczek,R; Hinterberger,W; Lechner,K, Linkesch,W; Greinix,H.T; Allogene KMT bei Patienten über 40 Jahren - ERfahrungen des KMT-Zentrums der Universität Wien.
Acta Med Aust1994; 21(3):8-8.-Jahrestagung der Österreichischen Gesellschaft für Inere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Kahls,P; Greinix,H; Brugger,S; Keil,F; Höcker,P; Lechner,K; Hinterberger,W; Linkesch,W; Allogene Knochenmarktransplantation (KMT) bei Patienten mit AML und CML; Ergebnisse des KMT-Zentrums der Universität Wien 1982-1993.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 3-3.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

 

Kahls,P; Greinix,H.T; Schwarzinger,I; Keil,F; Linkesch,W; Lechner,K; Thrombociti thrombocytopenic purpura(TTP)- like syndrome in patients receiving cyclosporine A and methylprednisolone for graft versus host disease (GVGHD) prophylaxis after allogeneic bone marrow transplantation(BMT).
Proceedings of the 25th Congress of the International Society of Hematology1994; 692-692.-25th Congress of the International Society of Hematology; APR 17-21, !994; Cancun,MEXICO. [Poster]

 

Kahls,P; Keil,F; Brugger,S.T; Linkesch,W; Höcker,P; Hawliczek;R; Rosenmayr,A; Hinterberger,W; Lechner,K; Greinix,H.T; Allogeneic bone marrow transplantation (BMT) at the University of Vienna: Experience in 173 patients.
Onkologie1994; 17(2):280-280. [Poster]

 

KALHS, P; BRUGGER, S; SCHWARZINGER, I; GREINIX, HT; KEIL, F; KYRLE, PA; KNOBL, P; LINKESCH, W; LECHNER, K SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION
BLOOD. 1994; 84(10): A489-A489.
Web of Science

 

Keil,F; Greinix,H; Zsuh,H; Linkesch,W; Kahls,P; Brugger,S; Lechner,K; Einfluss von IL3, SCF; GM-CSF und IL-1beta auf die proliferation von Vorläuferzellen, Differenzierung und STruktur der adhärenten Zellschicht in der Knochenmarklangzeitkultur (LTBMC)
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 2-2.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

 

Keil,F; Greinix,H.T; Zhu,H; Kahls,P; Linkesch,W; Brugger,S; Lechner,K, Einfluss von IL3beta SCF, GM-CSF und IL-1B auf die Proliferation von Vorläuferzellen, Differenzierung und Struktur der adhärenten Zellschicht in der Knochenmark-Langzeitkultur(LTBMC).
Acta Med Aust1994; 21(3):56-56.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Keil,F; Greinix,H.T; Zsuh,H; Brugger,S; Kahls,P; Linkesch,W; Lechner,K; Huber,H; Effect of IL3, SCF, GM-CSF and Il-1beta on CFU-proliferation, cytokine production and structure of the adherent layer in LTBMC.
Bone Marrow Transpl1994; 132-132.-20th Annual Meeting of EBMT; 1994; [Poster]

 

Keil,F; Greinix,H.T; Zsuh,H; Kahls,P; Brugger,S.T, Linkesch,W; Lechner,K; Effect of IL3, SCF, GM-CSF and IL-1beta on CFU-C proliferation, cytokine production and structure of the adherent layer in LTBMC.
Onkologie1994; 17(2):289-289. [Poster]

 

Keil,F;Greinix,HT;Kahls,P;Linkesch,W;Brugger,S;Mitterbauer,G;Knöbl,P;Mannhalter,C;Lechner,K Knochenmarktransplantation bei Ph pos. ALL
59. Hämatologisch-onkologischer Diskussionsabend der ÖGHO; JAN 13, 1994; Wien. 1994. [Oral Communication]

 

Linkesch, W Einführung zur Stammzelltransplantation
Cancer Club der Universität Wien; JAN 19, 1994; Wien, Austria. 1994. [Keynote lecture]

 

Linkesch, W High Dose Chemotherapy in Germ Cell Cancer - Introduction
Onkologisches Seminar; APRIL, 26 , 1994; Wien, AUSTRIA. 1994. [Keynote lecture]

 

Linkesch, W Einsatz von G-CSF in der Knochenmarktransplantation
Roche Symposium; NOV 3, 1994; Vienna, AUSTRIA. 1994. [Keynote lecture]

 

Linkesch, W; Stammzelltransplantation bei soliden Tumoren.
Wissenschaftliche Ges d Ärzte in d Steiermark; JUL 23, 1994; Villach, AUSTRIA. 1994. [Keynote lecture]

 

Linkesch, W; Anämien.
Hämatologisches Fortbildungsseminar d Ärztekammer f Niederösterreich; JUN 6, 1994; Waidhofen/Thaya, AUSTRIA. 1994. [Keynote lecture]

 

Linkesch, W; Longterm results of phase I/II trial of Carbo PEC with ABMT in refractory or relapsed NSGCT.
2nd International Symposium or High-Dose Chemotherapy and Stem Cell Transplantation in solid Tumors; APR 29-30, 994; Berlin, GERMANY. 1994. [Keynote lecture]

 

Linkesch, W; Allogene KMT.
Hämatologisches Fortbildungsseminar d Ärztekammer f Niederösterreich; JUN 6, 1994; Waidhofen/Thaya, AUSTRIA. 1994. [Keynote lecture]

 

Linkesch, W; Germ cell Tumors - The Wien trial.
EORTC - ABMT Group Meeting; SEP 16, 1994; Ravenna, ITALY. 1994. [Keynote lecture]

 

Linkesch, W; Stammzellltransplantation: Möglichkeiten und Grenzen.
6. Cytokin-Winterworkshop ; MAR 19, 1994; Leogang, AUSTRIA. 1994. [Keynote lecture]

 

Linkesch,W; Greinix,H; Kahls,P; Keil,F; Hinterberger,W; Lechner,K; Höcker,P; 300 Knochenmarktransplantationen an der Universität Wien AKH.
Proceedings of the Frühjahrstagung der Österr Ges f Hämatologie u Onkologie1994; 3-3.-Frühjahrstagung der Österr Ges f Hämatologie u Onkologie; [Keynote lecture]

 

Linkesch,W; Greinix,H.T; Kahls,P; Keil,F; Krainer,M; Longterm results of phase I/II trial of Carbo PEC with ABMT in refractory or relapsed NSGCT.
Proceedings of the 2nd International Symposium on High-Dose Chemotherapy and Stem Cell Transplantation in solid Tumors1994; 29-29.-2nd International Symposium on High-Dose Chemotherapy and Stem Cell Transplantation in solid Tumors; 1994; [Poster]

 

Linkesch,W; Schmidt,H; Anämiediagnostik
Acta Med Aust1994; -Jahrestagung der Österr Ges f Innere Medizin; SEP 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Link,H; Boogaerts,M.A; Fauser,A; Slavin,S; Reiffers,J; Gorin,N.C; Carella,A.M; Mandelli,F; Burdach,S; Ferrant,A; Linkesch,W; Tura,S; Bacigalupo,A; Schindel,F; Heinrichs,H; A controlled trial of recombinant erythopoietin after bone marrow transplantation.
Onkologie1994; 17(2):359-359. [Poster]

 

Link,H; Fauser,A; Hübner,G; Bacigalupo,A; Boogaerts,M; Burdach,S; Carella,A; Ferrant,A; Goldstone,A; Gorin,N; Krieger,O; Linkesch,W; Mandelli,F; McCann,S; Reiffers,J; Slavin,S; Steward,W; Tura,S; Zintl,F; Schindel-Künzel,F; Heinrichs,H; Recombinant human erythropoietin after bone marrow transplantation - final analysis of the European placebo controlled trial.
Bone Marrow Transpl1994; 96-96.-20th Annual Meeting of EBMT; 1994; [Poster]

 

Schmidt,H; Silly,H; Eibl,M; Schmid,Ch; Höfler,G; Haas,O.A; Linkesch,W; Krejs,G.J; Morbus Hodgkin as a secondary neoplasia in a patient wit spontaneaous remission of chronic lymphocytic leukemia and INV (9) as a constitutional karyotype abnormality.
Onkologie1994; 17(2):522-522. [Poster]

 

Schürer,G; Keil;F; Brugger,S; Linkesch,W; Greinix,H.T; Kahls,P; Allogene KMT bei multiplem Myelom.
Acta Med Aust1994; 21(3):10-10.-Jahrestagung der Österreichischen Gesellschaft für Inere Medizin; SEP, 1994; Salzburg, AUSTRIA. [Keynote lecture]

 

Schürer,G; Keil,F; Brugger,S.T; Linkesch,W; Greinix,H.T; Kahls,P; Allogeneic bone marrow transplantation in multiple myeloma.
Onkologie1994; 17(2):529-529. [Poster]

 

Thaler,G; Fridrik,M; Apfelbeck,U; Silly,H; Bernhard,M; Niessner,H; Ludwig,H; Abbrederis,K; Geissler,D; Michlmayr,G; Pont,J; Linkesch,W; Hausmaninger,H; Arneitz,K; Baldinger,C; Fereberger,W; Gadner,H; Duba,C; Fluckinger,T; Greil,R; Grünewald,K; Hilbe,W; Konwalinka,G; Niederwieser,D; Interferon-alpha 2C and LD-ARA-C for the treatment of patients with CML:Results of the Austrian multicenter Phase-II-Study.
Onkologie1994; 17(2):602-602. [Poster]

 

Fridrik,M.A; Hausmaninger,H; Linkesch,W; Michlmayr,G; Silly,H; Seewann,H.L; Klocker,J; Haidinger,R; Schiller,L, Pont,J; Lehnert,M; Radaszkiewicz,T; Raudaschl,G; Falk,M; A new hybrid regimen (CEOP-IMVP-DEXAL) in the treatment of high-grade Non-Hodgkin's Lymphoma(NHL). An Austrian Multicenter trial.
Proceedings of the XIIth meeting of the Int. Society of Haematology (European and African Division)1993; 51-51.-XIIth meeting of the Int. Society of Haematology (European and African Division); AUG 28-SEP 3, 1993; Vienna, AUSTRIA. [Poster]

 

Fridrik,M.A; Hausmaninger,H; Linkesch,W; Michlmayr,G; Silly,H; Seewann,H.L; Klocker,J; Haidinger,R; Schiller,L; Pont,J; Lehnert,M; Radaszkiewicz,T; Raudaschl,G; Falk,M; An Austrian multicenter trial with a new hybrid regim (CEOPI-MVP-DEXA) in the treatment of high-grade non-hodgkins lymphomas (NHL).
J Clin Oncology1993; 12: 376-376. [Poster]

 

Fridrik,M.A; Hausmaninger,H; Linkesch,W; Michlmayr,G; Silly,H; Seewann,H.L; Klocker,J; Haidinger,R; Schiller,L; Pont,J; Lehnert,M; Radaszkiewicz,T; Raudaschl,G; Falk,M; A new hybrid regim (CEOPI-MVP-DEXA) in the treatment of high-grade non-hodgkins lymphomas (NHL). An Austrian multicenter trial.
Ann Hematol 1993; 67: A35-A35. [Poster]

 

Gaiger,A; Lion,T; Kahls,P; Greinix,H; Keil,F; Henn,T; Laczika,K; Hinterberger,W; Linkesch,W; Mannhalter,C; Lechner,K; Qualitative and quantitative bcr-abl PCR analyses in patients with chronic myleoic leukemia (CML) following allogeneic and syngeneic bone marrow transplantation.
Proceedings of the 19th meeting of the EBMT1993; 37-37.-19th meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

 

Gaiger,A; Lion,T; Kahls,P; Henn,T; Greinix,H; Keil,F; Laczika,K; Linkesch,W; Mannhalter,C; Lechner,K; Monitoring of minimal residual disease and early detection of relapse in CML patients following bone marrow transplantation using qualitative and quantitative BCR-ABL PCR analysis.
Proceedings of the 27th Annual Scientific Meeting of the European Society for Clinical Investigation1993; 112-112.-27th Annual Scientific Meeting of the European Society for Clinical Investigation; APR 14-17,1993; Heidelberg,GERMANY. [Poster]

 

Greinix,H;Keil,F;Linkesch,W;Kahls,P;Scholten,Ch;Kier,P;Hinterberger,W;Lechner,K;Jäger,U Allogene Knochenmarktranspkantation bei NHL-Lymphomen mit t(14;18) Translokation
Wien Klin Wochenschr 1993. 1993; (105):743-743.-Wissenschaftl. Tagung der Gesellschaft der Ärzte; OKT 15, 1993; Wien. [Poster]

 

Greinix,H.T; Keil,F; Höcker,P; Linkesch,W; Kahls,P; Geissler,K; Lechner,K; Stem Cell Factor erhöht das Wachstum hämatopoetischer Progenitorzellen nach Ex-vivo Mafosfamidbehandlung des Knochenmarks.
Acta Chir Austriaca1993; 25: 12-12. [Keynote lecture]

 

Greinix,H.T; Keil,F; Linkesch,W; Kahls,P; Scholten,Ch; Kier,P; Hinterberger,W; Lechner,K; Jäger,U; Allogene Knochenmarktransplantation bei Non-Hodgkin Lymphomen mit t(14;18) Translokation.
Acta Chir Austriaca1993; 25: 10-10. [Keynote lecture]

 

Greinix,H.T; Keil,F; Scholten,Ch; Kahls,P; Linkesch,W; Kier,P; Hinterberger,W; Lechner,K, Jäger,U; Allogeneic bone marrow transplantation in Non-Hodgkin Lymohomas with T(14;18) translocation.
Proceedings of the XIIth meeting of the Int. Society of Haematology (European and African Division)1993; 165-165.-XIIth meeting of the Int. Society of Haematology (European and African Division); AUG 28-SEP 3, 1993; Vienna, AUSTRIA. [Poster]

 

Greinix,H.T; Keil,F; Scholten,Ch; Kahls,P; Linkesch,W; Kier,P; Hinterberger,W; Lechner,K; Jäger,U; Allogeneic bone marrow transplantation in Non-Hodgkin lymphomas with T(14;18) translocation.
Ann Hematol 1993; 67: A41-A41. [Poster]

 

Greinix,H.T; Kraupp,M; Linkesch,W; Kahls,P; Keil,F; Aminolevulinic acid dehydrase in evaluation of erythroid regeneration after bone marrow transplantation.
Proceedings of the 19th meeting of the EBMT1993; 119-119.-19th meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

 

Greinix,H.T; Linkesch,W; Kahls,P; Keil,F; Kapiots,S; Schwarzinger,I; Lechner,K; Beurteilung der hämapoetischen Regeneration nach Knochenmarktransplantation anhand hochfluoreszierender Retikulozyten.
Österr Ges f Hämatologie u Onkologie, Frühjahrstagung1993; 17-17. [Keynote lecture]

 

Höcker,P; Wagner,A; Gerhartl,K; Peters,Ch; Emminger,W; Linkesch,W; Hinterberger,W; Harvesting and transfusion of peripheral blood stem cell without and with autologous bone marrow.
Proceedings of the 19th meeting of the EBMT1993; 106-106.-19th meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

 

Kahls,P; Greinix,H; Brugger,St; Keil,F; Lechner,K; Linkesch,W; Allogene Knochenmarktransplantation bei Patienten mit AML und CML Ergebnisse des KMT-Zentrums der Universität Wien 1882 bis 1993.
Acta Chir Austriaca1993; 25: 9-9. [Keynote lecture]

 

Kahls,P; Greinix,H.T; Schwarzinger,I; Keil,F; Linkesch,W; Lechner,K; Thromotic-thrombocytopenic purpura(TTP)-like syndrome in patients receiving cyclosporine A and methylprednisolone for graft versus host disease(GVHD) proohylaxis after allogeneic bone marrow transplantation(BMT).
Proceedings of the 25th Congress of the International Society of Hematology1993; 692-692.-25th Congress of the International Society of Hematology; APR 17-21; Cancun, MEXICO. [Poster]

 

Kahls,P; Greinix,H.T; Schwarzinger,I; Müller,H; Keil,F; Linkesch,W; Lechner,K; Thrombocytic thrombocytopenic purpura (TTP)-like syndrome in patients receiving cyclosporine a and methylprednisolone for graft versus host disease(GVHD) prophylaxis.
Proceedings of the 19th Meeting of the EBMT1993; 17-17.-19th Meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

 

Kahls,P; Greinix,P.T; Schwarzinger,I; Kyrle,P.A; Keil,F; Müller,H; Linkesch,W; Lechner,K; Thrombotisch thrombozytopenische Purpura (TTP)-artiges Syndrom nach allogener Knochenmarkstransplantation (KMT) bei Gabe von Cyclosporin A plus Methylprednisolon (CSA-MP) als Graft-versus-host-disease (GVHD) Prophylaxe.
Österr Ges f Hämatologie, Frühjahrstagung1993; 16-16. [Keynote lecture]

 

Keil,F; Greinix,H; Kahls,P; Jäger,U; Scholten,Ch; Linkesch,W; Lechner,K; Allogene Knochenmarkstransplantation (KMT) bei Non Hodgkin Lymphomen (NHL) mit T(14;18) Translokation.
Proceedings of the Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie1993; 6-6.-Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie; 1993; [Keynote lecture]

 

Keil,F; Greinix,H; Kahls,P; Linkesch,W; Lechner,K; Expansion von myeloischen Vorläuferzellen durch IL-3, SCF und GM-SCF in der Langzeitknochenmarkkultur (LTBMC).
Acta Chir Austriaca1993; 25: 13-13. [Keynote lecture]

 

Keil,F; Greinix,H.T; Kahls,P; Linkesch,W; Lechner,K; Mannhalter,Ch; Allogene Knochenmarktransplantation bei Philadelphia-positiver ALL im zweiten Rezidiv.
Acta Chir Austriaca1993; 25: 11-11. [Keynote lecture]

 

Kusec,R; Laczika,K; Purtscher,B; Greinix,H; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; jäger,U; Monitoring of patients with t(8;21)-positive acute myeloid leukemia using AML 1/ETO RT-PCR.
New Trends in the Treatment of Acute Leukemia1993; 106-106.-ESO Meeting ; 1993; [Poster]

 

Kusec,R; Laczika,K; Purtscher,B; Greinix,H.T; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; Jäger,U; Monitoring of patients with t(8;21)-positive acute myeloid leukemia using AML1/ETO RT-PCR.
Ann Hematol 1993; 67: A73-A73. [Poster]

 

Kusec,R; Laczika,K; Purtscher,B; Greinix,H.T; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; Jäger,U;, PCR-Nachweis der AML1-ETO Fusions-RNA bei akuter myeloischer Leukämie mit t(8;21)
Wien Klin Wochenschr1993; 105: 741-741. [Keynote lecture]

 

Kusec,R; Laczika,K; Putscher,B; Greinix,H; Kahls,P; Knöbl,P; Linkesch,W; Haas,O; Lechner,K; Jäger,U; PCR-detection and monitoring of the AML 1/ETO fusion gene in patients with t(8;21)-positive acute myeloid Leukemia.
Proceedings of the XIIth meeting of the Int. Society of Haematology (European and African Division)1993; 495-495.-XIIth meeting of the Int. Society of Haematology (European and African Division); AUG 28-SEP 3, 1993; Vienna, AUSTRIA. [Poster]

 

Kusec,R;Lazika,K;Purtscher,B;Greinix,H;Kahls,P;Knöbl,P;Linkesch,W;Haas,OLechner,K;Jäger,U; PCR-Nachweis der AML1-ETO Fusions-RNA bei akuter myeloischer Leukämie mit t(8,21 )
Konferenzband der Frühjahrstagung der ÖGHO. 1993; 3-3.-Frühjahrstagung der Osterr. Gesellschaft für Hämatologie und Onkologie; MÄRZ 25-27, 1993; Wien, Austria. [Oral Communication]

 

LINK, H; FAUSER, A; HUBNER, G; BACIGALUPO, A; BOOGAERTS, M; BURDACH, S; CARELLA, A; FERRANT, A; GOLDSTONE, A; GORIN, N; KRIEGER, O; LINKESCH, W; MANDELLI, F; MCCANN, S; REIFFERS, J; SLAVIN, S; STEWARD, W; TURA, S; ZINTL, F; SCHINDELKUNZEL, F; HEINRICHS, H CLINICAL BONE-MARROW TRANSPLANTATION .3. RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION - A PROSPECTIVE PLACEBO-CONTROLLED TRIAL IN EUROPE
BLOOD. 1993; 82(10): A284-A284.
Web of Science

 

Linkesch, W. Clinical Aspects of Autologous Stem Cell Transplantation
European Stem Cell Club; JUNE, 3-5. 1993; Vienna, AUSTRIA. 1993. [Keynote lecture]

 

Linkesch, W; Greinix, HT; Höcker, P; Krainer, M; Kahls, P; Keil, F; Longterm follow up phase I/II trial of ultra-high carboplatin, VP16, Cyclophosphamide with ABMT in refractory or relapsed NSGCT.
Abstract Book1993; 35-35.-International Consensus Conference on Intensive Chemotherapy plus Hematopoietic stem cell transplantation in malignancies.; Jun 4-6, 1993; Lyon, FRANCE. [Poster]

 

Linkesch,W; Der Einsatz der Knochenmarktransplantation in der Therapie maligner Tumore.
Wiss Ges d Ärzte i d Stmk, Ausseer Symposium1993; 30-30. [Keynote lecture]

 

Linkesch,W; Rezidivtherapie maligner Non-Hodgkin-Lymphome
Acta Med Aust1993; 20: 52-52.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1993; Salzburg,AUSTRIA. [Keynote lecture]

 

Linkesch,W; Greinix,H; Kahls,P; Keil,F; Krainer,M; GM-CSF vs.G-CSF nach autologer Knochenmarktransplantation.
Acta Chir Austriaca1993; 25: 12-12. [Keynote lecture]

 

Linkesch,W; Greinix,H; Krainer,M; Wagner,A; Kahls,P; Höcker,P; Autologe Knochenmarktransplantation bei Hodentumoren - 5 Jahre klinische Erfahrungen.
Österr Ges f Hämatologie u Onkologie, Frühjahrstagung1993; 17-17. [Keynote lecture]

 

Linkesch,W; Greinix,H.T.; Höcker,P; Krainer,M; Wagner,W; Longterm follow up of phase I/II trial of ultra-high carboplatin, VP16, Cyclophosphamide with ABMT in refractory or relapsed NSGCT.
J Clin Oncol1993; 12: 232-232.-29th Annual Meeting; May 16-19, 1993; Orlando,FLORIDA. [Keynote lecture]

 

Linkesch,W; Greinix,H.T; Kahls,P; Krainer,M; Höcker,P; Keil,F; Longterm follow up of ultra-high carbolatin, VP 16, cyclophosphamide with ABMT in refractory or relapsed NSGCT.
Ann Hematol 1993; 67: A76-A76. [Poster]

 

Linkesch,W; Krainer,M; Greinix,H.T; Wagner,A; Höcker,P; Ultrahigh dose carboplatin etoposide, cyclophosphamide with ABMT in relapsed and refractory NSGCT-longterm follow up.
Proceedings of the 19th Meeting of the EBMT1993; 76-76.-19th Meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

 

Link,H; Heinrichs,H; Hübner,G; Diedrich,H; Bacigalupo,A; Boogaerts,M; Burdach,S; Carella,A; Fauser,A; Ferrant,A; Goldstone,A; Gorin,N; Krieger,O; Linkesch,W; Mandelli,F; McCann,S; Reiffers,J; Slavin,S; Steward,W; Tura,S; Zintl,F; Nicolay,U; Oster,W; Recombinant human erythropoietin after bone marrow transplantation: interim analysis of a prospective placebo controlled trial.
Ann Hematol1993; 66: A82-A82. [Poster]

 

Link,H; Oster,W; Hübner,G; Diedrich,H; Bacigalupo,A; Boogaerts,M; Burdach,S; Carella,A; Fauser,A; Ferrant,A; Goldstone,A; Gorin,N; Krieger,O; Linkesch,W; Mandelli,F; McCann,S; Reiffers,J; Slavin,S; Steward,W; Tura,S; Zintl,F; Nicolay,U; Heinrichs,H; Recombinant human Erythropoietin after bone marrow transplantation: Interim analysis of a prospective placebo controlled trial.
Proceedings of the 19th meeting of the EBMT1993; 111-111.-19th meeting of the EBMT; JAN 17-21, 1993; Garmisch-Partenkirchen,GERMANY. [Poster]

 

Österreicher,Ch; Brugger,St; Greinix,H; Kahls,p, Linkesch,W; Fulminante Candidasepsis mit Hautinfiltraten im Rahmen einer allogenen Knochenmarktransplantation-aplastische Anämie-Kasuistik.
Acta Chir Austriaca1993; 25: 12-12. [Keynote lecture]

 

Scholten,Ch; Greinix,H; Höcker,P; Keil,F; Geissler,K; Laczika,K; Purtscher,B; Linkesch,W; Lechner,K; Jäger,U; Klon-spezifische CDRIII-PCR zum Monitoring von B-Zell Lymphomen/Leukämien.
Proceedings of the Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie1993; 4-4.-Frühjahrstagung der Österr. Ges f Hämatologie u Onkologie; 1993; [Keynote lecture]

 

Scholten,Ch; Greinix,H; Höcker,P; Keil,F; Geissler,K; Laczika,K; Purtscher,B; Linkesch,W; Mitterbauer,G; Klonspezifische CDR III PCR zum Monitoring von B-Zell-Lymphomen/Leukämien.
Acta Med Aust1993; 20: 72-72.-Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP, 1993; Salzburg,AUSTRIA. [Keynote lecture]

 

Scholten,Ch;Greinix,H;Höcker,P;Keil,F;Geissler,K;Lazika,K;Purtscher,B;Linkesch,W;Lechner,K;Jäger,U Klon-spezifische CDRIII-PCR zum Monitoring von B-Zell Lymphomen/Leukämien
Konferenzband der Frühjahrstagung der ÖGHO. 1993; 4-4.-Frühjahrstagung der Osterr. Gesellschaft für Hämatologie und Onkologie; MÄRZ 25-27, 1993; Wien, Austria. [Oral Communication]

 

Thaler,J; Fluckinger,T; Fridrik,M; Silly,H; Seewann,H; Bernhart,M; Geissler,D; Michlmayr,G; Linkesch,W; Lang,A; Hausmaninger,H; Ludwig,H; Pont,J; Gadner,H; Huber,H; Greil,R; Duba,C; Grünewald,K; Niederwieser,D; Interferon-alpha-2c and low dose ARA-C for the treatment of patients with ph-positive CML:preliminary results of the Austrian multicenter phase-II study.
Ann Hematol 1993; 67: A125-A125. [Poster]

 

Thaler,J; Fluckinger,T; Fridrik,M; Silly,H; Seewann,H; Bernhart,M; Geissler,D; Michlmayr,G; Linkesch,W; Lang,A; Hausmaninger,H; Ludwig,H; Pont,J; Gadner,H; Huber,H; Grell,R; Duba,C; Grünewald,K; Niederwieser,D; Interferon-Alpha-2c and low dose ARA-C for the treatment of patients with ph-positive CML: preliminary results of the Austrian multicenter phase-II study.
Proceedings of the XIIth meeting of the Int. Society of Haematology (European and African Division)1993; 213-213.-XIIth meeting of the Int. Society of Haematology (European and African Division); AUG 28-SEP 3, 1993; Vienna, AUSTRIA. [Poster]

 

Zhu,H; Greinix,H.T; Kurz,M; Höcker,P; Keil,F; Linkesch,W; Ex-vivo-Expansion peripherer Stammzellen.
Acta Chir Austriaca1993; 25: 13-13. [Keynote lecture]

 

Gaiger,A; Lion,T; Kahls,P; Mitterbauer,G; Henn,T; Haas,O; Forstinger, C; Hinterberger,W; Linkesch,W; Mannhalter,C; Lechner,K; Frequent detection of BCR-ABL specific M-RNA and early detection of relapse in CML patients following not T-Cell depleted BMT using the PCR.
Ann Hematol1992; 65: A56-A56. [Poster]

 

Gaiger,A; Lion,T; Kahls,P; Mitterbauer,G; Henn,T; Haas,O; Hinterberger,W; Linkesch,W; Mannhalter,C; Lechner,K; Monitoring of minimal residual disease and early detection of relapse in CML patients following non T-cell depleted BMT using the PCR.
Ann Hematol1992; 65: 4-4. [Poster]

 

Gaiger,A; Lion,T; Kahls,P: Mitterbauer,G; Henn,T; Haas,O; Kier,P; Hinterberger, W; Linkesch, W; Mannhalter,C; Lechner,K Serial BCR-ABL, PCR Analysis jn CML Patients following Non-T-Cell depleted Bone Marrow Transplantation
Acta Medica Austriaca. 1992; 19(2):36-36.-22. Jahrestagung der ÖGIM; SEP 17-19, 1992; Wien, Austria. [Oral Communication]

 

Kahls,P; Forstinger,C; Laczika,K; Gaiger,A; Scholten,C; Linkesch,W; Hinterberger,W; Lechner,K; Bone marrow transplantation as treatment for chronic myelogenous leukemia (CML): experience in 40 patients.
Ann Hematol1992; 65: A12-A12. [Poster]

 

Linkesch, W Ultrahigh-dose Chemotherapie mit Stammzellrescue bei therpierefraktären und relapsierten nichtseminomatösen Hodentumoren
Konferenzband der 10. Jahrestagung der Österr. Gesellschaft für Urologie. 1992; -1o. Fortbildungstagung der Österreichischen Gesellschaft für Urologie; NOV 13-14 1992; Linz, Austria. [Keynote lecture]

 

Linkesch, W; Greinix, H; Kahls, P; Keil, F; Hinterberger, W; Lechner, K; Höcker, P 300 Knochenmarktransplantationen an der Universität Wien-AKH
Symposium Knochenmarktransplantation; OKT 28, 1992; Wien, Austria. 1992. [Keynote lecture]

 

Linkesch, W; Krainer, M: Wagner, A Phase 1/2 Trial of ultrahigh carboplatin, etoposide, cyclophosphamide with ABMT in refractory or relapsed nonseminatous germ cell tumors ( NSGCT )
J CLIN ONCOL. 19921992; 11: 196-196.-Annual Meeting of the American Society of Clinical Oncology; JUN 2-6, 1992; San Diego, USA. [Keynote lecture]

 

Linkesch, W; Krainer, M; Wagner,A PhaseI/II Trial of Ultrahigh Carboplatin, Etoposide, Cyclophosphamide with ABMT in refractory or relapsed NSGCT
Proceedings of the Internat. Symposium High-Dose Chemotherapy and SCT in Solid Tumors. 1992; 15-15.-Internat. Symposium on High-Dose Chemotherapy and Stem Cell Transplantation in Solid Tumors; MAY 4-6, 1992; Berlin, GERMANY. [Keynote lecture]

 

Linkesch,W Autologe Knochenmarktransplantation an der Medizinischen Klinik I
Symposium Knochenmarktransplantation; OKT 28, 1992; Wien, Austria. 1992. [Keynote lecture]

 

Linkesch,W; Hochdosierte Chemotherapie+/- Knochenmarktransplantation.
Acta Med Aust1992; 19: 32-32.-Jahrestagung der österreichischen Gesellschaft für Innere Medizin.; SEP, 1992; Salzburg,AUSTRIA. [Keynote lecture]

 

Linkesch,W; Krainer,M; Höcker,P; Wagner,A; GM-CSF versus G-CSF after ultrahigh-dose chemotherapy and ABMT in relapsed or refractory testicular cancer.
Proceedings of the EBMT1992; 138-138.-EBMT ; 1992; Stockholm. [Poster]

 

Linkesch,W; Krainer,M; Wagner,A; Longterm follow up salvage treatmnet in relapsed and refractory NSGCT using ultrahigh dose Carboplatin, Etoposide and Cyclophosphamide with ABMT.
Ann Hematol1992; 65: A90-A90. [Poster]

 

Linkesch,W; Wagner,A; Krainer,M; Phase I/II trial of ultrahighdose chemotherapy with ABMT in refractory or relapsed non-seminomatous germ cell tumors(NSGCT).
Proceedings of the EBMT1992; 182-182.-EBMT ; 1992; Stockholm. [Poster]

 

Linkesch,W;Krainer,M;Wagner,A Phase I/II trial of ultrahigh carboplatin, etoposide, cyclophosphamide with ABMT in refractory or relapsed nonseminomatous germ cell tumours(NSGCT).
J Clin Oncol1992; 11: 196-196.-28th Annual Meeting of ASCO; MAY, 7-19, 1992; San Diego, USA. [Keynote lecture]

 

Simonitsch,I; Radaskiewicz,T; Linkesch,W; Kinacyian,T; Volc-Platzer,B; Induction and modulation of HECA-452 expression on endothelial cells upon in vivo treatment with recombinant human granulocyte-macrophage colony stimulating factor (rh-GM-CSF).
Arch Dermatol Res1992; 284(1):24-24. [Poster]

 

Stockschläder,M; Kahls,P; Krüger,W; Linkesch,W; Peters,S; Lechner,K; Zander,A; Pentoxifyline did not prevent transplant-related toxicity in 30 allogeneic bone marrow transplant recipients.
Ann Hematol1992; 65: A129-A129. [Poster]

 

Stockschläder,M; Kahls,P; Peters,S; Linkesch,W; Krüger,W; Zeller,K; Lechner,K; Zander,A; Pentoxifylline did not prevent transplant-related toxicity in allogenic bone marrow transplantation recipients,
Blood1992; 10(80):237-237.-28th Annual Meeting ASH; MAY 17-19,1992; San Diego, CALIFORNIA. [Poster]

 

Thaler,J; Fluckinger,T; Huber,H;Seewann,H; Silly,H; Fridrik,M; Lang,A; Abbrederis,K; Linkesch,W; Geissler,D;Köck,L; Konwalinka, G; Duba,C; Grünewald, K; Niederwieser, D Kombination von Interferon-alpha-2C und Low-dose ARA-C in der Behandlung der CML: Erste Ergebnisse der Österr, Multizentrischen Phase II-Studie
Konferenzband. 1992; 5-5.-Frühjahrstagung der ÖGHO; APR 4, 1992; Wien, Austria. [Keynote lecture]

 

Thalhammer; Gisslinger,H; Scherrer,R; Kier,P; Linkesch,W; Floth,A; Etele-Hainz,A; Kainberger,F; Chott,A; Radaszkiewicz,T; Extramedullary relapse without bone marrow involvement in acute myelogenous leukemia(AML). Report of two cases and review of the literature.
Ann Hematol1992; 65: A26-A26. [Poster]

 

Wagner,A; Luger,A; Erlacher,L; Linkesch,W; Octreotide in the treatment of severe diarrhea after autologous bone marrow transplantation.
Proceedings of the EBMT1992; 186-186.-EBMT ; 1992; Stockholm. [Poster]

 

Baldus,M; Brass,H; Linkesch,W; Erfolgreiche Hochdosis-Chemotherapie mit autologer Stammzelltransplantation- eine ultima ratio-Behandlung beim Dysgerminom.
Proceedings of the 35. Jahres-Kongress der Saarländisch-Pfälzischen Internisten Gesellschaft1991; 68-69.-35. Jahres-Kongress der Saarländisch-Pfälzischen Internisten Gesellschaft; 1991; [Keynote lecture]

 

Barnas,U; Höcker,P; Linkesch,W; Die Therapie der erworbenen Erythroplasie mit Erythropoietin- Ergebnisse nach einem Jahr Therapie.
Acta Med Aust1991; 18(2):59-59.-Jahrestagung der österreichischen Gesellschaft für Innere Medizin; SEP, 1991; Salzburg,AUSTRIA. [Keynote lecture]

 

Barnas,U; Höcker,P; Linkesch,W; Treatment of acquired pure red cell anemia with recombinant human erythropoietin-a case report.
Ann Hematol1991; 63(1):64-64. [Poster]

 

Fridrik,M; Hausmaninger,H; Michlmayr,G; Linkesch,W; Silly,H; Seewann,H.L; Klocker,J; Haidinger,R; POnt,J; Schiller,H.L; Raudaschl; Radaszkiewicz,Th; Lehnert,M; Dose intensity of CEOP/IVMP-DEXA regimen in high malignant Non-Hodgkin Lymphomas.
Onkologie1991; 14(2):45-45. [Poster]

 

Fridrik,M.A; Hausmaninger,H; Michlmayr,G; Linkesch,W; Silly,H; Seewann,H; Klocker,J; Haidinger,R; Pont,J; Schiller,L; Raudaschl; Radaszkiewicz,T; Lehnert,M; Multizentrische Therapien eines neuen Chemotherapieschemas bei hochmalignen Non-Hodgkin Lymphomen.
Acta Med Aust1991; 18(2):59-59.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP, 1991; Salzburg,AUSTRIA. [Keynote lecture]

 

Krainer,M; Wagner,A; Höcker,P; Linkesch,W; Einsatz von Wachstumsfaktoren nach autologer Stammzelltransfusion.
Acta Med Aust1991; 18(2):60-60.-Jahrestagung der österreichischen Gesellschaft für Innere Medizin; SEP, 1991; Salzburg,AUSTRIA. [Keynote lecture]

 

Kwasny,W;Kornek,G;Depisch,D;Dittrich,Ch;Haider,K Linkesch,W;Scheithauer,W Amonafide zur Behandlung des metstasierten Mammakarzinoms
Konferenzband der 11. Wissenschaftl. Tagungder Deutschen Ges. f. Senologie. 1991; -11. Wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie; JUNI 21.22. 1991; München, Deutschland. [Oral Communication]

 

Linkesch,W Hochdosis-Chemotherapie mit autologem Knochenmarksupport bei Hodentumorpatienten
Symposium der interdisziplinären Arbeitsgemeinschaft Hodentumoren; DEZ 6, 1991; Hannover, Deutschland. 1991. [Keynote lecture]

 

Linkesch,W; Grassl,I; Continous infusion of Mitoxantrone combined with high-dose Cytarabine as induction-/postremession therapy in acute myeloblastic leukemia.
Annal Hematol 1991; 62(1):68-68. [Poster]

 

Linkesch,W; Grassl,I; Induktions- und Konsolidierungstherapie mit c-HAM bei akuter myeloischer Leukämie.
Klin. Wochenschrift1991; 69: 217-217. [Keynote lecture]

 

Linkesch,W; Kitzweger,E; Continous infusion of Mitoxantrone combined with high-dose Cytarabine (c-HAM) in acute myeloblastic leukemia.
Haematologica1991; 76: 90-90. [Poster]

 

Linkesch,W; Krainer,M; Höcker,P; Wagner,A; GM-CSF vs G-CSF after ultrahigh-dose chemotherapy and ABMT in testicular cancer.
Schweiz. Med. Wochenschrift1991; 121(43):173-173. [Poster]

 

Linkesch,W; Krainer,M; Wagner,A; Ultrahigh Carboplatin, VP 16, Cyclophosphamide with ABMT in Refractory or Relapsed Non-Seminomatous Germ Cell Tumors.
Onkologie1991; 14: 30-30. [Poster]

 

Linkesch,W; Krainer,M; Wagner,A; Höcker,P; Gm-CSF versus G-CSF after ultrahigh-dose chemotherapy and ABMT in testicular cancer.
Europ J Cancer1991; 2: 109-109. [Poster]

 

Linkesch,W; Kührer,I; Wagner,A; Rh-GM-CSF nach autologer Knochenmarktransplantation bei refraktären Keimzelltumoren.
Klin. Wochenschrift1991; 69: 253-253. [Keynote lecture]

 

Linkesch,W; Wagner,A; Höcker,P; Krainer,M; Ultrahochdosierte Chemotherapie mit autologer Knochenmarktransplantation bei Hodentumoren.
Acta Med Aust1991; 18(2):29-29.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP, 1991; Salzburg,AUSTRIA. [Keynote lecture]

 

Linkesch,W; Wagner,A; Krainer,M; Ultrahigh Carboplatin, VP-16, Cyclophosphamide with ABMT in testicular cancer.
Onkologie1991; 14(2):99-99. [Poster]

 

Pirker,R; Wallner,J; Geissler,K; Bettelheim,P; Linkesch,W; Ludwig,H; Lechner,K; MDR1 gene expression and treatment outcome in acute non-lymphocytic leukemia.
Annal Hematol 1991; 62(1):21-21. [Poster]

 

Pirker,R; Wallner,J; Geissler,K; Linkesch,W; Gsur,A; Haas,O; Scheiner,O; Ludwig,H; Lechner,K; MDR1 gene expression and treatment outcome in acute myeloid leukemia.
Europ J Cancer1991; 2: 247-247. [Poster]

 

Pirker,R; Wallner,J; Gsur,A; Geissler,K; Haas,O.A; Linkesch,W; Lechner,K; MDR1 gene expression in acute myeloid leukemia: a follow up.
Onkologie1991; 14(2):125-125. [Poster]

 

Scheithauer,W; Dittrich,C; Kornekt,G; Haider,K; Linkesch,W; Liebhard,A; Mayrhofer,T; Wiltschke,M, Depisch,D; Phase II study of amonafide in advanced breast cancer.
Ann Hematol1991; 63(1):61-61. [Poster]

 

Scheithauer,W; Dittrich,Ch; Kornek,G; Linkesch,W; Haider,K; Depisch,D; A phase II trial of amonafide in metastatic breast cancer.
J Clin Oncology1991; 10: 66-66. [Poster]

 

Virgolini,I; Li,S.R; Yiong,Q; Wagner,A; Sinzinger,H; Linkesch,W; Ex vivo und in vitro-Effekt von rh-GM-CSF auf den Lipidstoffwechsel und Plättchenfunktion.
Klin. Wochenschrift1991; 69: 220-220. [Keynote lecture]

 

Wagner,A; Luger,A; Schwarzberger,D; Linkesch,W; Sandostatin in der Therapie eines neuen Chemotherapieschemas bei hochmalignen Non-Hodgkin Lymphomen.
Acta Med Aust1991; 18(2):33-33.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP, 1991; Salzburg,AUSTRIA. [Keynote lecture]

 

Wagner,A; Luger,A; Schwarzenberger,D; Linkesch,W; Octreotide in the treatment of severe diarrhea after autologous bone marrow transplantation.
Onkologie1991; 14(2):168-168. [Poster]

 

Gisslinger,H; Krainer,M; Linkesch,W; Ludwig,H; Erythropoeitin therapy in myelodysplastic syndroms
Blut1990; 61(2/3):196-196. [Keynote lecture]

 

Grois,N; Köller,U; Kier,P; Kührer,I; Nowothny,H; Pont,J; Linkesch,W; Lutz,D; Lechner,K; Knapp,W; Gadner,H; Haas,O.A; Immunphenotypic characteristics of acute myeloid leukemias with a translocation t (8;21).
Blut1990; 61: 328-328. [Keynote lecture]

 

Höcker,P;Emminger,W;Peters,C;Hinterberger,W;Linkesch,W;Wagner,A;Gerhard,K Hämatopoietische Rekonstitution mit peripheren Blutstammzellen mit und ohne autologem Knochenmark. Ergebnisse bei 44 Patienten
Jahrestagung der AUSTROTRANSPLANT; Nov 8-11 1990; Mayrhofen, Austria. 1990. [Oral Communication]

 

KRAUPP, M; LEGENSTEIN, E; LINKESCH, W; WATZINGER, U; GRAF, H INFLUENCE OF RECOMBINANT ERYTHROPOIETIN ON HEME-BIOSYNTHESIS IN CHRONIC UREMIC PATIENTS
CLIN CHEM. 1990; 36(6): 974-974.
Web of Science

 

Link, H; Boogaerts, MA; Carella, AM; Ferrant, A; Gadner, H; Gorin, NC; Harabacz, I; Harrousseau, F; Herve, P; Holldack, J; Kolb, HJ; Krieger, O; Laba, B; Linkesch, W; Manelli, F; Maraninchi, D; Naparstek, E; Nicolay, U; Niederwieser, D; Reiffes, J; Rizzoli, V; Siegert, W; Verant, JP; de Witte, T RhGM-CSF after ABMT for ALL and NHL: a randomized double blind multicenter trial in Europe.
Blood1990; 10: 76--26th Annual Meeting ASCO; MAY 20-22, 1990; Washington,DC. [Poster]

 

Linkesch, W Bisher gewonnene Therapieerfahrungen in Wien
Hochdosistherapie bei recidivierten Hodentumoren; OKT 2, 1990; Bonn, Deutschland. 1990. [Keynote lecture]

 

Linkesch, W; Kührer, I; Wagner, A; Höcker, P KMT mit vollständig implantierten Kathetersystemen- Ergebnisse bei 50 Patienten
Jahrestagung der AUSTROTRANSPLANT; Nov 8-11 1990; Mayrhofen, Austria. 1990. [Oral Communication]

 

Linkesch, W; Kührer, I; Wagner, A; Höcker,P Autologe KMT bei refraktären Hodenkarzinomen- Ergebnisse bei 25 Patienten
Jahrestagung der AUSTROTRANSPLANT; Nov 8-11 1990; Mayrhofen, Austria. 1990. [Oral Communication]

 

Linkesch,W; Domingo-Albos,A; Hoffmann,R; et al. A randomized comparative trial of Amsacrine, Cytarabine and Thioguanid (AAT) vs Daunorubicin, Cytarabine and Thioguanine (DAT) as front line therapy for acute nonlymphocytic leukemia (ANLL)
Blut1990; 61(2/3):169-169. [Keynote lecture]

 

Linkesch,W; Grassi,I; Induktions-/ Postremissionstherapie mit c-HAM bei akuter myeloischer Leukämie.
Acta Med Aust1990; 17(2):33-33.-Jahrestagung der Österreichischen Gesellschaft für innere Medizin; SEP; 1990. [Keynote lecture]

 

Linkesch,W; Kührer,I; Wagner,A; Rhu-GM-CSF after ultrahigh dose Carboplatin, VP-16, Cyclophosphamide with ABMT in refractory germ cell cancer.
J Clin Oncology1990; 9: 141-141. [Poster]

 

Linkesch,W; Kührer,I; Wagner,A; Höcker,P; GM-CSF nach ultrahochdosierter Chemotherapie und konsekutiver autologer Knochenmarktransplantation bei Patienten mit Hodentumoren.
Acta Med Aust1990; 17(2):33-33.-Jahrestagung der Österreichischen Gesellschaft für innere Medizin; SEP; 1990. [Keynote lecture]

 

Linkesch,W; Kührer,I; Wagner,A; Höcker,P; Hoffmann,S; Rhu-GM-CSF after dose-intensive chemotherapy rescued by ABMT in refractory testicular cancer.
Bone Marrow Transplantation1990; 5(2):141-141. [Poster]

 

Linkesch,W; Kührer,I; Wagner,A; Hoffmann,S; Höcker,P; GM-CSF after ultra-high-dose chemotherapy with autologous bone marrow transplantation in refractory testicular cancer.
Blut1990; 61: 332-332. [Keynote lecture]

 

Linkesch,W; Wagner,A; Höcker,P;Kührer,I; Rh-GM-CSF after ABMT in refractory germ cell cancer.
Proceedings of the 17th Meeting of EBMT1990; 138-138.-17th Meeting of EBMT; 1990; Cortina d'Ampezzo, ITALY. [Poster]

 

Linkesch,W; Wagner,A; Kührer,I; Ultrahigh dose chemotherapy with ABMT and rhu-GM-CSF in refractory testicular cancer.
J Cancer Clin Oncol1990; 116: 590-590. [Poster]

 

Linkesch,W; Wagner,A; Kührer,I; Höcker,P; Continous GM-CSF after ultra high dose chemotherapy with ABMT in refractory germ cell cancer.
Blut1990; 61: 112-112. [Keynote lecture]

 

Linkesch,W;Kührer,I; Wagner, A;Kratzig,Ch Ultrahighdose Chemotherapy with autologous bone marrow Transplantation in patients with testicular cancer.
European Urology. 1990; 18/S1(90):352-352.-19th Congress of the European Association of Urology; June 13-16 , 1990; Amsterdam, NL. [Oral Communication]

 

Link,H; Siegert,W; Herve P; Ferrant,A; Vernant,J; Carella,A; Niederwieser,D; Slavin,S; Boogaerts,m, Maranchini; Kolb,H; Jarousseau,J; deWitte,T; Gorin,N; Rizzoli,V; Reiffers,J; Mandelli,F; Lutz,D; Gadner,H; Linkesch,W; Labar,B; Harabacz;I; Schulz,G; RH-GM-CSF after autologous bone marrow transplantation for ALL and Non-Hodgkin's Lymphoma.
Bone Marrow Transplantation1990; 5(2):147-147. [Poster]

 

Link,H;Boogaerts,M;Carella,A;Ferrant,AGadner,H;Gorin,N;Harabacz,I;Harrousseau,P;Serve,R;Kolb,H;Krieger,O:Labar,P;Linkesch,W;Mandelli,F;Maraninchi,D;Nicolay,C;Niederwieser,D;Reiffers,J;Rizzoli,V;Siegert,W;Slavin,S;Vernant,J;de Witte,T International Randomized Double Blind Trial:rhGM-CSF after Autologous Bone Marrow Transplantation for ALL and NHL
BLUT. 1990; 61(2/3):73-73.-Jahrestagung der OGHO und DGHO; SEP 30-OKT 5 1990; Köln, Germany. [Keynote lecture]

 

Pirker,R; Wallner,J; Geissler,K; Valent,P; Bettelheim,P; Lechner,K; Hopfner,M; Linkesch,W; Ludwig,H; MDR1 gene expression affects clinical outcome in acute myelogenous leukemia.
Annals of Oncology1990; 1: 8-8. [Poster]

 

Pirker,R; Wallner,J; Hopfner,M; Geissler,K; Bettelheim,P; Valent,P; Lechner,K; Linkesch,W; Ludwig,H; MDR gene expression in Acute Myelogeneous Leukemias.
Blut1990; 61(2/3):134-134. [Keynote lecture]

 

Rehberger,A; Gisslinger,H; Linkesch,W; Ludwig,H; Micksche,M; Natural killer cell function in patients with myeloproliferative disorders.
Blut1990; 61: 328-328. [Keynote lecture]

 

Virgolini. I; Li, SR; Wagner, A; Sinzinger, A; Linkesch, W Auswirkungen von rhGM-CSF auf den Lipidstoffwechsel nach autokoger KMT
Jahrestagung der AUSTROTRANSPLANT; Nov 8-11 1990; Mayrhofen, Austria. 1990. [Oral Communication]

 

Virgolini,I; Li,S.R; Wagner,A; Schwarzenberger,D; Sinzinger,H; Linkesch,W; Effects of Rh-GM-CSF on lipid metabolism and prostaglandin system following autologous bone marrow transplantation.
Proceedings of the 17th Meeting of EBMT1990; 180-180.-17th Meeting of EBMT; 1990; Cortina d'Ampezzo, ITALY. [Poster]

 

Wagner, A; Mayer, G; Linkesch, W; Acute renal failure after autologous stem cellretransfusion.
Bone Marrow Transplantation1990; 5(2):96-96. [Poster]

 

Wagner,A; Gherardini,R; Linkesch,W; Knochenmarktransplantation mit vollständig implantierten Kathetersystemen-ERgebnisse bei 40 Patienten.
Acta Med Aust1990; 17(2):25-25.-Jahrestagung der Österreichischen Gesellschaft für innere Medizin; SEP; 1990. [Keynote lecture]

 

Wagner,A; Mayer,G; Linkesch,W; Acute renal failure after autologous stem cell retransfusion.
Blut1990; 61(2):118-118. [Keynote lecture]

 

Wallner,J; Pirker,R; Hopfner,M; Geissler,K; Bettelheim,P; Valent,P; Lechner,K; Linkesch,W; Ludwig,H; Expression of the MDR1 gene in acue myelogenous leukemias.
Blut1990; 61: 328-328. [Keynote lecture]

 

Wiltschke,C; nanut,M; Steininger,A; Wagner,A; Linkesch,W; GM-CSF therapy in refractory non-seminomatous germ cell cancer patients treated with dose intense chemotherapy and stem cell retransfusion:leucocyte functions.
J Cancer Clin Oncol1990; 116: 294-294. [Poster]

 

Wiltschke,C; Nanut,M; Steininger,A; Wagner,A; Linkesch,W; Natural killer cell function in patients with myeloproliferative disorders.
Blut1990; 61: 332-332. [Keynote lecture]

 

Wiltschke,C; Nanut,M; Steininger,A; Wagner,A; Linkesch,W; Increased HLA DR expression on monocytes from patients receiving rhu-GM-CSF-after autologous bone marrow transplantation.
Bone Marrow Transplantation1990; 5(2):96-96. [Poster]

 

Chiba,P; Eheh,R; Tihan,T; Koller,U; Kraupp,M; Linkesch,W; 1-Beta-D-Arabinofuranosylcytosine Resistance in Myeloid Leukemia.
Proc Am Ass Canc Res 1989; 30: 74-74. [Poster]

 

Gisslinger,H; Linkesch,W; Chott,A; Ludwig,H; Long treatment with Interferon-alpha of excessive thrombocytosis in myeloproliferative disorders.
Proceedings of the Int Society of Haematology-Leukemia Symposium 1989; 60-60.-Int Society of Haematology-Leukemia Symposium ; 1989; Dresden. [Poster]

 

Gisslinger,H; Templ,H; Gilly,B; Swoboda,Th; Linkesch,W; Ludwig,H; Luger,A; Interferon-alpha stimulates the hipothalamic-pituitary-adrenal axis.
Proceedings of the 71th Annual Meeting of the Endocrine Society1989; 144-144.-71th Annual Meeting of the Endocrine Society; 1989; Seattle. [Poster]

 

Gludovacz,D; Linkesch,W; Ludwig,H; Gisslinger,H; O'Grady,J; Peskar,B.A; Sinzinger,H; Interferon-alpha induces normalization of Arachidonic acid conversion to Thromboxane B2 in 2 patients with myeloproliferative Syndrome.
Proceedings of the 6th meeting of the Danubian League against Thrombosis and Haemorrhagid Disorders1989; 54-54.-6th meeting of the Danubian League against Thrombosis and Haemorrhagid Disorders; 1989; [Poster]

 

Grois,N; Kührer,I; Nowotny,H; Pont,J; Linkesch,W; Lutz,D; Hinterberger,W; Lechner,K; Haas,O.A. Clinical, Haematological and cytogenetic characteristics of Acute Myeloid Leukemias with a Translocation t(8;21)
Blut1989; 59: 2-2. [Poster]

 

Höcker,P; Wahner,A; Gerhartl,A; Emminger,K; Emminger,W; Schmidmeier; Hinterberger,W; Linkesch,W; Harvesting of peripheral blood stem cell (PBSC) by haemapheresis.
Proceedings of the Internat Symposium: New Aspects in Childhood Leukemia1989; 48-48.-Internat Symposium: New Aspects in Childhood Leukemia; 1989; [Poster]

 

Krainer,M; Linkesch,W; SIL-2R und sCD8 bei Patienten mit chronisch lymphatischer Leukämie.
Klin Wochenschrift1989; 67: 162-162. [Poster]

 

Kraupp,M; Linkesch,W; Watzinger,U; Legenstein,E; Graf,H; Enzymes of heme biosynthesis in erythrocytes of patients with recombinant Erythropoietin.
Blut1989; 3: 340-340. [Keynote lecture]

 

Kraupp,M; Linkesch,W; Watzinger,U; Legenstein,U; Graf,H; Weitere Untersuchungen über die Hämsynthese in Erythrozyten von urämischen Patienten unter Therapie mit rekombinantem Erythropoietin.
Acta Med Aust1989; 16: 92-92.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP; Salzburg,AUSTRIA. [Keynote lecture]

 

Linkesch, W Myeloproliferative Erkrankungen
Hämatologie-Seminar der Ärztekammer für Wien; APR 19. 1989; Wien, Austria. 1989. [Keynote lecture]

 

Linkesch, W Ferritin bei malignen Erkrankungen
Konferenzband. 1989; 23-23.-3. Rostocker Symposium " Eisenstoffwechsel "; FEB 16-17, 1989; Rostock, DDR. [Keynote lecture]

 

Linkesch,W; Gherardini,R; Totally implantable portal Catheters in Bone Marrow Transplantation.
Proceedings of the Xth Congress of the Internat. Society of Heamatology1989; 93-93.-Xth Congress of the Internat. Society of Heamatology; [Poster]

 

Linkesch,W; Höcker,P; Kührer,I; Ultrahigh-dose Chemotherapy with autologous Bone Marrow Rescue (ABMT) in refractory germ cell tumors.
Blut1989; 3: 304-304. [Keynote lecture]

 

Linkesch,W; Krainer,M.W; sIL-2R and sCD8 in Patients with Chronic Lymphocytic Leukemia.
Blut1989; 59: 29-29. [Poster]

 

Linkesch,W; Kührer,I; Höcker,P; Ultrahigh-Dose Chemotherapy with Autologous Bone Marrow Rescue(ABMT) in Testicular Cancer.
Proceedings of the Xth Congress of the Internat. Society of Heamatology1989; 93-93.-Xth Congress of the Internat. Society of Haematology ; [Poster]

 

Linkesch,W; Kührer,I; Höcker,P; Autologe Knochenmarkstransplantation bei Hodentumoren.
Acta Med Aust1989; 16: 30-30.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP; Salzburg,AUSTRIA. [Keynote lecture]

 

Linkesch,W; Kührer,L; Höcker,P; Ultrahigh-dose Chemotherapy with Autologous Bone Marrow Rescue (ABMT) in refractory Germ Cell Tumors.
Bone Marrow Transplantation1989; 4(2):104-104. [Poster]

 

Linkesch,W; Michlmayr,G; Gerhartz,H; Illinger,H; König,H; Düllmann,J; Keilhauer,R; Moldrzyk,D; AAT versus DAT in adults with untreated ANLL.
Proceedings of the Int Society of Haematology-Leukemia Symposium 1989; 80-80.-Int Society of Haematology-Leukemia Symposium ; 1989; Dresden. [Poster]

 

Linkesch,W; Thaler,J; Gattringer,C; Konwalinka,G; Continous infusion of Mixantrone combined with high-dose Cytarabine (c-HAM) in refractory/relapsed AML and CML-Blast crisis.
Proceedings of the 2.Int Symp. on Acute Leukemias1989; 19-19.-2.Int Symp. on Acute Leukemias; 1989; Münster,GERMANY. [Poster]

 

Linkesch,W; Wagner,A; Ultrahochdosierte Chemotherapie mit autologer Knochenmarktransplantation bei refraktären Keimzelltumoren.
Klin. Wochenschrift1989; 67: 102-102. [Poster]

 

Linkesch,W;Domingo-Albos,A;Hoffmann,R;Schulhof,A,Makary,A;Amare,M;Rickles,F A randomized comparative trial of Amsacrine,Cytarabine and Thioguanine (AAT) vs DAUNORUBICINE;Cytarabine and Thioguanine (DAT) as frontline Therapy for Acute Nonlymphocytic Leukemia (ANLL)
J Clin Oncol1989; (8):204-204.-American Society of Clinical Oncology; MAY 28-31; San Diego. [Poster]

 

Pirker, R; Goldstein, L; Ludwig, H; Linkesch, W; Gottesmann, MM; Pastan, I Multidrug resistance (MDR1) gene expression in leukemias.
Proceedings of the NCI Meeting1989; 54-54.-NCI Meeting; 1989; Bethesda. [Poster]

 

Pirker,I; Goldstein,L.J; Ludwig H; Linkesch,W; Gottesmann,M.M; Pastan,I; Expression of a multidrug resistance gene in solid tumors and leukemias.
Ecco1989; 5: 420-420. [Poster]

 

Pirker,P; Goldstein,L; Ludwig,H; Linkesch,W; Depisch,D; Lechner,Ch; Klepetko,W; Gottesmann,M.M; Pastan,I; MDR1-Genexpression in soliden Tumoren und Leukämien.
Klin Wochenschrift1989; 67: 29-29. [Poster]

 

Pirker,R; Goldstein,L; Ludwig,H; Depisch,D; Linkesch,W; Klepetko,W; Gottesmann,M.M; Pastan,I; Expression of MDR1 in human Malignancies.
Cancer Immunol Immun1989; 28: 32-32. [Poster]

 

Pirker,R; Goldstein,L; Ludwig,H; Depisch,D; Linkesch,W; Lechner,C; Klepetko,W; Gottesmann,M.M; Pastan,I; Multidrug resistance(MDR1) gene expression in solid tumors and leukemias.
Blut1989; 3: 248-248. [Keynote lecture]

 

Pirker,R; Goldstein,L; Ludwig,H; Linkesch,W; Depisch,D; Klepetko,W; Lechner,K; Gottesmann,M,M; Pastan,I; Multidrug Resistance (MDR 1) gene in malignancies.
Proceedings of the 6th NCI-EORTC symposium1989; 365-365.-6th NCI-EORTC symposium; a1989; Amsterdam. [Poster]

 

Pirker,R; Goldstein,L; Ludwig,H; Linkesch,W; Depisch,D; Lechner,C; Klepetko,W; Gottesmann,M; Pastan,I; MDR1-Genexpression in malignen Erkrankungen.
Acta Med Aust1989; 16: 33-33.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP; Salzburg,AUSTRIA. [Keynote lecture]

 

Pirker,R; Goldstein,L; Ludwig,H; Linkesch,W; Lechner,C; Gottesmann,M.M; Pastan,I; Expression of a Multidrug Resistance Gene in Leukemia.
Blut1989; 59: [Poster]

 

Pirker,R; Goldstein,L; Ludwig,H; Linkesch,W; Lechner,Ch; Gottesmann,M.M; Pastan,I; Multidrug Resistance (MDRI) gene Expression in Leukemias.
Proc Am Ass Canc Res1989; 30: 517-517. [Poster]

 

CHIBA, P; TIHAN, T; EHER, R; POLTL, E; LINKESCH, W EFFECT OF CELL-GROWTH AND DIFFERENTIATION ON 1-BETA-D-ARABINOFURANOSYLCYTOSINE METABOLISM IN MYELOID CELLS
BLUT. 1988; 57(4): 202-202.
Web of Science

 

Chiba,P; Wallner,C; Eher,R; Linkesch,W; Effect of cell-cycle on enzymes of 1-Beta-D Arabinofuranosylcytosine metabolism in myeloid cells.
Proceedings of the 22th Congress of the Int Society of Haematology 1988; 114-114.-22th Congress of the Int Society of Haematology ; AUG; Milan,ITALY. [Poster]

 

CHOTT, A; THIELE, J; GISSLINGER, H; LINKESCH, W; FRITZ, E; RADASZKIEWICZ, T; LUDWIG, H MORPHOLOGICAL-CHANGES OF MEGAKARYOCYTES DURING INTERFERON TREATMENT OF CHRONIC MYELOPROLIFERATIVE DISORDERS WITH EXCESSIVE THROMBOCYTOSIS (CMPDWET)
BLUT. 1988; 57(4): 231-231.
Web of Science

 

Chott,A; Thiele,J; Radaszkiewicz,Th; Gisslinger,H; Linkesch,W; Ludwig,H; Interferon induced morphological changes of megakaryocytes.
Proceedings of the XVII International Congress of the International Academy of Pathology and 8th World Congress of Academic and Environmental Pathology1988; 352-352.-XVII International Congress of the International Academy of Pathology and 8th World Congress of Academic and Environmental Pathology; Dublin,IRELAND. [Poster]

 

GISSLINGER, H; WEISSEL, M; KUHRER, I; LINKESCH, W; LUDWIG, H OCCURRENCE OF THYROID AUTOIMMUNITY IN PATIENTS ON LONG-TERM THERAPY WITH RECOMBINANT INTERFERON-ALPHA
BLUT. 1988; 57(4): 225-225.
Web of Science

 

Gisslinger,H; Schweighofer,B; Chott,A; Linkesch,W; Radaszkiewicz,Th; Ludwig,H; Long-term treatment with Interferon Alfa of excessive thrombocytosis in myeloproliferative disorders.
Proceedings of the 22th Congress of the Int Society of Haematology 1988; 259-259.-22th Congress of the Int Society of Haematology ; AUG; Milan,ITALY. [Poster]

 

Gisslinger,H; Weissel,M; Kührer,I; Linkesch,W; Ludwig,H; Auftreten von Schilddrüsenantikörpern unter Behandlung mit rekombinantem Interferon alpha 2c.
Acta Med Austr1988; 15: 40-40.-Österreichische Jahrestagung für Innere Medizin; SEP; Salzburg,AUSTRIA. [Poster]

 

GRANINGER, W; MORAWETZ, A; LINKESCH, W; SMOLEN, J MOLECULAR MONITORING OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA DURING INTERFERON TREATMENT
BLUT. 1988; 57(4): 194-194.
Web of Science

 

Gruber,K; Mayr,B; Linkesch,W; Possibilities of interphase nucleus analyses in physiologic and neoplastic leucocytes.
Proceedings of the 22th Congress of the Int Society of Haematology 1988; 519-519.-22th Congress of the Int Society of Haematology ; AUG; Milan,ITALY. [Poster]

 

HAWLICZEK, R; EMMINGER, W; EMMINGERSCHMIDMEIER, W; LINKESCH, W; GADNER, H; HINTERBERGER, W; HOCKER, P; HAVELEZ, L MUCOSAL TOXICITY IS POSSIBLY RELATED TO EARLY MORTALITY FOLLOWING SUPRALETHAL CHEMO-RADIOTHERAPY AND STEM-CELL GRAFTING
BLUT. 1988; 57(4): 199-199.
Web of Science

 

HOCKER, P; HINTERBERGER, W; EMMINGERSCHMIDMEIER, W; LINKESCH, W; RITSCHL, P; GERHARTL, K; WAGNER, A COLLECTION, STORAGE AND RETRANSFUSION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC)
BLUT. 1988; 57(4): 267-267.
Web of Science

 

Kührer,I; Morawetz,A; Graninger,W; Linkesch,W; Recombinant Alpha 2-c Interferon therapy in patients with chronic myelogenous leukemia(CML).
Proceedings of the 22th Congress of the Int Society of Haematology 1988; 447-447.-22th Congress of the Int Society of Haematology ; AUG; Milan,ITALY. [Poster]

 

Linkesch, W; Legenstein, E; Mayer, G; Cada, E; Stummvoll, HK; Graf, H Treatment with Erythropoetin (r-huEPO) in patients on chronic haemodialysis.
Proceedings of the 25th Congress of the EDTA1988; 211-211.-25th Congress of the EDTA; SEP 5-8, 1988; Madrid,SPAIN. [Poster]

 

Linkesch, W; Legenstein, E; Mayer, G; Cada, E; Stummvoll, HK; Graf, H Therapie der renalen Anämie mit rekombinantem humanem Erythropoietin: Auswirkung auf Hämsynthese und Eisenstoffwechsel.
Acta Med Austr1988; 15: 70-70.-Österreichische Jahrestagung für Innere Medizin; SEP; Salzburg,AUSTRIA. [Poster]

 

Linkesch, W; Stummvoll, HK; Legenstein, E; Mayer, G; Cada, E; Graf, H Therapy of Renal Anemia with Erythropietin (r-huEPO)
Blut1988; 57(4):333-333. [Poster]

 

Linkesch,W; Czejka,M; Georgopoulos,A; Continous infusion of Mitoxantrone combined with high-dose Cytosinarabinosid(c-HAM): pharmakokinetic study and first clinical results.
Proceedings of the 22th Congress of the Int Society of Haematology 1988; 114-114.-22th Congress of the Int Society of Haematology ; AUG; Milan,ITALY. [Poster]

 

Linkesch,W; Gherardini,R; Totally implanted portal Catheters in Bone Marrow Transplantation and Cancer Patients.
Proceedings of the Workshop: Progress in regional Cancer Therapy 1988; 146-146.-Workshop: Progress in regional Cancer Therapy ; Nov 3-5, 1988; Vienna,AUSTRIA. [Poster]

 

Linkesch,W; Gherardini,R; Totally implanted portal catheters in bone marrow transplantation and cancer patients.
Proc Am Soc Clin Oncology1988; 7: 182-182. [Poster]

 

Linkesch,W; Michlmayr,G; Gerhartz,H; Illinger,H; König,H; Düllmann,J; Keilhauer,R; Moldrzyk,M; AAT vs DAT in untreated acute Non-lymphoblastic Leukemia: Austrian-german results.
Proceedings of the 22th Congress of the Int Society of Haematology 1988; 48-48.-22th Congress of the Int Society of Haematology ; AUG; Milan,ITALY. [Poster]

 

Linkesch,W; Rimpfl,T; Kührer,I; Gherardini,R; Hawliczek,R; Höcker,P; Totally implanted catheder systems in bone marrow transplantation.
Bone Marrow Transplantation1988; 3: 177-177. [Poster]

 

MICKSCHE, M; GISSLINGER, H; SCHEITHAUER, W; LINKESCH, W; LUDWIG, H NATURAL-KILLER CELL-ACTIVITY IN PERIPHERAL-BLOOD AND BONE-MARROW OF PATIENTS WITH MYELOMA, MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISEASES
BLUT. 1988; 57(4): 234-234.
Web of Science

 

Mitter,G; Zielinski,C; Linkesch,W; Ludwig,H; Müller,Ch; Weissel,M; Bakterielle Infekte bei Patienten mit onkologischen Erkrankungen.
Acta Med Austr1988; 15: 77-77.-Österreichische Jahrestagung für Innere Medizin; SEP; Salzburg,AUSTRIA. [Poster]

 

Müller,Ch; Zielinski,C; Linkesch,W; Ludwig,H; Sinzinger,H; In vivo tracing of 111-Indium-Oxine labelled human peripheral blood mononuclear cells in patients with lymphatic malignancies.
European J Clin Investigation1988; 18: 8-8. [Poster]

 

Müller,Ch; Zielinski,C; Linkesch,W; Sinzinger,H; In vivo traffic of In-111 oxine-labelled human mononuklear cells in hematologic malignancies.
New Approaches to radiolabelling Blood Cells and Imaging Thrombus and Inflammation.1988; 43-43. [Poster]

 

Pirker,R; Goldstein,L; Ludwig,H;Depisch,D; Linkesch,W; Klepetko,W; Gottesmann,M.M; Pastan,I; Expression of MDRI Gene in Human Malignancies.
Blut1988; 57(4):343-343. [Poster]

 

Scheithauer,W; Linkesch,W; Gisslinger,G; Linkesch,M; Ludwig,H; Effect of Interferon Alpha on in vivo reticuloendothelial (RES) function in myeloproliferative disease.
Proceedings of the 22th Congress of the Int Society of Haematology 1988; 449-449.-22th Congress of the Int Society of Haematology ; AUG; Milan,ITALY. [Poster]

 

Scheithauer,W; Gisslinger,H; Linkesch,W; Linkesch,M; Ludwig,H; Der Einfluss von rekombinantem Interferon Alpha 2 (rIFN) auf die in vivo FC-abhängige Phagozytose des retikuloendothelialen Systems (RES).
Klin Wochenschrift 661988; 66: 137-137. [Poster]

 

Gisslinger,H; Radaszkiewicz,T; Chott,A; Linkesch,W; Ludwig,H; Langzeittherapie mit REC-Interferon Alpha-2c bei excessiven Thrombozytosen myeloproliferativer ERkrankungen.
Klin Wochenschr1987; 65: 48-48. [Keynote lecture]

 

GRUBER, K; LINKESCH, W; KAIN, R NUCLEOLAR PATTERNS IN NORMAL GRANULOPOIESIS AND MYELOBLASTIC-LEUKEMIA
BLUT. 1987; 55(4): 318-318.
Web of Science

 

GRUBER, K; LINKESCH, W; MAYR, B DA-DAPI-POSITIVE HETEROCHROMATIN AND NUCLEOLI IN LEUKEMIC-CELLS
ONKOLOGIE. 1987; 10(5): 278-278.
Web of Science

 

HAWLICZEK, R; SCHMIDMEIER, W; LINKESCH, W; HACKL, A; URBAN, C ACUTE TOXICITY OF HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN COMBINATION WITH DIFFERENT CONDITIONING REGIMENS - PRELIMINARY-REPORT
STRAHLENTHER ONKOL. 1987; 163(4): 247-247.
Web of Science

 

KUHRER, I; LINKESCH, W; LUDWIG, H; GISSLINGER, H RESULTS OF RECOMBINANT ALPHA-2-C-INTERFERON THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
BLUT. 1987; 55(4): 390-390.
Web of Science

 

KUHRER, I; LINKESCH, W; LUDWIG, H; GISSLINGER, H INTERFERON THERAPY (REC-IFN-ALPHA-2C) IN CHRONIC MYELOID-LEUKEMIA
ONKOLOGIE. 1987; 10(5): 281-281.
Web of Science

 

Kührer,I; Linkesch,W; Ludwig,H; Gisslinger,H; Interferontherapie (ref IFN alpha 2c) bei Patienten mit chronisch myeloischer Leukämie.
Acta med Austr1987; 14: 8-8.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP; Salzburg. [Poster]

 

Kuzmits, R; Linkesch, W. Chemosensitivitätstestung leukämischer Blasten mittels Bioluminiszenz
Wiss. Sitzung der Gesellschaft für Innere Medizin in Wien; JAN, 29, 1987; Wien, AUSTRIA. 1987. [Keynote lecture]

 

LINKESCH, M; PRAGER, R; KLAUSER, R; LINKESCH, W; GISSLINGER, H; SCHERNTHANER, G EFFECT OF CHRONIC HYPERGLUCAGONEMIA ON GLUCOSE-TOLERANCE, INSULIN RESISTANCE AND INSULIN ACTION
DIABETOLOGIA. 1987; 30(7): A550-A550.
Web of Science

 

Linkesch, W Ferritin
Hämatologisches Seminar; APR 26 , 1987; Wien. 1987. [Keynote lecture]

 

Linkesch, W Hämatologie-Seminar
Fortbildung der Ärztekammer für Wien; OKT 9, 1987; Wien, Austria. 1987. [Keynote lecture]

 

Linkesch, W; Gisslinger, H Amsacrin-Cytosinarabinosid-Thioguanin ( AAT ) vs. Daunorubicin-Cytosinarabinosid-Thioguanin ( DAT )bei unbehandelter akuter nicht-lymphatischer Leukämie
Wiss. Sitzung der Gesellschaft für Innere Medizin in Wien; JAN, 29, 1987; Wien, AUSTRIA. 1987. [Keynote lecture]

 

LINKESCH, W; SINZINGER, H; LUDWIG, H; GISSLINGER, H TREATMENT WITH RIFN-ALPHA-2C CAN NORMALIZE ABNORMAL CONVERSION OF 14C-ARACHIDONIC ACID (AA) IN MYELOPROLIFERATIVE SYNDROME (MPS)
BLUT. 1987; 55(4): 387-387.
Web of Science

 

Linkesch,M: Klauser,R: Gisslinger,H; Linkesch,W;Prager,R;Schernthaner,G. Effekt von chronischer Hyperglukagonämie auf Insulinsekretion und Insulinwirkung bei nichtdiabetischen Patienten
Acta Medica Austriaca. 1987; 14(S1):64-64.-Jahrestagung der ÖGIM; SEPT, 17-19. 1987; Salzburg, AUSTRIA. [Oral Communication]

 

Linkesch,M; Klausner,R; Gisslinger,H; Linkesch,W; Prager,R; Schernthaner,G; Effekt von chronischer Hyperglukagonämie auf Insulinsekretion und Insulinwirkung bei nichtdiabetischen Patienten.
Akt Endokrin Stoffw1987; 8: 97-97. [Keynote lecture]

 

Linkesch,W; Linkesch,M; Gisslinger,H; Treatment of low grade Non-Hodgking's Lymphoma with high-dose intermittent prednimustine.
Blood1987; 70: 5-5.-29th annual meeting of ASH; DEC; USA. [Poster]

 

Linkesch,W; Radaszkiewicz,T; Linkesch,M; Amsacrine, Cytosine Arabinoside (Ara-C) Thiogusnine(TG) vs. Daunorubicin, Ara-C, TG as therapy in untreated acute non-lymphoblastic leukemia.
Proceedings of the 4th International symposium on therapy of acute leukemias.1987; 492-492.-4th International symposium on therapy of acute leukemias; FEB 7-12, 1987; Rome,ITALY. [Poster]

 

Linkesch,W; R,Gheradini; Implanted venous access portals in acute leukemia and bone marrow transplantation.
Proceedings of the 4th International symposium on therapy of acute leukemias.1987; 492-492.-4th International symposium on therapy of acute leukemias; FEB 7-12, 1987; Rome,ITALY. [Poster]

 

Linkesch,W; Sinzinger,H; Ludwig,H; Gisslinger,H; Interferontherapie bei myeloproloiferativem Syndrom:Normalisierung der Konversion von exogener Arachidonsäure.
Acta med Austr1987; 14: 7-7.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP; Salzburg. [Poster]

 

Ollenschläger,G; Linkesch,W; Roth,E; Hepatotoxizität der Therapie mit ASparaginase in Folge der Glutaminase-Wirkung von Crasnitin.
Med Welt1987; 48: 1631-1631. [Poster]

 

RASOULROCKENSCHAUB, S; LINKESCH, W; ZIELINSKI, C; LUDWIG, H VINDESINE-PREDNISOLONE THERAPY IN RECURRENT MULTIPLE-MYELOMA NOT RESPONDING TO CHEMOTHERAPY
ONKOLOGIE. 1987; 10(5): 279-279.
Web of Science

 

SCHEITHAUER, W; GISSLINGER, H; LINKESCH, W; LINKESCH, M; LUDWIG, H EFFECT OF RECOMBINANT INTERFERON ALPHA-2C (RIFN-A2) ON INVIVO FC-DEPENDENT PHAGOCYTIC-ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM (RES)
BLUT. 1987; 55(4): 254-254.
Web of Science

 

Scheithauer,W; Gisslinger,H; Linkesch,W; Linkesch,M; Ludwig,H; Inhibition der FC-abhängigen Phagozytose des retikuloendothelialen Systems durch rekombinantes Alpha-2-Interferon.
Acta Med Austr1987; 14: 5-5.-Jahrestagung der österreichischen Gesellschaft für innere Medizin.; SEP; Salzburg. [Poster]

 

Watzke,H; Hay,U; Zielinski,C; Linkesch,W; Kasabach-Merritt-Syndrom- ein Fallbericht.
Acta med Austr1987; 14: 71-71.-Jahrestagung der österreichischen Gesellschaft für innere Medizin; SEP; Salzburg. [Poster]

 

GISSLINGER, H; LINKESCH, W; CHOTT, A; SINZINGER, H; LUDWIG, H LONG-TERM RESULTS IN THE TREATMENT OF EXCESSIVE THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH RECOMBINANT ALPHA-2C INTERFERON
BLUT. 1986; 53(3): 128-128.
Web of Science

 

GISSLINGER, H; LINKESCH, W; HOCKER, P; CHOTT, A; SINZINGER, H; LUDWIG, H TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT INTERFERON-ALPHA-2C
ACTA MED AUST. 1986; 13: 67-67.
Web of Science

 

GISSLINGER, H; LINKESCH, W; HOCKER, P; SINZINGER, H; FLENER, R; LUDWIG, H THE TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT INTERFERON-ALPHA-2C
WIEN KLIN WOCHENSCHR. 1986; 98(17): 590-590.
Web of Science

 

GISSLINGER, H; LINKESCH, W; PANZER, S; CHOTT, A; SCHERNTHANER, G; LUDWIG, H USE OF DANAZOL FOR TREATMENT OF IMMUNE THROMBOCYTOPENIA
ACTA MED AUST. 1986; 13(1): 24-25.
Web of Science

 

Gisslinger,H; Gilly,B; Landesmann,U; Linkesch,W; Immunogold staining for leukocyte phenotyping.
Proceedings of the 14th International Cancer Congress1986; 1171-1171.-14th International Cancer Congress; AUG 21-27, 1986; Budapest. [Poster]

 

Gisslinger,H; Linkesch,W; Flener,R; Ludwig,H; Treatment of myelodysplastic Syndrome with REC-Interferon Alpha-2c.
Proceedings of the 21st Congress of the International Society of Haematology and 21st Congress of the international Society of blood transfusion1986; 526-526.-21st Congress of the International Society of Haematology and 21st Congress of the international Society of blood transfusion; AUG; Sidney. [Poster]

 

KUHRER, I; LUDWIG, H; LINKESCH, W; CORTELEZZI, A; POLLI, E; KUZMITS, R; FLENER, R COMBINED INTERFERON AND POLYCHEMOTHERAPY VERSUS POLYCHEMOTHERAPY ALONE IN MULTIPLE-MYELOMA
BLUT. 1986; 53(3): 129-129.
Web of Science

 

KUHRER, I; LUDWIG, H; LINKESCH, W; CORTELEZZI, A; POLLI, E; ROCKENSCHAUB, S; KUZMITS, R; FLENER, R COMPARISON OF THE EFFICIENCY OF COMBINED INTERFERON POLYCHEMOTHERAPY VERSUS POLYCHEMOTHERAPY IN MULTIPLE-MYELOMA
WIEN KLIN WOCHENSCHR. 1986; 98(17): 588-588.
Web of Science

 

Linkesch, W Serumferritin-Diagnostische und klinische Bedeutung
2. Symposium Eisenstoffwechsel; FEB 6-7 1986; Rostock, DDR. 1986. [Keynote lecture]

 

Linkesch,W; Gherardini,R; Totally implanted drug delivery system.
Proceedings of the 14th International Cancer Congress1986; 977-977.-14th International Cancer Congress; AUG 21-27, 1986; Budapest. [Poster]

 

Linkesch,W; Gisslinger,H; Radaszkiewicz,Th; Flener,R; Ludwig,H; Recombinant Interferon Alpha-2c Treatment in excessive thrombocytosis.
Proceedings of the 14th International Cancer Congress1986; 2: 646-646.-14th International Cancer Congress; AUG 21-27, 1986; Budapest. [Poster]

 

Linkesch,W; Gisslinger,H; Sinzinger,H; Ludwig,H; Interferon (rec.IFN-Alpha-2c) treatment in myeloprpliferative Syndrome.
Proceedings of the 21st Congress of the International Society of Haematology and 21st Congress of the international Society of blood transfusion1986; 390-390.-21st Congress of the International Society of Haematology and 21st Congress of the international Society of blood transfusion; AUG; Sidney. [Poster]

 

Mischke,M; Gisslinger,H; Scheithauer,W; Linkesch,W; Ludwig,H; Natural Killer (NK) cell activity in blood and bonemarrow of patients with multiple myeloma.
Proceedings of the 14th International Cancer Congress1986; 1170-1170.-14th International Cancer Congress; AUG 21-27,1986; Budapest. [Poster]

 

Müller,C; Zielinski,C; Linkesch,W; Ludwig,H; Sinzinger,H; Höfer,R; Use of 111-In-Oxin labelled human mononuclear cells for in vivo migration studies.
Nuclear Medicin1986; 103-103. [Poster]

 

STEFENELLI, T; RADASZKIEWICZ, T; LINKESCH, W THE THERAPY OF MYELOSARCOMAS
WIEN KLIN WOCHENSCHR. 1986; 98(17): 589-589.
Web of Science

 

BRICHTA, A; PREIS, P; LINKESCH, W; GISSLINGER, H; HOCKER, P LOW PERIPHERAL LEVELS OF CFU-GM IN PATIENTS WITH CML AND EXCESSIVE THROMBOCYTOSIS
BLUT. 1985; 51(3): 179-179.
Web of Science

 

Gissinger,G; Linkesch,W; Sinzinger,H; Preis,P, Brichta,A; Flener,R; Ludwig,H; Recombinant Interferon alfa-2c (rec-IFN alfa-2c) for treatment of Thrombocytosis in myeloproliferative disease.
Proceedings of the Ares Serono Symposia 1985; 90-90.-Ares Serono Symposia ; MAY; Rome,ITALY. [Poster]

 

GISSLINGER, H; PREIS, P; LINKESCH, W HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)
BLUT. 1985; 51(3): 210-210.
Web of Science

 

Gisslinger,H; Linkesch,W; Ludwig, H Therapie der Immunthrombopenie mit Danazol
Wissenschaftl Sitzung der ÖGIM; Nov 28, 1985; Wien, Austria. 1985. [Oral Communication]

 

KOVARIK, J; GRAF, H; WOLOSZCZUK, W; MEISINGER, V; LINKESCH, W; STUMMVOLL, HK; IRSCHIK, H DESFERAL TREATMENT OF HEMOSIDEROSIS SUBJECT TO TRANSFUSION IN PATIENTS WITH CHRONIC-HEMODIALYSIS THERAPY
ACTA MED AUST. 1985; 12(3-4): 72-72.
Web of Science

 

KUZMITS, R; AIGINGER, P; STEURER, G; LINKESCH, W; MULLER, MM DETERMINATION OF DRUG-INDUCED CYTO-TOXICITY IN ACUTE-LEUKEMIA USING FIREFLY BIOLUMINESCENCE INVITRO
BLUT. 1985; 51(3): 152-153.
Web of Science

 

KUZMITS, R; STEURER, G; LINKESCH, W; LUDWIG, H EFFECT OF CYTOSTATIC AGENTS ON GRANULOCYTE FUNCTION (PMA-INDUCED PRODUCTION OF SUPEROXIDES)
BLUT. 1985; 51(3): 182-182.
Web of Science

 

KUZMITS, R; STEURER, G; LINKESCH, W; LUDWIG, H; LEGENSTEIN, E INFLUENCE OF CYTOSTATIC AGENTS ON OXIDATIVE-METABOLISM (RESPIRATORY BURST) OF GRANULOCYTES
ACTA MED AUST. 1985; 12: 43-43.
Web of Science

 

LINKESCH, W CLINICAL-VALUE OF SERUM FERRITIN IN MALIGNANT DISEASES
ACTA MED AUST. 1985; 12: 48-49.
Web of Science

 

LINKESCH, W COMPLETELY IMPLANTABLE CATHETER SYSTEM - 1ST CLINICAL-EXPERIENCES
ACTA MED AUST. 1985; 12: 49-49.
Web of Science

 

LINKESCH, W; FLENER, R; GISSLINGER, H; LUDWIG, H; SINZINGER, H TREATMENT FOR EXCESSIVE THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH RECOMBINANT INTERFERON ALPHA-2C
BLUT. 1985; 51(3): 233-233.
Web of Science

 

LINKESCH, W; GISSLINGER, H; LUDWIG, H; SINZINGER, H; FLENER, R THERAPY OF EXCESSIVE THROMBOCYTOSES IN MYELOPROLIFERATIVE DISEASES WITH RECOMBINANT INTERFERON ALPHA-2C
ACTA MED AUST. 1985; 12: 48-48.
Web of Science

 

LINKESCH, W; GISSLINGER, H; RADASZKIEWICZ, T PHASE-III STUDY WITH AMSACRINE, CYTOSINE-ARABINOSIDE, THIOGUANINE (AAT) VS DAUNORUBICIN, CYT-ARA-C, THIOGUANINE (DAT) IN UNTREATED ACUTE NON-LYMPHOBLASTIC LEUKEMIA
BLUT. 1985; 51(3): 212-212.
Web of Science

 

LINKESCH, W; GISSLINGER, H; SINZINGER, H; LUDWIG, H INTERFERON ALPHA-2C IN THE THERAPY OF EXCESSIVE THROMBOCYTOSES IN MYELOPROLIFERATIVE DISEASES
ACTA MED AUST. 1985; 12(3-4): 88-&.
Web of Science

 

Linkesch,W; Serumferritin: Testsysteme - Referenzbereiche - klinische Praxis.
Wr klin Wschr1985; 97(12):539-539. [Poster]

 

Linkesch,W; Gisslinger,G; Radaszkiewicz,Th. Combination Therapy with Amasacrin(AMSA), Cytosine Arabinoside(ARA-C) and Thioguanine(TG) vs. Daunorubicin, ARA-Cand TG in untreated acute Non-Lymphoblastic Leukemia.
Proceedings of the 14th Internat Congress of Chemotherapy1985; 106-106.-14th Internat Congress of Chemotherapy; JUN; Kyoto, JAPAN. [Poster]

 

Linkesch,W; Gisslinger,H; Radaszkiewicz,Th; Amsacrin(AMSA) in Combination with Cytosine Arabinoside (ARA-C) and Thioguanine(TG) in untreated acute Non-Lymphoblastic Leukemia.
Proceedings of the 3rd European Conference on Clinical Onkology and Cancer Nursing1985; 129-129.-3rd European Conference on Clinical Onkology and Cancer Nursing; JUN; Stockholm,SWEDEN. [Poster]

 

LUDWIG, H; LINKESCH, W; KUZMITS, R; SCHEITHAUER, W; POTZI, P; KUHBOCK, J; FLENER, R RESULTS OF INTERFERON THERAPY IN MULTIPLE-MYELOMA
BLUT. 1985; 51(3): 233-233.
Web of Science

 

SINZINGER, H; LUDWIG, H; LINKESCH, W; GISSLINGER, H; FLENER, R INTERACTION BETWEEN INTERFERON AND THE PROSTAGLANDIN SYSTEM
ACTA MED AUST. 1985; 12: 73-73.
Web of Science

 

Sinzinger,H; Linkesch,W; Gisslinger,H; Flener,R; Ludwig,H; Ein neuer Prostaglandindefekt - Korrektur durch rekombinantes alpha-2-Interferon.
Wr klin Wschr1985; 97(14):610-610. [Keynote lecture]

 

BETTELHEIM, P; LUTZ, D; MAJDIC, O; NEUMANN, E; HAAS, O; LINKESCH, W; PAIETTA, E; LECHNER, K; KNAPP, W HETEROGENEITY IN CML BLAST CRISIS - IMMUNOLOGICAL PHENOTYPING IN 45 PATIENTS
BLUT. 1984; 49(3): 272-272.
Web of Science

 

Gisslinger, H; Linkesch, W Kombinationstherapie mit Amsacrin in der CML-Blastenkrise
42. Hämatologischer Diskussionsabend der ÖGHO; JAN 26, 1984; Wien, Austria. 1984. [Keynote lecture]

 

Huber,K; Scheithauer,W; Linkesch,W, Brunner,H; Ca 19-9, Serum Ferritin and CEA as Tumor Markers in Patients with Gastrointestinal Cancer.
Cancer Detection and Prevention1984; 7(5):516-516. [Poster]

 

KOVARIK, J; GRAF, H; IRSCHIK, H; WOLOSZCZUK, W; MEISINGER, V; LINKESCH, W; STUMMVOLL, HK; PINGGERA, WF TREATMENT OF IRON OVERLOAD BY DESFERRIOXAMINE (DFO) IN PATIENTS ON CHRONIC-HEMODIALYSIS (CHD) WITH TRANSFUSION DEPENDENT ANEMIA
KIDNEY INT. 1984; 26(4): 568-568.
Web of Science

 

Kovarik,J; Meisinger,V; Woloszczuk,W; Graf,H; Irschik,H; Linkesch,W; Stummvoll H.K; Pinggera,W.F; Treatment of hemodialysis(HD) related hemosiderosis with desferrioxamine(DFO) - kinetic study and longterm results.
Proceedings of the Bari Seminars in Nephrology1984; 55-55.-Bari Seminars in Nephrology; MAR 29-31, 1984; Bari, ITALY. [Poster]

 

KUZMITS, R; AIGINGER, P; MULLER, MM; STEURER, G; SCHWARZ, HP; LINKESCH, W; LUDWIG, H DETERMINATION OF DRUG-INDUCED CYTO-TOXICITY IN LEUKEMIC-CELLS USING BIOLUMINESCENCE
BLUT. 1984; 49(3): 275-276.
Web of Science

 

Kuzmits,R; Aiginer,P; Steurer G; Schwarz,H.P; Linkesch,W; Ludwig,H; Einfluss von Zytostatika auf den intrazellulären ATP-Gehalt von Leukämiezellen in vitro.
Acta Med Austr1984; 2: 21-21.-Jahrestagung der Österreichischen Gesellschaft für Medizin; SEP 17-19; Salzburg,Austria. [Poster]

 

Lang,H.R.M; Linkesch,W; Serumneopterin Evaluation of Leukemic Patients by Means of HPLS Applying in-line Deproteinization.
Cancer Detection and Prevention1984; 7(5):536-536. [Poster]

 

LINKESCH, W; KOVARIK, J; WOLOSZCZUK, W; MEISINGER, V; IRSCHIK, H LONG-TERM TREATMENT WITH DESFERRIOXAMINE (DFO) IN HEMODIALYSIS (HD)-RELATED HEMOSIDEROSIS
BLUT. 1984; 49(3): 245-245.
Web of Science

 

Linkesch,W; Wertigkeit von Serumferritin bei Leukämie.
Acta Med Austr1984; 2: 22-23.-Jahrestagung der Österreichischen Gesellschaft für Medizin; SEP 17-19; Salzburg,Austria. [Poster]

 

Linkesch,W; Lang,H.R.M; Determination of erythrocyte ferritin.
Proceedings of the Ferritins and Isoferritins as Biochemical Markers1984; 52-52.-Ferritins and Isoferritins as Biochemical Markers; MAY 17 1984; Milan,ITALY. [Poster]

 

Linkesch,W; Gisslinger,W; Radaszkiewicz,Th; Kombinationstherapie der akuten myeloischen Leukämie mit Amsacrin(AMSA) - erste Ergebnisse.
Acta Med Austr1984; 2: 23-23.-Jahrestagung der Österreichischen Gesellschaft für Medizin.; SEP 17-19; Salzburg,Austria. [Poster]

 

Linkesch,W; Schnack,Ch; Lang,H; Schernthaner,G; Studies on Ferritin in Diabetes Mellitus.
Proceedings of the 20th Congress of the International Society of Hematology1984; 309-309.-20th Congress of the International Society of Hematology; AUG 26-30, 1984; Buenos Aires, ARGENTINA. [Poster]

 

PREIS, P; ZIELINSKI, CC; LINKESCH, W; BETTELHEIM, P; PAVELKA, M; HAAS, O; POLLAK, C; AIGINGER, P PHENOTYPIC SHIFTS FROM ACUTE LYMPHOCYTIC-LEUKEMIA (T-ALL) TO EOSINOPHILIC LEUKEMIA IN A 14-YEAR-OLD PATIENT
BLUT. 1984; 49(3): 270-270.
Web of Science

 

Preis,P; Linkesch,W; Eibl,M.M; Zielinski,Ch; Shifts in ferritin and acute-phase proteins under plasmapheresis
Proceedings of the Ferritins and Isoferritins as Biochemical Markers1984; 49-49.-Ferritins and Isoferritins as Biochemical Markers; MAY 17 1984; Milan,ITALY. [Poster]

 

Stefanelli,Th; Linkesch,W; Radaszkiewicz,Th; Myelosarkom des Ovars.
Acta Med Austr1984; 2: 42-42.-Jahrestagung der Österreichischen Gesellschaft für Medizin.; SEP 17-19; Salzburg,Austria. [Poster]

 

BETTELHEIM, P; LUTZ, D; SCHMIDMEIER, W; PAIETTA, E; MAJDIC, O; LINKESCH, W; NEUMANN, E; HINTERBERGER, W; KRIEGER, O; LECHNER, K; KNAPP, W IMMUNOLOGICAL BLAST CELL CLASSIFICATION IN CASES OF DOUBLE LEUKEMIAS
ONKOLOGIE. 1983; 6(5): 217-217.
Web of Science

 

Graninger,W; Linkesch,W; Schernthaner,G; Long term-improvement of hemachromatosis by continous subcutaneous infusion of desferroxamin.
Proceedings of the 7th Meeting1983; 102-102.-ISH; SEP, 4-9, 1983; Barcelona,SPAIN. [Poster]

 

Linkesch, W. Möglichkeiten der ambulanten Chemotherapie maligner Lymphome
Gesellschaft der Ärzte in Wien; Juni, 11, 1983; Wien, AUSTRIA. 1983. [Keynote lecture]

 

LINKESCH, W; GRANINGER, W; SCHERNTHANER, G NEW ASPECTS IN THE TREATMENT OF HEMOCHROMATOSIS
BLUT. 1983; 47(3): 172-172.
Web of Science

 

Linkesch,W Serumferritin in acute and chronic leukemia.
Proceedings of the Int Symposium of Detection and Treatment of minimal residual disease in acute leukemia 1983; 22-22.-Int Symposium of Detection and Treatment of minimal residual disease in acute leukemia ; OCT 12-14, 1983; Rotterdam,THE NETHERLANDS. [Poster]

 

Linkesch,W; Legenstein,E; Müller,M; Heme Synthesis in malignant haematologic disease.
Proceedings of the 7th Meeting1983; 378-378.-ISH; SEP, 4-9, 1983; Barcelona,SPAIN. [Poster]

 

Lugner,T; Kokoschka,E; Linkesch,W; Serumferritin bei Patienten mit malignem Melanom.
Zentralblatt Haut-und Geschlechtskrankheiten.1983; 144: 1-1. [Poster]

 

Aiginger, P; Kolbe, H; Kuzmits, R; Kühböck, J; Linkesch, W; Spona, J; Ardalan, P. Prognostic Value of Alpha-1 Fetoprotein, Beta-human Choriongonadotropin and Ferritin in metastasized Testicular Cancer
Oncology Overview. 1982; 1/1982: 29-29.-American Association of Cancer Research; März,23 -25, 1981; Philadelphia, USA. [Keynote lecture]

 

Haber,P; Linkesch,W; Burghuber,O; Influence of an Endurance Training on red Blood Cell Count and Iron Metabolism.
Internat J of Sports Medicine1982; 33-33. [Poster]

 

Khoss, A; Linkesch, W Serumferritin als Kontrollparameter für den Eisenstoffwechsel bei congenitalen Vitien
Osterr. Gedellschaft für Kinderheikkunde; JAN 12, 1982; Wien, Austria. 1982. [Keynote lecture]

 

KHOSS, AE; LINKESCH, W IRON STATUS IN CHILDREN WITH CONGENITAL HEART-DISEASE
BLUT. 1982; 45(3): 209-209.
Web of Science

 

Kühböck,J; Pötzi,P; Aiginger,P; Linkesch,W; The treatment of renal cancer with Ifosfamide(IF) by Mono-and Combination Chemotherapy.
Proceedings of the 13th International Cancer Congress1982; 49-49.-13th international cancer congress; AUG 22-27,1982; Seattle,Wash,USA. [Poster]

 

Linkesch, W Klinische Bedeutung der Serumferritinbestimmung
Symposium Eisenstoffwechsel; APR 14-16 1982; Rostock, DDR. 1982. [Keynote lecture]

 

Linkesch, W; Aiginger, P. Tumor Associated Proteins
Oncology Overview. 1982; 1(1982: 26-26.-17. Nuklearmed. Symposium; März,23-25. 1980; Reinhardsbrunn, DDR. [Keynote lecture]

 

LINKESCH, W; GLOGAR, D; MAYR, H; MLCZOCH, J; KAINDL, F MYOGLOBIN VALUES IN PATIENTS WITH CONGESTIVE CARDIOMYOPATHY
ACTA MED AUST. 1982; 9: 123-123.
Web of Science

 

LINKESCH, W; HOCKER, P; STEINMANN, C IRON STATUS IN PLATELETPHERESIS AND LEUKAPHERESIS DONORS
BLUT. 1982; 45(3): 209-209.
Web of Science

 

LINKESCH, W; LUDWIG, H PRODUCTION OF FERRITIN IN LEUKEMIC-CELLS
BLUT. 1982; 45(3): 207-207.
Web of Science

 

Linkesch,W; Ludwig,H; Beta2-Mikroglobulin and Serum-Ferritin in Multiple Myeloma.
Proceedings of the 19th Congress1982; 254-254.-19th Congress of the Internat Soc of Haematology; SEP 19-22; Budapest,HUNGARY. [Poster]

 

Linkesch,W; Ludwig,H; Serum-Ferritin and beta2 Mikroglobulin in Multiple Myeloma.
Cancer Detection and Prevention1982; 5(2):259-259. [Poster]

 

Linkesch,W; Ludwig,H; Sinzinger,h; 6-Keto-prostaglandin F1Alpha in Leukemia, Lymphoma and Myeloproliferative Disorders.
Int Symp on Prostaglandines1982; [Poster]

 

Linkesch,W; Steinmann,Cl; Höcker,P; Iron Status in Cytaphereses Donors.
Proceedings of the 19th Congress1982; 307-307.-19th Congress of the Internat Soc of Haematology; SEP 19-22; Budapest,HUNGARY. [Poster]

 

Luger, T; Kokoschka, EM; Linkesch, W. Serum Ferritin in Patients with Malignant Melanoma
Oncology Overview. 1982; 1/1982: 32-32.-Deutsche Gesellschaft für Dermatologie; März,23 -25, 1980; Berlin. DEUTSCHLAND. [Keynote lecture]

 

WILLVONSEDER, R; HELLETZGRUBER, M; KOVARIK, J; ESCHBERGER, J; PLENK, H; SEIDL, G; LINKESCH, W; TILSCHER, H; WEISSEL, M CONTRIBUTION TO THE PATHO-PHYSIOLOGY OF CALCIUM-METABOLISM IN A CASE OF ALBERS-SCHONBERG OSTEOPETROSIS
ACTA MED AUST. 1982; 9(3): 10-10.
Web of Science

 

AIGINGER, P; KOLBE, H; KUZMITS, R; KUHBOCK, J; LINKESCH, W; SPONA, J; ARDALAN, B PROGNOSTIC VALUE OF ALPHA-1 FETOPROTEIN, BETA-HUMAN CHORIONGONADOTROPIN AND FERRITIN IN METASTASIZED TESTICULAR CANCER
PROC AMER ASS CANCER RES. 1981; 22(MAR): 347-347.
Web of Science

 

Aiginger, P;Kuzmits,R; Schwarz, HP; Linkesch, W; Ludwig, H; Pötzi, P; Kühböck, J Chemotherapie der Non-Hodgkin Lymphome im Alter
Konferenzband der 5. Internat. Arbeitstagung des LBI für Leukämieforschung und Hämatologie. 1981; 58-58.-5. Internationale Arbeitstagung des LBI für Leukämieforschung und Hämatologie; MÄRZ. 23-25, 1981; Wien, Austria. [Oral Communication]

 

GLOGAR, DH; MAYR, H; MLCZOCH, J; LINKESCH, W; PROBST, P; PACHINGER, O; ZASMETA, H; KAINDL, F CLINICAL PROGNOSIS IN CASES OF CONGESTIVE CARDIOMYOPATHY - PATIENT COLLECTIVE 1974-1980
ACTA MED AUST. 1981; 8: 170-170.
Web of Science

 

Linkesch, W Altersabhängige Veränderungen von Serumferritin, Serumeisen und Parametern des roten Blutbildes
Konferenzband der 5. Internat. Arbeitstagung des LBI für Leukämieforschung und Hämatologie. 1981; 7-7.-5. Internationale Arbeitstagung des LBI für Leukämieforschung und Hämatologie; MÄRZ. 23-25, 1981; Wien, Austria. [Keynote lecture]

 

Linkesch, W; Aiginger, P; Kühböck, J; Ludwig, H; Pötzi, P Besonderheiten der Polycythämia Vera im Alter
Konferenzband der 5. Internat. Arbeitstagung des LBI für Leukämieforschung und Hämatologie. 1981; 12-12.-5. Internationale Arbeitstagung des LBI für Leukämieforschung und Hämatologie; MÄRZ. 23-25, 1981; Wien, Austria. [Oral Communication]

 

LINKESCH, W; GLOGAR, D; MAYR, H; MLCZOCH, J; PACHINGER, O SERUM FERRITIN IN PATIENTS WITH CONGESTIVE CARDIOMYOPATHY
ACTA MED AUST. 1981; 8: 177-177.
Web of Science

 

LINKESCH, W; GLOGAR, D; MLCZOCH, J; MAYR, H; PACHINGER, O SERUM FERRITIN IN CONGESTIVE CARDIOMYOPATHY
Z KARDIOL. 1981; 70(8): 628-628.
Web of Science

 

LINKESCH, W; SINZINGER, H; SILBERBAUER, K THROMBOCYTE SURVIVAL-TIME IN MYELOPROLIFERATIVE DISEASES
ACTA MED AUST. 1981; 8: 194-195.
Web of Science

 

Linkesch,W; Silberbauer,K; Sinzinger,H; Platelet aggration and platelet sensivity to prostaglandines(PG12, PG D2).
Proceedings of the 6th Meeting1981; 309-309.-Int Society of Haematology; AUG 30-SEP 4,1981; München,GERMANY. [Poster]

 

Linkesch,W; Sinzinger,H; Silberbauer,K; Kyriazopoulos,G; In vivo platlet function in myeloproliferative diseases.
Proceedings of the 6th Meeting1981; 309-309.-Int Society of Haematology; AUG 30-SEP 4,1981; München,GERMANY. [Poster]

 

Ludwig, H; Pötzi, P;Aiginger, P; Linkesch, W; Kühböck, J Häufigkeit und Verlauf maligner Plasmazelldyskrasien in Abhängigkeit vom Lebensalter
Konferenzband der 5. Internat. Arbeitstagung des LBI für Leukämieforschung und Hämatologie. 1981; 44-44.-5. Internationale Arbeitstagung des LBI für Leukämieforschung und Hämatologie; MÄRZ. 23-25, 1981; Wien, Austria. [Oral Communication]

 

MAYR, H; GLOGAR, D; LINKESCH, W; MLCZOCH, J; PROBST, P IMMUNOGLOBULIN-E IN CONGESTIVE CARDIOMYOPATHY
Z KARDIOL. 1981; 70(8): 628-628.
Web of Science

 

Pötzi, P;Aiginger, P; Kühböck, J; Linkesch, W; Ludwig, H Zur Prognose der Lymphogranulomatose im fortgeschrittenen Lebensalter
Konferenzband der 5. Internat. Arbeitstagung des LBI für Leukämieforschung und Hämatologie. 1981; 51-51.-5. Internationale Arbeitstagung des LBI für Leukämieforschung und Hämatologie; MÄRZ. 23-25, 1981; Wien, Austria. [Oral Communication]

 

SILBERBAUER, K; LINKESCH, W; SINZINGER, H THROMBOCYTE FUNCTION DISTURBANCE IN PATIENTS WITH MYELOPROLIFERATIVE SYNDROME
ACTA MED AUST. 1981; 8: 200-200.
Web of Science

 

Aiginger, P; Kuzmits, R; Kühböck, J; Linkesch, W; Spona, J; Assessment of biochemical tests to screen for metastases in patients with testicular cancer.
Univ of Minnesota1980; 5-5.-Internat Symp on human testis cancer ; JUN 26-28,1980; Minnesota,MINNEAPOLIS. [Poster]

 

AIGINGER, P; KUZMITS, R; LINKESCH, W; KUHBOCK, J FUCOSYL-TRANSFERASE AND FERRITIN IN DIAGNOSIS OF RECURRENT MALIGNANT TESTICULAR-TUMORS
BLUT. 1980; 41(4): 305-305.
Web of Science

 

KOVARIK, J; WOLOSZCZUK, W; GRAF, H; LINKESCH, W; PAVELKA, R CALCIUM REGULATING HORMONES DURING PREGNANCY AND IN NEWBORN BABIES
J CLIN CHEM CLIN BIOCHEM. 1980; 18(10): 747-747.
Web of Science

 

Linkesch, W; Kühböck, J;Müller,M; Schwarz, HP Neue Aspekte des Eisenstoffwechsels bei der Polycythemia vera
37. Hämatologischer Diskussionsabend der ÖGHO; DEZ 18, 1980; Wien, Austria. 1980. [Keynote lecture]

 

LINKESCH, W; SCHWARZ, P; KUHBOCK, J HEME-SYNTHESIS AND IRON STATUS IN PATIENTS WITH POLYCYTHEMIA-VERA
BLUT. 1980; 41(4): 286-287.
Web of Science

 

Linkesch,W; Aiginger,P; Kühböck,J; Müller,M; Effects of Cytotoxic Chemotherapy on Heme Synthesizing Enzymes.
Proceedings of the 18th Congress1980; 224-224.-18th congress of the Internat Soc of Haematology; AUG 28-SEP 2, 1980; Montreal. [Poster]

 

Linkesch,W; Aiginger,P; Kuzmits,R; Weissel,M; Müller,M; Tumorassoziierte Proteine in der Serodiagnostik maligner Erkrankungen.
Acta Med Aust1980; 7: 169-169.-Österreichische Jahrestagung für Innere Medizin; SEP; Salzburg,AUSTRIA. [Poster]

 

Linkesch,W; Burghuber,O; Haber,P; Wolf,C; Müller,M; Hematiological and Iron Situation in Hard Trained Sportsmen.
Proceedings of the 18th Congress1980; 174-174.-18th congress of the Internat Soc of Haematology; AUG 28-SEP 2, 1980; Montreal. [Poster]

 

Linkesch,W; Polterauer,P; Combined Determination of Serum-alpha-1-Fetoprotein and Serumferritin in liver cancer.
Proceedings of the 18th Congress1980; 115-115.-18th congress of the Internat Soc of Haematology; AUG 28-SEP 2, 1980; Montreal. [Poster]

 

Woloszczuk,W; Kovarik,J; Linkesch,W; Pavelka,R; Graf,H, Calcitonin and parathroid hormone during pregnancy and in newborn babies.
Calcified Tissue Internat1980; 31: 142-142. [Poster]

 

Aiginger, P; Altmann, C; Kühlböck, J; Linkesch, W; Smolen, J; Steininger, H; Bergmann, H; Anemia in patients with testicular cancer.
Proceedings of the 5th meeting 1979; 2: 75-75.-Int Society of Haematology, European and African Division; AUG, 3-8, 1979; Hamburg,GERMANY. [Poster]

 

Küster,W; Kovarik,J; Seidl,G; Kotscher,E; Linkesch,W; Amighi,R; Willvonseder,R; Röntgenologische Skelettuntersuchungen und Knochendichtemessungen bei Altersosteoporose.
Acta Med Aust1979; 16: 5-5.-Österreichische Jahrestagung für Innere Medizin; SEP; Salzburg,AUSTRIA. [Poster]

 

LEGENSTEIN, E; LINKESCH, W; MULLER, MM DETERMINATION OF FERROCHETALASE IN WHOLE-BLOOD
J CLIN CHEM CLIN BIOCHEM. 1979; 17(3): 177-177.
Web of Science

 

LINKESCH, W CLINICAL SIGNIFICANCE OF SERUM FERRITIN
WIEN KLIN WOCHENSCHR. 1979; 91(10): 360-361.
Web of Science

 

LINKESCH, W; LEGENSTEIN, E; MULLER, MM DETERMINATION OF HEME-SYNTHESIZING ENZYMES IN WHOLE-BLOOD IN DIFFERENT TYPES OF ANEMIA
J CLIN CHEM CLIN BIOCHEM. 1979; 17(3): 178-178.
Web of Science

 

Linkesch,W; Aiginger,P;Kühlböck,J; Serumferritin levels in testicular cancer.
Proceedings of the 5th meeting 1979; 2: 82-82.-Int Society of Haematology, European and African Division; AUG, 3-8, 1979; Hamburg,GERMANY. [Poster]

 

Linkesch,W; Pavelka,R; Kofler E; Müller,M; Heme synthesis in pregnancy.
Proceedings of the 5th Meeting1979; 4: 18-18.-Int Society of Hematology, European and African Division; AUG 3-8,1997; Hamburg,GERMANY. [Poster]

 

Linkesch,W; Pietschmann,H; Wurm,E; Serumferritin levels in testicular cancer.
Proceedings of the 5th meeting 1979; 2: 82-82.-Int Society of Haematology, European and African Divisiion; AUG, 3-8, 1979; Hamburg,GERMANY. [Poster]

 

Haschke,F; Linkesch,W; Pavelka,R Serumferritin bei Frühgeborenen
Konferenzband1978; 113-113.-15. Jahrestagung der Österr. Ges. f. Kinderheilkunde; FEB 8-10, 1978; Wien. [Keynote lecture]

 

Kofler,R; Linkesch,W; Pavelka,R Serumferritin levels in gestosis and normal pregnancies
Proceedings1978; 26-26.-10th Internat. Meeting Organisation Gestosis; JUL 4-8, 1978; Cairo. [Keynote lecture]

 

Legenstein,E; Linkesch,W; Pinggera,WF; Müller,MM Heme synthetizing enzymes in uremic patients
8th Internat. Meeting on Clinical Enzymology; MAR 11-12, 1978; Venezia. 1978. [Keynote lecture]

 

LINKESCH, W; PAVELKA, R; KOFLER, E; HOFER, R SERUM FERRITIN IN NORMAL AND PATHOLOGICAL PREGNANCIES
BLUT. 1978; 37(3): 154-155.
Web of Science

 

Linkesch,W; Kornauth,W; Kühböck,J; Pötzi,P Estimation of bone marrow reserve with dexamethasone in cytotoxic chemotherapiy
Proceedings of the 17th ISH1978; 1: 943-943.-17th Congress of ISH and 15th Congress of ISBT; AUG 5.12, 1978; Paris. [Keynote lecture]

 

Linkesch,W; Legenstein,E; Stummvoll,HK; Wolf,A Heme synthetizing enzymes in patients on regular dialysis treatment
Proceedings of the 17th ISH1978; 1: 785-785.-!7th Congress of ISH and 15th Congress of ISBT; AUG 5.12, 1978; Paris. [Keynote lecture]

 

Linkesch,W: Müller, M: Stummvoll, HK; Wolf, A New aspects of regulation of heme synthesis in uremia
8 th Internat. Meeting of the Mediterranian Blood Club and Meeting of the Israeli Society of Haematology and Blood Transfusion; JAN 6-8, 1978; Herzelia. 1978. [Keynote lecture]

 

Linkesch,W; Scherak,M; Müller,M Hämsynthese bei anämischen Patienten mit chronischer Polyarthritis
Konferenzband1978; 8-8.-18. Tagung der Deutschen Gesellschaft für Rheumatologie; WAY 18-21. 1978; Wien. [Keynote lecture]

 

Linkesch,W; Scherak,O Serumferritin and the anemia of rheumatoid arthritis
Proceedings of the 15th ISH1978; 1: 182-182.-17th Congress of ISH and 15th Congress of ISBT; AUG 5.12, 1978; Paris. [Keynote lecture]

 

Linkesch,W; Scherak,O; Kolbe,H Serumferritin bei Patienten mit chronischer Polyarthritis
Konferenzband1978; 27-27.-18. Tagung der Deutschen Gesellschaft für Rheumatologie; MAY 18-21. 1978; Wien. [Keynote lecture]

 

Linkesch,W; Scherak,O; Müller,M Heme Synthesis in the anemia of rheumatoid arthritis
Proceedings of the 15th ISH1978; 1: 785-785.-17th Congress of ISH and 15th Confress of ISBT; AUG 5.12, 1978; Paris. [Keynote lecture]

 

Linkesch,W; Stummvoll,HK; Wolf,A Serumferritin and Iron Status in Patients on Maintenance Hemodialysis
Proceedings of the 15th EDTA1978; 338-338.-15th Congress of the EDTA; OCT 14-17, 1978; Istanbul. [Keynote lecture]

 

Linkesch,W; Stummvoll,HK; Wolf,A; Pinggera,W; Müller,M Uremic Toxins and Heme Synthesis in Uremia
Proceedings of the 15th EDTA1978; 294-294.-15th Congress of the EDTA; OCT 14-17, 1978; Istanbul. [Keynote lecture]

 

Linkesch,W; Wolf,A; Stummvoll,HK Serumferritin as a parameter of iron stores in chronic uremia
Proceedings of the 17th ISH1978; 1: 135-135.-17th Congress of ISH and 15th Congress of ISBT; AUG 5.12, 1978; Paris. [Keynote lecture]

 

Linkesch,W;Bergmann,H;Steinbach,K;Weissel,M Renale Hämosiderose und sideropenische Anämie nach Herzklappenersatz
Konferenzband der 84. Tagung der DGI. 1978; 104-104.-84. Tagung der Deutschen Gesellschaft für Innere Medizin; APR 2-6, 1978; Wiesbaden, Deutschland. [Oral Communication]

 

Niederbergwer, M; Linkesch, W; Glogar, D Quantitative Evaluation of the influence of Perhexiline in Angina Pectoris
Internat. Symposium on Perhexiline Maleat; SEP 18, 1978; Strasnourg, FRANCE. 1978. [Keynote lecture]

 

Linkesch, W: Bergmann,H; Steinbach,K; Höfer, R Sideropenic hemolytic anemia with normal iron excretion in prosthetic heart valves
Proceedings of the 4th Meeting of ISH-EAD1977; 516-516.-4 th Meeting of the ISH-EAD; AUG 16-22, 1977; Istanbul. [Keynote lecture]

 

LINKESCH, W; KORNAUTH, W; KUHBOCK, J; POTZI, P STIMULABILITY OF GRANULOPOIESIS AND CYTOSTATIC TOLERANCE
BLUT. 1977; 35(4): 353-353.
Web of Science

 

Linkesch, W; Bergmann, H; Steinbach, K; Höfer, R Ferrokinetik nach Herzklappenersatz
Z Kardiologie1976; Suppl(3):41-41.-Jahrestagung der Schweizer-Deutschen und Österr. Gesellschaften für Kardiologie; JUN 16-17, 1976; Vienna, Austria. [Keynote lecture]

 

Niederberger, M; Joskowicz, G; Linkesch, W Erweiterte Ischämiekriterien durch eine neuartige Darstellung der orthogonalen Ableitungen
Z Kardiologie1976; Suppl(3):96-96.-Jahrestagung der Schweiz,Deutschen und Österr. Gesellschaften für Kardiologie; JUN 16-17, 1976; Vienna, Austria. [Keynote lecture]

 

Niederberger, M; Linkesch, W; Glogar, D Zur quantitativen Beurteilung der Perhexiline bei Angina pectoris
Internat. Symposium on Perhexiline Maleate; May 2-3 , 1976; Vienna. 1976. [Keynote lecture]

 

KUHBOCK, J; LINKESCH, W; POTZI, P EFFECT OF SPLENECTOMY ON CYTOSTATIC TOLERANCE IN HODGKINS-DISEASE
BLUT. 1975; 31(3): 175-175.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum